Annotation Detail for MAPK1
Basic Information Top
| Gene Symbol: | MAPK1 ( ERK,ERK2,ERT1,MAPK2,P42MAPK,PRKM1,PRKM2,p38,p40,p41,p41mapk ) |
|---|---|
| Gene Full Name: | mitogen-activated protein kinase 1 |
| Band: | 22q11.22 |
| Quick Links | Entrez ID:5594; OMIM: 176948; Uniprot ID:MK01_HUMAN; ENSEMBL ID: ENSG00000100030; HGNC ID: 6871 |
| Relate to Another Database: | SFARIGene; denovo-db |
| Pathway ID | Pathway Name |
|---|---|
| PWY66-14 | MAP kinase cascade |
| Pathway ID | Pathway Name |
|---|---|
| hsa04914 | Progesterone-mediated oocyte maturation |
| hsa05160 | Hepatitis C |
| hsa04270 | Vascular smooth muscle contraction |
| hsa04912 | GnRH signaling pathway |
| hsa04910 | Insulin signaling pathway |
| hsa04916 | Melanogenesis |
| hsa04012 | ErbB signaling pathway |
| hsa04010 | MAPK signaling pathway |
| hsa04150 | mTOR signaling pathway |
| hsa04720 | Long-term potentiation |
| hsa04360 | Axon guidance |
| hsa04650 | Natural killer cell mediated cytotoxicity |
| hsa05142 | Chagas disease |
| hsa05140 | Leishmaniasis |
| hsa05145 | Toxoplasmosis |
| hsa04320 | Dorso-ventral axis formation |
| hsa04540 | Gap junction |
| hsa04620 | Toll-like receptor signaling pathway |
| hsa04621 | NOD-like receptor signaling pathway |
| hsa04730 | Long-term depression |
| hsa05010 | Alzheimer's disease |
| hsa05131 | Shigellosis |
| hsa05219 | Bladder cancer |
| hsa04722 | Neurotrophin signaling pathway |
| hsa04960 | Aldosterone-regulated sodium reabsorption |
| hsa04350 | TGF-beta signaling pathway |
| hsa05211 | Renal cell carcinoma |
| hsa05216 | Thyroid cancer |
| hsa04114 | Oocyte meiosis |
| hsa04520 | Adherens junction |
| hsa05223 | Non-small cell lung cancer |
| hsa05221 | Acute myeloid leukemia |
| hsa05220 | Chronic myeloid leukemia |
| hsa04810 | Regulation of actin cytoskeleton |
| hsa05218 | Melanoma |
| hsa05212 | Pancreatic cancer |
| hsa05213 | Endometrial cancer |
| hsa05210 | Colorectal cancer |
| hsa05214 | Glioma |
| hsa05215 | Prostate cancer |
| hsa04510 | Focal adhesion |
| hsa04062 | Chemokine signaling pathway |
| hsa05020 | Prion diseases |
| hsa04370 | VEGF signaling pathway |
| hsa05200 | Pathways in cancer |
| hsa04660 | T cell receptor signaling pathway |
| hsa04662 | B cell receptor signaling pathway |
| hsa04664 | Fc epsilon RI signaling pathway |
| hsa04666 | Fc gamma R-mediated phagocytosis |
| hsa04930 | Type II diabetes mellitus |
| Pathway ID | Pathway Name |
|---|---|
| Synaptic Transmission | |
| Signalling by NGF | |
| Axon guidance | |
| Hemostasis | |
| Signaling by EGFR | |
| Signaling by Insulin receptor | |
| Signaling by PDGF | |
| Opioid Signalling | |
| Signaling in Immune system |
| Pathway ID | Pathway Name |
|---|---|
| 200035 | S1P3 pathway |
| 200181 | S1P2 pathway |
| 200123 | BMP receptor signaling |
| 200182 | Trk receptor signaling mediated by the MAPK pathway |
| 200184 | Downstream signaling in naive CD8+ T cells |
| 200187 | Alpha-synuclein signaling |
| 200189 | FGF signaling pathway |
| 200188 | VEGFR3 signaling in lymphatic endothelium |
| 200032 | Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met) |
| 200003 | Fc-epsilon receptor I signaling in mast cells |
| 200004 | Endothelins |
| 200005 | BCR signaling pathway |
| 200006 | Signaling events mediated by PRL |
| 200009 | ErbB4 signaling events |
| 200128 | Neurotrophic factor-mediated Trk receptor signaling |
| 200134 | Syndecan-1-mediated signaling events |
| 200151 | VEGFR1 specific signals |
| 200015 | GMCSF-mediated signaling events |
| 200079 | Arf6 downstream pathway |
| 200088 | Ras signaling in the CD4+ TCR pathway |
| 200126 | ALK1 signaling events |
| 200080 | mTOR signaling pathway |
| 200081 | Class IB PI3K non-lipid kinase events |
| 200082 | IL2-mediated signaling events |
| 200145 | Nongenotropic Androgen signaling |
| 200066 | Angiopoietin receptor Tie2-mediated signaling |
| 200071 | S1P1 pathway |
| 200179 | Cellular roles of Anthrax toxin |
| 200072 | Regulation of Telomerase |
| 200074 | Netrin-mediated signaling |
| 200150 | CXCR3-mediated signaling events |
| 200164 | Syndecan-2-mediated signaling events |
| 200161 | Signaling events mediated by VEGFR1 and VEGFR2 |
| 200119 | ErbB2/ErbB3 signaling events |
| 200113 | ErbB1 downstream signaling |
| 200110 | IFN-gamma pathway |
| 200041 | EPHB forward signaling |
| 200042 | Osteopontin-mediated events |
| 200043 | S1P4 pathway |
| 200109 | Integrins in angiogenesis |
| 200100 | Ceramide signaling pathway |
| 200192 | Signaling events mediated by focal adhesion kinase |
| 200052 | Presenilin action in Notch and Wnt signaling |
| 200057 | CDC42 signaling events |
| 200056 | TRAIL signaling pathway |
| 200058 | Signaling events regulated by Ret tyrosine kinase |
| Pathway ID | Pathway Name |
|---|---|
| P00003 | Alzheimer disease-amyloid secretase pathway |
| P00035 | Interferon-gamma signaling pathway |
| P00053 | T cell activation |
| P00056 | VEGF signaling pathway |
| P00019 | Endothelin signaling pathway |
| P00018 | EGF receptor signaling pathway |
| P00005 | Angiogenesis |
| P00052 | TGF-beta signaling pathway |
| P00010 | B cell activation |
| P00049 | Parkinson disease |
| P00047 | PDGF signaling pathway |
| P00006 | Apoptosis signaling pathway |
| P00021 | FGF signaling pathway |
| P00032 | Insulin/IGF pathway-mitogen activated protein kinase kinase/MAP kinase cascade |
| P00036 | Interleukin signaling pathway |
| P00031 | Inflammation mediated by chemokine and cytokine signaling pathway |
| P04393 | Ras Pathway |
| Pathway ID | Pathway Name |
|---|---|
| 500179 | RSK activation |
| 500097 | L1CAM interactions |
| 500098 | Recycling pathway of L1 |
| 500177 | CREB phophorylation through the activation of Ras |
| 500086 | ERK2 activation |
| 500100 | Signal transduction by L1 |
| No data |
| No data |
| Desease Name |
|---|
| CHEMDEPENDENCY |
| alcohol consumption |
| No data |
| No data |
| Chemical ID | Chemical Name | Interaction | Interaction Action | Publication |
|---|---|---|---|---|
| C496879 | 103D5R | 103D5R results in decreased phosphorylation of MAPK1 protein | decreases phosphorylation | 15695405 |
| C025205 | 1,10-phenanthroline | 1,10-phenanthroline inhibits the reaction [Hydrogen Peroxide results in increased activity of MAPK1 protein] | decreases reaction|increases activity | 15328380 |
| C432747 | 1,1-dimethylbutyl-1-deoxy-Delta(9)-THC | 1,1-dimethylbutyl-1-deoxy-Delta(9)-THC results in increased phosphorylation of and results in increased activity of MAPK1 protein | increases activity|increases phosphorylation | 15821753 |
| C097949 | 1,25-dihydroxyvitamin D | 1,25-dihydroxyvitamin D results in increased phosphorylation of and results in increased activity of MAPK1 protein | increases activity|increases phosphorylation | 15331595 |
| C070379 | 1,2-bis(2-aminophenoxy)ethane N,N,N',N'-tetraacetic acid acetoxymethyl ester | [1,2-bis(2-aminophenoxy)ethane N,N,N',N'-tetraacetic acid acetoxymethyl ester co-treated with Genistein] inhibits the reaction [Thapsigargin promotes the reaction [Homocysteine results in increased phosphorylation of MAPK1 protein]] | affects cotreatment|decreases reaction|increases phosphorylation|increases reaction | 16251475 |
| C070379 | 1,2-bis(2-aminophenoxy)ethane N,N,N',N'-tetraacetic acid acetoxymethyl ester | 1,2-bis(2-aminophenoxy)ethane N,N,N',N'-tetraacetic acid acetoxymethyl ester inhibits the reaction [Homocysteine results in increased phosphorylation of MAPK1 protein] | decreases reaction|increases phosphorylation | 16251475 |
| C070379 | 1,2-bis(2-aminophenoxy)ethane N,N,N',N'-tetraacetic acid acetoxymethyl ester | 1,2-bis(2-aminophenoxy)ethane N,N,N',N'-tetraacetic acid acetoxymethyl ester inhibits the reaction [tributyltin results in increased phosphorylation of MAPK1 protein] | decreases reaction|increases phosphorylation | 11042092 |
| C070379 | 1,2-bis(2-aminophenoxy)ethane N,N,N',N'-tetraacetic acid acetoxymethyl ester | 1,2-bis(2-aminophenoxy)ethane N,N,N',N'-tetraacetic acid acetoxymethyl ester inhibits the reaction [Diethylstilbestrol results in increased phosphorylation of and results in increased activity of MAPK1 protein] | decreases reaction|increases activity|increases phosphorylation | 15072920 |
| C070379 | 1,2-bis(2-aminophenoxy)ethane N,N,N',N'-tetraacetic acid acetoxymethyl ester | 1,2-bis(2-aminophenoxy)ethane N,N,N',N'-tetraacetic acid acetoxymethyl ester inhibits the reaction [Estradiol results in increased phosphorylation of and results in increased activity of MAPK1 protein] | decreases reaction|increases activity|increases phosphorylation | 15072920 |
| C097240 | 15-deoxy-delta(12,14)-prostaglandin J2 | [15-deoxy-delta(12,14)-prostaglandin J2 co-treated with alitretinoin] results in decreased phosphorylation of MAPK1 protein | affects cotreatment|decreases phosphorylation | 16611854 |
| C060229 | 1-(6-((3-methoxyestra-1,3,5(10)-trien-17-yl)amino)hexyl)-1H-pyrrole-2,5-dione | 1-(6-((3-methoxyestra-1,3,5(10)-trien-17-yl)amino)hexyl)-1H-pyrrole-2,5-dione inhibits the reaction [Adenosine Triphosphate results in increased phosphorylation of MAPK1 protein] | decreases reaction|increases phosphorylation | 15034929 |
| C060229 | 1-(6-((3-methoxyestra-1,3,5(10)-trien-17-yl)amino)hexyl)-1H-pyrrole-2,5-dione | 1-(6-((3-methoxyestra-1,3,5(10)-trien-17-yl)amino)hexyl)-1H-pyrrole-2,5-dione inhibits the reaction [NTS protein results in increased phosphorylation of and results in increased activity of MAPK1 protein] | decreases reaction|increases activity|increases phosphorylation | 15177934 |
| C060229 | 1-(6-((3-methoxyestra-1,3,5(10)-trien-17-yl)amino)hexyl)-1H-pyrrole-2,5-dione | 1-(6-((3-methoxyestra-1,3,5(10)-trien-17-yl)amino)hexyl)-1H-pyrrole-2,5-dione inhibits the reaction [Estradiol results in increased activity of MAPK1 protein] | decreases reaction|increases activity | 16713447 |
| C112765 | 17-(allylamino)-17-demethoxygeldanamycin | 17-(allylamino)-17-demethoxygeldanamycin results in decreased phosphorylation of MAPK1 protein | decreases phosphorylation | 17157164 |
| C040168 | 19-oxo-11-deoxycorticosterone acetate | [19-oxo-11-deoxycorticosterone acetate co-treated with Potassium Chloride co-treated with Sodium Chloride] results in increased phosphorylation of MAPK1 protein | affects cotreatment|increases phosphorylation | 18823320 |
| C040168 | 19-oxo-11-deoxycorticosterone acetate | atrasentan inhibits the reaction [[19-oxo-11-deoxycorticosterone acetate co-treated with Potassium Chloride co-treated with Sodium Chloride] results in increased phosphorylation of MAPK1 protein] | affects cotreatment|decreases reaction|increases phosphorylation | 18823320 |
| C118559 | 1-bromopropane | 1-bromopropane results in increased phosphorylation of MAPK1 protein | increases phosphorylation | 18164123 |
| C118559 | 1-bromopropane | MAPK1 protein affects the reaction [1-bromopropane results in increased activity of [NFKB1 protein binds to RELA protein]] | affects binding|affects reaction|increases activity | 18164123 |
| C101670 | 2-(2-(4-(4-nitrobenzyloxy)phenyl)ethyl)isothiourea methanesulfonate | 2-(2-(4-(4-nitrobenzyloxy)phenyl)ethyl)isothiourea methanesulfonate inhibits the reaction [bufalin results in increased phosphorylation of MAPK1 protein] | decreases reaction|increases phosphorylation | 10712238 |
| C417207 | 2,2',4,6,6'-pentachlorobiphenyl | 2,2',4,6,6'-pentachlorobiphenyl results in increased phosphorylation of MAPK1 protein | increases phosphorylation | 16778083 |
| C417207 | 2,2',4,6,6'-pentachlorobiphenyl | PD168393 inhibits the reaction [2,2',4,6,6'-pentachlorobiphenyl results in increased phosphorylation of MAPK1 protein] | decreases reaction|increases phosphorylation | 16778083 |
| C417207 | 2,2',4,6,6'-pentachlorobiphenyl | SRC protein promotes the reaction [2,2',4,6,6'-pentachlorobiphenyl results in increased phosphorylation of MAPK1 protein] | increases phosphorylation|increases reaction | 16611624 |
| C417207 | 2,2',4,6,6'-pentachlorobiphenyl | WHI P154 inhibits the reaction [2,2',4,6,6'-pentachlorobiphenyl results in increased phosphorylation of MAPK1 protein] | decreases reaction|increases phosphorylation | 16778083 |
| C488185 | 2-(2-chloro-4-iodophenylamino)-N-cyclopropylmethoxy-3,4-difluoro-5-bromobenzamide | FGF1 protein inhibits the reaction [2-(2-chloro-4-iodophenylamino)-N-cyclopropylmethoxy-3,4-difluoro-5-bromobenzamide results in decreased phosphorylation of and results in decreased activity of MAPK1 protein] | decreases activity|decreases phosphorylation|decreases reaction | 15231676 |
| C488185 | 2-(2-chloro-4-iodophenylamino)-N-cyclopropylmethoxy-3,4-difluoro-5-bromobenzamide | NRG1 protein alternative form inhibits the reaction [2-(2-chloro-4-iodophenylamino)-N-cyclopropylmethoxy-3,4-difluoro-5-bromobenzamide results in decreased phosphorylation of and results in decreased activity of MAPK1 protein] | decreases activity|decreases phosphorylation|decreases reaction | 15231676 |
| C488185 | 2-(2-chloro-4-iodophenylamino)-N-cyclopropylmethoxy-3,4-difluoro-5-bromobenzamide | 2-(2-chloro-4-iodophenylamino)-N-cyclopropylmethoxy-3,4-difluoro-5-bromobenzamide results in decreased phosphorylation of MAPK1 protein | decreases phosphorylation | 16945347 |
| C120227 | 2-(2-chloro-4-iodophenylamino)-N-cyclopropylmethoxy-3,4-difluorobenzamide | 2-(2-chloro-4-iodophenylamino)-N-cyclopropylmethoxy-3,4-difluorobenzamide inhibits the reaction [Tetradecanoylphorbol Acetate results in increased activity of MAPK1 protein] | decreases reaction|increases activity | 11728381 |
| C120227 | 2-(2-chloro-4-iodophenylamino)-N-cyclopropylmethoxy-3,4-difluorobenzamide | 2-(2-chloro-4-iodophenylamino)-N-cyclopropylmethoxy-3,4-difluorobenzamide results in decreased expression of MAPK1 protein modified form | decreases expression | 19288272 |
| C120227 | 2-(2-chloro-4-iodophenylamino)-N-cyclopropylmethoxy-3,4-difluorobenzamide | 2-(2-chloro-4-iodophenylamino)-N-cyclopropylmethoxy-3,4-difluorobenzamide inhibits the reaction [Phenylephrine results in increased activity of MAPK1 protein] | decreases reaction|increases activity | 12513686 |
| C436083 | 2-(2-oxo-2-((3,7,11-trimethyl-2,6,10-dodecatrienyl)oxy)aminoethyl)phosphonic acid, (2,2-dimethyl-1-oxopropoxy)methyl ester sodium | 2-(2-oxo-2-((3,7,11-trimethyl-2,6,10-dodecatrienyl)oxy)aminoethyl)phosphonic acid, (2,2-dimethyl-1-oxopropoxy)methyl ester sodium inhibits the reaction [ammonium trichloro(dioxoethylene-O,O'-)tellurate results in increased phosphorylation of and results in increased activity of MAPK1 protein] | decreases reaction|increases activity|increases phosphorylation | 14656992 |
| C087667 | 2,3,3',4,4',5-hexachlorobiphenyl | 2,3,3',4,4',5-hexachlorobiphenyl binds to and results in increased activity of MAPK1 protein | affects binding|increases activity | 16293362 |
| C014024 | 2,4,5,2',4',5'-hexachlorobiphenyl | 2,4,5,2',4',5'-hexachlorobiphenyl binds to and results in increased activity of MAPK1 protein | affects binding|increases activity | 16293362 |
| C016403 | 2,4-dinitrotoluene | 2,4-dinitrotoluene affects the expression of MAPK1 mRNA | affects expression | 21346803 |
| C085911 | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Ethanol results in increased phosphorylation of MAPK1 protein] | decreases reaction|increases phosphorylation | 18295389 |
| C085911 | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Indomethacin results in increased phosphorylation of MAPK1 protein] | decreases reaction|increases phosphorylation | 17341418 |
| C085911 | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [NTS protein results in increased phosphorylation of and results in increased activity of MAPK1 protein] | decreases reaction|increases activity|increases phosphorylation | 15177934 |
| C085911 | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Paclitaxel results in increased activity of MAPK1 protein] | decreases reaction|increases activity | 16211241 |
| C085911 | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [PDGFB protein results in increased phosphorylation of and results in increased activity of MAPK1 protein] | decreases reaction|increases activity|increases phosphorylation | 15919668 |
| C085911 | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Thapsigargin results in increased phosphorylation of MAPK1 protein] | decreases reaction|increases phosphorylation | 15339911 |
| C085911 | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one results in decreased phosphorylation of MAPK1 protein | decreases phosphorylation | 14757120 |
| C085911 | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [IL4 protein results in increased phosphorylation of MAPK1 protein] | decreases reaction|increases phosphorylation | 16179367 |
| C085911 | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one results in decreased phosphorylation of MAPK1 protein | decreases phosphorylation | 16179367 |
| C085911 | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Endosulfan results in increased phosphorylation of MAPK1 protein] | decreases reaction|increases phosphorylation | 15531431 |
| C085911 | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Estradiol results in increased phosphorylation of and results in increased activity of MAPK1 protein] | decreases reaction|increases activity|increases phosphorylation | 15072920 |
| C085911 | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [ferrous sulfate results in increased phosphorylation of MAPK1 protein] | decreases reaction|increases phosphorylation | 17172471 |
| C085911 | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [IGF1 protein results in increased phosphorylation of MAPK1 protein] | decreases reaction|increases phosphorylation | 18388193 |
| C085911 | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Iron results in increased phosphorylation of MAPK1 protein] | decreases reaction|increases phosphorylation | 17172471 |
| C085911 | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [[FGF2 protein binds to and results in increased activity of FGFR4 protein] which results in increased phosphorylation of MAPK1 protein] | affects binding|decreases reaction|increases activity|increases phosphorylation | 11336793 |
| C023514 | 2,6-dinitrotoluene | 2,6-dinitrotoluene affects the expression of MAPK1 mRNA | affects expression | 21346803 |
| C046508 | 2,6-di-tert-butyl-4-hydroperoxy-4-methyl-2,5-cyclohexadienone | 2,6-di-tert-butyl-4-hydroperoxy-4-methyl-2,5-cyclohexadienone results in increased phosphorylation of and results in increased activity of MAPK1 protein | increases activity|increases phosphorylation | 8758915 |
| C046508 | 2,6-di-tert-butyl-4-hydroperoxy-4-methyl-2,5-cyclohexadienone | Suramin inhibits the reaction [2,6-di-tert-butyl-4-hydroperoxy-4-methyl-2,5-cyclohexadienone results in increased phosphorylation of and results in increased activity of MAPK1 protein] | decreases reaction|increases activity|increases phosphorylation | 8758915 |
| C109986 | 2-aminoethoxydiphenyl borate | 2-aminoethoxydiphenyl borate inhibits the reaction [Potassium results in increased phosphorylation of MAPK1 protein] | decreases reaction|increases phosphorylation | 11707519 |
| C031278 | 2-chloroethyl ethyl sulfide | 2-chloroethyl ethyl sulfide results in increased phosphorylation of MAPK1 protein | increases phosphorylation | 18675330 |
| C021296 | 2-ethoxyethanol | 2-ethoxyethanol results in increased expression of MAPK1 mRNA | increases expression | 19643169 |
| C054649 | 3-(2-hydroxy-4-(1,1-dimethylheptyl)phenyl)-4-(3-hydroxypropyl)cyclohexanol | 3-(2-hydroxy-4-(1,1-dimethylheptyl)phenyl)-4-(3-hydroxypropyl)cyclohexanol results in increased phosphorylation of and results in increased activity of MAPK1 protein | increases activity|increases phosphorylation | 12734338 |
| C054649 | 3-(2-hydroxy-4-(1,1-dimethylheptyl)phenyl)-4-(3-hydroxypropyl)cyclohexanol | CNR2 protein affects the reaction [3-(2-hydroxy-4-(1,1-dimethylheptyl)phenyl)-4-(3-hydroxypropyl)cyclohexanol results in increased phosphorylation of and results in increased activity of MAPK1 protein] | affects reaction|increases activity|increases phosphorylation | 12734338 |
| C079215 | 3,5-dihydroxyphenylglycine | 3,5-dihydroxyphenylglycine results in increased phosphorylation of MAPK1 protein | increases phosphorylation | 16600209 |
| C079215 | 3,5-dihydroxyphenylglycine | 6-methyl-2-(phenylethynyl)pyridine inhibits the reaction [N-(4-chloro-2-((1,3-dioxo-1,3-dihydro-2H-isoindol-2-yl)methyl)phenyl)-2-hydroxybenzamide promotes the reaction [3,5-dihydroxyphenylglycine results in increased phosphorylation of MAPK1 protein]] | decreases reaction|increases phosphorylation|increases reaction | 16600209 |
| C079215 | 3,5-dihydroxyphenylglycine | N-(4-chloro-2-((1,3-dioxo-1,3-dihydro-2H-isoindol-2-yl)methyl)phenyl)-2-hydroxybenzamide promotes the reaction [3,5-dihydroxyphenylglycine results in increased phosphorylation of MAPK1 protein] | increases phosphorylation|increases reaction | 16600209 |
| C079215 | 3,5-dihydroxyphenylglycine | 6-methyl-2-(phenylethynyl)pyridine inhibits the reaction [N-(4-chloro-2-((1,3-dioxo-1,3-dihydro-2H-isoindol-2-yl)methyl)phenyl)-2-hydroxybenzamide promotes the reaction [3,5-dihydroxyphenylglycine results in increased phosphorylation of MAPK1 protein]] | decreases reaction|increases phosphorylation|increases reaction | 16600209 |
| C082182 | 3,5-diiodothyropropionic acid | 3,5-diiodothyropropionic acid results in increased activity of MAPK1 protein | increases activity | 16384862 |
| C034534 | 3,7,11,15-tetramethyl-2,4,6,10,14-hexadecapentaenoic acid | 3,7,11,15-tetramethyl-2,4,6,10,14-hexadecapentaenoic acid results in decreased phosphorylation of MAPK1 protein | decreases phosphorylation | 21071580 |
| C091768 | 3'-methoxy-4'-nitroflavone | 3'-methoxy-4'-nitroflavone inhibits the reaction [Tetrachlorodibenzodioxin results in increased phosphorylation of and results in increased activity of MAPK1 protein] | decreases reaction|increases activity|increases phosphorylation | 12668121 |
| C088860 | 4-((3-bromophenyl)amino)-6,7-dimethoxyquinazoline | 4-((3-bromophenyl)amino)-6,7-dimethoxyquinazoline inhibits the reaction [betulinic acid results in increased phosphorylation of MAPK1 protein] | decreases reaction|increases phosphorylation | 16077934 |
| C088860 | 4-((3-bromophenyl)amino)-6,7-dimethoxyquinazoline | 4-((3-bromophenyl)amino)-6,7-dimethoxyquinazoline inhibits the reaction [NTS protein results in increased phosphorylation of and results in increased activity of MAPK1 protein] | decreases reaction|increases activity|increases phosphorylation | 15177934 |
| C088860 | 4-((3-bromophenyl)amino)-6,7-dimethoxyquinazoline | 4-((3-bromophenyl)amino)-6,7-dimethoxyquinazoline inhibits the reaction [Paclitaxel results in increased activity of MAPK1 protein] | decreases reaction|increases activity | 16211241 |
| C009505 | 4,4'-diaminodiphenylmethane | 4,4'-diaminodiphenylmethane results in increased expression of MAPK1 mRNA | increases expression | 18648102 |
| C090942 | 4-(4-fluorophenyl)-2-(4-hydroxyphenyl)-5-(4-pyridyl)imidazole | 4-(4-fluorophenyl)-2-(4-hydroxyphenyl)-5-(4-pyridyl)imidazole promotes the reaction [Cisplatin results in increased phosphorylation of and results in increased activity of MAPK1 protein] | increases activity|increases phosphorylation|increases reaction | 12663670 |
| C090942 | 4-(4-fluorophenyl)-2-(4-hydroxyphenyl)-5-(4-pyridyl)imidazole | 4-(4-fluorophenyl)-2-(4-hydroxyphenyl)-5-(4-pyridyl)imidazole promotes the reaction [sodium arsenite results in increased phosphorylation of MAPK1 protein] | increases phosphorylation|increases reaction | 12547826 |
| C119130 | 4-(5-(4-chlorophenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl)benzenesulfonamide | gefitinib promotes the reaction [[zoledronic acid co-treated with 4-(5-(4-chlorophenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl)benzenesulfonamide] results in decreased phosphorylation of MAPK1 protein] | affects cotreatment|decreases phosphorylation|increases reaction | 16322342 |
| C119130 | 4-(5-(4-chlorophenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl)benzenesulfonamide | [zoledronic acid co-treated with 4-(5-(4-chlorophenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl)benzenesulfonamide] results in decreased phosphorylation of MAPK1 protein | affects cotreatment|decreases phosphorylation | 16322342 |
| C108123 | 4-amino-5-(4-methylphenyl)-7-(tert-butyl)pyrazolo(3,4-d)pyrimidine | 4-amino-5-(4-methylphenyl)-7-(tert-butyl)pyrazolo(3,4-d)pyrimidine inhibits the reaction [arsenic trioxide results in increased phosphorylation of and results in increased activity of MAPK1 protein] | decreases reaction|increases activity|increases phosphorylation | 15961274 |
| C108123 | 4-amino-5-(4-methylphenyl)-7-(tert-butyl)pyrazolo(3,4-d)pyrimidine | 4-amino-5-(4-methylphenyl)-7-(tert-butyl)pyrazolo(3,4-d)pyrimidine results in decreased expression of MAPK1 protein modified form | decreases expression | 17492661 |
| C108123 | 4-amino-5-(4-methylphenyl)-7-(tert-butyl)pyrazolo(3,4-d)pyrimidine | 4-amino-5-(4-methylphenyl)-7-(tert-butyl)pyrazolo(3,4-d)pyrimidine inhibits the reaction [Anisomycin results in increased phosphorylation of MAPK1 protein] | decreases reaction|increases phosphorylation | 15772366 |
| C108123 | 4-amino-5-(4-methylphenyl)-7-(tert-butyl)pyrazolo(3,4-d)pyrimidine | 4-amino-5-(4-methylphenyl)-7-(tert-butyl)pyrazolo(3,4-d)pyrimidine inhibits the reaction [deoxynivalenol results in increased phosphorylation of MAPK1 protein] | decreases reaction|increases phosphorylation | 15772366 |
| C108123 | 4-amino-5-(4-methylphenyl)-7-(tert-butyl)pyrazolo(3,4-d)pyrimidine | 4-amino-5-(4-methylphenyl)-7-(tert-butyl)pyrazolo(3,4-d)pyrimidine inhibits the reaction [Emetine results in increased phosphorylation of MAPK1 protein] | decreases reaction|increases phosphorylation | 15772366 |
| C027576 | 4-hydroxy-2-nonenal | 4-hydroxy-2-nonenal results in decreased activity of MAPK1 protein | decreases activity | 17263905 |
| C027576 | 4-hydroxy-2-nonenal | 4-hydroxy-2-nonenal results in decreased phosphorylation of and results in decreased activity of MAPK1 protein | decreases activity|decreases phosphorylation | 16322078 |
| C027576 | 4-hydroxy-2-nonenal | resveratrol inhibits the reaction [4-hydroxy-2-nonenal results in decreased phosphorylation of and results in decreased activity of MAPK1 protein] | decreases activity|decreases phosphorylation|decreases reaction | 16322078 |
| C027576 | 4-hydroxy-2-nonenal | 4-hydroxy-2-nonenal results in decreased activity of MAPK1 protein | decreases activity | 16527993 |
| C014036 | 4-hydroxyestradiol-17 beta | 4-hydroxyestradiol-17 beta results in increased phosphorylation of and results in increased activity of MAPK1 protein | increases activity|increases phosphorylation | 15901486 |
| C014036 | 4-hydroxyestradiol-17 beta | U 0126 inhibits the reaction [4-hydroxyestradiol-17 beta results in increased phosphorylation of MAPK1 protein] | decreases reaction|increases phosphorylation | 15901486 |
| C030601 | 4-hydroxymercuribenzoate | 4-hydroxymercuribenzoate inhibits the reaction [Acetaldehyde results in increased phosphorylation of MAPK1 protein] | decreases reaction|increases phosphorylation | 11343241 |
| C016601 | 4-hydroxytamoxifen | 4-hydroxytamoxifen results in increased phosphorylation of MAPK1 protein | increases phosphorylation | 19549922 |
| C059539 | 4'-N-benzoylstaurosporine | 4'-N-benzoylstaurosporine affects the reaction [resveratrol results in increased phosphorylation of and results in increased activity of and results in increased localization of MAPK1 protein] | affects reaction|increases activity|increases localization|increases phosphorylation | 15542774 |
| C016583 | 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone | 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in increased phosphorylation of and results in increased activity of MAPK1 protein | increases activity|increases phosphorylation | 15603589 |
| C016583 | 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone | 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in increased phosphorylation of MAPK1 protein | increases phosphorylation | 16671086 18508827 |
| C016583 | 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone | Atenolol inhibits the reaction [4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in increased phosphorylation of MAPK1 protein] | decreases reaction|increases phosphorylation | 16671086 |
| C016583 | 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone | N-(2-(4-bromocinnamylamino)ethyl)-5-isoquinolinesulfonamide inhibits the reaction [4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in increased phosphorylation of MAPK1 protein] | decreases reaction|increases phosphorylation | 16671086 |
| C016583 | 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone | tyrphostin AG 1478 inhibits the reaction [4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in increased phosphorylation of MAPK1 protein] | decreases reaction|increases phosphorylation | 16671086 |
| C016583 | 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone | U 0126 inhibits the reaction [4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in increased phosphorylation of MAPK1 protein] | decreases reaction|increases phosphorylation | 18508827 |
| C016583 | 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone | [beta Carotene co-treated with alpha-Tocopherol co-treated with Ascorbic Acid] inhibits the reaction [4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in increased phosphorylation of MAPK1 protein] | affects cotreatment|decreases reaction|increases phosphorylation | 16401635 |
| C041594 | 4-nonylphenol | 4-nonylphenol results in increased phosphorylation of MAPK1 protein | increases phosphorylation | 19463694 17174995 |
| C080417 | 4-octylphenol | 4-octylphenol results in increased phosphorylation of MAPK1 protein | increases phosphorylation | 19463694 |
| C020922 | 4-O-methyl-12-O-tetradecanoylphorbol 13-acetate | 1-Butanol inhibits the reaction [[4-O-methyl-12-O-tetradecanoylphorbol 13-acetate co-treated with Ionomycin] results in increased phosphorylation of and results in increased activity of MAPK1 protein] | affects cotreatment|decreases reaction|increases activity|increases phosphorylation | 18423386 |
| C120076 | 5,11-diethyl-5,6,11,12-tetrahydrochrysene-2,8-diol | 5,11-diethyl-5,6,11,12-tetrahydrochrysene-2,8-diol inhibits the reaction [diarylpropionitrile results in increased phosphorylation of MAPK1 protein] | decreases reaction|increases phosphorylation | 15615701 |
| C120076 | 5,11-diethyl-5,6,11,12-tetrahydrochrysene-2,8-diol | 5,11-diethyl-5,6,11,12-tetrahydrochrysene-2,8-diol inhibits the reaction [propyl pyrazole triol results in increased phosphorylation of MAPK1 protein] | decreases reaction|increases phosphorylation | 15615701 |
| C503119 | 5-((4-methylphenyl)methylene)-2-(phenylamino)-4(5H)-thiazolone | 5-((4-methylphenyl)methylene)-2-(phenylamino)-4(5H)-thiazolone results in increased phosphorylation of MAPK1 protein | increases phosphorylation | 15831436 |
| C022909 | 5-methoxypsoralen | 5-methoxypsoralen results in increased phosphorylation of MAPK1 protein | increases phosphorylation | 17980360 |
| C106250 | 6,7-dimethoxy-3-phenylquinoxaline | [arsenic trioxide co-treated with 6,7-dimethoxy-3-phenylquinoxaline] results in decreased activity of MAPK1 protein | affects cotreatment|decreases activity | 17050201 |
| C106250 | 6,7-dimethoxy-3-phenylquinoxaline | [arsenic trioxide co-treated with 6,7-dimethoxy-3-phenylquinoxaline] results in decreased activity of MAPK1 protein | affects cotreatment|decreases activity | 17050201 |
| C010643 | 6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid | 6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid inhibits the reaction [Indomethacin results in increased phosphorylation of MAPK1 protein] | decreases reaction|increases phosphorylation | 17341418 |
| C010643 | 6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid | 6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid inhibits the reaction [Vitamin A results in increased phosphorylation of MAPK1 protein] | decreases reaction|increases phosphorylation | 16510265 |
| C121465 | 6-methyl-2-(phenylethynyl)pyridine | 6-methyl-2-(phenylethynyl)pyridine inhibits the reaction [N-(4-chloro-2-((1,3-dioxo-1,3-dihydro-2H-isoindol-2-yl)methyl)phenyl)-2-hydroxybenzamide promotes the reaction [3,5-dihydroxyphenylglycine results in increased phosphorylation of MAPK1 protein]] | decreases reaction|increases phosphorylation|increases reaction | 16600209 |
| C121465 | 6-methyl-2-(phenylethynyl)pyridine | 6-methyl-2-(phenylethynyl)pyridine inhibits the reaction [Dextroamphetamine results in increased phosphorylation of MAPK1 protein] | decreases reaction|increases phosphorylation | 12377393 |
| C121465 | 6-methyl-2-(phenylethynyl)pyridine | 6-methyl-2-(phenylethynyl)pyridine inhibits the reaction [N-(4-chloro-2-((1,3-dioxo-1,3-dihydro-2H-isoindol-2-yl)methyl)phenyl)-2-hydroxybenzamide promotes the reaction [3,5-dihydroxyphenylglycine results in increased phosphorylation of MAPK1 protein]] | decreases reaction|increases phosphorylation|increases reaction | 16600209 |
| C121707 | 7,3'-dihydroxy-4'-methoxyisoflavone | 7,3'-dihydroxy-4'-methoxyisoflavone results in increased phosphorylation of MAPK1 protein | increases phosphorylation | 20686605 |
| C003001 | 7-ketocholesterol | 7-ketocholesterol results in increased phosphorylation of MAPK1 protein | increases phosphorylation | 15955068 |
| C003001 | 7-ketocholesterol | U 0126 inhibits the reaction [7-ketocholesterol results in increased phosphorylation of MAPK1 protein] | decreases reaction|increases phosphorylation | 15955068 |
| C469552 | A 419259 | A 419259 inhibits the reaction [GRP protein results in increased phosphorylation of and results in increased activity of MAPK1 protein] | decreases reaction|increases activity|increases phosphorylation | 15342401 |
| D000079 | Acetaldehyde | 4-hydroxymercuribenzoate inhibits the reaction [Acetaldehyde results in increased phosphorylation of MAPK1 protein] | decreases reaction|increases phosphorylation | 11343241 |
| D000079 | Acetaldehyde | Acetaldehyde results in increased phosphorylation of and results in increased activity of MAPK1 protein | increases activity|increases phosphorylation | 17030193 14722101 |
| D000079 | Acetaldehyde | Acetaldehyde results in increased phosphorylation of MAPK1 protein | increases phosphorylation | 11343241 |
| D000079 | Acetaldehyde | calphostin C inhibits the reaction [Acetaldehyde results in increased phosphorylation of MAPK1 protein] | decreases reaction|increases phosphorylation | 11343241 |
| D000079 | Acetaldehyde | imatinib inhibits the reaction [Acetaldehyde results in increased phosphorylation of and results in increased activity of MAPK1 protein] | decreases reaction|increases activity|increases phosphorylation | 17030193 |
| D000079 | Acetaldehyde | MAPK1 protein promotes the reaction [Acetaldehyde results in increased expression of COL1A1 protein] | increases expression|increases reaction | 17030193 |
| D000079 | Acetaldehyde | PD 98059 inhibits the reaction [Acetaldehyde results in increased phosphorylation of and results in increased activity of MAPK1 protein] | decreases reaction|increases activity|increases phosphorylation | 17030193 |
| D000079 | Acetaldehyde | PD 98059 inhibits the reaction [Acetaldehyde results in increased phosphorylation of MAPK1 protein] | decreases reaction|increases phosphorylation | 11343241 |
| D000079 | Acetaldehyde | rottlerin inhibits the reaction [Acetaldehyde results in increased phosphorylation of and results in increased activity of MAPK1 protein] | decreases reaction|increases activity|increases phosphorylation | 17030193 |
| D000079 | Acetaldehyde | Acetaldehyde results in increased phosphorylation of and results in increased activity of MAPK1 protein | increases activity|increases phosphorylation | 12065697 |
| D000079 | Acetaldehyde | Acetylcysteine inhibits the reaction [Acetaldehyde results in increased phosphorylation of and results in increased activity of MAPK1 protein] | decreases reaction|increases activity|increases phosphorylation | 12065697 |
| D000082 | Acetaminophen | Acetaminophen inhibits the reaction [Doxorubicin results in increased phosphorylation of and results in increased activity of MAPK1 protein] | decreases reaction|increases activity|increases phosphorylation | 17526808 |
| D000082 | Acetaminophen | Acetaminophen results in decreased phosphorylation of and results in decreased activity of MAPK1 protein | decreases activity|decreases phosphorylation | 17526808 |
| D000082 | Acetaminophen | Acetaminophen affects the expression of MAPK1 mRNA | affects expression | 16701773 |
| D000082 | Acetaminophen | Acetaminophen results in increased phosphorylation of and results in increased activity of MAPK1 protein | increases activity|increases phosphorylation | 17088403 |
| D000082 | Acetaminophen | U 0126 inhibits the reaction [Acetaminophen results in increased phosphorylation of and results in increased activity of MAPK1 protein] | decreases reaction|increases activity|increases phosphorylation | 17088403 |
| D000082 | Acetaminophen | WAY 100635 inhibits the reaction [Acetaminophen results in increased phosphorylation of and results in increased activity of MAPK1 protein] | decreases reaction|increases activity|increases phosphorylation | 17088403 |
| D019342 | Acetic Acid | Acetic Acid promotes the reaction [Urethane results in increased activity of MAPK1 protein] | increases activity|increases reaction | 12951195 |
| D019342 | Acetic Acid | [Ether, Ethyl co-treated with Acetic Acid] results in increased activity of MAPK1 protein | affects cotreatment|increases activity | 12951195 |
| D019342 | Acetic Acid | [Ether, Ethyl co-treated with Acetic Acid] results in increased expression of MAPK1 protein modified form | affects cotreatment|increases expression | 15791581 |
| D019342 | Acetic Acid | [Ether, Ethyl co-treated with Acetic Acid] results in increased phosphorylation of and results in increased activity of MAPK1 protein | affects cotreatment|increases activity|increases phosphorylation | 15791581 |
| C038699 | acetophenone | [acetophenone co-treated with OLFR151 co-treated with GNAO1 co-treated with P2RY1] results in increased phosphorylation of MAPK1 protein | affects cotreatment|increases phosphorylation | 17472961 |
| C038699 | acetophenone | [acetophenone co-treated with OLFR151 co-treated with GNAO1 co-treated with P2RY2] results in increased phosphorylation of MAPK1 protein | affects cotreatment|increases phosphorylation | 17472961 |
| C038699 | acetophenone | Pertussis Toxin inhibits the reaction [[acetophenone co-treated with OLFR151 co-treated with P2RY1] results in increased phosphorylation of MAPK1 protein] | affects cotreatment|decreases reaction|increases phosphorylation | 17472961 |
| C038699 | acetophenone | Pertussis Toxin inhibits the reaction [[acetophenone co-treated with OLFR151 co-treated with P2RY2] results in increased phosphorylation of MAPK1 protein] | affects cotreatment|decreases reaction|increases phosphorylation | 17472961 |
| D000111 | Acetylcysteine | Acetylcysteine inhibits the reaction [Aldosterone results in increased phosphorylation of and results in increased activity of MAPK1 protein] | decreases reaction|increases activity|increases phosphorylation | 17596522 |
| D000111 | Acetylcysteine | Acetylcysteine inhibits the reaction [Curcumin results in increased phosphorylation of MAPK1 protein] | decreases reaction|increases phosphorylation | 18357586 |
| D000111 | Acetylcysteine | Acetylcysteine inhibits the reaction [Homocysteine results in increased phosphorylation of MAPK1 protein] | decreases reaction|increases phosphorylation | 16251475 |
| D000111 | Acetylcysteine | Acetylcysteine inhibits the reaction [Tetradecanoylphorbol Acetate results in increased phosphorylation of MAPK1 protein] | decreases reaction|increases phosphorylation | 15978937 |
| D000111 | Acetylcysteine | Acetylcysteine inhibits the reaction [Sodium Chloride results in increased phosphorylation of MAPK1 protein] | decreases reaction|increases phosphorylation | 16024921 |
| D000111 | Acetylcysteine | Acetylcysteine inhibits the reaction [Acetaldehyde results in increased phosphorylation of and results in increased activity of MAPK1 protein] | decreases reaction|increases activity|increases phosphorylation | 12065697 |
| D000111 | Acetylcysteine | Acetylcysteine inhibits the reaction [Ditiocarb results in increased phosphorylation of MAPK1 protein] | decreases reaction|increases phosphorylation | 16603213 |
| D000111 | Acetylcysteine | Acetylcysteine inhibits the reaction [EDN1 protein results in increased phosphorylation of MAPK1 protein] | decreases reaction|increases phosphorylation | 16261333 |
| D000111 | Acetylcysteine | Acetylcysteine inhibits the reaction [Ethanol results in increased phosphorylation of and results in increased activity of MAPK1 protein] | decreases reaction|increases activity|increases phosphorylation | 12065697 |
| D000111 | Acetylcysteine | Acetylcysteine inhibits the reaction [NGF protein results in increased phosphorylation of MAPK1 protein] | decreases reaction|increases phosphorylation | 16603213 |
| D000111 | Acetylcysteine | Acetylcysteine results in increased phosphorylation of MAPK1 protein | increases phosphorylation | 16983658 |
| D000111 | Acetylcysteine | U 0126 inhibits the reaction [Acetylcysteine results in increased phosphorylation of MAPK1 protein] | decreases reaction|increases phosphorylation | 16983658 |
| D000143 | Acids | Acids results in increased phosphorylation of MAPK1 protein | increases phosphorylation | 19074641 |
| D000143 | Acids | Curcumin inhibits the reaction [Acids results in increased phosphorylation of MAPK1 protein] | decreases reaction|increases phosphorylation | 19074641 |
| D017255 | Acitretin | Acitretin results in decreased expression of MAPK1 mRNA | decreases expression | 16610086 |
| D000171 | Acrolein | Acrolein results in increased phosphorylation of MAPK1 protein | increases phosphorylation | 17196791 |
| D000171 | Acrolein | Acrolein results in increased phosphorylation of MAPK1 protein | increases phosphorylation | 11504702 15531749 11329622 |
| D000171 | Acrolein | PD 98059 inhibits the reaction [Acrolein results in increased phosphorylation of MAPK1 protein] | decreases reaction|increases phosphorylation | 15531749 |
| D000171 | Acrolein | tyrphostin AG 1478 inhibits the reaction [Acrolein results in increased phosphorylation of MAPK1 protein] | decreases reaction|increases phosphorylation | 11329622 |
| D000171 | Acrolein | Acrolein results in increased phosphorylation of MAPK1 protein | increases phosphorylation | 12487375 |
| D000241 | Adenosine | Adenosine results in decreased phosphorylation of MAPK1 protein | decreases phosphorylation | 16611738 |
| D000241 | Adenosine | [Adenosine results in decreased phosphorylation of MAPK1 protein] which results in decreased expression of DPP4 mRNA | decreases expression|decreases phosphorylation | 16611738 |
| D000241 | Adenosine | [Adenosine results in decreased phosphorylation of MAPK1 protein] which results in decreased expression of DPP4 protein | decreases expression|decreases phosphorylation | 16611738 |
| D000244 | Adenosine Diphosphate | Adenosine Diphosphate results in increased phosphorylation of MAPK1 protein | increases phosphorylation | 15034929 |
| D000255 | Adenosine Triphosphate | 1-(6-((3-methoxyestra-1,3,5(10)-trien-17-yl)amino)hexyl)-1H-pyrrole-2,5-dione inhibits the reaction [Adenosine Triphosphate results in increased phosphorylation of MAPK1 protein] | decreases reaction|increases phosphorylation | 15034929 |
| D000255 | Adenosine Triphosphate | Adenosine Triphosphate results in increased phosphorylation of MAPK1 protein | increases phosphorylation | 15034929 |
| D000255 | Adenosine Triphosphate | Adenosine Triphosphate results in increased activity of MAPK1 protein | increases activity | 12513686 |
| D012436 | S-Adenosylmethionine | S-Adenosylmethionine inhibits the reaction [TGFB1 protein promotes the reaction [SP1 protein binds to MAPK1 protein modified form]] | affects binding|decreases reaction|increases reaction | 15983038 |
| D012436 | S-Adenosylmethionine | S-Adenosylmethionine inhibits the reaction [TGFB1 protein results in increased phosphorylation of MAPK1 protein] | decreases reaction|increases phosphorylation | 15983038 |
| C069028 | AG 127 | AG 127 inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of MAPK1 protein] | decreases reaction|increases phosphorylation | 16373689 |
| C412373 | AG 1879 | AG 1879 inhibits the reaction [daidzein results in increased phosphorylation of MAPK1 protein] | decreases reaction|increases phosphorylation | 16840783 |
| C412373 | AG 1879 | AG 1879 inhibits the reaction [equol results in increased phosphorylation of MAPK1 protein] | decreases reaction|increases phosphorylation | 16840783 |
| C412373 | AG 1879 | AG 1879 inhibits the reaction [Estradiol results in increased phosphorylation of MAPK1 protein] | decreases reaction|increases phosphorylation | 15930183 |
| C412373 | AG 1879 | AG 1879 inhibits the reaction [Genistein results in increased phosphorylation of MAPK1 protein] | decreases reaction|increases phosphorylation | 16840783 |
| C412373 | AG 1879 | AG 1879 inhibits the reaction [resveratrol results in increased phosphorylation of and results in increased activity of MAPK1 protein] | decreases reaction|increases activity|increases phosphorylation | 15615701 |
| C412373 | AG 1879 | AG 1879 inhibits the reaction [Tamoxifen results in increased phosphorylation of and results in increased activity of MAPK1 protein] | decreases reaction|increases activity|increases phosphorylation | 20211987 |
| C412373 | AG 1879 | AG 1879 inhibits the reaction [deoxynivalenol results in increased phosphorylation of MAPK1 protein] | decreases reaction|increases phosphorylation | 15772366 |
| C412373 | AG 1879 | AG 1879 inhibits the reaction [Lindane results in increased phosphorylation of MAPK1 protein] | decreases reaction|increases phosphorylation | 12807735 |
| C412373 | AG 1879 | AG 1879 inhibits the reaction [Diethylstilbestrol results in increased phosphorylation of and results in increased activity of MAPK1 protein] | decreases reaction|increases activity|increases phosphorylation | 15072920 |
| C412373 | AG 1879 | AG 1879 inhibits the reaction [Estradiol results in increased phosphorylation of and results in increased activity of MAPK1 protein] | decreases reaction|increases activity|increases phosphorylation | 15072920 |
| C412373 | AG 1879 | AG 1879 inhibits the reaction [Hydrogen Peroxide results in increased activity of MAPK1 protein] | decreases reaction|increases activity | 15574683 |
| C412373 | AG 1879 | AG 1879 inhibits the reaction [Potassium Chloride results in increased phosphorylation of MAPK1 protein] | decreases reaction|increases phosphorylation | 18004999 |
| C412373 | AG 1879 | AG 1879 inhibits the reaction [Testosterone results in increased phosphorylation of MAPK1 protein] | decreases reaction|increases phosphorylation | 17272394 |
| C412373 | AG 1879 | AG 1879 inhibits the reaction [Vitamin A results in increased phosphorylation of MAPK1 protein] | decreases reaction|increases phosphorylation | 16510265 |
| C412373 | AG 1879 | EGF protein inhibits the reaction [AG 1879 inhibits the reaction [Testosterone results in increased phosphorylation of MAPK1 protein]] | decreases reaction|increases phosphorylation | 17272394 |
| C031143 | AICA ribonucleotide | AICA ribonucleotide affects the reaction [IGF1 protein results in increased phosphorylation of MAPK1 protein] | affects reaction|increases phosphorylation | 17478073 |
| C031143 | AICA ribonucleotide | AICA ribonucleotide results in increased phosphorylation of MAPK1 protein | increases phosphorylation | 16837613 17478073 |
| C031143 | AICA ribonucleotide | FSHB protein affects the reaction [AICA ribonucleotide results in increased phosphorylation of MAPK1 protein] | affects reaction|increases phosphorylation | 16837613 |
| C031143 | AICA ribonucleotide | PRKAA1 gene mutant form inhibits the reaction [FSHB protein affects the reaction [AICA ribonucleotide results in increased phosphorylation of MAPK1 protein]] | affects reaction|decreases reaction|increases phosphorylation | 16837613 |
| C031143 | AICA ribonucleotide | PRKAA2 protein promotes the reaction [AICA ribonucleotide affects the reaction [IGF1 protein results in increased phosphorylation of MAPK1 protein]] | affects reaction|increases phosphorylation|increases reaction | 17478073 |
| C031143 | AICA ribonucleotide | AICA ribonucleotide inhibits the reaction [[IGF1 protein co-treated with FSHB protein] results in increased phosphorylation of MAPK1 protein] | affects cotreatment|decreases reaction|increases phosphorylation | 16020477 |
| C031143 | AICA ribonucleotide | AICA ribonucleotide inhibits the reaction [IGF1 protein results in increased phosphorylation of MAPK1 protein] | decreases reaction|increases phosphorylation | 16020477 |
| C031143 | AICA ribonucleotide | AICA ribonucleotide results in decreased phosphorylation of MAPK1 protein | decreases phosphorylation | 16020477 |
| D020875 | Enkephalin, Ala(2)-MePhe(4)-Gly(5)- | connective tissue-activating peptide inhibits the reaction [Enkephalin, Ala(2)-MePhe(4)-Gly(5)- results in increased phosphorylation of MAPK1 protein] | decreases reaction|increases phosphorylation | 16954126 |
| D020875 | Enkephalin, Ala(2)-MePhe(4)-Gly(5)- | Enkephalin, Ala(2)-MePhe(4)-Gly(5)- results in increased phosphorylation of MAPK1 protein | increases phosphorylation | 16954126 |
| D000420 | Albuterol | [Albuterol binds to and results in increased activity of ADRB2 protein] which results in increased phosphorylation of and results in increased activity of MAPK1 protein | affects binding|increases activity|increases phosphorylation | 16980553 |
| D000450 | Aldosterone | Acetylcysteine inhibits the reaction [Aldosterone results in increased phosphorylation of and results in increased activity of MAPK1 protein] | decreases reaction|increases activity|increases phosphorylation | 17596522 |
| D000450 | Aldosterone | Aldosterone results in increased phosphorylation of and results in increased activity of MAPK1 protein | increases activity|increases phosphorylation | 17596522 |
| D000450 | Aldosterone | eplerenone inhibits the reaction [Aldosterone results in increased phosphorylation of and results in increased activity of MAPK1 protein] | decreases reaction|increases activity|increases phosphorylation | 17596522 |
| D000450 | Aldosterone | Rotenone inhibits the reaction [Aldosterone results in increased phosphorylation of and results in increased activity of MAPK1 protein] | decreases reaction|increases activity|increases phosphorylation | 17596522 |
| C103303 | alitretinoin | [15-deoxy-delta(12,14)-prostaglandin J2 co-treated with alitretinoin] results in decreased phosphorylation of MAPK1 protein | affects cotreatment|decreases phosphorylation | 16611854 |
| C103303 | alitretinoin | alitretinoin results in decreased phosphorylation of and results in decreased activity of MAPK1 protein | decreases activity|decreases phosphorylation | 16043492 |
| C095512 | alpha-cyano-(3,4-dihydroxy)-N-benzylcinnamide | alpha-cyano-(3,4-dihydroxy)-N-benzylcinnamide promotes the reaction [sodium arsenite results in increased phosphorylation of MAPK1 protein] | increases phosphorylation|increases reaction | 20008137 |
| D013196 | Dihydrotestosterone | AR protein promotes the reaction [Dihydrotestosterone results in increased phosphorylation of and results in increased activity of MAPK1 protein] | increases activity|increases phosphorylation|increases reaction | 15466214 |
| D013196 | Dihydrotestosterone | bicalutamide inhibits the reaction [Dihydrotestosterone results in increased phosphorylation of and results in increased activity of MAPK1 protein] | decreases reaction|increases activity|increases phosphorylation | 15466214 |
| D013196 | Dihydrotestosterone | [Dihydrotestosterone results in increased activity of AR protein mutant form] which results in increased phosphorylation of MAPK1 protein | increases activity|increases phosphorylation | 18819937 |
| D013196 | Dihydrotestosterone | Dihydrotestosterone results in increased phosphorylation of and results in increased activity of MAPK1 protein | increases activity|increases phosphorylation | 15466214 |
| D013196 | Dihydrotestosterone | PD 98059 inhibits the reaction [Dihydrotestosterone results in increased phosphorylation of and results in increased activity of MAPK1 protein] | decreases reaction|increases activity|increases phosphorylation | 15466214 |
| C040534 | alpha-hexachlorocyclohexane | alpha-hexachlorocyclohexane affects the expression of MAPK1 mRNA | affects expression | 16940010 |
| C040534 | alpha-hexachlorocyclohexane | alpha-hexachlorocyclohexane results in decreased expression of MAPK1 mRNA | decreases expression | 16940010 |
| C040534 | alpha-hexachlorocyclohexane | alpha-hexachlorocyclohexane results in increased expression of MAPK1 mRNA | increases expression | 16940010 |
| C011512 | alpha-naphthoflavone | alpha-naphthoflavone inhibits the reaction [[Tetrachlorodibenzodioxin co-treated with Oxygen deficiency] results in increased phosphorylation of MAPK1 protein] | affects cotreatment|decreases reaction|increases phosphorylation | 19578757 |
| D024502 | alpha-Tocopherol | [beta Carotene co-treated with alpha-Tocopherol co-treated with Ascorbic Acid] inhibits the reaction [4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in increased phosphorylation of MAPK1 protein] | affects cotreatment|decreases reaction|increases phosphorylation | 16401635 |
| D000584 | Amiloride | Amiloride inhibits the reaction [IL1B protein results in increased phosphorylation of MAPK1 protein] | decreases reaction|increases phosphorylation | 12065299 |
| D015119 | 6-Aminocaproic Acid | 6-Aminocaproic Acid inhibits the reaction [PLG protein results in increased phosphorylation of MAPK1 protein] | decreases reaction|increases phosphorylation | 17482686 |
| D006710 | Homocysteine | [1,2-bis(2-aminophenoxy)ethane N,N,N',N'-tetraacetic acid acetoxymethyl ester co-treated with Genistein] inhibits the reaction [Thapsigargin promotes the reaction [Homocysteine results in increased phosphorylation of MAPK1 protein]] | affects cotreatment|decreases reaction|increases phosphorylation|increases reaction | 16251475 |
| D006710 | Homocysteine | 1,2-bis(2-aminophenoxy)ethane N,N,N',N'-tetraacetic acid acetoxymethyl ester inhibits the reaction [Homocysteine results in increased phosphorylation of MAPK1 protein] | decreases reaction|increases phosphorylation | 16251475 |
| D006710 | Homocysteine | Acetylcysteine inhibits the reaction [Homocysteine results in increased phosphorylation of MAPK1 protein] | decreases reaction|increases phosphorylation | 16251475 |
| D006710 | Homocysteine | Folic Acid inhibits the reaction [Homocysteine results in increased phosphorylation of MAPK1 protein] | decreases reaction|increases phosphorylation | 16251475 |
| D006710 | Homocysteine | Genistein inhibits the reaction [Homocysteine results in increased phosphorylation of MAPK1 protein] | decreases reaction|increases phosphorylation | 16251475 |
| D006710 | Homocysteine | Genistein inhibits the reaction [Thapsigargin promotes the reaction [Homocysteine results in increased phosphorylation of MAPK1 protein]] | decreases reaction|increases phosphorylation|increases reaction | 16251475 |
| D006710 | Homocysteine | Go 6976 inhibits the reaction [Homocysteine results in increased phosphorylation of MAPK1 protein] | decreases reaction|increases phosphorylation | 16251475 |
| D006710 | Homocysteine | Homocysteine results in increased phosphorylation of MAPK1 protein | increases phosphorylation | 16251475 |
| D006710 | Homocysteine | PD 98059 inhibits the reaction [Homocysteine results in increased phosphorylation of MAPK1 protein] | decreases reaction|increases phosphorylation | 16251475 |
| D006710 | Homocysteine | Pertussis Toxin inhibits the reaction [Homocysteine results in increased phosphorylation of MAPK1 protein] | decreases reaction|increases phosphorylation | 16251475 |
| D006710 | Homocysteine | Phorbol 12,13-Dibutyrate inhibits the reaction [Homocysteine results in increased phosphorylation of MAPK1 protein] | decreases reaction|increases phosphorylation | 16251475 |
| D006710 | Homocysteine | Phorbol 12,13-Dibutyrate promotes the reaction [Homocysteine results in increased phosphorylation of MAPK1 protein] | increases phosphorylation|increases reaction | 16251475 |
| D006710 | Homocysteine | Staurosporine inhibits the reaction [Homocysteine results in increased phosphorylation of MAPK1 protein] | decreases reaction|increases phosphorylation | 16251475 |
| D006710 | Homocysteine | Tetradecanoylphorbol Acetate promotes the reaction [Homocysteine results in increased phosphorylation of MAPK1 protein] | increases phosphorylation|increases reaction | 16251475 |
| D006710 | Homocysteine | Thapsigargin promotes the reaction [Homocysteine results in increased phosphorylation of MAPK1 protein] | increases phosphorylation|increases reaction | 16251475 |
| D006710 | Homocysteine | U 0126 inhibits the reaction [Homocysteine results in increased phosphorylation of MAPK1 protein] | decreases reaction|increases phosphorylation | 16251475 |
| D000499 | Allylamine | Allylamine results in increased activity of MAPK1 protein | increases activity | 15048878 |
| D000643 | Ammonium Chloride | Ammonium Chloride affects the expression of MAPK1 mRNA | affects expression | 16483693 |
| C054105 | ammonium trichloro(dioxoethylene-O,O'-)tellurate | 2-(2-oxo-2-((3,7,11-trimethyl-2,6,10-dodecatrienyl)oxy)aminoethyl)phosphonic acid, (2,2-dimethyl-1-oxopropoxy)methyl ester sodium inhibits the reaction [ammonium trichloro(dioxoethylene-O,O'-)tellurate results in increased phosphorylation of and results in increased activity of MAPK1 protein] | decreases reaction|increases activity|increases phosphorylation | 14656992 |
| C054105 | ammonium trichloro(dioxoethylene-O,O'-)tellurate | ammonium trichloro(dioxoethylene-O,O'-)tellurate results in increased phosphorylation of and results in increased activity of MAPK1 protein | increases activity|increases phosphorylation | 14656992 |
| C032473 | amosulalol | amosulalol affects the activity of MAPK1 protein | affects activity | 11693273 |
| D003913 | Dextroamphetamine | 6-methyl-2-(phenylethynyl)pyridine inhibits the reaction [Dextroamphetamine results in increased phosphorylation of MAPK1 protein] | decreases reaction|increases phosphorylation | 12377393 |
| D003913 | Dextroamphetamine | Dextroamphetamine results in increased phosphorylation of MAPK1 protein | increases phosphorylation | 16459022 12377393 |
| D003913 | Dextroamphetamine | N-phenyl-7-(hydroxyimino)cyclopropa(b)chromen-1a-carboxamide inhibits the reaction [Dextroamphetamine results in increased phosphorylation of MAPK1 protein] | decreases reaction|increases phosphorylation | 12377393 |
| D003913 | Dextroamphetamine | U 0126 inhibits the reaction [Dextroamphetamine results in increased phosphorylation of MAPK1 protein] | decreases reaction|increases phosphorylation | 16459022 |
| D000661 | Amphetamine | Amphetamine results in increased phosphorylation of MAPK1 protein | increases phosphorylation | 15329393 |
| D000661 | Amphetamine | Diltiazem affects the reaction [Amphetamine results in increased phosphorylation of MAPK1 protein] | affects reaction|increases phosphorylation | 15329393 |
| C023650 | aniline | aniline results in increased phosphorylation of MAPK1 protein | increases phosphorylation | 18420242 16169568 |
| D000841 | Anisomycin | Anisomycin results in increased phosphorylation of MAPK1 protein | increases phosphorylation | 12660819 |
| D000841 | Anisomycin | PD 98059 inhibits the reaction [Anisomycin results in increased phosphorylation of MAPK1 protein] | decreases reaction|increases phosphorylation | 12660819 |
| D000841 | Anisomycin | 4-amino-5-(4-methylphenyl)-7-(tert-butyl)pyrazolo(3,4-d)pyrimidine inhibits the reaction [Anisomycin results in increased phosphorylation of MAPK1 protein] | decreases reaction|increases phosphorylation | 15772366 |
| D000841 | Anisomycin | Anisomycin results in increased phosphorylation of MAPK1 protein | increases phosphorylation | 15772366 |
| D047310 | Apigenin | Apigenin inhibits the reaction [TNF protein results in increased activity of MAPK1 protein] | decreases reaction|increases activity | 15322261 |
| D016718 | Arachidonic Acid | MAPK1 protein affects the abundance of Arachidonic Acid | affects abundance | 16216387 |
| C119325 | arachidonyl-2-chloroethylamide | arachidonyl-2-chloroethylamide results in increased phosphorylation of and results in increased activity of MAPK1 protein | increases activity|increases phosphorylation | 12734338 |
| C119325 | arachidonyl-2-chloroethylamide | CNR1 protein affects the reaction [arachidonyl-2-chloroethylamide results in increased phosphorylation of and results in increased activity of MAPK1 protein] | affects reaction|increases activity|increases phosphorylation | 12734338 |
| C081565 | arachidonyltrifluoromethane | arachidonyltrifluoromethane inhibits the reaction [NRG1 protein alternative form results in increased phosphorylation of and results in increased activity of MAPK1 protein] | decreases reaction|increases activity|increases phosphorylation | 15231676 |
| C047981 | arginyl-glycyl-aspartic acid | arginyl-glycyl-aspartic acid inhibits the reaction [resveratrol results in increased phosphorylation of MAPK1 protein] | decreases reaction|increases phosphorylation | 16790523 |
| C047981 | arginyl-glycyl-aspartic acid | arginyl-glycyl-aspartic acid inhibits the reaction [resveratrol results in increased phosphorylation of MAPK1 protein] | decreases reaction|increases phosphorylation | 17984113 |
| C061640 | arjunolic acid | arjunolic acid inhibits the reaction [Streptozocin results in increased phosphorylation of MAPK1 protein] | decreases reaction|increases phosphorylation | 19682444 |
| D001149 | Arsenates | [Arsenates co-treated with chromium hexavalent ion] results in increased phosphorylation of MAPK1 protein | affects cotreatment|increases phosphorylation | 19895865 |
| D001151 | Arsenic | Arsenic results in increased phosphorylation of and results in increased activity of MAPK1 protein | increases activity|increases phosphorylation | 14633691 |
| C006632 | arsenic trioxide | 4-amino-5-(4-methylphenyl)-7-(tert-butyl)pyrazolo(3,4-d)pyrimidine inhibits the reaction [arsenic trioxide results in increased phosphorylation of and results in increased activity of MAPK1 protein] | decreases reaction|increases activity|increases phosphorylation | 15961274 |
| C006632 | arsenic trioxide | ARL6IP5 protein promotes the reaction [arsenic trioxide results in increased phosphorylation of and results in increased activity of MAPK1 protein] | increases activity|increases phosphorylation|increases reaction | 18387645 |
| C006632 | arsenic trioxide | arsenic trioxide affects the expression of MAPK1 mRNA | affects expression | 20458559 |
| C006632 | arsenic trioxide | [arsenic trioxide co-treated with 6,7-dimethoxy-3-phenylquinoxaline] results in decreased activity of MAPK1 protein | affects cotreatment|decreases activity | 17050201 |
| C006632 | arsenic trioxide | arsenic trioxide promotes the reaction [MAPK1 protein promotes the reaction [FOS protein binds to CDKN1A promoter]] | affects binding|increases reaction | 18822310 |
| C006632 | arsenic trioxide | arsenic trioxide results in increased expression of MAPK1 mRNA | increases expression | 17258074 |
| C006632 | arsenic trioxide | arsenic trioxide results in increased phosphorylation of and results in increased activity of MAPK1 protein | increases activity|increases phosphorylation | 18822310 18387645 18299328 15961274 16328441 |
| C006632 | arsenic trioxide | arsenic trioxide results in increased phosphorylation of MAPK1 protein | increases phosphorylation | 19088370 |
| C006632 | arsenic trioxide | [IL24 protein co-treated with arsenic trioxide] results in increased phosphorylation of MAPK1 protein | affects cotreatment|increases phosphorylation | 15580305 |
| C006632 | arsenic trioxide | PD 98059 inhibits the reaction [arsenic trioxide results in increased phosphorylation of MAPK1 protein] | decreases reaction|increases phosphorylation | 16328441 |
| C006632 | arsenic trioxide | U 0126 inhibits the reaction [arsenic trioxide results in increased phosphorylation of and results in increased activity of MAPK1 protein] | decreases reaction|increases activity|increases phosphorylation | 18299328 |
| C006632 | arsenic trioxide | U 0126 inhibits the reaction [arsenic trioxide results in increased phosphorylation of MAPK1 protein] | decreases reaction|increases phosphorylation | 19088370 |
| C006632 | arsenic trioxide | [arsenic trioxide co-treated with 6,7-dimethoxy-3-phenylquinoxaline] results in decreased activity of MAPK1 protein | affects cotreatment|decreases activity | 17050201 |
| C006632 | arsenic trioxide | arsenic trioxide results in increased phosphorylation of MAPK1 protein | increases phosphorylation | 15688020 |
| C015001 | arsenite | arsenite results in increased phosphorylation of and results in increased activity of MAPK1 protein | increases activity|increases phosphorylation | 16008523 |
| C015001 | arsenite | arsenite results in increased phosphorylation of MAPK1 protein | increases phosphorylation | 15037631 |
| C015001 | arsenite | PD 98059 inhibits the reaction [arsenite results in increased phosphorylation of and results in increased activity of MAPK1 protein] | decreases reaction|increases activity|increases phosphorylation | 16008523 |
| C015001 | arsenite | arsenite results in increased phosphorylation of MAPK1 protein | increases phosphorylation | 19808956 |
| C015001 | arsenite | MAP3K8 protein affects the reaction [arsenite results in increased phosphorylation of MAPK1 protein] | affects reaction|increases phosphorylation | 19808956 |
| C015001 | arsenite | arsenite results in increased phosphorylation of MAPK1 protein | increases phosphorylation | 17038550 |
| D017639 | Asbestos, Amosite | Asbestos, Amosite results in increased phosphorylation of MAPK1 protein | increases phosphorylation | 11306436 |
| D017639 | Asbestos, Amosite | Iron promotes the reaction [Asbestos, Amosite results in increased phosphorylation of MAPK1 protein] | increases phosphorylation|increases reaction | 11306436 |
| D017639 | Asbestos, Amosite | PD 98059 inhibits the reaction [Asbestos, Amosite results in increased phosphorylation of MAPK1 protein] | decreases reaction|increases phosphorylation | 11306436 |
| D017638 | Asbestos, Crocidolite | Asbestos, Crocidolite results in decreased phosphorylation of MAPK1 protein | decreases phosphorylation | 18314537 |
| D017638 | Asbestos, Crocidolite | Asbestos, Crocidolite results in increased phosphorylation of MAPK1 protein | increases phosphorylation | 16966607 |
| D017638 | Asbestos, Crocidolite | PD 98059 inhibits the reaction [Asbestos, Crocidolite results in increased phosphorylation of MAPK1 protein] | decreases reaction|increases phosphorylation | 16966607 |
| D017638 | Asbestos, Crocidolite | Asbestos, Crocidolite results in increased phosphorylation of MAPK1 protein | increases phosphorylation | 16966607 |
| D017638 | Asbestos, Crocidolite | Asbestos, Crocidolite affects the localization of MAPK1 protein modified form | affects localization | 12598305 |
| D017638 | Asbestos, Crocidolite | Asbestos, Crocidolite results in increased expression of MAPK1 protein | increases expression | 12598305 |
| D017638 | Asbestos, Crocidolite | Asbestos, Crocidolite results in increased phosphorylation of MAPK1 protein | increases phosphorylation | 18192500 12598305 |
| D017638 | Asbestos, Crocidolite | MAP2K1 protein affects the reaction [Asbestos, Crocidolite results in increased phosphorylation of MAPK1 protein] | affects reaction|increases phosphorylation | 18192500 |
| D001205 | Ascorbic Acid | [beta Carotene co-treated with alpha-Tocopherol co-treated with Ascorbic Acid] inhibits the reaction [4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in increased phosphorylation of MAPK1 protein] | affects cotreatment|decreases reaction|increases phosphorylation | 16401635 |
| D001241 | Aspirin | Aspirin results in decreased phosphorylation of and results in decreased activity of MAPK1 protein | decreases activity|decreases phosphorylation | 10993886 |
| D001262 | Atenolol | Atenolol inhibits the reaction [4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in increased phosphorylation of MAPK1 protein] | decreases reaction|increases phosphorylation | 16671086 |
| C065179 | atorvastatin | atorvastatin inhibits the reaction [Phenylephrine results in increased phosphorylation of and results in increased activity of MAPK1 protein] | decreases reaction|increases activity|increases phosphorylation | 18360054 |
| C430623 | atrasentan | atrasentan inhibits the reaction [[19-oxo-11-deoxycorticosterone acetate co-treated with Potassium Chloride co-treated with Sodium Chloride] results in increased phosphorylation of MAPK1 protein] | affects cotreatment|decreases reaction|increases phosphorylation | 18823320 |
| D001280 | Atrazine | Atrazine results in increased phosphorylation of MAPK1 protein | increases phosphorylation | 18461179 |
| C517975 | AZD 6244 | AZD 6244 results in decreased phosphorylation of and results in decreased activity of MAPK1 protein | decreases activity|decreases phosphorylation | 17876044 |
| C517975 | AZD 6244 | Doxorubicin promotes the reaction [AZD 6244 results in decreased phosphorylation of and results in decreased activity of MAPK1 protein] | decreases activity|decreases phosphorylation|increases reaction | 17876044 |
| C006680 | baicalein | baicalein results in decreased phosphorylation of and results in decreased activity of MAPK1 protein | decreases activity|decreases phosphorylation | 10718847 |
| C012765 | bakuchiol | bakuchiol results in increased phosphorylation of and results in increased activity of MAPK1 protein | increases activity|increases phosphorylation | 17292878 |
| C080985 | batimastat | batimastat inhibits the reaction [NTS protein results in increased phosphorylation of and results in increased activity of MAPK1 protein] | decreases reaction|increases activity|increases phosphorylation | 15247267 |
| C080985 | batimastat | batimastat inhibits the reaction [TAC1 protein results in increased phosphorylation of and results in increased activity of MAPK1 protein] | decreases reaction|increases activity|increases phosphorylation | 15319441 |
| C061004 | benidipine | benidipine results in decreased expression of MAPK1 protein | decreases expression | 16387788 |
| C043931 | benzo(a)pyrene-7,8-dihydrodiol-9,10-epoxide-DNA | benzo(a)pyrene-7,8-dihydrodiol-9,10-epoxide-DNA results in increased phosphorylation of and results in increased activity of MAPK1 protein | increases activity|increases phosphorylation | 12213569 |
| C076588 | benzo(a)pyrene-7,8-dione | benzo(a)pyrene-7,8-dione results in increased phosphorylation of and results in increased activity of MAPK1 protein | increases activity|increases phosphorylation | 12213569 |
| D019324 | beta-Naphthoflavone | [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in decreased expression of MAPK1 mRNA | affects cotreatment|decreases expression | 18164116 |
| D001564 | Benzo(a)pyrene | Benzo(a)pyrene results in increased activity of MAPK1 protein | increases activity | 15792794 |
| D001564 | Benzo(a)pyrene | Benzo(a)pyrene results in increased phosphorylation of and results in increased activity of MAPK1 protein | increases activity|increases phosphorylation | 12213569 |
| D001564 | Benzo(a)pyrene | Benzo(a)pyrene results in increased phosphorylation of MAPK1 protein | increases phosphorylation | 18321868 |
| D001564 | Benzo(a)pyrene | Curcumin inhibits the reaction [Benzo(a)pyrene results in increased phosphorylation of MAPK1 protein] | decreases reaction|increases phosphorylation | 18321868 |
| D015123 | 7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide | DNMT3A protein affects the reaction [7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in increased expression of MAPK1 protein modified form] | affects reaction|increases expression | 20426865 |
| C004532 | benzoquinone | benzoquinone results in increased phosphorylation of and results in increased activity of MAPK1 protein | increases activity|increases phosphorylation | 15795063 |
| C004532 | benzoquinone | CAT protein inhibits the reaction [benzoquinone results in increased phosphorylation of and results in increased activity of MAPK1 protein] | decreases reaction|increases activity|increases phosphorylation | 15795063 |
| C004532 | benzoquinone | PD 98059 inhibits the reaction [benzoquinone results in increased phosphorylation of and results in increased activity of MAPK1 protein] | decreases reaction|increases activity|increases phosphorylation | 15795063 |
| D019207 | beta Carotene | [beta Carotene co-treated with alpha-Tocopherol co-treated with Ascorbic Acid] inhibits the reaction [4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in increased phosphorylation of MAPK1 protein] | affects cotreatment|decreases reaction|increases phosphorylation | 16401635 |
| C023888 | beta-hexachlorocyclohexane | beta-hexachlorocyclohexane results in decreased expression of MAPK1 protein | decreases expression | 12948864 |
| C002070 | betulinic acid | 4-((3-bromophenyl)amino)-6,7-dimethoxyquinazoline inhibits the reaction [betulinic acid results in increased phosphorylation of MAPK1 protein] | decreases reaction|increases phosphorylation | 16077934 |
| C002070 | betulinic acid | betulinic acid results in increased phosphorylation of MAPK1 protein | increases phosphorylation | 16077934 |
| C053541 | bicalutamide | bicalutamide inhibits the reaction [Dihydrotestosterone results in increased phosphorylation of and results in increased activity of MAPK1 protein] | decreases reaction|increases activity|increases phosphorylation | 15466214 |
| C053541 | bicalutamide | bicalutamide results in increased phosphorylation of and results in increased activity of MAPK1 protein | increases activity|increases phosphorylation | 15466214 |
| C053541 | bicalutamide | PD 98059 inhibits the reaction [bicalutamide results in increased phosphorylation of and results in increased activity of MAPK1 protein] | decreases reaction|increases activity|increases phosphorylation | 15466214 |
| C034786 | bis(4-hydroxycinnamoyl)methane | bis(4-hydroxycinnamoyl)methane results in increased phosphorylation of MAPK1 protein | increases phosphorylation | 17535857 |
| C088060 | bisindolylmaleimide | bisindolylmaleimide inhibits the reaction [NTS protein results in increased phosphorylation of and results in increased activity of MAPK1 protein] | decreases reaction|increases activity|increases phosphorylation | 15177934 |
| C088060 | bisindolylmaleimide | bisindolylmaleimide inhibits the reaction [Tetradecanoylphorbol Acetate results in increased phosphorylation of and results in increased activity of MAPK1 protein] | decreases reaction|increases activity|increases phosphorylation | 12761878 |
| C088060 | bisindolylmaleimide | bisindolylmaleimide inhibits the reaction [Phenylephrine results in increased phosphorylation of MAPK1 protein] | decreases reaction|increases phosphorylation | 14975926 |
| C070515 | bisindolylmaleimide I | bisindolylmaleimide I inhibits the reaction [Fenretinide results in increased phosphorylation of MAPK1 protein] | decreases reaction|increases phosphorylation | 16407847 |
| C070515 | bisindolylmaleimide I | bisindolylmaleimide I inhibits the reaction [NRG1 protein alternative form results in increased phosphorylation of and results in increased activity of MAPK1 protein] | decreases reaction|increases activity|increases phosphorylation | 15231676 |
| C070515 | bisindolylmaleimide I | bisindolylmaleimide I inhibits the reaction [Tetradecanoylphorbol Acetate results in increased phosphorylation of MAPK1 protein] | decreases reaction|increases phosphorylation | 18628248 |
| C070515 | bisindolylmaleimide I | bisindolylmaleimide I inhibits the reaction [Phenylephrine results in increased phosphorylation of MAPK1 protein] | decreases reaction|increases phosphorylation | 17306214 |
| C070515 | bisindolylmaleimide I | bisindolylmaleimide I inhibits the reaction [P2RY1 protein affects the reaction [Nucleotides results in increased phosphorylation of and results in increased activity of MAPK1 protein]] | affects reaction|decreases reaction|increases activity|increases phosphorylation | 17620283 |
| C070515 | bisindolylmaleimide I | bisindolylmaleimide I inhibits the reaction [Phenylephrine results in increased activity of MAPK1 protein] | decreases reaction|increases activity | 12720544 |
| C070515 | bisindolylmaleimide I | bisindolylmaleimide I inhibits the reaction [Phenylephrine results in increased phosphorylation of MAPK1 protein] | decreases reaction|increases phosphorylation | 18445782 |
| C070515 | bisindolylmaleimide I | bisindolylmaleimide I promotes the reaction [muconaldehyde results in increased phosphorylation of MAPK1 protein] | increases phosphorylation|increases reaction | 15690152 |
| C006780 | bisphenol A | [bisphenol A co-treated with LIF protein] results in increased phosphorylation of MAPK1 protein | affects cotreatment|increases phosphorylation | 14975756 |
| C006780 | bisphenol A | bisphenol A results in increased phosphorylation of MAPK1 protein | increases phosphorylation | 18544561 20678512 |
| C006780 | bisphenol A | PD 98059 inhibits the reaction [bisphenol A results in increased phosphorylation of MAPK1 protein] | decreases reaction|increases phosphorylation | 18544561 |
| C006780 | bisphenol A | bisphenol A results in increased phosphorylation of and results in increased activity of MAPK1 protein | increases activity|increases phosphorylation | 12021184 |
| C006780 | bisphenol A | [bisphenol A results in increased phosphorylation of and results in increased activity of MAPK1 protein] which results in increased expression of NR4A1 mRNA | increases activity|increases expression|increases phosphorylation | 12021184 |
| C006780 | bisphenol A | bisphenol A results in increased phosphorylation of MAPK1 protein | increases phosphorylation | 15242752 15642633 |
| C006780 | bisphenol A | Tamoxifen affects the reaction [bisphenol A results in increased phosphorylation of MAPK1 protein] | affects reaction|increases phosphorylation | 15242752 |
| C006780 | bisphenol A | bisphenol A inhibits the reaction [Estradiol results in increased phosphorylation of MAPK1 protein] | decreases reaction|increases phosphorylation | 16123166 |
| C006780 | bisphenol A | bisphenol A results in increased expression of and results in increased phosphorylation of MAPK1 protein | increases expression|increases phosphorylation | 17322771 |
| C006780 | bisphenol A | bisphenol A results in increased phosphorylation of MAPK1 protein | increases phosphorylation | 19463694 20096755 16123166 |
| C005961 | bis(tri-n-butyltin)oxide | bis(tri-n-butyltin)oxide results in decreased expression of MAPK1 mRNA | decreases expression | 17553608 |
| C053428 | BMY 7378 | BMY 7378 inhibits the reaction [Phenylephrine results in increased phosphorylation of MAPK1 protein] | decreases reaction|increases phosphorylation | 16760267 |
| C400082 | bortezomib | [bortezomib co-treated with Butyrates] results in decreased expression of MAPK1 protein | affects cotreatment|decreases expression | 12893773 |
| C400082 | bortezomib | [bortezomib co-treated with vorinostat] results in decreased expression of MAPK1 protein | affects cotreatment|decreases expression | 12893773 |
| C439264 | bovine serum albumin-corticosterone conjugate | bovine serum albumin-corticosterone conjugate results in increased phosphorylation of and results in increased activity of MAPK1 protein | increases activity|increases phosphorylation | 15961565 |
| C022777 | bufalin | 2-(2-(4-(4-nitrobenzyloxy)phenyl)ethyl)isothiourea methanesulfonate inhibits the reaction [bufalin results in increased phosphorylation of MAPK1 protein] | decreases reaction|increases phosphorylation | 10712238 |
| C022777 | bufalin | bufalin results in increased phosphorylation of MAPK1 protein | increases phosphorylation | 10712238 |
| C022777 | bufalin | Ro 31-8220 inhibits the reaction [bufalin results in increased phosphorylation of MAPK1 protein] | decreases reaction|increases phosphorylation | 10712238 |
| C022777 | bufalin | SB 203580 promotes the reaction [bufalin results in increased phosphorylation of MAPK1 protein] | increases phosphorylation|increases reaction | 10712238 |
| D020001 | 1-Butanol | 1-Butanol inhibits the reaction [Serotonin results in increased phosphorylation of and results in increased activity of MAPK1 protein] | decreases reaction|increases activity|increases phosphorylation | 18621911 |
| D020001 | 1-Butanol | 1-Butanol inhibits the reaction [Phenylephrine results in increased phosphorylation of and results in increased activity of MAPK1 protein] | decreases reaction|increases activity|increases phosphorylation | 17461971 |
| D020001 | 1-Butanol | 1-Butanol inhibits the reaction [[4-O-methyl-12-O-tetradecanoylphorbol 13-acetate co-treated with Ionomycin] results in increased phosphorylation of and results in increased activity of MAPK1 protein] | affects cotreatment|decreases reaction|increases activity|increases phosphorylation | 18423386 |
| D020001 | 1-Butanol | 1-Butanol inhibits the reaction [AGT protein results in increased phosphorylation of and results in increased activity of MAPK1 protein] | decreases reaction|increases activity|increases phosphorylation | 12890486 |
| D020001 | 1-Butanol | 1-Butanol inhibits the reaction [PDGFB protein results in increased phosphorylation of MAPK1 protein] | decreases reaction|increases phosphorylation | 15919668 |
| D020001 | 1-Butanol | 1-Butanol inhibits the reaction [VEGFA protein results in increased phosphorylation of and results in increased activity of MAPK1 protein] | decreases reaction|increases activity|increases phosphorylation | 14704231 |
| D020001 | 1-Butanol | 1-Butanol results in decreased phosphorylation of and results in decreased activity of MAPK1 protein | decreases activity|decreases phosphorylation | 15657063 |
| D020001 | 1-Butanol | 1-Butanol inhibits the reaction [EGF protein results in increased phosphorylation of MAPK1 protein] | decreases reaction|increases phosphorylation | 11134345 |
| D020001 | 1-Butanol | 1-Butanol inhibits the reaction [P2RY1 protein affects the reaction [Nucleotides results in increased phosphorylation of and results in increased activity of MAPK1 protein]] | affects reaction|decreases reaction|increases activity|increases phosphorylation | 17620283 |
| D020001 | 1-Butanol | 1-Butanol inhibits the reaction [PLD1 protein affects the reaction [lysophosphatidic acid results in increased phosphorylation of MAPK1 protein]] | affects reaction|decreases reaction|increases phosphorylation | 11243883 |
| D020001 | 1-Butanol | 1-Butanol inhibits the reaction [Potassium Chloride results in increased phosphorylation of MAPK1 protein] | decreases reaction|increases phosphorylation | 18004999 |
| D002083 | Butylated Hydroxyanisole | Butylated Hydroxyanisole inhibits the reaction [Fenretinide results in increased phosphorylation of MAPK1 protein] | decreases reaction|increases phosphorylation | 16407847 |
| D002084 | Butylated Hydroxytoluene | Butylated Hydroxytoluene inhibits the reaction [Tyramine results in increased activity of MAPK1 protein] | decreases reaction|increases activity | 17561096 |
| D020122 | tert-Butylhydroperoxide | [tert-Butylhydroperoxide co-treated with U 0126] results in decreased phosphorylation of MAPK1 protein | affects cotreatment|decreases phosphorylation | 17003459 |
| D020122 | tert-Butylhydroperoxide | tert-Butylhydroperoxide results in decreased phosphorylation of MAPK1 protein | decreases phosphorylation | 17003459 |
| D020122 | tert-Butylhydroperoxide | tert-Butylhydroperoxide results in increased phosphorylation of and results in increased activity of MAPK1 protein | increases activity|increases phosphorylation | 16672322 |
| D002087 | Butyrates | [bortezomib co-treated with Butyrates] results in decreased expression of MAPK1 protein | affects cotreatment|decreases expression | 12893773 |
| D002087 | Butyrates | Butyrates results in decreased expression of MAPK1 protein | decreases expression | 12893773 |
| D002087 | Butyrates | [D 21266 co-treated with Butyrates] results in decreased activity of MAPK1 protein | affects cotreatment|decreases activity | 15781658 |
| D002087 | Butyrates | Butyrates results in decreased phosphorylation of and results in decreased activity of MAPK1 protein | decreases activity|decreases phosphorylation | 15978324 |
| D002104 | Cadmium | Cadmium results in increased phosphorylation of MAPK1 protein | increases phosphorylation | 17335952 |
| D002104 | Cadmium | Cadmium inhibits the reaction [CNTF protein results in increased phosphorylation of MAPK1 protein] | decreases reaction|increases phosphorylation | 16843830 |
| D002104 | Cadmium | Cadmium results in increased phosphorylation of MAPK1 protein | increases phosphorylation | 16959797 17055454 17125913 |
| D002104 | Cadmium | diacetyldichlorofluorescein inhibits the reaction [Cadmium results in increased phosphorylation of MAPK1 protein] | decreases reaction|increases phosphorylation | 16959797 |
| D002104 | Cadmium | fulvestrant inhibits the reaction [Cadmium results in increased phosphorylation of MAPK1 protein] | decreases reaction|increases phosphorylation | 17125913 |
| D002104 | Cadmium | Manganese inhibits the reaction [Cadmium results in increased phosphorylation of MAPK1 protein] | decreases reaction|increases phosphorylation | 17055454 |
| D002104 | Cadmium | Cadmium results in increased phosphorylation of and results in increased activity of MAPK1 protein | increases activity|increases phosphorylation | 16728380 |
| D002104 | Cadmium | Silymarin inhibits the reaction [Cadmium results in increased phosphorylation of and results in increased activity of MAPK1 protein] | decreases reaction|increases activity|increases phosphorylation | 16728380 |
| D002104 | Cadmium | Cadmium results in increased phosphorylation of MAPK1 protein | increases phosphorylation | 16568437 |
| D019256 | Cadmium Chloride | Cadmium Chloride inhibits the reaction [CNTF protein results in increased phosphorylation of MAPK1 protein] | decreases reaction|increases phosphorylation | 16843830 |
| D019256 | Cadmium Chloride | Cadmium Chloride results in increased phosphorylation of MAPK1 protein | increases phosphorylation | 17125913 16959797 |
| D019256 | Cadmium Chloride | diacetyldichlorofluorescein inhibits the reaction [Cadmium Chloride results in increased phosphorylation of MAPK1 protein] | decreases reaction|increases phosphorylation | 16959797 |
| D019256 | Cadmium Chloride | fulvestrant inhibits the reaction [Cadmium Chloride results in increased phosphorylation of MAPK1 protein] | decreases reaction|increases phosphorylation | 17125913 |
| D019256 | Cadmium Chloride | Cadmium Chloride results in increased phosphorylation of and results in increased activity of MAPK1 protein | increases activity|increases phosphorylation | 16728380 |
| D019256 | Cadmium Chloride | Silymarin inhibits the reaction [Cadmium Chloride results in increased phosphorylation of and results in increased activity of MAPK1 protein] | decreases reaction|increases activity|increases phosphorylation | 16728380 |
| D019256 | Cadmium Chloride | Cadmium Chloride results in increased phosphorylation of MAPK1 protein | increases phosphorylation | 17027146 |
| D019256 | Cadmium Chloride | GH1 protein promotes the reaction [Cadmium Chloride results in increased phosphorylation of MAPK1 protein] | increases phosphorylation|increases reaction | 17027146 |
| C472707 | caffeoylquinic acid | caffeoylquinic acid analog results in increased phosphorylation of MAPK1 protein | increases phosphorylation | 19647727 |
| D000001 | Calcimycin | Calcimycin results in increased phosphorylation of and results in increased activity of MAPK1 protein | increases activity|increases phosphorylation | 16000378 |
| D000001 | Calcimycin | CRYAB protein inhibits the reaction [Calcimycin results in increased phosphorylation of and results in increased activity of MAPK1 protein] | decreases reaction|increases activity|increases phosphorylation | 16000378 |
| D000001 | Calcimycin | U 0126 inhibits the reaction [Calcimycin results in increased phosphorylation of and results in increased activity of MAPK1 protein] | decreases reaction|increases activity|increases phosphorylation | 16000378 |
| D002118 | Calcium | Calcium results in increased phosphorylation of MAPK1 protein | increases phosphorylation | 15800129 |
| D002118 | Calcium | Calcium results in increased phosphorylation of MAPK1 protein | increases phosphorylation | 17537980 |
| D002118 | Calcium | Calcium deficiency inhibits the reaction [AGT protein results in increased phosphorylation of MAPK1 protein] | decreases reaction|increases phosphorylation | 10660688 |
| D002118 | Calcium | Calcium deficiency inhibits the reaction [Carbachol results in increased phosphorylation of and results in increased activity of MAPK1 protein] | decreases reaction|increases activity|increases phosphorylation | 16877402 |
| C058819 | calphostin C | calphostin C inhibits the reaction [Acetaldehyde results in increased phosphorylation of MAPK1 protein] | decreases reaction|increases phosphorylation | 11343241 |
| C058819 | calphostin C | calphostin C inhibits the reaction [Dieldrin results in increased phosphorylation of MAPK1 protein] | decreases reaction|increases phosphorylation | 15888667 |
| C058819 | calphostin C | calphostin C inhibits the reaction [Endosulfan results in increased phosphorylation of MAPK1 protein] | decreases reaction|increases phosphorylation | 15888667 |
| C058819 | calphostin C | calphostin C inhibits the reaction [Heptachlor results in increased phosphorylation of MAPK1 protein] | decreases reaction|increases phosphorylation | 15888667 |
| C058819 | calphostin C | calphostin C inhibits the reaction [Lindane results in increased phosphorylation of MAPK1 protein] | decreases reaction|increases phosphorylation | 15888667 |
| C058819 | calphostin C | calphostin C inhibits the reaction [Carbachol results in increased phosphorylation of and results in increased activity of MAPK1 protein] | decreases reaction|increases activity|increases phosphorylation | 16877402 |
| C058819 | calphostin C | calphostin C inhibits the reaction [EGF protein results in increased phosphorylation of and results in increased activity of MAPK1 protein] | decreases reaction|increases activity|increases phosphorylation | 16877402 |
| C058819 | calphostin C | calphostin C inhibits the reaction [Phenylephrine results in increased phosphorylation of and results in increased activity of MAPK1 protein] | decreases reaction|increases activity|increases phosphorylation | 16877402 |
| D002211 | Capsaicin | Capsaicin results in increased phosphorylation of MAPK1 protein | increases phosphorylation | 19059400 |
| D002211 | Capsaicin | capsazepine inhibits the reaction [Capsaicin results in increased phosphorylation of MAPK1 protein] | decreases reaction|increases phosphorylation | 19059400 |
| D002211 | Capsaicin | PD 98059 inhibits the reaction [Capsaicin results in increased phosphorylation of MAPK1 protein] | decreases reaction|increases phosphorylation | 19059400 |
| D002211 | Capsaicin | Capsaicin results in increased phosphorylation of MAPK1 protein | increases phosphorylation | 16788306 |
| D002211 | Capsaicin | SR140333B inhibits the reaction [Capsaicin results in increased phosphorylation of MAPK1 protein] | decreases reaction|increases phosphorylation | 16788306 |
| C071423 | capsazepine | capsazepine inhibits the reaction [Capsaicin results in increased phosphorylation of MAPK1 protein] | decreases reaction|increases phosphorylation | 19059400 |
| D002217 | Carbachol | Carbachol results in increased activity of MAPK1 protein | increases activity | 19002953 |
| D002217 | Carbachol | Calcium deficiency inhibits the reaction [Carbachol results in increased phosphorylation of and results in increased activity of MAPK1 protein] | decreases reaction|increases activity|increases phosphorylation | 16877402 |
| D002217 | Carbachol | calphostin C inhibits the reaction [Carbachol results in increased phosphorylation of and results in increased activity of MAPK1 protein] | decreases reaction|increases activity|increases phosphorylation | 16877402 |
| D002217 | Carbachol | Carbachol results in decreased phosphorylation of MAPK1 protein | decreases phosphorylation | 17008368 |
| D002217 | Carbachol | Carbachol results in increased phosphorylation of and results in increased activity of MAPK1 protein | increases activity|increases phosphorylation | 16877402 |
| D002217 | Carbachol | PTK2B protein affects the reaction [Carbachol results in increased phosphorylation of and results in increased activity of MAPK1 protein] | affects reaction|increases activity|increases phosphorylation | 16877402 |
| D002217 | Carbachol | Ro 31-8220 inhibits the reaction [Carbachol results in increased phosphorylation of and results in increased activity of MAPK1 protein] | decreases reaction|increases activity|increases phosphorylation | 16877402 |
| D002217 | Carbachol | SRC protein affects the reaction [Carbachol results in increased phosphorylation of and results in increased activity of MAPK1 protein] | affects reaction|increases activity|increases phosphorylation | 16877402 |
| D002251 | Carbon Tetrachloride | Carbon Tetrachloride results in increased phosphorylation of MAPK1 protein | increases phosphorylation | 17482686 |
| D002251 | Carbon Tetrachloride | PLG protein affects the reaction [Carbon Tetrachloride results in increased phosphorylation of MAPK1 protein] | affects reaction|increases phosphorylation | 17482686 |
| D002251 | Carbon Tetrachloride | Carbon Tetrachloride results in decreased phosphorylation of and results in decreased activity of MAPK1 protein | decreases activity|decreases phosphorylation | 17156884 |
| D002251 | Carbon Tetrachloride | Carbon Tetrachloride results in increased expression of MAPK1 mRNA | increases expression | 17805973 |
| D002251 | Carbon Tetrachloride | Carbon Tetrachloride results in increased expression of MAPK1 protein | increases expression | 17805973 |
| D002251 | Carbon Tetrachloride | Carbon Tetrachloride results in increased phosphorylation of MAPK1 protein | increases phosphorylation | 17285312 |
| C043211 | carvedilol | [Doxorubicin co-treated with carvedilol] results in increased phosphorylation of MAPK1 protein | affects cotreatment|increases phosphorylation | 16213474 |
| D002392 | Catechin | Catechin analog results in decreased phosphorylation of MAPK1 protein | decreases phosphorylation | 16413414 |
| D002392 | Catechin | Catechin inhibits the reaction [Glucose results in increased phosphorylation of MAPK1 protein] | decreases reaction|increases phosphorylation | 19557821 |
| D002392 | Catechin | Catechin results in increased phosphorylation of MAPK1 protein | increases phosphorylation | 17379280 |
| D002392 | Catechin | Catechin results in increased phosphorylation of MAPK1 protein | increases phosphorylation | 15879681 |
| C033394 | CGP 12177 | CGP 12177 results in increased activity of MAPK1 protein | increases activity | 15563584 |
| C016299 | chelerythrine | chelerythrine inhibits the reaction [IL8 protein results in increased phosphorylation of MAPK1 protein] | decreases reaction|increases phosphorylation | 15831558 |
| C016299 | chelerythrine | chelerythrine inhibits the reaction [Estradiol results in increased activity of MAPK1 protein] | decreases reaction|increases activity | 16713447 |
| D002706 | Chlordan | Chlordan results in increased phosphorylation of and results in increased activity of MAPK1 protein | increases activity|increases phosphorylation | 11532878 |
| D002713 | Chlorine | [Ozone co-treated with Chlorine] results in decreased expression of MAPK1 mRNA | affects cotreatment|decreases expression | 18636392 |
| D002726 | Chlorogenic Acid | Chlorogenic Acid inhibits the reaction [Tetradecanoylphorbol Acetate results in increased phosphorylation of MAPK1 protein] | decreases reaction|increases phosphorylation | 15944151 |
| D004390 | Chlorpyrifos | Chlorpyrifos results in increased expression of MAPK1 protein | increases expression | 16790487 |
| C011724 | cholest-5-en-3 beta,7 alpha-diol | cholest-5-en-3 beta,7 alpha-diol results in increased activity of MAPK1 protein | increases activity | 11058697 |
| D008078 | Cholesterol, LDL | Cholesterol, LDL metabolite results in increased phosphorylation of MAPK1 protein | increases phosphorylation | 11414687 |
| D008078 | Cholesterol, LDL | MAPK1 protein promotes the reaction [Cholesterol, LDL metabolite results in increased expression of MMP1 mRNA] | increases expression|increases reaction | 11414687 |
| D008078 | Cholesterol, LDL | Quercetin inhibits the reaction [Cholesterol, LDL metabolite results in increased phosphorylation of MAPK1 protein] | decreases reaction|increases phosphorylation | 11414687 |
| D002857 | Chromium | Chromium promotes the reaction [INS1 protein results in increased phosphorylation of MAPK1 protein] | increases phosphorylation|increases reaction | 16842748 |
| D017608 | Chromium Compounds | Chromium Compounds promotes the reaction [INS1 protein results in increased phosphorylation of MAPK1 protein] | increases phosphorylation|increases reaction | 16842748 |
| C074702 | chromium hexavalent ion | chromium hexavalent ion inhibits the reaction [Nickel results in increased phosphorylation of MAPK1 protein] | decreases reaction|increases phosphorylation | 19403854 |
| C074702 | chromium hexavalent ion | chromium hexavalent ion results in increased phosphorylation of MAPK1 protein | increases phosphorylation | 17045426 |
| C074702 | chromium hexavalent ion | [Arsenates co-treated with chromium hexavalent ion] results in increased phosphorylation of MAPK1 protein | affects cotreatment|increases phosphorylation | 19895865 |
| C074702 | chromium hexavalent ion | chromium hexavalent ion results in increased phosphorylation of MAPK1 protein | increases phosphorylation | 19895865 |
| C012843 | cinnamic aldehyde | cinnamic aldehyde results in increased phosphorylation of and results in increased activity of MAPK1 protein | increases activity|increases phosphorylation | 15964311 |
| C012843 | cinnamic aldehyde | cinnamic aldehyde results in decreased phosphorylation of MAPK1 protein | decreases phosphorylation | 17486422 |
| C014282 | cirazoline | cirazoline results in increased phosphorylation of MAPK1 protein | increases phosphorylation | 15550506 |
| C014282 | cirazoline | PD 98059 inhibits the reaction [cirazoline results in increased phosphorylation of MAPK1 protein] | decreases reaction|increases phosphorylation | 15550506 |
| D007464 | Clioquinol | [Clioquinol co-treated with Copper] results in increased phosphorylation of MAPK1 protein | affects cotreatment|increases phosphorylation | 16648635 |
| D007464 | Clioquinol | [Clioquinol co-treated with Zinc] results in increased phosphorylation of MAPK1 protein | affects cotreatment|increases phosphorylation | 16648635 |
| D007464 | Clioquinol | PD 98059 inhibits the reaction [[Clioquinol co-treated with Copper] results in increased phosphorylation of MAPK1 protein] | affects cotreatment|decreases reaction|increases phosphorylation | 16648635 |
| C488583 | Clostridium difficile lethal toxin B | Clostridium difficile lethal toxin B inhibits the reaction [EDN1 protein results in increased phosphorylation of MAPK1 protein] | decreases reaction|increases phosphorylation | 11158304 |
| D003024 | Clozapine | Clozapine inhibits the reaction [Haloperidol results in increased phosphorylation of MAPK1 protein] | decreases reaction|increases phosphorylation | 12871586 |
| D003024 | Clozapine | Clozapine results in decreased phosphorylation of MAPK1 protein | decreases phosphorylation | 12871586 |
| D003024 | Clozapine | Clozapine results in decreased expression of MAPK1 mRNA | decreases expression | 15860345 |
| C018021 | cobaltous chloride | cobaltous chloride results in increased phosphorylation of MAPK1 protein | increases phosphorylation | 17640750 |
| C009862 | connective tissue-activating peptide | connective tissue-activating peptide inhibits the reaction [Enkephalin, Ala(2)-MePhe(4)-Gly(5)- results in increased phosphorylation of MAPK1 protein] | decreases reaction|increases phosphorylation | 16954126 |
| D003300 | Copper | [Clioquinol co-treated with Copper] results in increased phosphorylation of MAPK1 protein | affects cotreatment|increases phosphorylation | 16648635 |
| D003300 | Copper | PD 98059 inhibits the reaction [[Clioquinol co-treated with Copper] results in increased phosphorylation of MAPK1 protein] | affects cotreatment|decreases reaction|increases phosphorylation | 16648635 |
| D003300 | Copper | Copper results in increased phosphorylation of and results in increased activity of MAPK1 protein | increases activity|increases phosphorylation | 16672322 |
| D003300 | Copper | myxothiazol inhibits the reaction [Copper results in increased phosphorylation of MAPK1 protein] | decreases reaction|increases phosphorylation | 16672322 |
| D003345 | Corticosterone | Corticosterone results in increased phosphorylation of MAPK1 protein | increases phosphorylation | 19175364 |
| D003345 | Corticosterone | Curcumin inhibits the reaction [Corticosterone results in increased phosphorylation of MAPK1 protein] | decreases reaction|increases phosphorylation | 19175364 |
| C067957 | corticosterone-21-hemisuccinate | corticosterone-21-hemisuccinate results in increased phosphorylation of and results in increased activity of MAPK1 protein | increases activity|increases phosphorylation | 15961565 |
| D003375 | Coumestrol | Coumestrol results in increased phosphorylation of MAPK1 protein | increases phosphorylation | 17174995 15531431 |
| C477330 | CP-654577 | CP-654577 results in decreased phosphorylation of MAPK1 protein | decreases phosphorylation | 12907618 |
| C494620 | CPS 11 | CPS 11 results in increased phosphorylation of MAPK1 protein | increases phosphorylation | 15858615 |
| C494622 | CPS 49 | CPS 49 results in increased phosphorylation of MAPK1 protein | increases phosphorylation | 15858615 |
| D003474 | Curcumin | Acetylcysteine inhibits the reaction [Curcumin results in increased phosphorylation of MAPK1 protein] | decreases reaction|increases phosphorylation | 18357586 |
| D003474 | Curcumin | Curcumin inhibits the reaction [Acids results in increased phosphorylation of MAPK1 protein] | decreases reaction|increases phosphorylation | 19074641 |
| D003474 | Curcumin | Curcumin inhibits the reaction [EGF protein results in increased phosphorylation of MAPK1 protein] | decreases reaction|increases phosphorylation | 18214481 |
| D003474 | Curcumin | Curcumin results in decreased expression of MAPK1 protein | decreases expression | 18555241 |
| D003474 | Curcumin | Curcumin results in increased phosphorylation of and results in increased activity of MAPK1 protein | increases activity|increases phosphorylation | 18357586 |
| D003474 | Curcumin | Curcumin results in increased phosphorylation of MAPK1 protein | increases phosphorylation | 18316600 |
| D003474 | Curcumin | MAPK1 protein affects the reaction [Curcumin results in increased expression of CDKN1A mRNA] | affects reaction|increases expression | 18316600 |
| D003474 | Curcumin | Curcumin inhibits the reaction [Benzo(a)pyrene results in increased phosphorylation of MAPK1 protein] | decreases reaction|increases phosphorylation | 18321868 |
| D003474 | Curcumin | Curcumin results in increased phosphorylation of MAPK1 protein | increases phosphorylation | 17535857 |
| D003474 | Curcumin | Curcumin inhibits the reaction [Corticosterone results in increased phosphorylation of MAPK1 protein] | decreases reaction|increases phosphorylation | 19175364 |
| D003474 | Curcumin | Curcumin inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of MAPK1 protein] | decreases reaction|increases phosphorylation | 16934299 |
| D003474 | Curcumin | Curcumin inhibits the reaction [PDGFB protein results in increased phosphorylation of MAPK1 protein] | decreases reaction|increases phosphorylation | 18784349 |
| D003474 | Curcumin | Curcumin results in decreased phosphorylation of and results in decreased activity of MAPK1 protein | decreases activity|decreases phosphorylation | 17372590 |
| D003474 | Curcumin | Curcumin results in decreased phosphorylation of MAPK1 protein | decreases phosphorylation | 17965732 18332871 |
| D003474 | Curcumin | tin protoporphyrin IX inhibits the reaction [Curcumin inhibits the reaction [PDGFB protein results in increased phosphorylation of MAPK1 protein]] | decreases reaction|increases phosphorylation | 18784349 |
| D003513 | Cycloheximide | Cycloheximide results in increased phosphorylation of MAPK1 protein | increases phosphorylation | 15087236 |
| D003513 | Cycloheximide | TAS2R105 protein affects the reaction [Cycloheximide results in increased phosphorylation of MAPK1 protein] | affects reaction|increases phosphorylation | 15087236 |
| D003513 | Cycloheximide | Pertussis Toxin inhibits the reaction [TAS2R105 protein affects the reaction [Cycloheximide results in increased phosphorylation of MAPK1 protein]] | affects reaction|decreases reaction|increases phosphorylation | 15087236 |
| D003513 | Cycloheximide | Cycloheximide inhibits the reaction [Progesterone results in increased phosphorylation of MAPK1 protein] | decreases reaction|increases phosphorylation | 14694440 |
| D003520 | Cyclophosphamide | Cyclophosphamide results in increased expression of MAPK1 mRNA | increases expression | 11599041 |
| D016572 | Cyclosporine | Cyclosporine inhibits the reaction [Phenylephrine results in increased phosphorylation of and results in increased activity of MAPK1 protein] | decreases reaction|increases activity|increases phosphorylation | 16513848 |
| C052570 | cyfluthrin | cyfluthrin results in increased expression of MAPK1 protein | increases expression | 16790487 |
| C105905 | D 21266 | [D 21266 co-treated with Butyrates] results in decreased activity of MAPK1 protein | affects cotreatment|decreases activity | 15781658 |
| C105905 | D 21266 | [D 21266 co-treated with trichostatin A] results in decreased activity of MAPK1 protein | affects cotreatment|decreases activity | 15781658 |
| C105905 | D 21266 | [D 21266 co-treated with vorinostat] results in decreased activity of MAPK1 protein | affects cotreatment|decreases activity | 15781658 |
| D015084 | 2,4-Dichlorophenoxyacetic Acid | 2,4-Dichlorophenoxyacetic Acid results in increased phosphorylation of MAPK1 protein | increases phosphorylation | 14694440 17055699 |
| D003606 | Dacarbazine | MAPK1 protein modified form results in decreased susceptibility to Dacarbazine | decreases response to substance | 15123733 |
| D003609 | Dactinomycin | Dactinomycin results in increased phosphorylation of and results in increased activity of MAPK1 protein | increases activity|increases phosphorylation | 14640974 |
| D003609 | Dactinomycin | U 0126 inhibits the reaction [Dactinomycin results in increased phosphorylation of and results in increased activity of MAPK1 protein] | decreases reaction|increases activity|increases phosphorylation | 14640974 |
| D003609 | Dactinomycin | PLD1 protein promotes the reaction [Dactinomycin results in increased phosphorylation of and results in increased activity of MAPK1 protein] | increases activity|increases phosphorylation|increases reaction | 14640974 |
| D003609 | Dactinomycin | PLD2 protein promotes the reaction [Dactinomycin results in increased phosphorylation of and results in increased activity of MAPK1 protein] | increases activity|increases phosphorylation|increases reaction | 14640974 |
| C004742 | daidzein | AG 1879 inhibits the reaction [daidzein results in increased phosphorylation of MAPK1 protein] | decreases reaction|increases phosphorylation | 16840783 |
| C004742 | daidzein | daidzein results in increased phosphorylation of MAPK1 protein | increases phosphorylation | 16840783 |
| C004742 | daidzein | daidzein promotes the reaction [GNB1 protein results in increased activity of PLCB2 protein results in increased activity of MAPK1 protein] | increases activity|increases reaction | 16972265 |
| C004742 | daidzein | daidzein results in increased phosphorylation of and results in increased activity of MAPK1 protein | increases activity|increases phosphorylation | 16972265 |
| D003634 | DDT | DDT results in increased phosphorylation of MAPK1 protein | increases phosphorylation | 14604893 |
| D003634 | DDT | DDT results in increased activity of MAPK1 protein | increases activity | 12523960 |
| D003634 | DDT | DDT results in increased phosphorylation of MAPK1 protein | increases phosphorylation | 12523960 |
| C017180 | decamethrin | decamethrin results in increased phosphorylation of MAPK1 protein | increases phosphorylation | 16166269 |
| C017180 | decamethrin | Nicardipine inhibits the reaction [decamethrin results in increased phosphorylation of MAPK1 protein] | decreases reaction|increases phosphorylation | 16166269 |
| C014347 | decitabine | decitabine results in increased phosphorylation of MAPK1 protein | increases phosphorylation | 19147557 |
| C044919 | deferiprone | deferiprone inhibits the reaction [ferrous sulfate results in increased phosphorylation of MAPK1 protein] | decreases reaction|increases phosphorylation | 17172471 |
| C044919 | deferiprone | deferiprone inhibits the reaction [Iron results in increased phosphorylation of MAPK1 protein] | decreases reaction|increases phosphorylation | 17172471 |
| D003676 | Deferoxamine | Deferoxamine results in increased phosphorylation of MAPK1 protein | increases phosphorylation | 20368581 |
| D003676 | Deferoxamine | Deferoxamine inhibits the reaction [PDGFB protein results in increased phosphorylation of MAPK1 protein] | decreases reaction|increases phosphorylation | 18032466 |
| D003687 | Dehydroepiandrosterone | Dehydroepiandrosterone results in increased phosphorylation of MAPK1 protein | increases phosphorylation | 16373398 |
| D003687 | Dehydroepiandrosterone | PD 98059 inhibits the reaction [Dehydroepiandrosterone results in increased phosphorylation of MAPK1 protein] | decreases reaction|increases phosphorylation | 16373398 |
| C485706 | delta(4)-tibolone | delta(4)-tibolone results in decreased phosphorylation of MAPK1 protein | decreases phosphorylation | 14764805 |
| C050229 | demethoxycurcumin | demethoxycurcumin results in increased phosphorylation of MAPK1 protein | increases phosphorylation | 17535857 |
| C007262 | deoxynivalenol | deoxynivalenol results in increased phosphorylation of and results in increased activity of MAPK1 protein | increases activity|increases phosphorylation | 18006205 18485432 19360757 |
| C007262 | deoxynivalenol | deoxynivalenol results in increased phosphorylation of MAPK1 protein | increases phosphorylation | 17707346 |
| C007262 | deoxynivalenol | [deoxynivalenol results in increased phosphorylation of MAPK1 protein] which results in increased expression of IL8 protein | increases expression|increases phosphorylation | 17707346 |
| C007262 | deoxynivalenol | MAPK1 protein promotes the reaction [deoxynivalenol results in increased expression of PPARG mRNA] | increases expression|increases reaction | 18485432 |
| C007262 | deoxynivalenol | 4-amino-5-(4-methylphenyl)-7-(tert-butyl)pyrazolo(3,4-d)pyrimidine inhibits the reaction [deoxynivalenol results in increased phosphorylation of MAPK1 protein] | decreases reaction|increases phosphorylation | 15772366 |
| C007262 | deoxynivalenol | AG 1879 inhibits the reaction [deoxynivalenol results in increased phosphorylation of MAPK1 protein] | decreases reaction|increases phosphorylation | 15772366 |
| C007262 | deoxynivalenol | deoxynivalenol results in increased phosphorylation of MAPK1 protein | increases phosphorylation | 15772366 12377986 18502741 12604842 16009389 14690764 14644621 15570035 15976193 16424113 |
| C007262 | deoxynivalenol | Docosahexaenoic Acids inhibits the reaction [deoxynivalenol results in increased phosphorylation of MAPK1 protein] | decreases reaction|increases phosphorylation | 15570035 14690764 |
| C007262 | deoxynivalenol | Eicosapentaenoic Acid inhibits the reaction [deoxynivalenol results in increased phosphorylation of MAPK1 protein] | decreases reaction|increases phosphorylation | 14690764 |
| C007262 | deoxynivalenol | Fish Oils inhibits the reaction [deoxynivalenol results in increased phosphorylation of MAPK1 protein] | decreases reaction|increases phosphorylation | 14690764 |
| C007262 | deoxynivalenol | Lipopolysaccharides inhibits the reaction [deoxynivalenol results in increased phosphorylation of MAPK1 protein] | decreases reaction|increases phosphorylation | 16009389 |
| C007262 | deoxynivalenol | deoxynivalenol results in increased activity of MAPK1 protein | increases activity | 19674540 |
| D003907 | Dexamethasone | Dexamethasone inhibits the reaction [Zymosan results in increased phosphorylation of MAPK1 protein] | decreases reaction|increases phosphorylation | 10874129 |
| C029569 | diacetyldichlorofluorescein | diacetyldichlorofluorescein inhibits the reaction [Cadmium Chloride results in increased phosphorylation of MAPK1 protein] | decreases reaction|increases phosphorylation | 16959797 |
| C029569 | diacetyldichlorofluorescein | diacetyldichlorofluorescein inhibits the reaction [Cadmium results in increased phosphorylation of MAPK1 protein] | decreases reaction|increases phosphorylation | 16959797 |
| C029569 | diacetyldichlorofluorescein | diacetyldichlorofluorescein inhibits the reaction [Hemin results in increased phosphorylation of MAPK1 protein] | decreases reaction|increases phosphorylation | 16959797 |
| C029569 | diacetyldichlorofluorescein | diacetyldichlorofluorescein inhibits the reaction [sodium arsenite results in increased phosphorylation of MAPK1 protein] | decreases reaction|increases phosphorylation | 16959797 |
| C492519 | diarylpropionitrile | 5,11-diethyl-5,6,11,12-tetrahydrochrysene-2,8-diol inhibits the reaction [diarylpropionitrile results in increased phosphorylation of MAPK1 protein] | decreases reaction|increases phosphorylation | 15615701 |
| C492519 | diarylpropionitrile | diarylpropionitrile results in increased phosphorylation of MAPK1 protein | increases phosphorylation | 15615701 |
| C041517 | dibenzo(a,l)pyrene | dibenzo(a,l)pyrene results in increased phosphorylation of and results in increased activity of MAPK1 protein | increases activity|increases phosphorylation | 16005925 |
| C041517 | dibenzo(a,l)pyrene | pifithrin inhibits the reaction [dibenzo(a,l)pyrene results in increased phosphorylation of MAPK1 protein] | decreases reaction|increases phosphorylation | 16005925 |
| C041517 | dibenzo(a,l)pyrene | U 0126 inhibits the reaction [dibenzo(a,l)pyrene results in increased phosphorylation of MAPK1 protein] | decreases reaction|increases phosphorylation | 16005925 |
| C020735 | dibutyldichlorotin | dibutyldichlorotin results in increased phosphorylation of and results in increased activity of MAPK1 protein | increases activity|increases phosphorylation | 16181675 |
| D002945 | Cisplatin | Cisplatin results in increased phosphorylation of and results in increased activity of MAPK1 protein | increases activity|increases phosphorylation | 16013042 |
| D002945 | Cisplatin | PD 98059 inhibits the reaction [Cisplatin results in increased phosphorylation of and results in increased activity of MAPK1 protein] | decreases reaction|increases activity|increases phosphorylation | 16013042 |
| D002945 | Cisplatin | U 0126 inhibits the reaction [Cisplatin results in increased phosphorylation of and results in increased activity of MAPK1 protein] | decreases reaction|increases activity|increases phosphorylation | 16013042 |
| D002945 | Cisplatin | 4-(4-fluorophenyl)-2-(4-hydroxyphenyl)-5-(4-pyridyl)imidazole promotes the reaction [Cisplatin results in increased phosphorylation of and results in increased activity of MAPK1 protein] | increases activity|increases phosphorylation|increases reaction | 12663670 |
| D002945 | Cisplatin | Cisplatin results in increased phosphorylation of and results in increased activity of MAPK1 protein | increases activity|increases phosphorylation | 12663670 |
| D002945 | Cisplatin | PD 98059 inhibits the reaction [Cisplatin results in increased phosphorylation of and results in increased activity of MAPK1 protein] | decreases reaction|increases activity|increases phosphorylation | 12663670 |
| D003633 | Dichlorodiphenyl Dichloroethylene | [Dichlorodiphenyl Dichloroethylene results in increased activity of AR protein mutant form] which results in increased phosphorylation of MAPK1 protein | increases activity|increases phosphorylation | 18819937 |
| D003633 | Dichlorodiphenyl Dichloroethylene | Dichlorodiphenyl Dichloroethylene results in increased activity of MAPK1 protein | increases activity | 12523960 |
| D003633 | Dichlorodiphenyl Dichloroethylene | Dichlorodiphenyl Dichloroethylene results in increased phosphorylation of MAPK1 protein | increases phosphorylation | 17174995 12523960 15531431 |
| D001728 | Dicumarol | Dicumarol inhibits the reaction [TNF protein results in increased phosphorylation of MAPK1 protein] | decreases reaction|increases phosphorylation | 17669387 |
| D004026 | Dieldrin | calphostin C inhibits the reaction [Dieldrin results in increased phosphorylation of MAPK1 protein] | decreases reaction|increases phosphorylation | 15888667 |
| D004026 | Dieldrin | Dieldrin results in increased phosphorylation of and results in increased activity of MAPK1 protein | increases activity|increases phosphorylation | 15888667 |
| D004026 | Dieldrin | geldanamycin inhibits the reaction [Dieldrin results in increased phosphorylation of MAPK1 protein] | decreases reaction|increases phosphorylation | 15888667 |
| D004026 | Dieldrin | U 0126 inhibits the reaction [Dieldrin results in increased phosphorylation of MAPK1 protein] | decreases reaction|increases phosphorylation | 15888667 |
| D004026 | Dieldrin | Dieldrin results in increased phosphorylation of MAPK1 protein | increases phosphorylation | 17174995 15531431 |
| D004041 | Dietary Fats | [Dietary Fats co-treated with Diethylnitrosamine] results in increased phosphorylation of MAPK1 protein | affects cotreatment|increases phosphorylation | 19004024 |
| D004041 | Dietary Fats | lycopene inhibits the reaction [[Dietary Fats co-treated with Diethylnitrosamine] results in increased phosphorylation of MAPK1 protein] | affects cotreatment|decreases reaction|increases phosphorylation | 19551842 |
| D004041 | Dietary Fats | Plant Extracts inhibits the reaction [[Dietary Fats co-treated with Diethylnitrosamine] results in increased phosphorylation of MAPK1 protein] | affects cotreatment|decreases reaction|increases phosphorylation | 19551842 |
| D004051 | Diethylhexyl Phthalate | Diethylhexyl Phthalate results in decreased expression of MAPK1 protein | decreases expression | 16455614 |
| D004052 | Diethylnitrosamine | Diethylnitrosamine results in increased phosphorylation of and results in increased activity of MAPK1 protein | increases activity|increases phosphorylation | 18691550 17942915 |
| D004052 | Diethylnitrosamine | MET protein inhibits the reaction [Diethylnitrosamine results in increased phosphorylation of and results in increased activity of MAPK1 protein] | decreases reaction|increases activity|increases phosphorylation | 17942915 |
| D004052 | Diethylnitrosamine | [Dietary Fats co-treated with Diethylnitrosamine] results in increased phosphorylation of MAPK1 protein | affects cotreatment|increases phosphorylation | 19004024 |
| D004052 | Diethylnitrosamine | [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in decreased expression of MAPK1 mRNA | affects cotreatment|decreases expression | 18164116 |
| D004052 | Diethylnitrosamine | Diethylnitrosamine results in increased expression of MAPK1 | increases expression | 17055752 |
| D004052 | Diethylnitrosamine | Diethylnitrosamine results in increased phosphorylation of MAPK1 protein | increases phosphorylation | 21056072 |
| D004052 | Diethylnitrosamine | lycopene inhibits the reaction [[Dietary Fats co-treated with Diethylnitrosamine] results in increased phosphorylation of MAPK1 protein] | affects cotreatment|decreases reaction|increases phosphorylation | 19551842 |
| D004052 | Diethylnitrosamine | Plant Extracts inhibits the reaction [[Dietary Fats co-treated with Diethylnitrosamine] results in increased phosphorylation of MAPK1 protein] | affects cotreatment|decreases reaction|increases phosphorylation | 19551842 |
| D004054 | Diethylstilbestrol | Diethylstilbestrol affects the phosphorylation of MAPK1 protein | affects phosphorylation | 15242752 |
| D004054 | Diethylstilbestrol | Tamoxifen affects the reaction [Diethylstilbestrol affects the phosphorylation of MAPK1 protein] | affects phosphorylation|affects reaction | 15242752 |
| D004054 | Diethylstilbestrol | 1,2-bis(2-aminophenoxy)ethane N,N,N',N'-tetraacetic acid acetoxymethyl ester inhibits the reaction [Diethylstilbestrol results in increased phosphorylation of and results in increased activity of MAPK1 protein] | decreases reaction|increases activity|increases phosphorylation | 15072920 |
| D004054 | Diethylstilbestrol | AG 1879 inhibits the reaction [Diethylstilbestrol results in increased phosphorylation of and results in increased activity of MAPK1 protein] | decreases reaction|increases activity|increases phosphorylation | 15072920 |
| D004054 | Diethylstilbestrol | Diethylstilbestrol results in increased phosphorylation of and results in increased activity of MAPK1 protein | increases activity|increases phosphorylation | 15072920 |
| D004054 | Diethylstilbestrol | Diethylstilbestrol results in increased phosphorylation of MAPK1 protein | increases phosphorylation | 17174995 |
| D004054 | Diethylstilbestrol | Nystatin inhibits the reaction [Diethylstilbestrol results in increased phosphorylation of and results in increased activity of MAPK1 protein] | decreases reaction|increases activity|increases phosphorylation | 15072920 |
| D002117 | Calcitriol | Calcitriol inhibits the reaction [IL2 protein results in increased phosphorylation of MAPK1 protein] | decreases reaction|increases phosphorylation | 15879110 |
| D002117 | Calcitriol | Calcitriol results in increased phosphorylation of and results in increased activity of MAPK1 protein | increases activity|increases phosphorylation | 12761878 |
| D002117 | Calcitriol | tyrphostin AG 1478 inhibits the reaction [Calcitriol results in increased phosphorylation of and results in increased activity of MAPK1 protein] | decreases reaction|increases activity|increases phosphorylation | 12761878 |
| D004110 | Diltiazem | Diltiazem affects the reaction [Amphetamine results in increased phosphorylation of MAPK1 protein] | affects reaction|increases phosphorylation | 15329393 |
| C062856 | dimethylarsine | dimethylarsine results in increased phosphorylation of MAPK1 protein | increases phosphorylation | 12475910 |
| D004128 | Dimethylnitrosamine | Dimethylnitrosamine results in increased phosphorylation of and results in increased activity of MAPK1 protein | increases activity|increases phosphorylation | 19555203 |
| D004128 | Dimethylnitrosamine | Dimethylnitrosamine results in increased phosphorylation of MAPK1 protein | increases phosphorylation | 11884234 |
| D004128 | Dimethylnitrosamine | Tetrachlorodibenzodioxin promotes the reaction [Dimethylnitrosamine results in increased phosphorylation of and results in increased activity of MAPK1 protein] | increases activity|increases phosphorylation|increases reaction | 19555203 |
| D004128 | Dimethylnitrosamine | Dimethylnitrosamine results in increased expression of and results in increased phosphorylation of and results in increased activity of MAPK1 protein | increases activity|increases expression|increases phosphorylation | 12971962 |
| D004128 | Dimethylnitrosamine | Dimethylnitrosamine results in increased expression of MAPK1 protein | increases expression | 17032414 |
| D011397 | Promegestone | fulvestrant inhibits the reaction [Promegestone results in increased phosphorylation of MAPK1 protein] | decreases reaction|increases phosphorylation | 16020483 |
| D011397 | Promegestone | Mifepristone inhibits the reaction [Promegestone results in increased phosphorylation of MAPK1 protein] | decreases reaction|increases phosphorylation | 16020483 |
| D011397 | Promegestone | Promegestone results in increased phosphorylation of MAPK1 protein | increases phosphorylation | 16020483 |
| C007517 | diphenyleneiodonium | diphenyleneiodonium inhibits the reaction [Particulate Matter results in increased phosphorylation of MAPK1 protein] | decreases reaction|increases phosphorylation | 16571865 |
| C007517 | diphenyleneiodonium | diphenyleneiodonium inhibits the reaction [Tetradecanoylphorbol Acetate results in increased phosphorylation of MAPK1 protein] | decreases reaction|increases phosphorylation | 15978937 19804834 |
| C007517 | diphenyleneiodonium | diphenyleneiodonium inhibits the reaction [Particulate Matter results in increased phosphorylation of MAPK1 protein] | decreases reaction|increases phosphorylation | 19371610 |
| C007517 | diphenyleneiodonium | diphenyleneiodonium inhibits the reaction [Doxorubicin results in increased phosphorylation of MAPK1 protein] | decreases reaction|increases phosphorylation | 17384286 |
| C031291 | diphenyliodonium | diphenyliodonium inhibits the reaction [EDN1 protein results in increased phosphorylation of MAPK1 protein] | decreases reaction|increases phosphorylation | 16261333 |
| C031291 | diphenyliodonium | diphenyliodonium inhibits the reaction [Glucose results in increased phosphorylation of MAPK1 protein] | decreases reaction|increases phosphorylation | 16572112 |
| C031291 | diphenyliodonium | diphenyliodonium inhibits the reaction [Glycosylation End Products, Advanced results in increased phosphorylation of MAPK1 protein] | decreases reaction|increases phosphorylation | 16572112 |
| D011756 | Diphosphates | Diphosphates results in increased phosphorylation of and results in increased activity of MAPK1 protein | increases activity|increases phosphorylation | 17383965 |
| D004178 | Diquat | Diquat results in increased phosphorylation of MAPK1 protein | increases phosphorylation | 20826540 |
| D004050 | Ditiocarb | Acetylcysteine inhibits the reaction [Ditiocarb results in increased phosphorylation of MAPK1 protein] | decreases reaction|increases phosphorylation | 16603213 |
| D004050 | Ditiocarb | Ditiocarb results in increased phosphorylation of MAPK1 protein | increases phosphorylation | 16603213 |
| D004050 | Ditiocarb | Nitric Oxide affects the reaction [Ditiocarb results in increased phosphorylation of MAPK1 protein] | affects reaction|increases phosphorylation | 16603213 |
| D004050 | Ditiocarb | U 0126 inhibits the reaction [Ditiocarb results in increased phosphorylation of MAPK1 protein] | decreases reaction|increases phosphorylation | 16603213 |
| D004280 | Dobutamine | [Dobutamine co-treated with ICI 118551] results in increased activity of MAPK1 protein | affects cotreatment|increases activity | 19719783 |
| D004280 | Dobutamine | Dobutamine results in increased phosphorylation of MAPK1 protein | increases phosphorylation | 16760913 |
| C067311 | docetaxel | docetaxel results in increased phosphorylation of MAPK1 protein | increases phosphorylation | 15970518 |
| D004281 | Docosahexaenoic Acids | Docosahexaenoic Acids inhibits the reaction [deoxynivalenol results in increased phosphorylation of MAPK1 protein] | decreases reaction|increases phosphorylation | 15570035 14690764 |
| D004298 | Dopamine | Dopamine results in increased phosphorylation of and results in increased activity of MAPK1 protein | increases activity|increases phosphorylation | 18977218 |
| D004298 | Dopamine | RGS3 protein affects the reaction [Dopamine results in increased phosphorylation of and results in increased activity of MAPK1 protein] | affects reaction|increases activity|increases phosphorylation | 18977218 |
| D004298 | Dopamine | Dopamine results in increased phosphorylation of MAPK1 protein | increases phosphorylation | 16760913 |
| D017292 | Doxazosin | Doxazosin affects the phosphorylation of MAPK1 protein | affects phosphorylation | 18084315 |
| D004317 | Doxorubicin | Acetaminophen inhibits the reaction [Doxorubicin results in increased phosphorylation of and results in increased activity of MAPK1 protein] | decreases reaction|increases activity|increases phosphorylation | 17526808 |
| D004317 | Doxorubicin | Doxorubicin affects the phosphorylation of and affects the activity of MAPK1 protein | affects activity|affects phosphorylation | 18468633 |
| D004317 | Doxorubicin | Doxorubicin results in increased expression of MAPK1 mRNA | increases expression | 16001973 |
| D004317 | Doxorubicin | Doxorubicin results in increased phosphorylation of and results in increased activity of MAPK1 protein | increases activity|increases phosphorylation | 17526808 |
| D004317 | Doxorubicin | Doxorubicin results in increased phosphorylation of MAPK1 protein | increases phosphorylation | 18468633 15557793 17974986 |
| D004317 | Doxorubicin | PD 98059 inhibits the reaction [Doxorubicin results in increased phosphorylation of and results in increased activity of MAPK1 protein] | decreases reaction|increases activity|increases phosphorylation | 17526808 |
| D004317 | Doxorubicin | pyrrolidine dithiocarbamic acid inhibits the reaction [Doxorubicin results in increased phosphorylation of MAPK1 protein] | decreases reaction|increases phosphorylation | 15557793 |
| D004317 | Doxorubicin | U 0126 inhibits the reaction [Doxorubicin results in increased phosphorylation of MAPK1 protein] | decreases reaction|increases phosphorylation | 15557793 18468633 |
| D004317 | Doxorubicin | CSF3 protein inhibits the reaction [Doxorubicin results in decreased phosphorylation of and results in decreased activity of MAPK1 protein] | decreases activity|decreases phosphorylation|decreases reaction | 17334414 |
| D004317 | Doxorubicin | Doxorubicin promotes the reaction [AZD 6244 results in decreased phosphorylation of and results in decreased activity of MAPK1 protein] | decreases activity|decreases phosphorylation|increases reaction | 17876044 |
| D004317 | Doxorubicin | Doxorubicin results in decreased phosphorylation of and results in decreased activity of MAPK1 protein | decreases activity|decreases phosphorylation | 17334414 18083897 16449733 |
| D004317 | Doxorubicin | Doxorubicin results in decreased phosphorylation of MAPK1 protein | decreases phosphorylation | 16109756 |
| D004317 | Doxorubicin | Doxorubicin results in increased phosphorylation of MAPK1 protein | increases phosphorylation | 17974986 12884365 |
| D004317 | Doxorubicin | EPO protein inhibits the reaction [Doxorubicin results in decreased phosphorylation of and results in decreased activity of MAPK1 protein] | decreases activity|decreases phosphorylation|decreases reaction | 16449733 |
| D004317 | Doxorubicin | HGF protein inhibits the reaction [Doxorubicin results in decreased phosphorylation of and results in decreased activity of MAPK1 protein] | decreases activity|decreases phosphorylation|decreases reaction | 18083897 |
| D004317 | Doxorubicin | HGF protein inhibits the reaction [Doxorubicin results in decreased phosphorylation of MAPK1 protein] | decreases phosphorylation|decreases reaction | 16109756 |
| D004317 | Doxorubicin | NRG1 protein affects the reaction [Doxorubicin affects the phosphorylation of MAPK1 protein] | affects phosphorylation|affects reaction | 15833803 |
| D004317 | Doxorubicin | pifithrin promotes the reaction [Doxorubicin results in increased phosphorylation of MAPK1 protein] | increases phosphorylation|increases reaction | 12884365 |
| D004317 | Doxorubicin | diphenyleneiodonium inhibits the reaction [Doxorubicin results in increased phosphorylation of MAPK1 protein] | decreases reaction|increases phosphorylation | 17384286 |
| D004317 | Doxorubicin | [Doxorubicin co-treated with carvedilol] results in increased phosphorylation of MAPK1 protein | affects cotreatment|increases phosphorylation | 16213474 |
| D004317 | Doxorubicin | [Doxorubicin co-treated with Razoxane] results in increased phosphorylation of MAPK1 protein | affects cotreatment|increases phosphorylation | 16213474 |
| D004317 | Doxorubicin | Doxorubicin results in increased phosphorylation of and results in increased activity of MAPK1 protein | increases activity|increases phosphorylation | 15843167 18373386 16687611 |
| D004317 | Doxorubicin | Doxorubicin results in increased phosphorylation of MAPK1 protein | increases phosphorylation | 17384286 17384285 |
| D004317 | Doxorubicin | manganese(III)-tetrakis(4-benzoic acid)porphyrin inhibits the reaction [Doxorubicin results in increased phosphorylation of MAPK1 protein] | decreases reaction|increases phosphorylation | 17384286 |
| D004317 | Doxorubicin | [PD 98059 inhibits the reaction [Oleylethanolamide results in increased phosphorylation of MAPK1 protein]] which results in increased susceptibility to Doxorubicin | decreases reaction|increases phosphorylation|increases response to substance | 16269455 |
| D004317 | Doxorubicin | pifithrin inhibits the reaction [Doxorubicin results in increased phosphorylation of and results in increased activity of MAPK1 protein] | decreases reaction|increases activity|increases phosphorylation | 16687611 |
| D004317 | Doxorubicin | tyrphostin AG 1478 inhibits the reaction [Doxorubicin results in increased phosphorylation of and results in increased activity of MAPK1 protein] | decreases reaction|increases activity|increases phosphorylation | 15843167 |
| D004317 | Doxorubicin | U 0126 inhibits the reaction [Doxorubicin results in increased phosphorylation of and results in increased activity of MAPK1 protein] | decreases reaction|increases activity|increases phosphorylation | 15843167 |
| C060327 | dracorhodin | dracorhodin analog results in increased phosphorylation of MAPK1 protein | increases phosphorylation | 16864444 |
| C060327 | dracorhodin | PD 98059 inhibits the reaction [dracorhodin analog results in increased phosphorylation of MAPK1 protein] | decreases reaction|increases phosphorylation | 16864444 |
| D004365 | Drugs, Chinese Herbal | Drugs, Chinese Herbal results in increased phosphorylation of MAPK1 protein | increases phosphorylation | 15894585 |
| D004365 | Drugs, Chinese Herbal | Drugs, Chinese Herbal inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of and results in increased activity of MAPK1 protein] | decreases reaction|increases activity|increases phosphorylation | 17996413 |
| D004365 | Drugs, Chinese Herbal | Drugs, Chinese Herbal inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of MAPK1 protein] | decreases reaction|increases phosphorylation | 19051357 |
| D004365 | Drugs, Chinese Herbal | Drugs, Chinese Herbal results in increased phosphorylation of MAPK1 protein | increases phosphorylation | 19647727 |
| D015777 | Eicosanoids | [U 0126 results in decreased phosphorylation of MAPK1 protein] inhibits the reaction [Pam(3)CSK(4) peptide results in increased metabolism of Eicosanoids] | decreases phosphorylation|decreases reaction|increases metabolic processing | 17369491 |
| D015118 | Eicosapentaenoic Acid | Eicosapentaenoic Acid inhibits the reaction [deoxynivalenol results in increased phosphorylation of MAPK1 protein] | decreases reaction|increases phosphorylation | 14690764 |
| D004640 | Emetine | 4-amino-5-(4-methylphenyl)-7-(tert-butyl)pyrazolo(3,4-d)pyrimidine inhibits the reaction [Emetine results in increased phosphorylation of MAPK1 protein] | decreases reaction|increases phosphorylation | 15772366 |
| D004640 | Emetine | Emetine results in increased phosphorylation of MAPK1 protein | increases phosphorylation | 15772366 |
| D004642 | Emodin | Emodin inhibits the reaction [PDGFB protein results in increased phosphorylation of MAPK1 protein] | decreases reaction|increases phosphorylation | 15288473 |
| D004726 | Endosulfan | calphostin C inhibits the reaction [Endosulfan results in increased phosphorylation of MAPK1 protein] | decreases reaction|increases phosphorylation | 15888667 |
| D004726 | Endosulfan | [Endosulfan co-treated with LIF protein] results in increased phosphorylation of MAPK1 protein | affects cotreatment|increases phosphorylation | 14975756 |
| D004726 | Endosulfan | Endosulfan results in increased phosphorylation of and results in increased activity of MAPK1 protein | increases activity|increases phosphorylation | 15888667 |
| D004726 | Endosulfan | geldanamycin inhibits the reaction [Endosulfan results in increased phosphorylation of MAPK1 protein] | decreases reaction|increases phosphorylation | 15888667 |
| D004726 | Endosulfan | U 0126 inhibits the reaction [Endosulfan results in increased phosphorylation of MAPK1 protein] | decreases reaction|increases phosphorylation | 15888667 |
| D004726 | Endosulfan | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Endosulfan results in increased phosphorylation of MAPK1 protein] | decreases reaction|increases phosphorylation | 15531431 |
| D004726 | Endosulfan | Endosulfan results in decreased activity of MAPK1 protein | decreases activity | 11767051 |
| D004726 | Endosulfan | Endosulfan results in increased phosphorylation of MAPK1 protein | increases phosphorylation | 17174995 15531431 |
| D004726 | Endosulfan | fulvestrant inhibits the reaction [Endosulfan results in increased phosphorylation of MAPK1 protein] | decreases reaction|increases phosphorylation | 15531431 |
| C045651 | epigallocatechin gallate | epigallocatechin gallate inhibits the reaction [IL1B protein results in increased phosphorylation of MAPK1 protein] | decreases reaction|increases phosphorylation | 16206353 |
| C045651 | epigallocatechin gallate | epigallocatechin gallate inhibits the reaction [Glucose results in increased phosphorylation of MAPK1 protein] | decreases reaction|increases phosphorylation | 19557821 |
| C045651 | epigallocatechin gallate | epigallocatechin gallate inhibits the reaction [HGF protein results in increased phosphorylation of MAPK1 protein] | decreases reaction|increases phosphorylation | 19244381 |
| C045651 | epigallocatechin gallate | epigallocatechin gallate results in increased phosphorylation of and results in increased activity of MAPK1 protein | increases activity|increases phosphorylation | 15210717 |
| D004837 | Epinephrine | Epinephrine inhibits the reaction [Estradiol results in decreased phosphorylation of MAPK1 protein] | decreases phosphorylation|decreases reaction | 15292328 |
| C414690 | eplerenone | eplerenone inhibits the reaction [Aldosterone results in increased phosphorylation of and results in increased activity of MAPK1 protein] | decreases reaction|increases activity|increases phosphorylation | 17596522 |
| C007610 | equol | AG 1879 inhibits the reaction [equol results in increased phosphorylation of MAPK1 protein] | decreases reaction|increases phosphorylation | 16840783 |
| C007610 | equol | equol results in increased phosphorylation of MAPK1 protein | increases phosphorylation | 16840783 |
| C529414 | erigeroflavanone | erigeroflavanone inhibits the reaction [Hydrogen Peroxide results in increased phosphorylation of MAPK1 protein] | decreases reaction|increases phosphorylation | 19557877 |
| C073539 | erucin | erucin results in increased phosphorylation of and results in increased activity of MAPK1 protein | increases activity|increases phosphorylation | 15896333 |
| C007628 | esculetin | [esculetin co-treated with Paclitaxel] results in decreased expression of MAPK1 protein | affects cotreatment|decreases expression | 16051289 |
| C007628 | esculetin | esculetin results in decreased phosphorylation of and results in decreased activity of MAPK1 protein | decreases activity|decreases phosphorylation | 16051289 |
| C074283 | estradiol 3-benzoate | estradiol 3-benzoate results in decreased phosphorylation of MAPK1 protein | decreases phosphorylation | 15778002 |
| D004958 | Estradiol | Estradiol results in increased phosphorylation of and results in increased activity of MAPK1 protein | increases activity|increases phosphorylation | 15615701 |
| D004958 | Estradiol | fulvestrant inhibits the reaction [Estradiol results in increased phosphorylation of and results in increased activity of MAPK1 protein] | decreases reaction|increases activity|increases phosphorylation | 15615701 |
| D004958 | Estradiol | N-((2-(hydroxyaminocarbonyl)methyl)-4-methylpentanoyl)-3-(2'-naphthyl)alanylalanine, 2-aminoethylamide inhibits the reaction [Estradiol results in increased phosphorylation of and results in increased activity of MAPK1 protein] | decreases reaction|increases activity|increases phosphorylation | 15615701 |
| D004958 | Estradiol | tyrphostin AG 1478 inhibits the reaction [Estradiol results in increased phosphorylation of and results in increased activity of MAPK1 protein] | decreases reaction|increases activity|increases phosphorylation | 15615701 |
| D004958 | Estradiol | AG 1879 inhibits the reaction [Estradiol results in increased phosphorylation of MAPK1 protein] | decreases reaction|increases phosphorylation | 15930183 |
| D004958 | Estradiol | BRCA1 protein inhibits the reaction [Estradiol results in increased phosphorylation of and results in increased activity of MAPK1 protein] | decreases reaction|increases activity|increases phosphorylation | 18997820 |
| D004958 | Estradiol | Epinephrine inhibits the reaction [Estradiol results in decreased phosphorylation of MAPK1 protein] | decreases phosphorylation|decreases reaction | 15292328 |
| D004958 | Estradiol | ESR1 protein promotes the reaction [Estradiol results in increased phosphorylation of MAPK1 protein] | increases phosphorylation|increases reaction | 20372779 |
| D004958 | Estradiol | ESR2 protein promotes the reaction [Estradiol results in increased phosphorylation of MAPK1 protein] | increases phosphorylation|increases reaction | 20372779 |
| D004958 | Estradiol | [Estradiol co-treated with ESR1 protein] results in increased phosphorylation of MAPK1 protein | affects cotreatment|increases phosphorylation | 15185748 |
| D004958 | Estradiol | [Estradiol co-treated with LIF protein] results in increased phosphorylation of MAPK1 protein | affects cotreatment|increases phosphorylation | 14975756 |
| D004958 | Estradiol | Estradiol promotes the reaction [EGF protein results in increased phosphorylation of MAPK1 protein] | increases phosphorylation|increases reaction | 16901965 |
| D004958 | Estradiol | Estradiol results in decreased expression of MAPK1 protein | decreases expression | 12948864 |
| D004958 | Estradiol | Estradiol results in decreased phosphorylation of MAPK1 protein | decreases phosphorylation | 15292328 |
| D004958 | Estradiol | Estradiol results in increased activity of MAPK1 protein | increases activity | 14710592 |
| D004958 | Estradiol | Estradiol results in increased phosphorylation of and results in increased activity of MAPK1 protein | increases activity|increases phosphorylation | 18997820 17689939 15090535 |
| D004958 | Estradiol | Estradiol results in increased phosphorylation of MAPK1 protein | increases phosphorylation | 20372779 17088408 15930183 18544561 15358673 |
| D004958 | Estradiol | fulvestrant inhibits the reaction [Estradiol results in increased activity of MAPK1 protein] | decreases reaction|increases activity | 14710592 |
| D004958 | Estradiol | fulvestrant inhibits the reaction [Estradiol results in increased phosphorylation of and results in increased activity of MAPK1 protein] | decreases reaction|increases activity|increases phosphorylation | 17689939 |
| D004958 | Estradiol | Isoproterenol inhibits the reaction [Estradiol results in decreased phosphorylation of MAPK1 protein] | decreases phosphorylation|decreases reaction | 15292328 |
| D004958 | Estradiol | methyl-beta-cyclodextrin inhibits the reaction [Estradiol results in increased phosphorylation of MAPK1 protein] | decreases reaction|increases phosphorylation | 15930183 |
| D004958 | Estradiol | Mifepristone inhibits the reaction [Progesterone promotes the reaction [Estradiol results in increased phosphorylation of MAPK1 protein]] | decreases reaction|increases phosphorylation|increases reaction | 15358673 |
| D004958 | Estradiol | Norepinephrine inhibits the reaction [Estradiol results in decreased phosphorylation of MAPK1 protein] | decreases phosphorylation|decreases reaction | 15292328 |
| D004958 | Estradiol | OR486 inhibits the reaction [Estradiol results in decreased phosphorylation of MAPK1 protein] | decreases phosphorylation|decreases reaction | 15292328 |
| D004958 | Estradiol | PD 98059 inhibits the reaction [Estradiol results in increased phosphorylation of and results in increased activity of MAPK1 protein] | decreases reaction|increases activity|increases phosphorylation | 17689939 |
| D004958 | Estradiol | PD 98059 inhibits the reaction [Estradiol results in increased phosphorylation of MAPK1 protein] | decreases reaction|increases phosphorylation | 18544561 15930183 |
| D004958 | Estradiol | Progesterone promotes the reaction [Estradiol results in increased phosphorylation of MAPK1 protein] | increases phosphorylation|increases reaction | 15358673 |
| D004958 | Estradiol | SB 203580 inhibits the reaction [Estradiol results in increased phosphorylation of and results in increased activity of MAPK1 protein] | decreases reaction|increases activity|increases phosphorylation | 17689939 |
| D004958 | Estradiol | Suramin inhibits the reaction [Estradiol results in increased phosphorylation of MAPK1 protein] | decreases reaction|increases phosphorylation | 15930183 |
| D004958 | Estradiol | Estradiol results in decreased phosphorylation of MAPK1 protein | decreases phosphorylation | 19279558 |
| D004958 | Estradiol | Estradiol results in increased phosphorylation of MAPK1 protein | increases phosphorylation | 19340542 17174166 |
| D004958 | Estradiol | U 0126 inhibits the reaction [Estradiol results in increased phosphorylation of MAPK1 protein] | decreases reaction|increases phosphorylation | 17174166 |
| D004958 | Estradiol | 1,2-bis(2-aminophenoxy)ethane N,N,N',N'-tetraacetic acid acetoxymethyl ester inhibits the reaction [Estradiol results in increased phosphorylation of and results in increased activity of MAPK1 protein] | decreases reaction|increases activity|increases phosphorylation | 15072920 |
| D004958 | Estradiol | 1-(6-((3-methoxyestra-1,3,5(10)-trien-17-yl)amino)hexyl)-1H-pyrrole-2,5-dione inhibits the reaction [Estradiol results in increased activity of MAPK1 protein] | decreases reaction|increases activity | 16713447 |
| D004958 | Estradiol | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Estradiol results in increased phosphorylation of and results in increased activity of MAPK1 protein] | decreases reaction|increases activity|increases phosphorylation | 15072920 |
| D004958 | Estradiol | AG 1879 inhibits the reaction [Estradiol results in increased phosphorylation of and results in increased activity of MAPK1 protein] | decreases reaction|increases activity|increases phosphorylation | 15072920 |
| D004958 | Estradiol | bisphenol A inhibits the reaction [Estradiol results in increased phosphorylation of MAPK1 protein] | decreases reaction|increases phosphorylation | 16123166 |
| D004958 | Estradiol | chelerythrine inhibits the reaction [Estradiol results in increased activity of MAPK1 protein] | decreases reaction|increases activity | 16713447 |
| D004958 | Estradiol | Estradiol results in decreased phosphorylation of and results in decreased activity of MAPK1 protein | decreases activity|decreases phosphorylation | 20926581 |
| D004958 | Estradiol | Estradiol results in increased phosphorylation of and results in increased activity of MAPK1 protein | increases activity|increases phosphorylation | 20926581 16713447 15072920 |
| D004958 | Estradiol | Estradiol results in increased phosphorylation of MAPK1 protein | increases phosphorylation | 16123166 19463694 17174995 15531431 |
| D004958 | Estradiol | Nystatin inhibits the reaction [Estradiol results in increased phosphorylation of and results in increased activity of MAPK1 protein] | decreases reaction|increases activity|increases phosphorylation | 15072920 |
| D004958 | Estradiol | Tamoxifen inhibits the reaction [Estradiol results in increased activity of MAPK1 protein] | decreases reaction|increases activity | 16713447 |
| D004958 | Estradiol | U 0126 inhibits the reaction [Estradiol results in increased phosphorylation of MAPK1 protein] | decreases reaction|increases phosphorylation | 16123166 |
| C015854 | estradiol valerate | estradiol valerate results in increased activity of MAPK1 protein | increases activity | 14710592 |
| C015854 | estradiol valerate | fulvestrant inhibits the reaction [estradiol valerate results in increased activity of MAPK1 protein] | decreases reaction|increases activity | 14710592 |
| D002393 | Estrogens, Catechol | MAPK1 protein results in decreased susceptibility to Estrogens, Catechol | decreases response to substance | 15901486 |
| D000431 | Ethanol | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Ethanol results in increased phosphorylation of MAPK1 protein] | decreases reaction|increases phosphorylation | 18295389 |
| D000431 | Ethanol | Ethanol results in increased phosphorylation of and results in increased activity of MAPK1 protein | increases activity|increases phosphorylation | 18295389 |
| D000431 | Ethanol | PD 98059 inhibits the reaction [Ethanol results in increased phosphorylation of MAPK1 protein] | decreases reaction|increases phosphorylation | 18295389 |
| D000431 | Ethanol | pinocembrin inhibits the reaction [Ethanol results in increased phosphorylation of MAPK1 protein] | decreases reaction|increases phosphorylation | 18295389 |
| D000431 | Ethanol | Propolis inhibits the reaction [Ethanol results in increased phosphorylation of MAPK1 protein] | decreases reaction|increases phosphorylation | 18295389 |
| D000431 | Ethanol | Ethanol results in decreased phosphorylation of and results in decreased activity of MAPK1 protein | decreases activity|decreases phosphorylation | 10993886 18358832 |
| D000431 | Ethanol | Phosphatidic Acids inhibits the reaction [Ethanol results in decreased phosphorylation of and results in decreased activity of MAPK1 protein] | decreases activity|decreases phosphorylation|decreases reaction | 18358832 |
| D000431 | Ethanol | Acetylcysteine inhibits the reaction [Ethanol results in increased phosphorylation of and results in increased activity of MAPK1 protein] | decreases reaction|increases activity|increases phosphorylation | 12065697 |
| D000431 | Ethanol | Ethanol results in increased expression of MAPK1 mRNA | increases expression | 16098508 |
| D000431 | Ethanol | Ethanol results in increased phosphorylation of and results in increased activity of MAPK1 protein | increases activity|increases phosphorylation | 12065697 |
| D004986 | Ether, Ethyl | [Ether, Ethyl co-treated with Acetic Acid] results in increased activity of MAPK1 protein | affects cotreatment|increases activity | 12951195 |
| D004986 | Ether, Ethyl | [Ether, Ethyl co-treated with Acetic Acid] results in increased expression of MAPK1 protein modified form | affects cotreatment|increases expression | 15791581 |
| D004986 | Ether, Ethyl | [Ether, Ethyl co-treated with Acetic Acid] results in increased phosphorylation of and results in increased activity of MAPK1 protein | affects cotreatment|increases activity|increases phosphorylation | 15791581 |
| D004997 | Ethinyl Estradiol | Ethinyl Estradiol results in increased expression of MAPK1 mRNA | increases expression | 17606305 |
| D004997 | Ethinyl Estradiol | Ethinyl Estradiol results in increased activity of MAPK1 protein | increases activity | 14710592 |
| D004997 | Ethinyl Estradiol | fulvestrant inhibits the reaction [Ethinyl Estradiol results in increased activity of MAPK1 protein] | decreases reaction|increases activity | 14710592 |
| D004997 | Ethinyl Estradiol | Ethinyl Estradiol results in increased expression of MAPK1 mRNA | increases expression | 17942748 |
| D004997 | Ethinyl Estradiol | [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of MAPK1 mRNA | affects cotreatment|increases expression | 17942748 |
| C507035 | ethyl 6-(N-(2-chloro-4-fluorophenyl)sulfamoyl)cyclohex-1-ene-1-carboxylate | ethyl 6-(N-(2-chloro-4-fluorophenyl)sulfamoyl)cyclohex-1-ene-1-carboxylate inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of MAPK1 protein] | decreases reaction|increases phosphorylation | 16373689 |
| C045989 | eticlopride | eticlopride results in increased phosphorylation of MAPK1 protein | increases phosphorylation | 12871586 |
| D018690 | Excitatory Amino Acid Agonists | Excitatory Amino Acid Agonists results in increased phosphorylation of MAPK1 protein | increases phosphorylation | 19201465 |
| D018690 | Excitatory Amino Acid Agonists | mangiferin inhibits the reaction [Excitatory Amino Acid Agonists results in increased phosphorylation of MAPK1 protein] | decreases reaction|increases phosphorylation | 19201465 |
| D018690 | Excitatory Amino Acid Agonists | morin inhibits the reaction [Excitatory Amino Acid Agonists results in increased phosphorylation of MAPK1 protein] | decreases reaction|increases phosphorylation | 19201465 |
| C093323 | farnesylthiosalicylic acid | farnesylthiosalicylic acid inhibits the reaction [Hydrogen Peroxide results in increased activity of MAPK1 protein] | decreases reaction|increases activity | 15328380 |
| D005280 | Fenoterol | [Fenoterol binds to and results in increased activity of ADRB2 protein] which results in increased phosphorylation of and results in increased activity of MAPK1 protein | affects binding|increases activity|increases phosphorylation | 16980553 |
| C024555 | ferric chloride | [Vanadates co-treated with ferric chloride] results in increased phosphorylation of MAPK1 protein | affects cotreatment|increases phosphorylation | 16728372 |
| C020748 | ferrous sulfate | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [ferrous sulfate results in increased phosphorylation of MAPK1 protein] | decreases reaction|increases phosphorylation | 17172471 |
| C020748 | ferrous sulfate | deferiprone inhibits the reaction [ferrous sulfate results in increased phosphorylation of MAPK1 protein] | decreases reaction|increases phosphorylation | 17172471 |
| C020748 | ferrous sulfate | ferrous sulfate results in increased phosphorylation of MAPK1 protein | increases phosphorylation | 17172471 |
| C020748 | ferrous sulfate | Filipin inhibits the reaction [ferrous sulfate results in increased phosphorylation of MAPK1 protein] | decreases reaction|increases phosphorylation | 17172471 |
| C020748 | ferrous sulfate | HRAS protein affects the reaction [ferrous sulfate results in increased phosphorylation of MAPK1 protein] | affects reaction|increases phosphorylation | 17172471 |
| C020748 | ferrous sulfate | PIK3R1 protein affects the reaction [ferrous sulfate results in increased phosphorylation of MAPK1 protein] | affects reaction|increases phosphorylation | 17172471 |
| C020748 | ferrous sulfate | SB 203580 promotes the reaction [ferrous sulfate results in increased phosphorylation of MAPK1 protein] | increases phosphorylation|increases reaction | 17172471 |
| C020748 | ferrous sulfate | U 0126 inhibits the reaction [ferrous sulfate results in increased phosphorylation of MAPK1 protein] | decreases reaction|increases phosphorylation | 17172471 |
| C004999 | ferulic acid | ferulic acid results in decreased activity of MAPK1 protein | decreases activity | 15486966 |
| C004999 | ferulic acid | ferulic acid results in decreased activity of MAPK1 protein | decreases activity | 15363954 |
| D005372 | Filipin | Filipin inhibits the reaction [ferrous sulfate results in increased phosphorylation of MAPK1 protein] | decreases reaction|increases phosphorylation | 17172471 |
| D005372 | Filipin | Filipin inhibits the reaction [Iron results in increased phosphorylation of MAPK1 protein] | decreases reaction|increases phosphorylation | 17172471 |
| D005395 | Fish Oils | Fish Oils inhibits the reaction [deoxynivalenol results in increased phosphorylation of MAPK1 protein] | decreases reaction|increases phosphorylation | 14690764 |
| D005419 | Flavonoids | Flavonoids results in decreased expression of MAPK1 mRNA | decreases expression | 18035473 |
| C024352 | fludarabine | fludarabine results in decreased phosphorylation of MAPK1 protein | decreases phosphorylation | 15213310 |
| D005492 | Folic Acid | Folic Acid inhibits the reaction [Homocysteine results in increased phosphorylation of MAPK1 protein] | decreases reaction|increases phosphorylation | 16251475 |
| D005492 | Folic Acid | Folic Acid inhibits the reaction [IGF1R protein results in increased phosphorylation of MAPK1 protein] | decreases reaction|increases phosphorylation | 16728583 |
| D005492 | Folic Acid | Folic Acid results in increased activity of MAPK1 protein | increases activity | 15728788 |
| D005492 | Folic Acid | [Folic Acid results in increased activity of MAPK1 protein] which results in increased expression of PTHLH protein | increases activity|increases expression | 15728788 |
| C012629 | formoterol | [formoterol binds to and results in increased activity of ADRB2 protein] which results in increased phosphorylation of and results in increased activity of MAPK1 protein | affects binding|increases activity|increases phosphorylation | 16980553 |
| C012629 | formoterol | formoterol results in increased phosphorylation of and results in increased activity of MAPK1 protein | increases activity|increases phosphorylation | 15603589 |
| D009240 | N-Formylmethionine Leucyl-Phenylalanine | N-Formylmethionine Leucyl-Phenylalanine results in increased phosphorylation of and results in increased activity of MAPK1 protein | increases activity|increases phosphorylation | 11427526 17377739 |
| D009240 | N-Formylmethionine Leucyl-Phenylalanine | N-Formylmethionine Leucyl-Phenylalanine results in increased phosphorylation of MAPK1 protein | increases phosphorylation | 15494208 |
| D009240 | N-Formylmethionine Leucyl-Phenylalanine | nordy inhibits the reaction [N-Formylmethionine Leucyl-Phenylalanine results in increased phosphorylation of and results in increased activity of MAPK1 protein] | decreases reaction|increases activity|increases phosphorylation | 17377739 |
| D009240 | N-Formylmethionine Leucyl-Phenylalanine | PLD1 protein affects the reaction [N-Formylmethionine Leucyl-Phenylalanine results in increased phosphorylation of and results in increased activity of MAPK1 protein] | affects reaction|increases activity|increases phosphorylation | 11427526 |
| D009240 | N-Formylmethionine Leucyl-Phenylalanine | resveratrol inhibits the reaction [N-Formylmethionine Leucyl-Phenylalanine results in increased phosphorylation of MAPK1 protein] | decreases reaction|increases phosphorylation | 16212921 |
| D009240 | N-Formylmethionine Leucyl-Phenylalanine | N-Formylmethionine Leucyl-Phenylalanine results in increased phosphorylation of MAPK1 protein | increases phosphorylation | 11145705 16621998 |
| D009240 | N-Formylmethionine Leucyl-Phenylalanine | RAC2 protein affects the reaction [N-Formylmethionine Leucyl-Phenylalanine results in increased phosphorylation of MAPK1 protein] | affects reaction|increases phosphorylation | 11145705 |
| D009240 | N-Formylmethionine Leucyl-Phenylalanine | N-Formylmethionine Leucyl-Phenylalanine results in increased phosphorylation of and results in increased activity of MAPK1 protein | increases activity|increases phosphorylation | 17560994 |
| D009240 | N-Formylmethionine Leucyl-Phenylalanine | resveratrol inhibits the reaction [N-Formylmethionine Leucyl-Phenylalanine results in increased phosphorylation of MAPK1 protein] | decreases reaction|increases phosphorylation | 16212921 |
| D005576 | Forskolin | Forskolin inhibits the reaction [FGF10 protein results in increased phosphorylation of MAPK1 protein] | decreases reaction|increases phosphorylation | 12533312 14975937 |
| D005576 | Forskolin | Forskolin inhibits the reaction [Hydrogen Peroxide results in increased phosphorylation of MAPK1 protein] | decreases reaction|increases phosphorylation | 14975937 |
| D005576 | Forskolin | Forskolin inhibits the reaction [Shiga Toxin results in increased activity of MAPK1 protein] | decreases reaction|increases activity | 11675405 |
| D005576 | Forskolin | Forskolin results in increased phosphorylation of MAPK1 protein | increases phosphorylation | 17322281 |
| D005576 | Forskolin | N-(2-(4-bromocinnamylamino)ethyl)-5-isoquinolinesulfonamide inhibits the reaction [Forskolin results in increased phosphorylation of MAPK1 protein] | decreases reaction|increases phosphorylation | 17322281 |
| D005576 | Forskolin | Forskolin results in increased phosphorylation of MAPK1 protein | increases phosphorylation | 18004999 |
| D005576 | Forskolin | N-(2-(4-bromocinnamylamino)ethyl)-5-isoquinolinesulfonamide inhibits the reaction [Forskolin results in increased phosphorylation of MAPK1 protein] | decreases reaction|increases phosphorylation | 18004999 |
| D005620 | Freund's Adjuvant | [Urethane co-treated with Freund's Adjuvant] results in increased expression of MAPK1 mRNA | affects cotreatment|increases expression | 12400877 |
| C070081 | fulvestrant | fulvestrant inhibits the reaction [Estradiol results in increased phosphorylation of and results in increased activity of MAPK1 protein] | decreases reaction|increases activity|increases phosphorylation | 15615701 |
| C070081 | fulvestrant | fulvestrant inhibits the reaction [propyl pyrazole triol results in increased phosphorylation of MAPK1 protein] | decreases reaction|increases phosphorylation | 15615701 |
| C070081 | fulvestrant | fulvestrant inhibits the reaction [resveratrol results in increased phosphorylation of and results in increased activity of MAPK1 protein] | decreases reaction|increases activity|increases phosphorylation | 15615701 |
| C070081 | fulvestrant | fulvestrant inhibits the reaction [Cadmium Chloride results in increased phosphorylation of MAPK1 protein] | decreases reaction|increases phosphorylation | 17125913 |
| C070081 | fulvestrant | fulvestrant inhibits the reaction [Cadmium results in increased phosphorylation of MAPK1 protein] | decreases reaction|increases phosphorylation | 17125913 |
| C070081 | fulvestrant | fulvestrant inhibits the reaction [Estradiol results in increased activity of MAPK1 protein] | decreases reaction|increases activity | 14710592 |
| C070081 | fulvestrant | fulvestrant inhibits the reaction [Estradiol results in increased phosphorylation of and results in increased activity of MAPK1 protein] | decreases reaction|increases activity|increases phosphorylation | 17689939 |
| C070081 | fulvestrant | fulvestrant inhibits the reaction [estradiol valerate results in increased activity of MAPK1 protein] | decreases reaction|increases activity | 14710592 |
| C070081 | fulvestrant | fulvestrant inhibits the reaction [Ethinyl Estradiol results in increased activity of MAPK1 protein] | decreases reaction|increases activity | 14710592 |
| C070081 | fulvestrant | fulvestrant inhibits the reaction [resveratrol results in increased phosphorylation of and results in increased activity of MAPK1 protein] | decreases reaction|increases activity|increases phosphorylation | 17689939 |
| C070081 | fulvestrant | fulvestrant inhibits the reaction [octylphenol results in increased phosphorylation of MAPK1 protein] | decreases reaction|increases phosphorylation | 18417718 |
| C070081 | fulvestrant | fulvestrant inhibits the reaction [Endosulfan results in increased phosphorylation of MAPK1 protein] | decreases reaction|increases phosphorylation | 15531431 |
| C070081 | fulvestrant | fulvestrant inhibits the reaction [Promegestone results in increased phosphorylation of MAPK1 protein] | decreases reaction|increases phosphorylation | 16020483 |
| C054597 | garcinol | garcinol results in decreased phosphorylation of and results in decreased activity of MAPK1 protein | decreases activity|decreases phosphorylation | 16052481 |
| C419708 | gefitinib | gefitinib inhibits the reaction [Dinoprostone results in increased phosphorylation of MAPK1 protein] | decreases reaction|increases phosphorylation | 17805209 |
| C419708 | gefitinib | gefitinib inhibits the reaction [EGF protein results in increased phosphorylation of and results in increased activity of MAPK1 protein] | decreases reaction|increases activity|increases phosphorylation | 17898861 |
| C419708 | gefitinib | gefitinib inhibits the reaction [EGF protein results in increased phosphorylation of MAPK1 protein] | decreases reaction|increases phosphorylation | 19233551 |
| C419708 | gefitinib | gefitinib promotes the reaction [[zoledronic acid co-treated with 4-(5-(4-chlorophenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl)benzenesulfonamide] results in decreased phosphorylation of MAPK1 protein] | affects cotreatment|decreases phosphorylation|increases reaction | 16322342 |
| C419708 | gefitinib | gefitinib results in decreased expression of MAPK1 protein modified form | decreases expression | 19288272 |
| C001277 | geldanamycin | geldanamycin inhibits the reaction [Dieldrin results in increased phosphorylation of MAPK1 protein] | decreases reaction|increases phosphorylation | 15888667 |
| C001277 | geldanamycin | geldanamycin inhibits the reaction [Endosulfan results in increased phosphorylation of MAPK1 protein] | decreases reaction|increases phosphorylation | 15888667 |
| C001277 | geldanamycin | geldanamycin inhibits the reaction [Heptachlor results in increased phosphorylation of MAPK1 protein] | decreases reaction|increases phosphorylation | 15888667 |
| C001277 | geldanamycin | geldanamycin inhibits the reaction [Lindane results in increased phosphorylation of MAPK1 protein] | decreases reaction|increases phosphorylation | 15888667 |
| C001277 | geldanamycin | geldanamycin inhibits the reaction [Tretinoin results in increased phosphorylation of MAPK1 protein] | decreases reaction|increases phosphorylation | 17293044 |
| C001277 | geldanamycin | geldanamycin results in decreased phosphorylation of MAPK1 protein | decreases phosphorylation | 17293044 |
| C001277 | geldanamycin | geldanamycin inhibits the reaction [Tetradecanoylphorbol Acetate results in increased phosphorylation of and results in increased activity of MAPK1 protein] | decreases reaction|increases activity|increases phosphorylation | 8816498 |
| D019833 | Genistein | [1,2-bis(2-aminophenoxy)ethane N,N,N',N'-tetraacetic acid acetoxymethyl ester co-treated with Genistein] inhibits the reaction [Thapsigargin promotes the reaction [Homocysteine results in increased phosphorylation of MAPK1 protein]] | affects cotreatment|decreases reaction|increases phosphorylation|increases reaction | 16251475 |
| D019833 | Genistein | AG 1879 inhibits the reaction [Genistein results in increased phosphorylation of MAPK1 protein] | decreases reaction|increases phosphorylation | 16840783 |
| D019833 | Genistein | Genistein inhibits the reaction [Homocysteine results in increased phosphorylation of MAPK1 protein] | decreases reaction|increases phosphorylation | 16251475 |
| D019833 | Genistein | Genistein inhibits the reaction [Thapsigargin promotes the reaction [Homocysteine results in increased phosphorylation of MAPK1 protein]] | decreases reaction|increases phosphorylation|increases reaction | 16251475 |
| D019833 | Genistein | Genistein results in increased expression of and results in increased phosphorylation of MAPK1 protein | increases expression|increases phosphorylation | 16149052 |
| D019833 | Genistein | Genistein results in increased phosphorylation of and results in increased activity of MAPK1 protein | increases activity|increases phosphorylation | 15090535 |
| D019833 | Genistein | Genistein results in increased phosphorylation of MAPK1 protein | increases phosphorylation | 16840783 17088408 |
| D019833 | Genistein | [Tretinoin co-treated with Genistein] results in increased phosphorylation of MAPK1 protein | affects cotreatment|increases phosphorylation | 16149052 |
| D019833 | Genistein | [Genistein co-treated with Methoxychlor] results in decreased expression of MAPK1 mRNA | affects cotreatment|decreases expression | 16443925 |
| D019833 | Genistein | Genistein results in decreased expression of MAPK1 mRNA | decreases expression | 16443925 |
| D019833 | Genistein | Genistein results in decreased phosphorylation of MAPK1 protein | decreases phosphorylation | 15781664 |
| D005839 | Gentamicins | CASR protein promotes the reaction [Gentamicins results in increased phosphorylation of and results in increased activity of MAPK1 protein] | increases activity|increases phosphorylation|increases reaction | 17537980 |
| D005839 | Gentamicins | Gentamicins results in increased phosphorylation of and results in increased activity of MAPK1 protein | increases activity|increases phosphorylation | 17537980 |
| D005839 | Gentamicins | PD 98059 inhibits the reaction [Gentamicins results in increased phosphorylation of and results in increased activity of MAPK1 protein] | decreases reaction|increases activity|increases phosphorylation | 17537980 |
| C063170 | Ginkgo biloba extract 761 | Ginkgo biloba extract 761 inhibits the reaction [APP protein results in increased phosphorylation of and results in increased activity of MAPK1 protein] | decreases reaction|increases activity|increases phosphorylation | 19464278 |
| C063170 | Ginkgo biloba extract 761 | Ginkgo biloba extract 761 inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of MAPK1 protein] | decreases reaction|increases phosphorylation | 11543732 |
| C045856 | ginkgolide B | ginkgolide B inhibits the reaction [APP protein results in increased phosphorylation of and results in increased activity of MAPK1 protein] | decreases reaction|increases activity|increases phosphorylation | 19464278 |
| D005912 | Gliotoxin | Gliotoxin results in increased phosphorylation of and results in increased activity of MAPK1 protein | increases activity|increases phosphorylation | 17466404 |
| C480175 | glucan phosphate | glucan phosphate inhibits the reaction [Zymosan results in increased activity of MAPK1 protein] | decreases reaction|increases activity | 17458858 |
| D005936 | Glucans | Glucans results in increased phosphorylation of MAPK1 protein | increases phosphorylation | 19041413 |
| D005947 | Glucose | Catechin inhibits the reaction [Glucose results in increased phosphorylation of MAPK1 protein] | decreases reaction|increases phosphorylation | 19557821 |
| D005947 | Glucose | epigallocatechin gallate inhibits the reaction [Glucose results in increased phosphorylation of MAPK1 protein] | decreases reaction|increases phosphorylation | 19557821 |
| D005947 | Glucose | Glucose results in increased phosphorylation of MAPK1 protein | increases phosphorylation | 19557821 |
| D005947 | Glucose | Luteolin inhibits the reaction [Glucose results in increased phosphorylation of MAPK1 protein] | decreases reaction|increases phosphorylation | 19557821 |
| D005947 | Glucose | Quercetin inhibits the reaction [Glucose results in increased phosphorylation of MAPK1 protein] | decreases reaction|increases phosphorylation | 19557821 |
| D005947 | Glucose | Rutin inhibits the reaction [Glucose results in increased phosphorylation of MAPK1 protein] | decreases reaction|increases phosphorylation | 19557821 |
| D005947 | Glucose | [Oxygen deficiency co-treated with Glucose deficiency] results in increased phosphorylation of MAPK1 protein | affects cotreatment|increases phosphorylation | 19303870 |
| D005947 | Glucose | diphenyliodonium inhibits the reaction [Glucose results in increased phosphorylation of MAPK1 protein] | decreases reaction|increases phosphorylation | 16572112 |
| D005947 | Glucose | Glucose affects the phosphorylation of MAPK1 protein | affects phosphorylation | 19020779 |
| D005947 | Glucose | Glucose results in increased phosphorylation of MAPK1 protein | increases phosphorylation | 16572112 19861503 |
| D005947 | Glucose | MAPK1 protein promotes the reaction [NRG1 protein results in increased transport of Glucose] | increases reaction|increases transport | 14711829 |
| D005947 | Glucose | PD 98059 inhibits the reaction [Glucose results in increased phosphorylation of MAPK1 protein] | decreases reaction|increases phosphorylation | 16572112 |
| D005947 | Glucose | Superoxides affects the reaction [Glucose results in increased phosphorylation of MAPK1 protein] | affects reaction|increases phosphorylation | 16572112 |
| C086566 | glycitein | glycitein results in increased phosphorylation of MAPK1 protein | increases phosphorylation | 17088408 |
| D017127 | Glycosylation End Products, Advanced | diphenyliodonium inhibits the reaction [Glycosylation End Products, Advanced results in increased phosphorylation of MAPK1 protein] | decreases reaction|increases phosphorylation | 16572112 |
| D017127 | Glycosylation End Products, Advanced | Glycosylation End Products, Advanced results in increased phosphorylation of MAPK1 protein | increases phosphorylation | 16572112 |
| D017127 | Glycosylation End Products, Advanced | PD 98059 inhibits the reaction [Glycosylation End Products, Advanced results in increased phosphorylation of MAPK1 protein] | decreases reaction|increases phosphorylation | 16572112 |
| D017127 | Glycosylation End Products, Advanced | Superoxides affects the reaction [Glycosylation End Products, Advanced results in increased phosphorylation of MAPK1 protein] | affects reaction|increases phosphorylation | 16572112 |
| C078131 | GM 6001 | GM 6001 inhibits the reaction [Asbestos, Serpentine results in increased phosphorylation of MAPK1 protein] | decreases reaction|increases phosphorylation | 16571779 |
| C078131 | GM 6001 | GM 6001 inhibits the reaction [Hydrogen Peroxide results in increased activity of MAPK1 protein] | decreases reaction|increases activity | 15574683 |
| C078131 | GM 6001 | GM 6001 inhibits the reaction [Phenylephrine results in increased phosphorylation of MAPK1 protein] | decreases reaction|increases phosphorylation | 16760267 |
| C081021 | Go 6976 | Go 6976 inhibits the reaction [Homocysteine results in increased phosphorylation of MAPK1 protein] | decreases reaction|increases phosphorylation | 16251475 |
| C081021 | Go 6976 | Go 6976 results in decreased phosphorylation of MAPK1 protein | decreases phosphorylation | 19393235 |
| C081021 | Go 6976 | Go 6976 inhibits the reaction [Tetradecanoylphorbol Acetate results in increased activity of MAPK1 protein] | decreases reaction|increases activity | 12720544 |
| C506645 | GW2974 | GW2974 inhibits the reaction [Oleylethanolamide results in increased phosphorylation of MAPK1 protein] | decreases reaction|increases phosphorylation | 16269455 |
| D006220 | Haloperidol | Clozapine inhibits the reaction [Haloperidol results in increased phosphorylation of MAPK1 protein] | decreases reaction|increases phosphorylation | 12871586 |
| D006220 | Haloperidol | Haloperidol results in increased phosphorylation of MAPK1 protein | increases phosphorylation | 12871586 |
| D006220 | Haloperidol | SL 327 inhibits the reaction [Haloperidol results in increased phosphorylation of MAPK1 protein] | decreases reaction|increases phosphorylation | 12871586 |
| D006220 | Haloperidol | Haloperidol results in decreased expression of MAPK1 mRNA | decreases expression | 15860345 |
| D006427 | Hemin | diacetyldichlorofluorescein inhibits the reaction [Hemin results in increased phosphorylation of MAPK1 protein] | decreases reaction|increases phosphorylation | 16959797 |
| D006427 | Hemin | Hemin results in increased phosphorylation of MAPK1 protein | increases phosphorylation | 16959797 |
| D006493 | Heparin | Heparin inhibits the reaction [FGF1 protein results in increased phosphorylation of MAPK1 protein] | decreases reaction|increases phosphorylation | 14966081 |
| D006493 | Heparin | Heparin inhibits the reaction [FGF2 protein results in increased phosphorylation of MAPK1 protein] | decreases reaction|increases phosphorylation | 14966081 |
| D006533 | Heptachlor | calphostin C inhibits the reaction [Heptachlor results in increased phosphorylation of MAPK1 protein] | decreases reaction|increases phosphorylation | 15888667 |
| D006533 | Heptachlor | geldanamycin inhibits the reaction [Heptachlor results in increased phosphorylation of MAPK1 protein] | decreases reaction|increases phosphorylation | 15888667 |
| D006533 | Heptachlor | Heptachlor results in decreased expression of MAPK1 protein | decreases expression | 9704902 |
| D006533 | Heptachlor | Heptachlor results in increased phosphorylation of and results in increased activity of MAPK1 protein | increases activity|increases phosphorylation | 9704902 15888667 |
| D006533 | Heptachlor | U 0126 inhibits the reaction [Heptachlor results in increased phosphorylation of MAPK1 protein] | decreases reaction|increases phosphorylation | 15888667 |
| D006533 | Heptachlor | Heptachlor results in increased phosphorylation of and results in increased activity of MAPK1 protein | increases activity|increases phosphorylation | 14678745 |
| D006588 | Hexanones | Hexanones results in decreased activity of MAPK1 protein | decreases activity | 14757120 |
| D006632 | Histamine | [Histamine binds to and results in increased activity of HRH4 protein] which results in increased phosphorylation of MAPK1 protein | affects binding|increases activity|increases phosphorylation | 11181941 |
| D017313 | Fenretinide | bisindolylmaleimide I inhibits the reaction [Fenretinide results in increased phosphorylation of MAPK1 protein] | decreases reaction|increases phosphorylation | 16407847 |
| D017313 | Fenretinide | Butylated Hydroxyanisole inhibits the reaction [Fenretinide results in increased phosphorylation of MAPK1 protein] | decreases reaction|increases phosphorylation | 16407847 |
| D017313 | Fenretinide | Fenretinide results in increased phosphorylation of MAPK1 protein | increases phosphorylation | 16407847 |
| D017313 | Fenretinide | [IL24 protein co-treated with Fenretinide] results in increased phosphorylation of MAPK1 protein | affects cotreatment|increases phosphorylation | 15580305 |
| D017313 | Fenretinide | PD 98059 inhibits the reaction [Fenretinide results in increased phosphorylation of MAPK1 protein] | decreases reaction|increases phosphorylation | 16407847 |
| D006812 | Humic Substances | Humic Substances results in increased phosphorylation of MAPK1 protein | increases phosphorylation | 19686714 |
| D006812 | Humic Substances | PD 98059 inhibits the reaction [Humic Substances results in increased phosphorylation of MAPK1 protein] | decreases reaction|increases phosphorylation | 19686714 |
| D006820 | Hyaluronic Acid | Hyaluronic Acid analog results in increased phosphorylation of MAPK1 protein | increases phosphorylation | 12402308 |
| D006843 | Hydrocarbons, Chlorinated | Hydrocarbons, Chlorinated results in decreased activity of MAPK1 protein | decreases activity | 14757120 |
| D006861 | Hydrogen Peroxide | 1,10-phenanthroline inhibits the reaction [Hydrogen Peroxide results in increased activity of MAPK1 protein] | decreases reaction|increases activity | 15328380 |
| D006861 | Hydrogen Peroxide | farnesylthiosalicylic acid inhibits the reaction [Hydrogen Peroxide results in increased activity of MAPK1 protein] | decreases reaction|increases activity | 15328380 |
| D006861 | Hydrogen Peroxide | Hydrogen Peroxide results in increased phosphorylation of and results in increased activity of MAPK1 protein | increases activity|increases phosphorylation | 15328380 |
| D006861 | Hydrogen Peroxide | Mannitol inhibits the reaction [Hydrogen Peroxide results in increased activity of MAPK1 protein] | decreases reaction|increases activity | 15328380 |
| D006861 | Hydrogen Peroxide | PD 98059 inhibits the reaction [Hydrogen Peroxide results in increased activity of MAPK1 protein] | decreases reaction|increases activity | 15328380 |
| D006861 | Hydrogen Peroxide | Suramin inhibits the reaction [Hydrogen Peroxide results in increased activity of MAPK1 protein] | decreases reaction|increases activity | 15328380 |
| D006861 | Hydrogen Peroxide | tyrphostin 51 inhibits the reaction [Hydrogen Peroxide results in increased activity of MAPK1 protein] | decreases reaction|increases activity | 15328380 |
| D006861 | Hydrogen Peroxide | W 7 inhibits the reaction [Hydrogen Peroxide results in increased activity of MAPK1 protein] | decreases reaction|increases activity | 15328380 |
| D006861 | Hydrogen Peroxide | CAT protein inhibits the reaction [Hydrogen Peroxide results in increased phosphorylation of and results in increased activity of MAPK1 protein] | decreases reaction|increases activity|increases phosphorylation | 11603923 |
| D006861 | Hydrogen Peroxide | Forskolin inhibits the reaction [Hydrogen Peroxide results in increased phosphorylation of MAPK1 protein] | decreases reaction|increases phosphorylation | 14975937 |
| D006861 | Hydrogen Peroxide | Hydrogen Peroxide results in increased activity of MAPK1 protein | increases activity | 12676768 |
| D006861 | Hydrogen Peroxide | Hydrogen Peroxide results in increased phosphorylation of and results in increased activity of MAPK1 protein | increases activity|increases phosphorylation | 10640773 11603923 |
| D006861 | Hydrogen Peroxide | Hydrogen Peroxide results in increased phosphorylation of MAPK1 protein | increases phosphorylation | 14975937 |
| D006861 | Hydrogen Peroxide | PD 98059 inhibits the reaction [Hydrogen Peroxide results in increased phosphorylation of and results in increased activity of MAPK1 protein] | decreases reaction|increases activity|increases phosphorylation | 10640773 |
| D006861 | Hydrogen Peroxide | erigeroflavanone inhibits the reaction [Hydrogen Peroxide results in increased phosphorylation of MAPK1 protein] | decreases reaction|increases phosphorylation | 19557877 |
| D006861 | Hydrogen Peroxide | Hydrogen Peroxide affects the reaction [SHC1 protein affects the phosphorylation of MAPK1 protein] | affects phosphorylation|affects reaction | 16972253 |
| D006861 | Hydrogen Peroxide | Hydrogen Peroxide results in increased phosphorylation of MAPK1 protein | increases phosphorylation | 19557877 |
| D006861 | Hydrogen Peroxide | AG 1879 inhibits the reaction [Hydrogen Peroxide results in increased activity of MAPK1 protein] | decreases reaction|increases activity | 15574683 |
| D006861 | Hydrogen Peroxide | GM 6001 inhibits the reaction [Hydrogen Peroxide results in increased activity of MAPK1 protein] | decreases reaction|increases activity | 15574683 |
| D006861 | Hydrogen Peroxide | Hydrogen Peroxide results in increased activity of MAPK1 protein | increases activity | 15574683 |
| D006861 | Hydrogen Peroxide | Hydrogen Peroxide results in increased phosphorylation of and results in increased activity of MAPK1 protein | increases activity|increases phosphorylation | 10972672 |
| D006861 | Hydrogen Peroxide | Hydrogen Peroxide results in increased phosphorylation of MAPK1 protein | increases phosphorylation | 16284289 17204550 |
| D006861 | Hydrogen Peroxide | marimastat inhibits the reaction [Hydrogen Peroxide results in increased activity of MAPK1 protein] | decreases reaction|increases activity | 15574683 |
| D006861 | Hydrogen Peroxide | Progesterone promotes the reaction [Hydrogen Peroxide results in increased phosphorylation of MAPK1 protein] | increases phosphorylation|increases reaction | 16284289 |
| D006861 | Hydrogen Peroxide | Quercetin inhibits the reaction [Hydrogen Peroxide results in increased phosphorylation of and results in increased activity of MAPK1 protein] | decreases reaction|increases activity|increases phosphorylation | 10972672 |
| D006861 | Hydrogen Peroxide | RLN2 protein promotes the reaction [Hydrogen Peroxide results in increased phosphorylation of MAPK1 protein] | increases phosphorylation|increases reaction | 17204550 |
| D006861 | Hydrogen Peroxide | tyrphostin AG 1478 inhibits the reaction [Hydrogen Peroxide results in increased activity of MAPK1 protein] | decreases reaction|increases activity | 15574683 |
| D006861 | Hydrogen Peroxide | U 0126 inhibits the reaction [Hydrogen Peroxide results in increased activity of MAPK1 protein] | decreases reaction|increases activity | 12513686 |
| C031927 | hydroquinone | [CSF2 protein co-treated with hydroquinone] results in increased phosphorylation of and results in increased activity of MAPK1 protein | affects cotreatment|increases activity|increases phosphorylation | 15129224 |
| C031927 | hydroquinone | hydroquinone results in increased phosphorylation of and results in increased activity of MAPK1 protein | increases activity|increases phosphorylation | 15129224 |
| C031927 | hydroquinone | PD 98059 inhibits the reaction [hydroquinone results in increased phosphorylation of and results in increased activity of MAPK1 protein] | decreases reaction|increases activity|increases phosphorylation | 15129224 |
| D012701 | Serotonin | 1-Butanol inhibits the reaction [Serotonin results in increased phosphorylation of and results in increased activity of MAPK1 protein] | decreases reaction|increases activity|increases phosphorylation | 18621911 |
| D012701 | Serotonin | Serotonin results in increased phosphorylation of and results in increased activity of MAPK1 protein | increases activity|increases phosphorylation | 18621911 |
| C001654 | hyperforin | hyperforin results in increased phosphorylation of MAPK1 protein | increases phosphorylation | 15622447 |
| C477872 | IC 87114 | IC 87114 inhibits the reaction [IL4 protein results in increased phosphorylation of MAPK1 protein] | decreases reaction|increases phosphorylation | 16179367 |
| C477872 | IC 87114 | IC 87114 results in decreased phosphorylation of MAPK1 protein | decreases phosphorylation | 16179367 |
| C056599 | icariin | icariin results in increased phosphorylation of MAPK1 protein | increases phosphorylation | 18423597 |
| C056599 | icariin | U 0126 inhibits the reaction [icariin results in increased phosphorylation of MAPK1 protein] | decreases reaction|increases phosphorylation | 18423597 |
| C026777 | ICI 118551 | ICI 118551 inhibits the reaction [Terbutaline inhibits the reaction [Shiga Toxin results in increased expression of MAPK1 protein]] | decreases reaction|increases expression | 11675405 |
| C026777 | ICI 118551 | [Dobutamine co-treated with ICI 118551] results in increased activity of MAPK1 protein | affects cotreatment|increases activity | 19719783 |
| C026777 | ICI 118551 | ICI 118551 inhibits the reaction [Terbutaline inhibits the reaction [Lipopolysaccharides results in increased activity of MAPK1 protein]] | decreases reaction|increases activity | 12608646 |
| D016285 | Iloprost | Iloprost results in increased phosphorylation of and results in increased activity of MAPK1 protein | increases activity|increases phosphorylation | 16373414 |
| D016285 | Iloprost | PD 98059 inhibits the reaction [Iloprost results in increased phosphorylation of and results in increased activity of MAPK1 protein] | decreases reaction|increases activity|increases phosphorylation | 16373414 |
| D016285 | Iloprost | tyrphostin AG 1478 inhibits the reaction [Iloprost results in increased phosphorylation of and results in increased activity of MAPK1 protein] | decreases reaction|increases activity|increases phosphorylation | 16373414 |
| C097613 | imatinib | imatinib inhibits the reaction [Acetaldehyde results in increased phosphorylation of and results in increased activity of MAPK1 protein] | decreases reaction|increases activity|increases phosphorylation | 17030193 |
| C097613 | imatinib | imatinib results in decreased phosphorylation of MAPK1 protein | decreases phosphorylation | 15100154 |
| C031534 | imperatorin | imperatorin results in increased phosphorylation of MAPK1 protein | increases phosphorylation | 17980360 |
| C078038 | inchinko-to | inchinko-to inhibits the reaction [PDGFB protein results in increased phosphorylation of MAPK1 protein] | decreases reaction|increases phosphorylation | 15288473 |
| D007213 | Indomethacin | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Indomethacin results in increased phosphorylation of MAPK1 protein] | decreases reaction|increases phosphorylation | 17341418 |
| D007213 | Indomethacin | 6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid inhibits the reaction [Indomethacin results in increased phosphorylation of MAPK1 protein] | decreases reaction|increases phosphorylation | 17341418 |
| D007213 | Indomethacin | Indomethacin results in increased phosphorylation of MAPK1 protein | increases phosphorylation | 12485869 17341418 |
| D007213 | Indomethacin | Indomethacin results in decreased phosphorylation of and results in decreased activity of MAPK1 protein | decreases activity|decreases phosphorylation | 10993886 |
| D015759 | Ionomycin | 1-Butanol inhibits the reaction [[4-O-methyl-12-O-tetradecanoylphorbol 13-acetate co-treated with Ionomycin] results in increased phosphorylation of and results in increased activity of MAPK1 protein] | affects cotreatment|decreases reaction|increases activity|increases phosphorylation | 18423386 |
| D015759 | Ionomycin | PLD2 protein promotes the reaction [[Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in increased phosphorylation of and results in increased activity of MAPK1 protein] | affects cotreatment|increases activity|increases phosphorylation|increases reaction | 18423386 |
| D015759 | Ionomycin | [Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in increased phosphorylation of and results in increased activity of MAPK1 protein | affects cotreatment|increases activity|increases phosphorylation | 18423386 |
| D015759 | Ionomycin | PLD2 protein promotes the reaction [[Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in increased phosphorylation of and results in increased activity of MAPK1 protein] | affects cotreatment|increases activity|increases phosphorylation|increases reaction | 18423386 |
| D015759 | Ionomycin | [Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in increased phosphorylation of and results in increased activity of MAPK1 protein | affects cotreatment|increases activity|increases phosphorylation | 18423386 |
| D015759 | Ionomycin | Ionomycin results in increased phosphorylation of and results in increased activity of MAPK1 protein | increases activity|increases phosphorylation | 16877402 |
| D007501 | Iron | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Iron results in increased phosphorylation of MAPK1 protein] | decreases reaction|increases phosphorylation | 17172471 |
| D007501 | Iron | deferiprone inhibits the reaction [Iron results in increased phosphorylation of MAPK1 protein] | decreases reaction|increases phosphorylation | 17172471 |
| D007501 | Iron | Filipin inhibits the reaction [Iron results in increased phosphorylation of MAPK1 protein] | decreases reaction|increases phosphorylation | 17172471 |
| D007501 | Iron | HRAS protein affects the reaction [Iron results in increased phosphorylation of MAPK1 protein] | affects reaction|increases phosphorylation | 17172471 |
| D007501 | Iron | Iron promotes the reaction [Asbestos, Amosite results in increased phosphorylation of MAPK1 protein] | increases phosphorylation|increases reaction | 11306436 |
| D007501 | Iron | Iron results in increased phosphorylation of MAPK1 protein | increases phosphorylation | 17172471 |
| D007501 | Iron | PIK3R1 protein affects the reaction [Iron results in increased phosphorylation of MAPK1 protein] | affects reaction|increases phosphorylation | 17172471 |
| D007501 | Iron | SB 203580 promotes the reaction [Iron results in increased phosphorylation of MAPK1 protein] | increases phosphorylation|increases reaction | 17172471 |
| D007501 | Iron | U 0126 inhibits the reaction [Iron results in increased phosphorylation of MAPK1 protein] | decreases reaction|increases phosphorylation | 17172471 |
| D007501 | Iron | [Vanadium co-treated with Iron] results in increased phosphorylation of MAPK1 protein | affects cotreatment|increases phosphorylation | 16728372 |
| D007531 | Isoflurophate | Isoflurophate inhibits the reaction [PLG protein results in increased phosphorylation of MAPK1 protein] | decreases reaction|increases phosphorylation | 17482686 |
| D007545 | Isoproterenol | [Isoproterenol binds to and results in increased activity of ADRB2 protein] which results in increased phosphorylation of and results in increased activity of MAPK1 protein | affects binding|increases activity|increases phosphorylation | 16980553 |
| D007545 | Isoproterenol | Isoproterenol inhibits the reaction [Estradiol results in decreased phosphorylation of MAPK1 protein] | decreases phosphorylation|decreases reaction | 15292328 |
| D007545 | Isoproterenol | Isoproterenol results in increased activity of MAPK1 protein | increases activity | 19002953 |
| D007545 | Isoproterenol | Isoproterenol results in increased phosphorylation of and results in increased activity of MAPK1 protein | increases activity|increases phosphorylation | 10888249 |
| D007545 | Isoproterenol | MAP2K1 protein affects the reaction [Isoproterenol results in increased phosphorylation of and results in increased activity of MAPK1 protein] | affects reaction|increases activity|increases phosphorylation | 10888249 |
| C432307 | isorhapontigenin | isorhapontigenin inhibits the reaction [AGT protein results in increased phosphorylation of MAPK1 protein] | decreases reaction|increases phosphorylation | 15607907 |
| C063587 | juzentaihoto | juzentaihoto inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of MAPK1 protein] | decreases reaction|increases phosphorylation | 15778123 |
| C006552 | kaempferol | kaempferol inhibits the reaction [IL1B protein results in increased phosphorylation of MAPK1 protein] | decreases reaction|increases phosphorylation | 19367675 |
| C006552 | kaempferol | kaempferol results in increased phosphorylation of MAPK1 protein | increases phosphorylation | 18346843 |
| C057416 | KT 5720 | KT 5720 inhibits the reaction [Terbutaline inhibits the reaction [Shiga Toxin results in increased expression of MAPK1 protein]] | decreases reaction|increases expression | 11675405 |
| C073601 | KT 5823 | KT 5823 promotes the reaction [EDN1 protein results in increased phosphorylation of MAPK1 protein] | increases phosphorylation|increases reaction | 16389725 |
| C490728 | lapatinib | lapatinib results in decreased expression of MAPK1 protein | decreases expression | 16091755 |
| C037068 | latrunculin B | latrunculin B inhibits the reaction [Phenylephrine results in increased phosphorylation of and results in increased activity of MAPK1 protein] | decreases reaction|increases activity|increases phosphorylation | 11739382 |
| D007854 | Lead | Lead results in decreased phosphorylation of and results in decreased activity of MAPK1 protein | decreases activity|decreases phosphorylation | 17298174 |
| C008261 | lead acetate | lead acetate results in decreased phosphorylation of and results in decreased activity of MAPK1 protein | decreases activity|decreases phosphorylation | 17298174 |
| C067431 | letrozole | letrozole results in increased expression of and results in increased phosphorylation of MAPK1 protein | increases expression|increases phosphorylation | 15967659 |
| D001556 | Lindane | calphostin C inhibits the reaction [Lindane results in increased phosphorylation of MAPK1 protein] | decreases reaction|increases phosphorylation | 15888667 |
| D001556 | Lindane | geldanamycin inhibits the reaction [Lindane results in increased phosphorylation of MAPK1 protein] | decreases reaction|increases phosphorylation | 15888667 |
| D001556 | Lindane | Lindane results in increased phosphorylation of and results in increased activity of MAPK1 protein | increases activity|increases phosphorylation | 15888667 |
| D001556 | Lindane | U 0126 inhibits the reaction [Lindane results in increased phosphorylation of MAPK1 protein] | decreases reaction|increases phosphorylation | 15888667 |
| D001556 | Lindane | AG 1879 inhibits the reaction [Lindane results in increased phosphorylation of MAPK1 protein] | decreases reaction|increases phosphorylation | 12807735 |
| D001556 | Lindane | Lindane results in increased phosphorylation of and results in increased activity of MAPK1 protein | increases activity|increases phosphorylation | 12807735 |
| D001556 | Lindane | Lindane results in increased phosphorylation of MAPK1 protein | increases phosphorylation | 16818664 |
| D001556 | Lindane | PD 98059 inhibits the reaction [Lindane results in increased phosphorylation of MAPK1 protein] | decreases reaction|increases phosphorylation | 12807735 |
| C482199 | lipopolysaccharide, E coli O55-B5 | [lipopolysaccharide, E coli O55-B5 co-treated with IFNG protein] results in increased phosphorylation of MAPK1 protein | affects cotreatment|increases phosphorylation | 11420121 |
| D008070 | Lipopolysaccharides | Lipopolysaccharides results in increased phosphorylation of MAPK1 protein | increases phosphorylation | 19041413 |
| D008070 | Lipopolysaccharides | Lipopolysaccharides results in increased phosphorylation of and results in increased activity of MAPK1 protein | increases activity|increases phosphorylation | 15671028 |
| D008070 | Lipopolysaccharides | AG 127 inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of MAPK1 protein] | decreases reaction|increases phosphorylation | 16373689 |
| D008070 | Lipopolysaccharides | CD14 protein affects the reaction [Lipopolysaccharides results in increased phosphorylation of MAPK1 protein] | affects reaction|increases phosphorylation | 11123339 |
| D008070 | Lipopolysaccharides | Drugs, Chinese Herbal inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of and results in increased activity of MAPK1 protein] | decreases reaction|increases activity|increases phosphorylation | 17996413 |
| D008070 | Lipopolysaccharides | Drugs, Chinese Herbal inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of MAPK1 protein] | decreases reaction|increases phosphorylation | 19051357 |
| D008070 | Lipopolysaccharides | ethyl 6-(N-(2-chloro-4-fluorophenyl)sulfamoyl)cyclohex-1-ene-1-carboxylate inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of MAPK1 protein] | decreases reaction|increases phosphorylation | 16373689 |
| D008070 | Lipopolysaccharides | Ginkgo biloba extract 761 inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of MAPK1 protein] | decreases reaction|increases phosphorylation | 11543732 |
| D008070 | Lipopolysaccharides | GSTP1 protein inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of MAPK1 protein] | decreases reaction|increases phosphorylation | 16023107 |
| D008070 | Lipopolysaccharides | ITGAM protein affects the reaction [Lipopolysaccharides results in increased phosphorylation of MAPK1 protein] | affects reaction|increases phosphorylation | 11123339 |
| D008070 | Lipopolysaccharides | juzentaihoto inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of MAPK1 protein] | decreases reaction|increases phosphorylation | 15778123 |
| D008070 | Lipopolysaccharides | Lipopolysaccharides inhibits the reaction [deoxynivalenol results in increased phosphorylation of MAPK1 protein] | decreases reaction|increases phosphorylation | 16009389 |
| D008070 | Lipopolysaccharides | Lipopolysaccharides results in increased phosphorylation of and results in increased activity of MAPK1 protein | increases activity|increases phosphorylation | 19159680 12619901 16880258 17996413 |
| D008070 | Lipopolysaccharides | Lipopolysaccharides results in increased phosphorylation of MAPK1 protein | increases phosphorylation | 16023107 16373689 19051357 11123339 15933225 14734799 11543732 16724238 18683823 14644621 12848851 11163183 11023991 15795323 15778123 |
| D008070 | Lipopolysaccharides | Lithium promotes the reaction [Lipopolysaccharides results in increased phosphorylation of and results in increased activity of MAPK1 protein] | increases activity|increases phosphorylation|increases reaction | 19159680 |
| D008070 | Lipopolysaccharides | MAP3K8 protein affects the reaction [Lipopolysaccharides results in increased phosphorylation of MAPK1 protein] | affects reaction|increases phosphorylation | 11163183 |
| D008070 | Lipopolysaccharides | methyldithiocarbamate inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of MAPK1 protein] | decreases reaction|increases phosphorylation | 15933225 |
| D008070 | Lipopolysaccharides | Quercetin inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of and results in increased activity of MAPK1 protein] | decreases reaction|increases activity|increases phosphorylation | 12619901 |
| D008070 | Lipopolysaccharides | Quercetin inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of MAPK1 protein] | decreases reaction|increases phosphorylation | 11543732 |
| D008070 | Lipopolysaccharides | shogaol inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of MAPK1 protein] | decreases reaction|increases phosphorylation | 18683823 |
| D008070 | Lipopolysaccharides | U 0126 inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of MAPK1 protein] | decreases reaction|increases phosphorylation | 11543732 |
| D008070 | Lipopolysaccharides | VAV1 protein affects the reaction [Lipopolysaccharides results in increased phosphorylation of MAPK1 protein] | affects reaction|increases phosphorylation | 12848851 |
| D008070 | Lipopolysaccharides | ADRB2 protein promotes the reaction [Terbutaline inhibits the reaction [Lipopolysaccharides results in increased activity of MAPK1 protein]] | decreases reaction|increases activity|increases reaction | 10469353 |
| D008070 | Lipopolysaccharides | Curcumin inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of MAPK1 protein] | decreases reaction|increases phosphorylation | 16934299 |
| D008070 | Lipopolysaccharides | ICI 118551 inhibits the reaction [Terbutaline inhibits the reaction [Lipopolysaccharides results in increased activity of MAPK1 protein]] | decreases reaction|increases activity | 12608646 |
| D008070 | Lipopolysaccharides | [Lipopolysaccharides co-treated with IFNG protein] results in increased phosphorylation of MAPK1 protein | affects cotreatment|increases phosphorylation | 16488514 |
| D008070 | Lipopolysaccharides | Lipopolysaccharides results in increased activity of MAPK1 protein | increases activity | 12608646 10857765 10469353 |
| D008070 | Lipopolysaccharides | Lipopolysaccharides results in increased phosphorylation of and results in increased activity of MAPK1 protein | increases activity|increases phosphorylation | 10357911 |
| D008070 | Lipopolysaccharides | Lipopolysaccharides results in increased phosphorylation of MAPK1 protein | increases phosphorylation | 17172471 16934299 |
| D008070 | Lipopolysaccharides | Manganese promotes the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased phosphorylation of MAPK1 protein] | affects cotreatment|increases phosphorylation|increases reaction | 16488514 |
| D008070 | Lipopolysaccharides | MAPK1 protein promotes the reaction [Lipopolysaccharides results in increased expression of IL6 protein] | increases expression|increases reaction | 10469353 |
| D008070 | Lipopolysaccharides | Sodium Salicylate inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of and results in increased activity of MAPK1 protein] | decreases reaction|increases activity|increases phosphorylation | 10357911 |
| D008070 | Lipopolysaccharides | Terbutaline inhibits the reaction [Lipopolysaccharides results in increased activity of MAPK1 protein] | decreases reaction|increases activity | 12608646 10857765 10469353 |
| C009900 | lipoteichoic acid | lipoteichoic acid results in increased phosphorylation of MAPK1 protein | increases phosphorylation | 19573522 |
| C009900 | lipoteichoic acid | Propofol inhibits the reaction [lipoteichoic acid results in increased phosphorylation of MAPK1 protein] | decreases reaction|increases phosphorylation | 19573522 |
| D008094 | Lithium | Lithium promotes the reaction [Lipopolysaccharides results in increased phosphorylation of and results in increased activity of MAPK1 protein] | increases activity|increases phosphorylation|increases reaction | 19159680 |
| D008094 | Lithium | Lithium results in increased phosphorylation of and results in increased activity of MAPK1 protein | increases activity|increases phosphorylation | 19159680 |
| D019808 | Losartan | Losartan inhibits the reaction [[AGT protein binds to and results in increased localization of AGTR1A protein] which results in increased phosphorylation of and results in increased activity of MAPK1 protein] | affects binding|decreases reaction|increases activity|increases localization|increases phosphorylation | 18267125 |
| D047311 | Luteolin | Luteolin inhibits the reaction [Glucose results in increased phosphorylation of MAPK1 protein] | decreases reaction|increases phosphorylation | 19557821 |
| D047311 | Luteolin | Luteolin inhibits the reaction [TNF protein results in increased activity of MAPK1 protein] | decreases reaction|increases activity | 15322261 |
| D047311 | Luteolin | Luteolin results in decreased phosphorylation of and results in decreased activity of MAPK1 protein | decreases activity|decreases phosphorylation | 10718847 |
| C025430 | LY 117018 | LY 117018 results in increased phosphorylation of MAPK1 protein | increases phosphorylation | 17174166 |
| C025430 | LY 117018 | U 0126 inhibits the reaction [LY 117018 results in increased phosphorylation of MAPK1 protein] | decreases reaction|increases phosphorylation | 17174166 |
| C015329 | lycopene | lycopene inhibits the reaction [[Dietary Fats co-treated with Diethylnitrosamine] results in increased phosphorylation of MAPK1 protein] | affects cotreatment|decreases reaction|increases phosphorylation | 19551842 |
| C032881 | lysophosphatidic acid | lysophosphatidic acid results in increased phosphorylation of MAPK1 protein | increases phosphorylation | 17919812 |
| C032881 | lysophosphatidic acid | resveratrol inhibits the reaction [lysophosphatidic acid results in increased phosphorylation of MAPK1 protein] | decreases reaction|increases phosphorylation | 17919812 |
| C032881 | lysophosphatidic acid | 1-Butanol inhibits the reaction [PLD1 protein affects the reaction [lysophosphatidic acid results in increased phosphorylation of MAPK1 protein]] | affects reaction|decreases reaction|increases phosphorylation | 11243883 |
| C032881 | lysophosphatidic acid | lysophosphatidic acid results in increased phosphorylation of MAPK1 protein | increases phosphorylation | 11243883 |
| C032881 | lysophosphatidic acid | Pertussis Toxin inhibits the reaction [lysophosphatidic acid results in increased phosphorylation of MAPK1 protein] | decreases reaction|increases phosphorylation | 15081308 11243883 |
| C032881 | lysophosphatidic acid | PLD1 protein affects the reaction [lysophosphatidic acid results in increased phosphorylation of MAPK1 protein] | affects reaction|increases phosphorylation | 11243883 |
| C005095 | malachite green | malachite green results in decreased phosphorylation of MAPK1 protein | decreases phosphorylation | 16675904 |
| C005095 | malachite green | malachite green results in increased phosphorylation of MAPK1 protein | increases phosphorylation | 15566957 |
| C065861 | malvidin | malvidin results in decreased phosphorylation of MAPK1 protein | decreases phosphorylation | 15964118 |
| D008344 | Maneb | [Paraquat co-treated with Maneb] results in increased phosphorylation of MAPK1 protein | affects cotreatment|increases phosphorylation | 15824117 |
| D008345 | Manganese | Manganese inhibits the reaction [Cadmium results in increased phosphorylation of MAPK1 protein] | decreases reaction|increases phosphorylation | 17055454 |
| D008345 | Manganese | Manganese results in decreased phosphorylation of MAPK1 protein | decreases phosphorylation | 17043766 |
| D008345 | Manganese | Manganese results in increased phosphorylation of MAPK1 protein | increases phosphorylation | 17045426 |
| D008345 | Manganese | Manganese promotes the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased phosphorylation of MAPK1 protein] | affects cotreatment|increases phosphorylation|increases reaction | 16488514 |
| D008345 | Manganese | Manganese results in increased phosphorylation of MAPK1 protein | increases phosphorylation | 16488514 16787641 |
| D008345 | Manganese | U 0126 inhibits the reaction [Manganese results in increased phosphorylation of MAPK1 protein] | decreases reaction|increases phosphorylation | 16787641 |
| C025340 | manganese chloride | manganese chloride results in increased phosphorylation of MAPK1 protein | increases phosphorylation | 16787641 |
| C025340 | manganese chloride | U 0126 inhibits the reaction [manganese chloride results in increased phosphorylation of MAPK1 protein] | decreases reaction|increases phosphorylation | 16787641 |
| C097284 | manganese(III)-tetrakis(4-benzoic acid)porphyrin | manganese(III)-tetrakis(4-benzoic acid)porphyrin inhibits the reaction [Doxorubicin results in increased phosphorylation of MAPK1 protein] | decreases reaction|increases phosphorylation | 17384286 |
| C013592 | mangiferin | mangiferin inhibits the reaction [Excitatory Amino Acid Agonists results in increased phosphorylation of MAPK1 protein] | decreases reaction|increases phosphorylation | 19201465 |
| D008353 | Mannitol | Mannitol inhibits the reaction [Hydrogen Peroxide results in increased activity of MAPK1 protein] | decreases reaction|increases activity | 15328380 |
| C100342 | marimastat | marimastat inhibits the reaction [Hydrogen Peroxide results in increased activity of MAPK1 protein] | decreases reaction|increases activity | 15574683 |
| D008558 | Melphalan | Melphalan results in increased phosphorylation of and results in increased activity of MAPK1 protein | increases activity|increases phosphorylation | 16025434 |
| D008687 | Metformin | Metformin inhibits the reaction [IL1B protein results in increased phosphorylation of MAPK1 protein] | decreases reaction|increases phosphorylation | 16385087 |
| D008687 | Metformin | PRKAA1 gene mutant form inhibits the reaction [Metformin results in increased phosphorylation of MAPK1 protein] | decreases reaction|increases phosphorylation | 16760380 |
| D008694 | Methamphetamine | Methamphetamine results in increased expression of MAPK1 mRNA | increases expression | 19149911 |
| C088155 | methanandamide | CNR1 protein affects the reaction [methanandamide results in increased phosphorylation of and results in increased activity of MAPK1 protein] | affects reaction|increases activity|increases phosphorylation | 12734338 |
| C088155 | methanandamide | methanandamide results in increased phosphorylation of and results in increased activity of MAPK1 protein | increases activity|increases phosphorylation | 12734338 |
| C019003 | methaneselenol | methaneselenol results in decreased phosphorylation of and results in decreased activity of MAPK1 protein | decreases activity|decreases phosphorylation | 19625696 |
| C054938 | methoctramine | methoctramine analog results in increased phosphorylation of MAPK1 protein | increases phosphorylation | 19576191 |
| D008723 | Methohexital | Methohexital results in decreased phosphorylation of MAPK1 protein | decreases phosphorylation | 15263067 |
| C013598 | methoxyacetic acid | methoxyacetic acid results in increased phosphorylation of MAPK1 protein | increases phosphorylation | 18486176 15103026 |
| C013598 | methoxyacetic acid | U 0126 inhibits the reaction [methoxyacetic acid results in increased phosphorylation of MAPK1 protein] | decreases reaction|increases phosphorylation | 18486176 |
| D008731 | Methoxychlor | [Methoxychlor co-treated with LIF protein] results in increased phosphorylation of MAPK1 protein | affects cotreatment|increases phosphorylation | 14975756 |
| D008731 | Methoxychlor | Methoxychlor results in increased phosphorylation of MAPK1 protein | increases phosphorylation | 15979571 |
| D008731 | Methoxychlor | [Genistein co-treated with Methoxychlor] results in decreased expression of MAPK1 mRNA | affects cotreatment|decreases expression | 16443925 |
| D008731 | Methoxychlor | Methoxychlor results in decreased expression of MAPK1 mRNA | decreases expression | 16443925 |
| C014659 | methyl(acetoxymethyl)nitrosamine | methyl(acetoxymethyl)nitrosamine results in increased phosphorylation of and results in increased activity of MAPK1 protein | increases activity|increases phosphorylation | 12693035 |
| C014659 | methyl(acetoxymethyl)nitrosamine | PD 98059 inhibits the reaction [methyl(acetoxymethyl)nitrosamine results in increased activity of MAPK1 protein] | decreases reaction|increases activity | 12693035 |
| C080197 | methylarsine oxide | methylarsine oxide results in increased phosphorylation of MAPK1 protein | increases phosphorylation | 12475910 |
| C108732 | methyl-beta-cyclodextrin | methyl-beta-cyclodextrin inhibits the reaction [Estradiol results in increased phosphorylation of MAPK1 protein] | decreases reaction|increases phosphorylation | 15930183 |
| C005219 | methyl cellosolve | methyl cellosolve results in increased expression of MAPK1 mRNA | increases expression | 19643169 |
| C008435 | methyldithiocarbamate | methyldithiocarbamate inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of MAPK1 protein] | decreases reaction|increases phosphorylation | 15933225 |
| D008767 | Methylmercury Compounds | Methylmercury Compounds results in decreased phosphorylation of and results in decreased activity of MAPK1 protein | decreases activity|decreases phosphorylation | 17298174 |
| D018817 | N-Methyl-3,4-methylenedioxyamphetamine | N-Methyl-3,4-methylenedioxyamphetamine results in increased expression of MAPK1 mRNA | increases expression | 19285098 |
| D008770 | Methylnitrosourea | MAPK1 protein modified form results in increased susceptibility to Methylnitrosourea | increases response to substance | 15528971 |
| D008770 | Methylnitrosourea | MAPK1 protein results in increased susceptibility to Methylnitrosourea | increases response to substance | 15528971 |
| D008770 | Methylnitrosourea | Methylnitrosourea results in increased phosphorylation of and results in increased activity of MAPK1 protein | increases activity|increases phosphorylation | 12693035 |
| D008770 | Methylnitrosourea | PD 98059 inhibits the reaction [Methylnitrosourea results in increased activity of MAPK1 protein] | decreases reaction|increases activity | 12693035 |
| C008493 | methylselenic acid | methylselenic acid results in increased phosphorylation of MAPK1 protein | increases phosphorylation | 15845651 |
| D015741 | Metribolone | Metribolone results in increased phosphorylation of MAPK1 protein | increases phosphorylation | 17272394 |
| D015741 | Metribolone | tyrphostin AG 1478 inhibits the reaction [Metribolone results in increased phosphorylation of MAPK1 protein] | decreases reaction|increases phosphorylation | 17272394 |
| D015735 | Mifepristone | Mifepristone inhibits the reaction [Progesterone promotes the reaction [EGF protein results in increased phosphorylation of MAPK1 protein]] | decreases reaction|increases phosphorylation|increases reaction | 16175315 |
| D015735 | Mifepristone | Mifepristone inhibits the reaction [Progesterone promotes the reaction [Estradiol results in increased phosphorylation of MAPK1 protein]] | decreases reaction|increases phosphorylation|increases reaction | 15358673 |
| D015735 | Mifepristone | Mifepristone inhibits the reaction [Promegestone results in increased phosphorylation of MAPK1 protein] | decreases reaction|increases phosphorylation | 16020483 |
| C093875 | montelukast | montelukast affects the expression of MAPK1 protein modified form | affects expression | 18059327 |
| C008548 | morin | morin inhibits the reaction [Excitatory Amino Acid Agonists results in increased phosphorylation of MAPK1 protein] | decreases reaction|increases phosphorylation | 19201465 |
| C104727 | moxifloxacin | moxifloxacin results in decreased phosphorylation of MAPK1 protein | decreases phosphorylation | 16352735 |
| C034476 | muconaldehyde | bisindolylmaleimide I promotes the reaction [muconaldehyde results in increased phosphorylation of MAPK1 protein] | increases phosphorylation|increases reaction | 15690152 |
| C034476 | muconaldehyde | muconaldehyde results in increased phosphorylation of MAPK1 protein | increases phosphorylation | 15690152 |
| C034476 | muconaldehyde | PD 98059 inhibits the reaction [muconaldehyde results in increased phosphorylation of MAPK1 protein] | decreases reaction|increases phosphorylation | 15690152 |
| D009151 | Mustard Gas | Mustard Gas results in increased phosphorylation of MAPK1 protein | increases phosphorylation | 18200059 |
| C040015 | myricetin | myricetin inhibits the reaction [EGF protein results in increased phosphorylation of MAPK1 protein] | decreases reaction|increases phosphorylation | 17693661 |
| C040015 | myricetin | myricetin inhibits the reaction [Tetradecanoylphorbol Acetate results in increased phosphorylation of MAPK1 protein] | decreases reaction|increases phosphorylation | 17693661 |
| C040015 | myricetin | myricetin results in decreased activity of MAPK1 protein | decreases activity | 17693661 |
| C030517 | myxothiazol | myxothiazol inhibits the reaction [Copper results in increased phosphorylation of MAPK1 protein] | decreases reaction|increases phosphorylation | 16672322 |
| C030517 | myxothiazol | myxothiazol results in decreased phosphorylation of MAPK1 protein | decreases phosphorylation | 16672322 |
| C063509 | N-(2-(4-bromocinnamylamino)ethyl)-5-isoquinolinesulfonamide | N-(2-(4-bromocinnamylamino)ethyl)-5-isoquinolinesulfonamide inhibits the reaction [4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in increased phosphorylation of MAPK1 protein] | decreases reaction|increases phosphorylation | 16671086 |
| C063509 | N-(2-(4-bromocinnamylamino)ethyl)-5-isoquinolinesulfonamide | N-(2-(4-bromocinnamylamino)ethyl)-5-isoquinolinesulfonamide inhibits the reaction [Terbutaline inhibits the reaction [Shiga Toxin results in increased expression of MAPK1 protein]] | decreases reaction|increases expression | 11675405 |
| C063509 | N-(2-(4-bromocinnamylamino)ethyl)-5-isoquinolinesulfonamide | N-(2-(4-bromocinnamylamino)ethyl)-5-isoquinolinesulfonamide inhibits the reaction [Forskolin results in increased phosphorylation of MAPK1 protein] | decreases reaction|increases phosphorylation | 17322281 |
| C063509 | N-(2-(4-bromocinnamylamino)ethyl)-5-isoquinolinesulfonamide | N-(2-(4-bromocinnamylamino)ethyl)-5-isoquinolinesulfonamide inhibits the reaction [FGF2 protein results in increased phosphorylation of MAPK1 protein] | decreases reaction|increases phosphorylation | 16269011 |
| C063509 | N-(2-(4-bromocinnamylamino)ethyl)-5-isoquinolinesulfonamide | N-(2-(4-bromocinnamylamino)ethyl)-5-isoquinolinesulfonamide inhibits the reaction [Forskolin results in increased phosphorylation of MAPK1 protein] | decreases reaction|increases phosphorylation | 18004999 |
| C063509 | N-(2-(4-bromocinnamylamino)ethyl)-5-isoquinolinesulfonamide | N-(2-(4-bromocinnamylamino)ethyl)-5-isoquinolinesulfonamide inhibits the reaction [Nitroprusside results in increased phosphorylation of MAPK1 protein] | decreases reaction|increases phosphorylation | 16439612 |
| C080955 | N-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide | N-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide inhibits the reaction [resveratrol promotes the reaction [MAPK1 protein binds to PTGS2 protein]] | affects binding|decreases reaction|increases reaction | 17984113 |
| C092152 | N-((2-(hydroxyaminocarbonyl)methyl)-4-methylpentanoyl)-3-(2'-naphthyl)alanylalanine, 2-aminoethylamide | N-((2-(hydroxyaminocarbonyl)methyl)-4-methylpentanoyl)-3-(2'-naphthyl)alanylalanine, 2-aminoethylamide inhibits the reaction [Estradiol results in increased phosphorylation of and results in increased activity of MAPK1 protein] | decreases reaction|increases activity|increases phosphorylation | 15615701 |
| C092152 | N-((2-(hydroxyaminocarbonyl)methyl)-4-methylpentanoyl)-3-(2'-naphthyl)alanylalanine, 2-aminoethylamide | N-((2-(hydroxyaminocarbonyl)methyl)-4-methylpentanoyl)-3-(2'-naphthyl)alanylalanine, 2-aminoethylamide inhibits the reaction [resveratrol results in increased phosphorylation of and results in increased activity of MAPK1 protein] | decreases reaction|increases activity|increases phosphorylation | 15615701 |
| C481648 | N-(2-methyl-4,5-bis(methylsulfonyl)benzoyl)guanidine | N-(2-methyl-4,5-bis(methylsulfonyl)benzoyl)guanidine inhibits the reaction [Phenylephrine results in increased phosphorylation of and results in increased activity of MAPK1 protein] | decreases reaction|increases activity|increases phosphorylation | 16513848 |
| C481448 | N-(4-chloro-2-((1,3-dioxo-1,3-dihydro-2H-isoindol-2-yl)methyl)phenyl)-2-hydroxybenzamide | 6-methyl-2-(phenylethynyl)pyridine inhibits the reaction [N-(4-chloro-2-((1,3-dioxo-1,3-dihydro-2H-isoindol-2-yl)methyl)phenyl)-2-hydroxybenzamide promotes the reaction [3,5-dihydroxyphenylglycine results in increased phosphorylation of MAPK1 protein]] | decreases reaction|increases phosphorylation|increases reaction | 16600209 |
| C481448 | N-(4-chloro-2-((1,3-dioxo-1,3-dihydro-2H-isoindol-2-yl)methyl)phenyl)-2-hydroxybenzamide | N-(4-chloro-2-((1,3-dioxo-1,3-dihydro-2H-isoindol-2-yl)methyl)phenyl)-2-hydroxybenzamide promotes the reaction [3,5-dihydroxyphenylglycine results in increased phosphorylation of MAPK1 protein] | increases phosphorylation|increases reaction | 16600209 |
| C481448 | N-(4-chloro-2-((1,3-dioxo-1,3-dihydro-2H-isoindol-2-yl)methyl)phenyl)-2-hydroxybenzamide | 6-methyl-2-(phenylethynyl)pyridine inhibits the reaction [N-(4-chloro-2-((1,3-dioxo-1,3-dihydro-2H-isoindol-2-yl)methyl)phenyl)-2-hydroxybenzamide promotes the reaction [3,5-dihydroxyphenylglycine results in increased phosphorylation of MAPK1 protein]] | decreases reaction|increases phosphorylation|increases reaction | 16600209 |
| C084956 | N(6)-(3-iodobenzyl)-5'-N-methylcarboxamidoadenosine | N(6)-(3-iodobenzyl)-5'-N-methylcarboxamidoadenosine results in increased phosphorylation of MAPK1 protein | increases phosphorylation | 16025880 |
| C084956 | N(6)-(3-iodobenzyl)-5'-N-methylcarboxamidoadenosine | U 0126 inhibits the reaction [N(6)-(3-iodobenzyl)-5'-N-methylcarboxamidoadenosine results in increased phosphorylation of MAPK1 protein] | decreases reaction|increases phosphorylation | 16025880 |
| C529068 | naringenin-7-O-glucoside | naringenin-7-O-glucoside results in increased expression of MAPK1 protein | increases expression | 18652870 |
| D009355 | Neomycin | CASR protein promotes the reaction [Neomycin results in increased phosphorylation of and results in increased activity of MAPK1 protein] | increases activity|increases phosphorylation|increases reaction | 17537980 |
| D009355 | Neomycin | Neomycin results in increased phosphorylation of and results in increased activity of MAPK1 protein | increases activity|increases phosphorylation | 17537980 |
| D009355 | Neomycin | PD 98059 inhibits the reaction [Neomycin results in increased phosphorylation of and results in increased activity of MAPK1 protein] | decreases reaction|increases activity|increases phosphorylation | 17537980 |
| D009529 | Nicardipine | Nicardipine inhibits the reaction [decamethrin results in increased phosphorylation of MAPK1 protein] | decreases reaction|increases phosphorylation | 16166269 |
| D009532 | Nickel | chromium hexavalent ion inhibits the reaction [Nickel results in increased phosphorylation of MAPK1 protein] | decreases reaction|increases phosphorylation | 19403854 |
| D009532 | Nickel | Nickel results in increased phosphorylation of MAPK1 protein | increases phosphorylation | 19403854 17045426 |
| D009538 | Nicotine | Nicotine results in increased phosphorylation of and results in increased activity of MAPK1 protein | increases activity|increases phosphorylation | 15983034 |
| D009569 | Nitric Oxide | Nitric Oxide affects the reaction [Ditiocarb results in increased phosphorylation of MAPK1 protein] | affects reaction|increases phosphorylation | 16603213 |
| D009569 | Nitric Oxide | Nitric Oxide affects the reaction [NGF protein results in increased activity of MAPK1 protein] | affects reaction|increases activity | 14713289 |
| D009569 | Nitric Oxide | Nitric Oxide inhibits the reaction [EDN1 protein results in increased phosphorylation of MAPK1 protein] | decreases reaction|increases phosphorylation | 16389725 |
| D009569 | Nitric Oxide | Nitric Oxide results in decreased expression of MAPK1 protein | decreases expression | 15640287 |
| D020030 | Nitric Oxide Donors | Nitric Oxide Donors inhibits the reaction [EDN1 protein results in increased phosphorylation of MAPK1 protein] | decreases reaction|increases phosphorylation | 16389725 |
| D020030 | Nitric Oxide Donors | Nitric Oxide Donors results in decreased expression of MAPK1 protein | decreases expression | 15640287 |
| D009599 | Nitroprusside | Nitroprusside results in decreased phosphorylation of MAPK1 protein | decreases phosphorylation | 15486966 |
| D009599 | Nitroprusside | N-(2-(4-bromocinnamylamino)ethyl)-5-isoquinolinesulfonamide inhibits the reaction [Nitroprusside results in increased phosphorylation of MAPK1 protein] | decreases reaction|increases phosphorylation | 16439612 |
| D009599 | Nitroprusside | Nitroprusside inhibits the reaction [EDN1 protein results in increased phosphorylation of MAPK1 protein] | decreases reaction|increases phosphorylation | 16389725 |
| D009599 | Nitroprusside | Nitroprusside results in increased phosphorylation of MAPK1 protein | increases phosphorylation | 16439612 |
| D026423 | S-Nitroso-N-Acetylpenicillamine | S-Nitroso-N-Acetylpenicillamine results in decreased expression of MAPK1 protein | decreases expression | 15640287 |
| C014707 | nitrosobenzylmethylamine | nitrosobenzylmethylamine results in increased expression of MAPK1 mRNA | increases expression | 17616710 |
| D009605 | Nitrosomethylurethane | Nitrosomethylurethane results in increased phosphorylation of and results in increased activity of MAPK1 protein | increases activity|increases phosphorylation | 12693035 |
| D009605 | Nitrosomethylurethane | PD 98059 inhibits the reaction [Nitrosomethylurethane results in increased activity of MAPK1 protein] | decreases reaction|increases activity | 12693035 |
| C061800 | N,N-dimethylsphingosine | N,N-dimethylsphingosine inhibits the reaction [Tyramine results in increased activity of MAPK1 protein] | decreases reaction|increases activity | 17561096 |
| C004845 | N,N'-diphenyl-4-phenylenediamine | N,N'-diphenyl-4-phenylenediamine inhibits the reaction [zinc chloride results in increased phosphorylation of MAPK1 protein] | decreases reaction|increases phosphorylation | 16960431 |
| C004845 | N,N'-diphenyl-4-phenylenediamine | N,N'-diphenyl-4-phenylenediamine inhibits the reaction [Zinc results in increased phosphorylation of MAPK1 protein] | decreases reaction|increases phosphorylation | 16960431 |
| C025256 | nonylphenol | nonylphenol results in increased phosphorylation of MAPK1 protein | increases phosphorylation | 15242752 |
| C025256 | nonylphenol | Tamoxifen affects the reaction [nonylphenol results in increased phosphorylation of MAPK1 protein] | affects reaction|increases phosphorylation | 15242752 |
| C025256 | nonylphenol | nonylphenol results in increased phosphorylation of MAPK1 protein | increases phosphorylation | 15531431 |
| C051844 | norbinaltorphimine | norbinaltorphimine inhibits the reaction [U 69593 results in increased phosphorylation of MAPK1 protein] | decreases reaction|increases phosphorylation | 16954126 |
| C510003 | nordy | nordy inhibits the reaction [N-Formylmethionine Leucyl-Phenylalanine results in increased phosphorylation of and results in increased activity of MAPK1 protein] | decreases reaction|increases activity|increases phosphorylation | 17377739 |
| D009638 | Norepinephrine | Norepinephrine inhibits the reaction [Estradiol results in decreased phosphorylation of MAPK1 protein] | decreases phosphorylation|decreases reaction | 15292328 |
| C442478 | N-phenyl-7-(hydroxyimino)cyclopropa(b)chromen-1a-carboxamide | N-phenyl-7-(hydroxyimino)cyclopropa(b)chromen-1a-carboxamide inhibits the reaction [Dextroamphetamine results in increased phosphorylation of MAPK1 protein] | decreases reaction|increases phosphorylation | 12377393 |
| C404397 | NSC 680410 | NSC 680410 results in decreased phosphorylation of MAPK1 protein | decreases phosphorylation | 14647418 |
| D009711 | Nucleotides | 1-Butanol inhibits the reaction [P2RY1 protein affects the reaction [Nucleotides results in increased phosphorylation of and results in increased activity of MAPK1 protein]] | affects reaction|decreases reaction|increases activity|increases phosphorylation | 17620283 |
| D009711 | Nucleotides | bisindolylmaleimide I inhibits the reaction [P2RY1 protein affects the reaction [Nucleotides results in increased phosphorylation of and results in increased activity of MAPK1 protein]] | affects reaction|decreases reaction|increases activity|increases phosphorylation | 17620283 |
| D009711 | Nucleotides | ITGB3 protein affects the reaction [Nucleotides results in increased phosphorylation of MAPK1 protein] | affects reaction|increases phosphorylation | 17620283 |
| D009711 | Nucleotides | Nucleotides results in increased phosphorylation of and results in increased activity of MAPK1 protein | increases activity|increases phosphorylation | 17620283 |
| D009711 | Nucleotides | P2RY1 protein affects the reaction [Nucleotides results in increased phosphorylation of and results in increased activity of MAPK1 protein] | affects reaction|increases activity|increases phosphorylation | 17620283 |
| D009711 | Nucleotides | rottlerin inhibits the reaction [P2RY1 protein affects the reaction [Nucleotides results in increased phosphorylation of and results in increased activity of MAPK1 protein]] | affects reaction|decreases reaction|increases activity|increases phosphorylation | 17620283 |
| D009761 | Nystatin | Nystatin inhibits the reaction [Diethylstilbestrol results in increased phosphorylation of and results in increased activity of MAPK1 protein] | decreases reaction|increases activity|increases phosphorylation | 15072920 |
| D009761 | Nystatin | Nystatin inhibits the reaction [Estradiol results in increased phosphorylation of and results in increased activity of MAPK1 protein] | decreases reaction|increases activity|increases phosphorylation | 15072920 |
| C474055 | octylphenol | fulvestrant inhibits the reaction [octylphenol results in increased phosphorylation of MAPK1 protein] | decreases reaction|increases phosphorylation | 18417718 |
| C474055 | octylphenol | octylphenol results in increased phosphorylation of MAPK1 protein | increases phosphorylation | 18417718 |
| C474055 | octylphenol | U 0126 inhibits the reaction [octylphenol results in increased phosphorylation of MAPK1 protein] | decreases reaction|increases phosphorylation | 18417718 |
| D019319 | Okadaic Acid | Okadaic Acid results in increased activity of MAPK1 protein | increases activity | 7723735 |
| C488250 | oleoylethanolamide | oleoylethanolamide affects the phosphorylation of and affects the activity of MAPK1 protein | affects activity|affects phosphorylation | 19345745 |
| C440229 | Oleylethanolamide | GW2974 inhibits the reaction [Oleylethanolamide results in increased phosphorylation of MAPK1 protein] | decreases reaction|increases phosphorylation | 16269455 |
| C440229 | Oleylethanolamide | Oleylethanolamide promotes the reaction [ERBB2 protein binds to MAPK1 protein modified form] | affects binding|increases reaction | 16269455 |
| C440229 | Oleylethanolamide | Oleylethanolamide results in increased phosphorylation of MAPK1 protein | increases phosphorylation | 16269455 |
| C440229 | Oleylethanolamide | PD 98059 inhibits the reaction [Oleylethanolamide results in increased phosphorylation of MAPK1 protein] | decreases reaction|increases phosphorylation | 16269455 |
| C440229 | Oleylethanolamide | [PD 98059 inhibits the reaction [Oleylethanolamide results in increased phosphorylation of MAPK1 protein]] which results in increased susceptibility to Doxorubicin | decreases reaction|increases phosphorylation|increases response to substance | 16269455 |
| C440229 | Oleylethanolamide | tyrphostin AG 1478 inhibits the reaction [Oleylethanolamide results in increased phosphorylation of MAPK1 protein] | decreases reaction|increases phosphorylation | 16269455 |
| C440229 | Oleylethanolamide | tyrphostin AG825 inhibits the reaction [Oleylethanolamide results in increased phosphorylation of MAPK1 protein] | decreases reaction|increases phosphorylation | 16269455 |
| D053683 | Oncostatin M | Oncostatin M results in increased phosphorylation of MAPK1 protein | increases phosphorylation | 15654950 |
| C016340 | o,p'-DDT | o,p'-DDT results in increased phosphorylation of MAPK1 protein | increases phosphorylation | 11222871 |
| C016340 | o,p'-DDT | o,p'-DDT results in increased activity of MAPK1 protein | increases activity | 12523960 |
| C016340 | o,p'-DDT | o,p'-DDT results in increased phosphorylation of MAPK1 protein | increases phosphorylation | 12523960 |
| C057726 | OR486 | OR486 inhibits the reaction [Estradiol results in decreased phosphorylation of MAPK1 protein] | decreases phosphorylation|decreases reaction | 15292328 |
| C030110 | oxaliplatin | oxaliplatin results in increased phosphorylation of and results in increased activity of MAPK1 protein | increases activity|increases phosphorylation | 18790786 |
| D010100 | Oxygen | alpha-naphthoflavone inhibits the reaction [[Tetrachlorodibenzodioxin co-treated with Oxygen deficiency] results in increased phosphorylation of MAPK1 protein] | affects cotreatment|decreases reaction|increases phosphorylation | 19578757 |
| D010100 | Oxygen | [Tetrachlorodibenzodioxin co-treated with Oxygen deficiency] results in increased phosphorylation of MAPK1 protein | affects cotreatment|increases phosphorylation | 19578757 |
| D010100 | Oxygen | [Oxygen deficiency co-treated with Glucose deficiency] results in increased phosphorylation of MAPK1 protein | affects cotreatment|increases phosphorylation | 19303870 |
| D010126 | Ozone | Ozone results in increased phosphorylation of MAPK1 protein | increases phosphorylation | 19536146 |
| D010126 | Ozone | Ozone results in increased phosphorylation of and results in increased activity of MAPK1 protein | increases activity|increases phosphorylation | 18207479 |
| D010126 | Ozone | TNF protein affects the reaction [Ozone results in increased phosphorylation of and results in increased activity of MAPK1 protein] | affects reaction|increases activity|increases phosphorylation | 18207479 |
| D010126 | Ozone | [Ozone co-treated with Chlorine] results in decreased expression of MAPK1 mRNA | affects cotreatment|decreases expression | 18636392 |
| C492719 | p38alpha inhibitor CMPD1 | p38alpha inhibitor CMPD1 promotes the reaction [sodium arsenite results in increased phosphorylation of MAPK1 protein] | increases phosphorylation|increases reaction | 12547826 |
| D017239 | Paclitaxel | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Paclitaxel results in increased activity of MAPK1 protein] | decreases reaction|increases activity | 16211241 |
| D017239 | Paclitaxel | 4-((3-bromophenyl)amino)-6,7-dimethoxyquinazoline inhibits the reaction [Paclitaxel results in increased activity of MAPK1 protein] | decreases reaction|increases activity | 16211241 |
| D017239 | Paclitaxel | [esculetin co-treated with Paclitaxel] results in decreased expression of MAPK1 protein | affects cotreatment|decreases expression | 16051289 |
| D017239 | Paclitaxel | Paclitaxel results in increased activity of MAPK1 protein | increases activity | 16211241 |
| D017239 | Paclitaxel | Paclitaxel results in increased phosphorylation of and results in increased expression of MAPK1 protein | increases expression|increases phosphorylation | 16051289 |
| D017239 | Paclitaxel | [PD168393 co-treated with Paclitaxel] results in decreased phosphorylation of and results in decreased activity of MAPK1 protein | affects cotreatment|decreases activity|decreases phosphorylation | 16413505 |
| D017239 | Paclitaxel | U 0126 inhibits the reaction [Paclitaxel results in increased activity of MAPK1 protein] | decreases reaction|increases activity | 16211241 |
| D017239 | Paclitaxel | CD14 protein affects the reaction [Paclitaxel results in increased phosphorylation of MAPK1 protein] | affects reaction|increases phosphorylation | 11123339 |
| D017239 | Paclitaxel | ITGAM protein affects the reaction [Paclitaxel results in increased phosphorylation of MAPK1 protein] | affects reaction|increases phosphorylation | 11123339 |
| D017239 | Paclitaxel | Paclitaxel results in increased phosphorylation of MAPK1 protein | increases phosphorylation | 11123339 |
| C508075 | Pam(3)CSK(4) peptide | Pam(3)CSK(4) peptide results in increased phosphorylation of MAPK1 protein | increases phosphorylation | 17369491 |
| C508075 | Pam(3)CSK(4) peptide | [U 0126 results in decreased phosphorylation of MAPK1 protein] inhibits the reaction [Pam(3)CSK(4) peptide results in increased metabolism of Eicosanoids] | decreases phosphorylation|decreases reaction|increases metabolic processing | 17369491 |
| D010269 | Paraquat | [Paraquat co-treated with Maneb] results in increased phosphorylation of MAPK1 protein | affects cotreatment|increases phosphorylation | 15824117 |
| D010269 | Paraquat | Paraquat results in increased phosphorylation of MAPK1 protein | increases phosphorylation | 16797015 17662968 |
| D010269 | Paraquat | Paraquat results in decreased phosphorylation of and results in decreased activity of MAPK1 protein | decreases activity|decreases phosphorylation | 17298174 |
| D010269 | Paraquat | Paraquat results in increased phosphorylation of MAPK1 protein | increases phosphorylation | 16687388 |
| D010269 | Paraquat | PD 98059 inhibits the reaction [Paraquat results in increased phosphorylation of MAPK1 protein] | decreases reaction|increases phosphorylation | 16687388 |
| D052638 | Particulate Matter | diphenyleneiodonium inhibits the reaction [Particulate Matter results in increased phosphorylation of MAPK1 protein] | decreases reaction|increases phosphorylation | 16571865 |
| D052638 | Particulate Matter | NCF1 protein affects the reaction [Particulate Matter results in increased phosphorylation of MAPK1 protein] | affects reaction|increases phosphorylation | 16571865 |
| D052638 | Particulate Matter | Particulate Matter results in increased phosphorylation of MAPK1 protein | increases phosphorylation | 16571865 |
| D052638 | Particulate Matter | CYBB gene mutant form inhibits the reaction [Particulate Matter results in increased phosphorylation of MAPK1 protein] | decreases reaction|increases phosphorylation | 19371610 |
| D052638 | Particulate Matter | diphenyleneiodonium inhibits the reaction [Particulate Matter results in increased phosphorylation of MAPK1 protein] | decreases reaction|increases phosphorylation | 19371610 |
| D052638 | Particulate Matter | NCF2 protein affects the reaction [Particulate Matter results in increased phosphorylation of MAPK1 protein] | affects reaction|increases phosphorylation | 19371610 |
| D052638 | Particulate Matter | Particulate Matter results in increased phosphorylation of MAPK1 protein | increases phosphorylation | 19371610 |
| C073402 | PD 123319 | PD 123319 inhibits the reaction [AGT protein results in increased phosphorylation of MAPK1 protein] | decreases reaction|increases phosphorylation | 19041135 |
| C509204 | PD168393 | [PD168393 co-treated with Paclitaxel] results in decreased phosphorylation of and results in decreased activity of MAPK1 protein | affects cotreatment|decreases activity|decreases phosphorylation | 16413505 |
| C509204 | PD168393 | PD168393 inhibits the reaction [2,2',4,6,6'-pentachlorobiphenyl results in increased phosphorylation of MAPK1 protein] | decreases reaction|increases phosphorylation | 16778083 |
| C408604 | PD 169316 | PD 169316 promotes the reaction [sodium arsenite results in increased phosphorylation of MAPK1 protein] | increases phosphorylation|increases reaction | 12547826 |
| C115711 | PD 173074 | PD 173074 results in decreased phosphorylation of MAPK1 protein | decreases phosphorylation | 15029211 |
| C093973 | PD 98059 | PD 98059 inhibits the reaction [Dehydroepiandrosterone results in increased phosphorylation of MAPK1 protein] | decreases reaction|increases phosphorylation | 16373398 |
| C093973 | PD 98059 | PD 98059 inhibits the reaction [propyl pyrazole triol results in increased phosphorylation of MAPK1 protein] | decreases reaction|increases phosphorylation | 15615701 |
| C093973 | PD 98059 | PD 98059 inhibits the reaction [resveratrol results in increased phosphorylation of and results in increased activity of MAPK1 protein] | decreases reaction|increases activity|increases phosphorylation | 15615701 |
| C093973 | PD 98059 | PD 98059 results in decreased phosphorylation of MAPK1 protein | decreases phosphorylation | 15817663 |
| C093973 | PD 98059 | PD 98059 inhibits the reaction [Cisplatin results in increased phosphorylation of and results in increased activity of MAPK1 protein] | decreases reaction|increases activity|increases phosphorylation | 16013042 |
| C093973 | PD 98059 | PD 98059 inhibits the reaction [Hydrogen Peroxide results in increased activity of MAPK1 protein] | decreases reaction|increases activity | 15328380 |
| C093973 | PD 98059 | FGF1 protein inhibits the reaction [PD 98059 results in decreased phosphorylation of and results in decreased activity of MAPK1 protein] | decreases activity|decreases phosphorylation|decreases reaction | 15231676 |
| C093973 | PD 98059 | NRG1 protein alternative form inhibits the reaction [PD 98059 results in decreased phosphorylation of and results in decreased activity of MAPK1 protein] | decreases activity|decreases phosphorylation|decreases reaction | 15231676 |
| C093973 | PD 98059 | PD 98059 inhibits the reaction [Acetaldehyde results in increased phosphorylation of and results in increased activity of MAPK1 protein] | decreases reaction|increases activity|increases phosphorylation | 17030193 |
| C093973 | PD 98059 | PD 98059 inhibits the reaction [Acetaldehyde results in increased phosphorylation of MAPK1 protein] | decreases reaction|increases phosphorylation | 11343241 |
| C093973 | PD 98059 | PD 98059 inhibits the reaction [Acrolein results in increased phosphorylation of MAPK1 protein] | decreases reaction|increases phosphorylation | 15531749 |
| C093973 | PD 98059 | PD 98059 inhibits the reaction [Anisomycin results in increased phosphorylation of MAPK1 protein] | decreases reaction|increases phosphorylation | 12660819 |
| C093973 | PD 98059 | PD 98059 inhibits the reaction [arsenic trioxide results in increased phosphorylation of MAPK1 protein] | decreases reaction|increases phosphorylation | 16328441 |
| C093973 | PD 98059 | PD 98059 inhibits the reaction [arsenite results in increased phosphorylation of and results in increased activity of MAPK1 protein] | decreases reaction|increases activity|increases phosphorylation | 16008523 |
| C093973 | PD 98059 | PD 98059 inhibits the reaction [Asbestos, Crocidolite results in increased phosphorylation of MAPK1 protein] | decreases reaction|increases phosphorylation | 16966607 |
| C093973 | PD 98059 | PD 98059 inhibits the reaction [benzoquinone results in increased phosphorylation of and results in increased activity of MAPK1 protein] | decreases reaction|increases activity|increases phosphorylation | 15795063 |
| C093973 | PD 98059 | PD 98059 inhibits the reaction [bicalutamide results in increased phosphorylation of and results in increased activity of MAPK1 protein] | decreases reaction|increases activity|increases phosphorylation | 15466214 |
| C093973 | PD 98059 | PD 98059 inhibits the reaction [bisphenol A results in increased phosphorylation of MAPK1 protein] | decreases reaction|increases phosphorylation | 18544561 |
| C093973 | PD 98059 | PD 98059 inhibits the reaction [C5 protein results in increased phosphorylation of MAPK1 protein] | decreases reaction|increases phosphorylation | 16116186 |
| C093973 | PD 98059 | PD 98059 inhibits the reaction [Capsaicin results in increased phosphorylation of MAPK1 protein] | decreases reaction|increases phosphorylation | 19059400 |
| C093973 | PD 98059 | PD 98059 inhibits the reaction [Cisplatin results in increased phosphorylation of and results in increased activity of MAPK1 protein] | decreases reaction|increases activity|increases phosphorylation | 12663670 |
| C093973 | PD 98059 | PD 98059 inhibits the reaction [[Clioquinol co-treated with Copper] results in increased phosphorylation of MAPK1 protein] | affects cotreatment|decreases reaction|increases phosphorylation | 16648635 |
| C093973 | PD 98059 | PD 98059 inhibits the reaction [CXCL2 protein results in increased phosphorylation of and results in increased activity of MAPK1 protein] | decreases reaction|increases activity|increases phosphorylation | 15608143 |
| C093973 | PD 98059 | PD 98059 inhibits the reaction [Dihydrotestosterone results in increased phosphorylation of and results in increased activity of MAPK1 protein] | decreases reaction|increases activity|increases phosphorylation | 15466214 |
| C093973 | PD 98059 | PD 98059 inhibits the reaction [Doxorubicin results in increased phosphorylation of and results in increased activity of MAPK1 protein] | decreases reaction|increases activity|increases phosphorylation | 17526808 |
| C093973 | PD 98059 | PD 98059 inhibits the reaction [dracorhodin analog results in increased phosphorylation of MAPK1 protein] | decreases reaction|increases phosphorylation | 16864444 |
| C093973 | PD 98059 | PD 98059 inhibits the reaction [EDN2 protein results in increased phosphorylation of MAPK1 protein] | decreases reaction|increases phosphorylation | 12207323 |
| C093973 | PD 98059 | PD 98059 inhibits the reaction [EGF protein results in increased phosphorylation of MAPK1 protein] | decreases reaction|increases phosphorylation | 15531749 15466214 |
| C093973 | PD 98059 | PD 98059 inhibits the reaction [Estradiol results in increased phosphorylation of and results in increased activity of MAPK1 protein] | decreases reaction|increases activity|increases phosphorylation | 17689939 |
| C093973 | PD 98059 | PD 98059 inhibits the reaction [Estradiol results in increased phosphorylation of MAPK1 protein] | decreases reaction|increases phosphorylation | 18544561 15930183 |
| C093973 | PD 98059 | PD 98059 inhibits the reaction [Ethanol results in increased phosphorylation of MAPK1 protein] | decreases reaction|increases phosphorylation | 18295389 |
| C093973 | PD 98059 | PD 98059 inhibits the reaction [Fenretinide results in increased phosphorylation of MAPK1 protein] | decreases reaction|increases phosphorylation | 16407847 |
| C093973 | PD 98059 | PD 98059 inhibits the reaction [FGF2 protein results in increased phosphorylation of MAPK1 protein] | decreases reaction|increases phosphorylation | 15631803 |
| C093973 | PD 98059 | PD 98059 inhibits the reaction [Gentamicins results in increased phosphorylation of and results in increased activity of MAPK1 protein] | decreases reaction|increases activity|increases phosphorylation | 17537980 |
| C093973 | PD 98059 | PD 98059 inhibits the reaction [Homocysteine results in increased phosphorylation of MAPK1 protein] | decreases reaction|increases phosphorylation | 16251475 |
| C093973 | PD 98059 | PD 98059 inhibits the reaction [Humic Substances results in increased phosphorylation of MAPK1 protein] | decreases reaction|increases phosphorylation | 19686714 |
| C093973 | PD 98059 | PD 98059 inhibits the reaction [Hydrogen Peroxide results in increased phosphorylation of and results in increased activity of MAPK1 protein] | decreases reaction|increases activity|increases phosphorylation | 10640773 |
| C093973 | PD 98059 | PD 98059 inhibits the reaction [hydroquinone results in increased phosphorylation of and results in increased activity of MAPK1 protein] | decreases reaction|increases activity|increases phosphorylation | 15129224 |
| C093973 | PD 98059 | PD 98059 inhibits the reaction [IL17A protein results in increased phosphorylation of and results in increased activity of MAPK1 protein] | decreases reaction|increases activity|increases phosphorylation | 12016129 |
| C093973 | PD 98059 | PD 98059 inhibits the reaction [IL1B protein results in increased phosphorylation of MAPK1 protein] | decreases reaction|increases phosphorylation | 11854442 |
| C093973 | PD 98059 | PD 98059 inhibits the reaction [Iloprost results in increased phosphorylation of and results in increased activity of MAPK1 protein] | decreases reaction|increases activity|increases phosphorylation | 16373414 |
| C093973 | PD 98059 | PD 98059 inhibits the reaction [Neomycin results in increased phosphorylation of and results in increased activity of MAPK1 protein] | decreases reaction|increases activity|increases phosphorylation | 17537980 |
| C093973 | PD 98059 | PD 98059 inhibits the reaction [Phosphates results in increased phosphorylation of MAPK1 protein] | decreases reaction|increases phosphorylation | 16763222 |
| C093973 | PD 98059 | PD 98059 inhibits the reaction [Polymyxin B results in increased phosphorylation of and results in increased activity of MAPK1 protein] | decreases reaction|increases activity|increases phosphorylation | 15671028 |
| C093973 | PD 98059 | PD 98059 inhibits the reaction [Quercetin results in increased phosphorylation of MAPK1 protein] | decreases reaction|increases phosphorylation | 18377872 |
| C093973 | PD 98059 | PD 98059 inhibits the reaction [resveratrol results in increased phosphorylation of and results in increased activity of MAPK1 protein] | decreases reaction|increases activity|increases phosphorylation | 17689939 |
| C093973 | PD 98059 | PD 98059 inhibits the reaction [resveratrol results in increased phosphorylation of MAPK1 protein] | decreases reaction|increases phosphorylation | 17554206 16814113 |
| C093973 | PD 98059 | PD 98059 inhibits the reaction [sodium arsenite results in increased phosphorylation of MAPK1 protein] | decreases reaction|increases phosphorylation | 12482858 12660819 |
| C093973 | PD 98059 | PD 98059 inhibits the reaction [Tamoxifen results in increased phosphorylation of and results in increased activity of MAPK1 protein] | decreases reaction|increases activity|increases phosphorylation | 20211987 |
| C093973 | PD 98059 | PD 98059 inhibits the reaction [Tetradecanoylphorbol Acetate results in increased phosphorylation of and results in increased activity of MAPK1 protein] | decreases reaction|increases activity|increases phosphorylation | 16091123 |
| C093973 | PD 98059 | PD 98059 inhibits the reaction [Tetradecanoylphorbol Acetate results in increased phosphorylation of MAPK1 protein] | decreases reaction|increases phosphorylation | 18628248 |
| C093973 | PD 98059 | PD 98059 inhibits the reaction [TGFB1 protein results in increased phosphorylation of and results in increased activity of MAPK1 protein] | decreases reaction|increases activity|increases phosphorylation | 16361081 |
| C093973 | PD 98059 | PD 98059 inhibits the reaction [Thyroxine results in increased phosphorylation of and results in increased activity of MAPK1 protein] | decreases reaction|increases activity|increases phosphorylation | 17174366 |
| C093973 | PD 98059 | PD 98059 inhibits the reaction [TNF protein results in increased phosphorylation of MAPK1 protein] | decreases reaction|increases phosphorylation | 15322261 |
| C093973 | PD 98059 | PD 98059 inhibits the reaction [Tretinoin results in increased phosphorylation of MAPK1 protein] | decreases reaction|increases phosphorylation | 16149052 |
| C093973 | PD 98059 | PD 98059 results in decreased activity of MAPK1 protein | decreases activity | 15563584 15486966 |
| C093973 | PD 98059 | PD 98059 results in decreased expression of MAPK1 protein modified form | decreases expression | 17492661 |
| C093973 | PD 98059 | PD 98059 results in decreased phosphorylation of MAPK1 protein | decreases phosphorylation | 11322385 |
| C093973 | PD 98059 | [Selenium co-treated with PD 98059] results in decreased expression of MAPK1 protein modified form | affects cotreatment|decreases expression | 18583539 |
| C093973 | PD 98059 | PD 98059 inhibits the reaction [EDN1 protein results in increased phosphorylation of MAPK1 protein] | decreases reaction|increases phosphorylation | 11583584 |
| C093973 | PD 98059 | PD 98059 inhibits the reaction [FGF23 protein results in increased phosphorylation of MAPK1 protein] | decreases reaction|increases phosphorylation | 17699549 |
| C093973 | PD 98059 | PD 98059 inhibits the reaction [Lindane results in increased phosphorylation of MAPK1 protein] | decreases reaction|increases phosphorylation | 12807735 |
| C093973 | PD 98059 | PD 98059 inhibits the reaction [Phenylephrine results in increased phosphorylation of MAPK1 protein] | decreases reaction|increases phosphorylation | 17306214 |
| C093973 | PD 98059 | PD 98059 inhibits the reaction [pifithrin results in increased phosphorylation of MAPK1 protein] | decreases reaction|increases phosphorylation | 12884365 |
| C093973 | PD 98059 | PD 98059 inhibits the reaction [pirinixic acid results in increased phosphorylation of MAPK1 protein] | decreases reaction|increases phosphorylation | 18602970 |
| C093973 | PD 98059 | PD 98059 inhibits the reaction [PLG protein results in increased phosphorylation of MAPK1 protein] | decreases reaction|increases phosphorylation | 17482686 |
| C093973 | PD 98059 | PD 98059 inhibits the reaction [Quercetin results in increased phosphorylation of MAPK1 protein] | decreases reaction|increases phosphorylation | 15876423 |
| C093973 | PD 98059 | PD 98059 inhibits the reaction [sodium arsenite results in increased phosphorylation of MAPK1 protein] | decreases reaction|increases phosphorylation | 20008137 |
| C093973 | PD 98059 | PD 98059 results in decreased activity of MAPK1 protein | decreases activity | 11683414 15821753 |
| C093973 | PD 98059 | PD 98059 results in decreased phosphorylation of and results in decreased activity of MAPK1 protein | decreases activity|decreases phosphorylation | 12758056 |
| C093973 | PD 98059 | PD 98059 results in decreased phosphorylation of MAPK1 protein | decreases phosphorylation | 15695173 |
| C093973 | PD 98059 | PD 98059 inhibits the reaction [FGF2 protein results in increased phosphorylation of MAPK1 protein] | decreases reaction|increases phosphorylation | 16269011 |
| C093973 | PD 98059 | PD 98059 inhibits the reaction [AGT protein results in increased phosphorylation of MAPK1 protein] | decreases reaction|increases phosphorylation | 15539634 |
| C093973 | PD 98059 | PD 98059 inhibits the reaction [Asbestos, Amosite results in increased phosphorylation of MAPK1 protein] | decreases reaction|increases phosphorylation | 11306436 |
| C093973 | PD 98059 | PD 98059 inhibits the reaction [cirazoline results in increased phosphorylation of MAPK1 protein] | decreases reaction|increases phosphorylation | 15550506 |
| C093973 | PD 98059 | PD 98059 inhibits the reaction [FGF20 protein results in increased phosphorylation of MAPK1 protein] | decreases reaction|increases phosphorylation | 12704805 |
| C093973 | PD 98059 | PD 98059 inhibits the reaction [Glucose results in increased phosphorylation of MAPK1 protein] | decreases reaction|increases phosphorylation | 16572112 |
| C093973 | PD 98059 | PD 98059 inhibits the reaction [Glycosylation End Products, Advanced results in increased phosphorylation of MAPK1 protein] | decreases reaction|increases phosphorylation | 16572112 |
| C093973 | PD 98059 | PD 98059 inhibits the reaction [methyl(acetoxymethyl)nitrosamine results in increased activity of MAPK1 protein] | decreases reaction|increases activity | 12693035 |
| C093973 | PD 98059 | PD 98059 inhibits the reaction [Methylnitrosourea results in increased activity of MAPK1 protein] | decreases reaction|increases activity | 12693035 |
| C093973 | PD 98059 | PD 98059 inhibits the reaction [muconaldehyde results in increased phosphorylation of MAPK1 protein] | decreases reaction|increases phosphorylation | 15690152 |
| C093973 | PD 98059 | PD 98059 inhibits the reaction [Nitrosomethylurethane results in increased activity of MAPK1 protein] | decreases reaction|increases activity | 12693035 |
| C093973 | PD 98059 | PD 98059 inhibits the reaction [Oleylethanolamide results in increased phosphorylation of MAPK1 protein] | decreases reaction|increases phosphorylation | 16269455 |
| C093973 | PD 98059 | [PD 98059 inhibits the reaction [Oleylethanolamide results in increased phosphorylation of MAPK1 protein]] which results in increased susceptibility to Doxorubicin | decreases reaction|increases phosphorylation|increases response to substance | 16269455 |
| C093973 | PD 98059 | PD 98059 inhibits the reaction [Paraquat results in increased phosphorylation of MAPK1 protein] | decreases reaction|increases phosphorylation | 16687388 |
| C093973 | PD 98059 | PD 98059 inhibits the reaction [pentaacetyl geniposide results in increased phosphorylation of MAPK1 protein] | decreases reaction|increases phosphorylation | 17651887 |
| C093973 | PD 98059 | PD 98059 inhibits the reaction [Phenylephrine results in increased phosphorylation of MAPK1 protein] | decreases reaction|increases phosphorylation | 10727428 |
| C093973 | PD 98059 | PD 98059 inhibits the reaction [resveratrol results in increased phosphorylation of and affects the localization of MAPK1 protein] | affects localization|decreases reaction|increases phosphorylation | 17984113 |
| C093973 | PD 98059 | PD 98059 inhibits the reaction [resveratrol results in increased phosphorylation of MAPK1 protein] | decreases reaction|increases phosphorylation | 16525036 |
| C093973 | PD 98059 | PD 98059 inhibits the reaction [Testosterone results in increased phosphorylation of MAPK1 protein] | decreases reaction|increases phosphorylation | 17272394 |
| C093973 | PD 98059 | PD 98059 inhibits the reaction [Tetradecanoylphorbol Acetate results in increased phosphorylation of and results in increased activity of MAPK1 protein] | decreases reaction|increases activity|increases phosphorylation | 11532878 |
| C093973 | PD 98059 | PD 98059 inhibits the reaction [Vitamin A results in increased phosphorylation of MAPK1 protein] | decreases reaction|increases phosphorylation | 16510265 |
| C093973 | PD 98059 | PD 98059 results in decreased phosphorylation of MAPK1 protein | decreases phosphorylation | 16046226 |
| C093973 | PD 98059 | PD 98059 results in decreased activity of MAPK1 protein | decreases activity | 12369790 16046226 16052512 15537881 |
| C074968 | pentaacetyl geniposide | PD 98059 inhibits the reaction [pentaacetyl geniposide results in increased phosphorylation of MAPK1 protein] | decreases reaction|increases phosphorylation | 17651887 |
| C074968 | pentaacetyl geniposide | pentaacetyl geniposide results in decreased phosphorylation of and results in decreased activity of MAPK1 protein | decreases activity|decreases phosphorylation | 19464279 |
| C074968 | pentaacetyl geniposide | pentaacetyl geniposide results in increased phosphorylation of MAPK1 protein | increases phosphorylation | 17651887 |
| D010424 | Pentobarbital | Pentobarbital results in decreased phosphorylation of MAPK1 protein | decreases phosphorylation | 15263067 |
| D010457 | Peptidoglycan | Peptidoglycan results in increased phosphorylation of MAPK1 protein | increases phosphorylation | 19041413 |
| D037342 | Pertussis Toxin | Pertussis Toxin inhibits the reaction [ADORA1 protein results in increased activity of MAPK1 protein] | decreases reaction|increases activity | 16322354 |
| D037342 | Pertussis Toxin | Pertussis Toxin inhibits the reaction [C5 protein results in increased phosphorylation of MAPK1 protein] | decreases reaction|increases phosphorylation | 16116186 |
| D037342 | Pertussis Toxin | Pertussis Toxin inhibits the reaction [Homocysteine results in increased phosphorylation of MAPK1 protein] | decreases reaction|increases phosphorylation | 16251475 |
| D037342 | Pertussis Toxin | Pertussis Toxin inhibits the reaction [Tamoxifen results in increased phosphorylation of and results in increased activity of MAPK1 protein] | decreases reaction|increases activity|increases phosphorylation | 20211987 |
| D037342 | Pertussis Toxin | Pertussis Toxin inhibits the reaction [Phenylephrine results in increased phosphorylation of MAPK1 protein] | decreases reaction|increases phosphorylation | 10660688 |
| D037342 | Pertussis Toxin | Pertussis Toxin inhibits the reaction [TAS2R105 protein affects the reaction [Cycloheximide results in increased phosphorylation of MAPK1 protein]] | affects reaction|decreases reaction|increases phosphorylation | 15087236 |
| D037342 | Pertussis Toxin | Pertussis Toxin inhibits the reaction [lysophosphatidic acid results in increased phosphorylation of MAPK1 protein] | decreases reaction|increases phosphorylation | 15081308 11243883 |
| D037342 | Pertussis Toxin | Pertussis Toxin inhibits the reaction [[acetophenone co-treated with OLFR151 co-treated with P2RY1] results in increased phosphorylation of MAPK1 protein] | affects cotreatment|decreases reaction|increases phosphorylation | 17472961 |
| D037342 | Pertussis Toxin | Pertussis Toxin inhibits the reaction [[acetophenone co-treated with OLFR151 co-treated with P2RY2] results in increased phosphorylation of MAPK1 protein] | affects cotreatment|decreases reaction|increases phosphorylation | 17472961 |
| D010634 | Phenobarbital | Phenobarbital results in increased expression of MAPK1 mRNA | increases expression | 16940010 |
| D010656 | Phenylephrine | 1-Butanol inhibits the reaction [Phenylephrine results in increased phosphorylation of and results in increased activity of MAPK1 protein] | decreases reaction|increases activity|increases phosphorylation | 17461971 |
| D010656 | Phenylephrine | Phenylephrine results in increased phosphorylation of and results in increased activity of MAPK1 protein | increases activity|increases phosphorylation | 17461971 |
| D010656 | Phenylephrine | Phenylephrine results in increased phosphorylation of MAPK1 protein | increases phosphorylation | 17976640 |
| D010656 | Phenylephrine | RAF1 protein affects the reaction [Phenylephrine results in increased phosphorylation of MAPK1 protein] | affects reaction|increases phosphorylation | 17976640 |
| D010656 | Phenylephrine | CAV3 protein inhibits the reaction [Phenylephrine results in increased phosphorylation of MAPK1 protein] | decreases reaction|increases phosphorylation | 12847114 |
| D010656 | Phenylephrine | Phenylephrine results in increased phosphorylation of and results in increased activity of MAPK1 protein | increases activity|increases phosphorylation | 18977218 |
| D010656 | Phenylephrine | RGS3 protein affects the reaction [[Timolol co-treated with Phenylephrine] results in increased phosphorylation of and results in increased activity of MAPK1 protein] | affects cotreatment|affects reaction|increases activity|increases phosphorylation | 18977218 |
| D010656 | Phenylephrine | RGS4 protein affects the reaction [[Timolol co-treated with Phenylephrine] results in increased phosphorylation of and results in increased activity of MAPK1 protein] | affects cotreatment|affects reaction|increases activity|increases phosphorylation | 18977218 |
| D010656 | Phenylephrine | [Timolol co-treated with Phenylephrine] results in increased phosphorylation of and results in increased activity of MAPK1 protein | affects cotreatment|increases activity|increases phosphorylation | 18977218 |
| D010656 | Phenylephrine | atorvastatin inhibits the reaction [Phenylephrine results in increased phosphorylation of and results in increased activity of MAPK1 protein] | decreases reaction|increases activity|increases phosphorylation | 18360054 |
| D010656 | Phenylephrine | bisindolylmaleimide I inhibits the reaction [Phenylephrine results in increased phosphorylation of MAPK1 protein] | decreases reaction|increases phosphorylation | 17306214 |
| D010656 | Phenylephrine | NPY5R protein affects the reaction [NPY protein promotes the reaction [Phenylephrine results in increased phosphorylation of MAPK1 protein]] | affects reaction|increases phosphorylation|increases reaction | 10660688 |
| D010656 | Phenylephrine | NPY protein promotes the reaction [Phenylephrine results in increased phosphorylation of MAPK1 protein] | increases phosphorylation|increases reaction | 10660688 |
| D010656 | Phenylephrine | PD 98059 inhibits the reaction [Phenylephrine results in increased phosphorylation of MAPK1 protein] | decreases reaction|increases phosphorylation | 17306214 |
| D010656 | Phenylephrine | Pertussis Toxin inhibits the reaction [Phenylephrine results in increased phosphorylation of MAPK1 protein] | decreases reaction|increases phosphorylation | 10660688 |
| D010656 | Phenylephrine | Phenylephrine results in increased activity of MAPK1 protein | increases activity | 19002953 |
| D010656 | Phenylephrine | Phenylephrine results in increased phosphorylation of and results in increased activity of MAPK1 protein | increases activity|increases phosphorylation | 18360054 11739382 |
| D010656 | Phenylephrine | Phenylephrine results in increased phosphorylation of MAPK1 protein | increases phosphorylation | 12094073 11195782 17306214 11804996 10660688 |
| D010656 | Phenylephrine | Prazosin inhibits the reaction [Phenylephrine results in increased phosphorylation of MAPK1 protein] | decreases reaction|increases phosphorylation | 17306214 11804996 |
| D010656 | Phenylephrine | Tetradecanoylphorbol Acetate inhibits the reaction [NPY protein promotes the reaction [Phenylephrine results in increased phosphorylation of MAPK1 protein]] | decreases reaction|increases phosphorylation|increases reaction | 10660688 |
| D010656 | Phenylephrine | Tetradecanoylphorbol Acetate inhibits the reaction [Phenylephrine results in increased phosphorylation of MAPK1 protein] | decreases reaction|increases phosphorylation | 10660688 |
| D010656 | Phenylephrine | tyrphostin AG 1478 inhibits the reaction [Phenylephrine results in increased phosphorylation of and results in increased activity of MAPK1 protein] | decreases reaction|increases activity|increases phosphorylation | 18360054 |
| D010656 | Phenylephrine | U 0126 inhibits the reaction [Phenylephrine results in increased phosphorylation of MAPK1 protein] | decreases reaction|increases phosphorylation | 12729908 |
| D010656 | Phenylephrine | Phenylephrine results in increased expression of MAPK1 protein | increases expression | 17122163 |
| D010656 | Phenylephrine | Phenylephrine results in increased phosphorylation of MAPK1 protein | increases phosphorylation | 17122163 |
| D010656 | Phenylephrine | 2-(2-chloro-4-iodophenylamino)-N-cyclopropylmethoxy-3,4-difluorobenzamide inhibits the reaction [Phenylephrine results in increased activity of MAPK1 protein] | decreases reaction|increases activity | 12513686 |
| D010656 | Phenylephrine | ADAM17 protein affects the reaction [Phenylephrine results in increased phosphorylation of MAPK1 protein] | affects reaction|increases phosphorylation | 16760267 |
| D010656 | Phenylephrine | bisindolylmaleimide I inhibits the reaction [Phenylephrine results in increased activity of MAPK1 protein] | decreases reaction|increases activity | 12720544 |
| D010656 | Phenylephrine | bisindolylmaleimide I inhibits the reaction [Phenylephrine results in increased phosphorylation of MAPK1 protein] | decreases reaction|increases phosphorylation | 18445782 |
| D010656 | Phenylephrine | bisindolylmaleimide inhibits the reaction [Phenylephrine results in increased phosphorylation of MAPK1 protein] | decreases reaction|increases phosphorylation | 14975926 |
| D010656 | Phenylephrine | BMY 7378 inhibits the reaction [Phenylephrine results in increased phosphorylation of MAPK1 protein] | decreases reaction|increases phosphorylation | 16760267 |
| D010656 | Phenylephrine | calphostin C inhibits the reaction [Phenylephrine results in increased phosphorylation of and results in increased activity of MAPK1 protein] | decreases reaction|increases activity|increases phosphorylation | 16877402 |
| D010656 | Phenylephrine | CAT protein inhibits the reaction [Phenylephrine results in increased phosphorylation of and results in increased activity of MAPK1 protein] | decreases reaction|increases activity|increases phosphorylation | 16513848 |
| D010656 | Phenylephrine | Cyclosporine inhibits the reaction [Phenylephrine results in increased phosphorylation of and results in increased activity of MAPK1 protein] | decreases reaction|increases activity|increases phosphorylation | 16513848 |
| D010656 | Phenylephrine | DUSP6 protein inhibits the reaction [Phenylephrine results in increased phosphorylation of MAPK1 protein] | decreases reaction|increases phosphorylation | 15757502 |
| D010656 | Phenylephrine | [EGF protein binds to EGFR protein] promotes the reaction [Phenylephrine results in increased phosphorylation of MAPK1 protein] | affects binding|increases phosphorylation|increases reaction | 16760267 |
| D010656 | Phenylephrine | GLRX3 protein inhibits the reaction [Phenylephrine results in increased phosphorylation of and results in increased activity of MAPK1 protein] | decreases reaction|increases activity|increases phosphorylation | 16809552 |
| D010656 | Phenylephrine | GM 6001 inhibits the reaction [Phenylephrine results in increased phosphorylation of MAPK1 protein] | decreases reaction|increases phosphorylation | 16760267 |
| D010656 | Phenylephrine | latrunculin B inhibits the reaction [Phenylephrine results in increased phosphorylation of and results in increased activity of MAPK1 protein] | decreases reaction|increases activity|increases phosphorylation | 11739382 |
| D010656 | Phenylephrine | MAP2K1 protein affects the reaction [Phenylephrine results in increased phosphorylation of and results in increased activity of MAPK1 protein] | affects reaction|increases activity|increases phosphorylation | 10888249 |
| D010656 | Phenylephrine | MAPK1 protein affects the reaction [Phenylephrine results in increased expression of ELK1 mRNA] | affects reaction|increases expression | 10900171 |
| D010656 | Phenylephrine | MAPK1 protein affects the reaction [Phenylephrine results in increased phosphorylation of GATA4 protein] | affects reaction|increases phosphorylation | 10788492 |
| D010656 | Phenylephrine | MAPK1 protein promotes the reaction [Phenylephrine results in increased expression of EP300 mRNA] | increases expression|increases reaction | 11705990 |
| D010656 | Phenylephrine | MAPK1 protein promotes the reaction [Phenylephrine results in increased expression of JUN mRNA] | increases expression|increases reaction | 19002563 |
| D010656 | Phenylephrine | N-(2-methyl-4,5-bis(methylsulfonyl)benzoyl)guanidine inhibits the reaction [Phenylephrine results in increased phosphorylation of and results in increased activity of MAPK1 protein] | decreases reaction|increases activity|increases phosphorylation | 16513848 |
| D010656 | Phenylephrine | PD 98059 inhibits the reaction [Phenylephrine results in increased phosphorylation of MAPK1 protein] | decreases reaction|increases phosphorylation | 10727428 |
| D010656 | Phenylephrine | Phenylephrine affects the phosphorylation of MAPK1 protein | affects phosphorylation | 18084315 |
| D010656 | Phenylephrine | Phenylephrine results in increased activity of MAPK1 protein | increases activity | 11693273 |
| D010656 | Phenylephrine | Phenylephrine results in increased phosphorylation of and results in increased activity of MAPK1 protein | increases activity|increases phosphorylation | 16517124 11705990 16877402 15007106 10888249 15452191 11739382 16809552 16513848 |
| D010656 | Phenylephrine | Phenylephrine results in increased phosphorylation of MAPK1 protein | increases phosphorylation | 19540241 18445782 15757502 11854500 16760267 10727428 |
| D010656 | Phenylephrine | [Phenylephrine results in increased phosphorylation of MAPK1 protein] which affects the expression of TGFB1I1 protein | affects expression|increases phosphorylation | 19540241 |
| D010656 | Phenylephrine | Prazosin inhibits the reaction [Phenylephrine results in increased activity of MAPK1 protein] | decreases reaction|increases activity | 12513686 |
| D010656 | Phenylephrine | Prazosin inhibits the reaction [Phenylephrine results in increased phosphorylation of MAPK1 protein] | decreases reaction|increases phosphorylation | 18445782 |
| D010656 | Phenylephrine | RGS2 protein inhibits the reaction [Phenylephrine results in increased phosphorylation of and results in increased activity of MAPK1 protein] | decreases reaction|increases activity|increases phosphorylation | 16517124 |
| D010656 | Phenylephrine | Ro 31-8220 inhibits the reaction [Phenylephrine results in increased phosphorylation of and results in increased activity of MAPK1 protein] | decreases reaction|increases activity|increases phosphorylation | 16877402 |
| D010656 | Phenylephrine | rottlerin inhibits the reaction [Phenylephrine results in increased activity of MAPK1 protein] | decreases reaction|increases activity | 12720544 |
| D010656 | Phenylephrine | rottlerin promotes the reaction [Phenylephrine results in increased phosphorylation of MAPK1 protein] | increases phosphorylation|increases reaction | 14975926 |
| D010656 | Phenylephrine | Ruthenium Red inhibits the reaction [Phenylephrine results in increased phosphorylation of and results in increased activity of MAPK1 protein] | decreases reaction|increases activity|increases phosphorylation | 16513848 |
| D010656 | Phenylephrine | SLC9A1 protein promotes the reaction [Phenylephrine results in increased phosphorylation of and results in increased activity of MAPK1 protein] | increases activity|increases phosphorylation|increases reaction | 16513848 |
| D010656 | Phenylephrine | tyrphostin AG 1478 inhibits the reaction [Phenylephrine results in increased phosphorylation of and results in increased activity of MAPK1 protein] | decreases reaction|increases activity|increases phosphorylation | 14676212 |
| D010656 | Phenylephrine | U 0126 inhibits the reaction [Phenylephrine results in increased activity of MAPK1 protein] | decreases reaction|increases activity | 12513686 |
| D010656 | Phenylephrine | Y 27632 inhibits the reaction [Phenylephrine results in increased phosphorylation of and results in increased activity of MAPK1 protein] | decreases reaction|increases activity|increases phosphorylation | 11739382 |
| D010656 | Phenylephrine | MAPK1 protein promotes the reaction [Phenylephrine results in increased expression of CREBBP mRNA] | increases expression|increases reaction | 11705990 |
| D010672 | Phenytoin | Phenytoin results in decreased phosphorylation of MAPK1 protein | decreases phosphorylation | 15948689 |
| D015240 | Phorbol 12,13-Dibutyrate | Phorbol 12,13-Dibutyrate inhibits the reaction [Homocysteine results in increased phosphorylation of MAPK1 protein] | decreases reaction|increases phosphorylation | 16251475 |
| D015240 | Phorbol 12,13-Dibutyrate | Phorbol 12,13-Dibutyrate promotes the reaction [Homocysteine results in increased phosphorylation of MAPK1 protein] | increases phosphorylation|increases reaction | 16251475 |
| D010710 | Phosphates | AKT1 protein affects the reaction [Phosphates results in increased phosphorylation of MAPK1 protein] | affects reaction|increases phosphorylation | 16763222 |
| D010710 | Phosphates | PD 98059 inhibits the reaction [Phosphates results in increased phosphorylation of MAPK1 protein] | decreases reaction|increases phosphorylation | 16763222 |
| D010710 | Phosphates | Phosphates results in increased phosphorylation of and results in increased activity of MAPK1 protein | increases activity|increases phosphorylation | 16763222 |
| D010712 | Phosphatidic Acids | Phosphatidic Acids results in increased phosphorylation of and results in increased activity of MAPK1 protein | increases activity|increases phosphorylation | 18621911 |
| D010712 | Phosphatidic Acids | Phosphatidic Acids inhibits the reaction [Ethanol results in decreased phosphorylation of and results in decreased activity of MAPK1 protein] | decreases activity|decreases phosphorylation|decreases reaction | 18358832 |
| D010712 | Phosphatidic Acids | Phosphatidic Acids results in increased phosphorylation of and results in increased activity of MAPK1 protein | increases activity|increases phosphorylation | 18358832 |
| D010712 | Phosphatidic Acids | U 0126 inhibits the reaction [Phosphatidic Acids results in increased phosphorylation of and results in increased activity of MAPK1 protein] | decreases reaction|increases activity|increases phosphorylation | 18358832 |
| D010716 | Phosphatidylinositols | MAPK1 protein affects the reaction [Phosphatidylinositols results in increased expression of APOA1 protein] | affects reaction|increases expression | 19013290 |
| D010716 | Phosphatidylinositols | Phosphatidylinositols results in increased phosphorylation of MAPK1 protein | increases phosphorylation | 19013290 |
| C008890 | phosphoramidon | phosphoramidon inhibits the reaction [NTS protein results in increased phosphorylation of and results in increased activity of MAPK1 protein] | decreases reaction|increases activity|increases phosphorylation | 15177934 |
| D010833 | Phytic Acid | Phytic Acid results in decreased activity of MAPK1 protein | decreases activity | 15868430 |
| C415032 | picropodophyllin | picropodophyllin results in decreased phosphorylation of MAPK1 protein | decreases phosphorylation | 16166596 |
| C121565 | pifithrin | PD 98059 inhibits the reaction [pifithrin results in increased phosphorylation of MAPK1 protein] | decreases reaction|increases phosphorylation | 12884365 |
| C121565 | pifithrin | pifithrin promotes the reaction [Doxorubicin results in increased phosphorylation of MAPK1 protein] | increases phosphorylation|increases reaction | 12884365 |
| C121565 | pifithrin | pifithrin results in increased phosphorylation of MAPK1 protein | increases phosphorylation | 12884365 |
| C121565 | pifithrin | pifithrin inhibits the reaction [dibenzo(a,l)pyrene results in increased phosphorylation of MAPK1 protein] | decreases reaction|increases phosphorylation | 16005925 |
| C121565 | pifithrin | pifithrin inhibits the reaction [Doxorubicin results in increased phosphorylation of and results in increased activity of MAPK1 protein] | decreases reaction|increases activity|increases phosphorylation | 16687611 |
| C004479 | pimagedine | pimagedine results in decreased phosphorylation of and results in decreased activity of MAPK1 protein | decreases activity|decreases phosphorylation | 12473873 |
| C016063 | pinocembrin | pinocembrin inhibits the reaction [Ethanol results in increased phosphorylation of MAPK1 protein] | decreases reaction|increases phosphorylation | 18295389 |
| C006253 | pirinixic acid | PD 98059 inhibits the reaction [pirinixic acid results in increased phosphorylation of MAPK1 protein] | decreases reaction|increases phosphorylation | 18602970 |
| C006253 | pirinixic acid | pirinixic acid results in increased phosphorylation of MAPK1 protein | increases phosphorylation | 18602970 |
| D010936 | Plant Extracts | Plant Extracts results in increased phosphorylation of MAPK1 protein | increases phosphorylation | 20132043 |
| D010936 | Plant Extracts | Plant Extracts inhibits the reaction [[Dietary Fats co-treated with Diethylnitrosamine] results in increased phosphorylation of MAPK1 protein] | affects cotreatment|decreases reaction|increases phosphorylation | 19551842 |
| D010936 | Plant Extracts | Plant Extracts results in decreased phosphorylation of MAPK1 protein | decreases phosphorylation | 16254570 |
| D011112 | Polymyxin B | PD 98059 inhibits the reaction [Polymyxin B results in increased phosphorylation of and results in increased activity of MAPK1 protein] | decreases reaction|increases activity|increases phosphorylation | 15671028 |
| D011112 | Polymyxin B | Polymyxin B results in increased phosphorylation of and results in increased activity of MAPK1 protein | increases activity|increases phosphorylation | 15671028 |
| C079805 | poly(N-isopropylacrylamide-N-tert-butylacrylamide)copolymer | poly(N-isopropylacrylamide-N-tert-butylacrylamide)copolymer results in decreased phosphorylation of MAPK1 protein | decreases phosphorylation | 16460797 |
| C025299 | polyphenols | polyphenols results in increased phosphorylation of and results in increased activity of MAPK1 protein | increases activity|increases phosphorylation | 19602430 |
| D011134 | Polysaccharides | Polysaccharides results in increased phosphorylation of MAPK1 protein | increases phosphorylation | 15894585 |
| D011188 | Potassium | 2-aminoethoxydiphenyl borate inhibits the reaction [Potassium results in increased phosphorylation of MAPK1 protein] | decreases reaction|increases phosphorylation | 11707519 |
| D011188 | Potassium | Potassium results in increased phosphorylation of MAPK1 protein | increases phosphorylation | 11707519 |
| D011189 | Potassium Chloride | [19-oxo-11-deoxycorticosterone acetate co-treated with Potassium Chloride co-treated with Sodium Chloride] results in increased phosphorylation of MAPK1 protein | affects cotreatment|increases phosphorylation | 18823320 |
| D011189 | Potassium Chloride | 1-Butanol inhibits the reaction [Potassium Chloride results in increased phosphorylation of MAPK1 protein] | decreases reaction|increases phosphorylation | 18004999 |
| D011189 | Potassium Chloride | AG 1879 inhibits the reaction [Potassium Chloride results in increased phosphorylation of MAPK1 protein] | decreases reaction|increases phosphorylation | 18004999 |
| D011189 | Potassium Chloride | atrasentan inhibits the reaction [[19-oxo-11-deoxycorticosterone acetate co-treated with Potassium Chloride co-treated with Sodium Chloride] results in increased phosphorylation of MAPK1 protein] | affects cotreatment|decreases reaction|increases phosphorylation | 18823320 |
| D011189 | Potassium Chloride | CAMK2D protein affects the reaction [Potassium Chloride results in increased phosphorylation of MAPK1 protein] | affects reaction|increases phosphorylation | 18004999 |
| D011189 | Potassium Chloride | PLD2 protein promotes the reaction [Potassium Chloride results in increased phosphorylation of MAPK1 protein] | increases phosphorylation|increases reaction | 18004999 |
| D011189 | Potassium Chloride | Potassium Chloride results in increased phosphorylation of MAPK1 protein | increases phosphorylation | 18004999 |
| D011189 | Potassium Chloride | SRC protein affects the reaction [Potassium Chloride results in increased phosphorylation of and results in increased activity of MAPK1 protein] | affects reaction|increases activity|increases phosphorylation | 18004999 |
| D011224 | Prazosin | Prazosin inhibits the reaction [Phenylephrine results in increased phosphorylation of MAPK1 protein] | decreases reaction|increases phosphorylation | 11804996 17306214 |
| D011224 | Prazosin | Prazosin affects the activity of MAPK1 protein | affects activity | 11693273 |
| D011224 | Prazosin | Prazosin inhibits the reaction [Phenylephrine results in increased activity of MAPK1 protein] | decreases reaction|increases activity | 12513686 |
| D011224 | Prazosin | Prazosin inhibits the reaction [Phenylephrine results in increased phosphorylation of MAPK1 protein] | decreases reaction|increases phosphorylation | 18445782 |
| D011280 | Pregnanolone | Pregnanolone results in decreased phosphorylation of and results in decreased activity of MAPK1 protein | decreases activity|decreases phosphorylation | 16581232 |
| C035988 | procymidone | procymidone results in increased expression of MAPK1 mRNA | increases expression | 15686871 |
| D011374 | Progesterone | Mifepristone inhibits the reaction [Progesterone promotes the reaction [EGF protein results in increased phosphorylation of MAPK1 protein]] | decreases reaction|increases phosphorylation|increases reaction | 16175315 |
| D011374 | Progesterone | Mifepristone inhibits the reaction [Progesterone promotes the reaction [Estradiol results in increased phosphorylation of MAPK1 protein]] | decreases reaction|increases phosphorylation|increases reaction | 15358673 |
| D011374 | Progesterone | Progesterone promotes the reaction [EGF protein results in increased phosphorylation of MAPK1 protein] | increases phosphorylation|increases reaction | 16175315 |
| D011374 | Progesterone | Progesterone promotes the reaction [Estradiol results in increased phosphorylation of MAPK1 protein] | increases phosphorylation|increases reaction | 15358673 |
| D011374 | Progesterone | Progesterone results in decreased phosphorylation of MAPK1 protein | decreases phosphorylation | 17492661 |
| D011374 | Progesterone | Progesterone results in increased phosphorylation of MAPK1 protein | increases phosphorylation | 16175315 15358673 |
| D011374 | Progesterone | U 0126 inhibits the reaction [Progesterone promotes the reaction [EGF protein results in increased phosphorylation of MAPK1 protein]] | decreases reaction|increases phosphorylation|increases reaction | 16175315 |
| D011374 | Progesterone | Progesterone promotes the reaction [Hydrogen Peroxide results in increased phosphorylation of MAPK1 protein] | increases phosphorylation|increases reaction | 16284289 |
| D011374 | Progesterone | Cycloheximide inhibits the reaction [Progesterone results in increased phosphorylation of MAPK1 protein] | decreases reaction|increases phosphorylation | 14694440 |
| D011374 | Progesterone | Progesterone results in increased phosphorylation of MAPK1 protein | increases phosphorylation | 14694440 17055699 |
| D015742 | Propofol | Propofol inhibits the reaction [lipoteichoic acid results in increased phosphorylation of MAPK1 protein] | decreases reaction|increases phosphorylation | 19573522 |
| D011429 | Propolis | Propolis inhibits the reaction [Ethanol results in increased phosphorylation of MAPK1 protein] | decreases reaction|increases phosphorylation | 18295389 |
| C467746 | propyl pyrazole triol | 5,11-diethyl-5,6,11,12-tetrahydrochrysene-2,8-diol inhibits the reaction [propyl pyrazole triol results in increased phosphorylation of MAPK1 protein] | decreases reaction|increases phosphorylation | 15615701 |
| C467746 | propyl pyrazole triol | fulvestrant inhibits the reaction [propyl pyrazole triol results in increased phosphorylation of MAPK1 protein] | decreases reaction|increases phosphorylation | 15615701 |
| C467746 | propyl pyrazole triol | PD 98059 inhibits the reaction [propyl pyrazole triol results in increased phosphorylation of MAPK1 protein] | decreases reaction|increases phosphorylation | 15615701 |
| C467746 | propyl pyrazole triol | propyl pyrazole triol results in increased phosphorylation of MAPK1 protein | increases phosphorylation | 15615701 |
| C467746 | propyl pyrazole triol | [propyl pyrazole triol binds to and results in increased activity of ESR1 protein] which results in increased phosphorylation of and results in increased activity of MAPK1 protein | affects binding|increases activity|increases phosphorylation | 18446233 |
| D015232 | Dinoprostone | Dinoprostone results in increased phosphorylation of MAPK1 protein | increases phosphorylation | 17805209 |
| D015232 | Dinoprostone | gefitinib inhibits the reaction [Dinoprostone results in increased phosphorylation of MAPK1 protein] | decreases reaction|increases phosphorylation | 17805209 |
| D015237 | Dinoprost | Dinoprost affects the localization of MAPK1 protein | affects localization | 15654655 |
| D015237 | Dinoprost | Tetradecanoylphorbol Acetate inhibits the reaction [Dinoprost affects the localization of MAPK1 protein] | affects localization|decreases reaction | 15654655 |
| C526689 | punarnavine | punarnavine results in decreased expression of MAPK1 mRNA | decreases expression | 19171408 |
| C020972 | pyrrolidine dithiocarbamic acid | pyrrolidine dithiocarbamic acid inhibits the reaction [Doxorubicin results in increased phosphorylation of MAPK1 protein] | decreases reaction|increases phosphorylation | 15557793 |
| D011794 | Quercetin | PD 98059 inhibits the reaction [Quercetin results in increased phosphorylation of MAPK1 protein] | decreases reaction|increases phosphorylation | 18377872 |
| D011794 | Quercetin | Quercetin inhibits the reaction [APP protein results in increased phosphorylation of and results in increased activity of MAPK1 protein] | decreases reaction|increases activity|increases phosphorylation | 19464278 |
| D011794 | Quercetin | Quercetin inhibits the reaction [Cholesterol, LDL metabolite results in increased phosphorylation of MAPK1 protein] | decreases reaction|increases phosphorylation | 11414687 |
| D011794 | Quercetin | Quercetin inhibits the reaction [Glucose results in increased phosphorylation of MAPK1 protein] | decreases reaction|increases phosphorylation | 19557821 |
| D011794 | Quercetin | Quercetin inhibits the reaction [IL1B protein results in increased phosphorylation of MAPK1 protein] | decreases reaction|increases phosphorylation | 19367675 |
| D011794 | Quercetin | Quercetin inhibits the reaction [MAPK1 protein results in increased expression of MMP1 mRNA] | decreases reaction|increases expression | 11414687 |
| D011794 | Quercetin | Quercetin inhibits the reaction [S100B protein results in increased expression of MAPK1 protein] | decreases reaction|increases expression | 17103373 |
| D011794 | Quercetin | Quercetin inhibits the reaction [S100B protein results in increased phosphorylation of MAPK1 protein] | decreases reaction|increases phosphorylation | 17103373 |
| D011794 | Quercetin | Quercetin inhibits the reaction [Tetradecanoylphorbol Acetate results in increased phosphorylation of MAPK1 protein] | decreases reaction|increases phosphorylation | 18628248 |
| D011794 | Quercetin | Quercetin inhibits the reaction [TNF protein results in increased phosphorylation of and results in increased activity of MAPK1 protein] | decreases reaction|increases activity|increases phosphorylation | 12589822 |
| D011794 | Quercetin | Quercetin results in decreased phosphorylation of and results in decreased activity of MAPK1 protein | decreases activity|decreases phosphorylation | 10718847 |
| D011794 | Quercetin | Quercetin results in decreased phosphorylation of MAPK1 protein | decreases phosphorylation | 16996034 |
| D011794 | Quercetin | Quercetin results in increased phosphorylation of and results in increased activity of MAPK1 protein | increases activity|increases phosphorylation | 15090535 |
| D011794 | Quercetin | Quercetin results in increased phosphorylation of MAPK1 protein | increases phosphorylation | 18377872 18419748 18346843 17379280 |
| D011794 | Quercetin | PD 98059 inhibits the reaction [Quercetin results in increased phosphorylation of MAPK1 protein] | decreases reaction|increases phosphorylation | 15876423 |
| D011794 | Quercetin | Quercetin inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of and results in increased activity of MAPK1 protein] | decreases reaction|increases activity|increases phosphorylation | 12619901 |
| D011794 | Quercetin | Quercetin inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of MAPK1 protein] | decreases reaction|increases phosphorylation | 11543732 |
| D011794 | Quercetin | Quercetin results in increased phosphorylation of MAPK1 protein | increases phosphorylation | 15876423 |
| D011794 | Quercetin | Quercetin affects the phosphorylation of MAPK1 protein | affects phosphorylation | 19423323 |
| D011794 | Quercetin | Quercetin inhibits the reaction [Hydrogen Peroxide results in increased phosphorylation of and results in increased activity of MAPK1 protein] | decreases reaction|increases activity|increases phosphorylation | 10972672 |
| D011794 | Quercetin | Quercetin results in decreased phosphorylation of MAPK1 protein | decreases phosphorylation | 15118350 |
| D020849 | Raloxifene | Raloxifene results in increased phosphorylation of MAPK1 protein | increases phosphorylation | 16798746 |
| D020849 | Raloxifene | Raloxifene results in increased phosphorylation of MAPK1 protein | increases phosphorylation | 17174166 |
| D020849 | Raloxifene | U 0126 inhibits the reaction [Raloxifene results in increased phosphorylation of MAPK1 protein] | decreases reaction|increases phosphorylation | 17174166 |
| D011929 | Razoxane | [Doxorubicin co-treated with Razoxane] results in increased phosphorylation of MAPK1 protein | affects cotreatment|increases phosphorylation | 16213474 |
| D017382 | Reactive Oxygen Species | Reactive Oxygen Species affects the reaction [Tetradecanoylphorbol Acetate results in increased phosphorylation of MAPK1 protein] | affects reaction|increases phosphorylation | 19804834 |
| D017382 | Reactive Oxygen Species | Reactive Oxygen Species results in increased phosphorylation of MAPK1 protein | increases phosphorylation | 15888667 |
| D017382 | Reactive Oxygen Species | Reactive Oxygen Species affects the reaction [Sodium Chloride results in increased phosphorylation of MAPK1 protein] | affects reaction|increases phosphorylation | 16024921 |
| C059514 | resveratrol | fulvestrant inhibits the reaction [resveratrol results in increased phosphorylation of and results in increased activity of MAPK1 protein] | decreases reaction|increases activity|increases phosphorylation | 15615701 |
| C059514 | resveratrol | N-((2-(hydroxyaminocarbonyl)methyl)-4-methylpentanoyl)-3-(2'-naphthyl)alanylalanine, 2-aminoethylamide inhibits the reaction [resveratrol results in increased phosphorylation of and results in increased activity of MAPK1 protein] | decreases reaction|increases activity|increases phosphorylation | 15615701 |
| C059514 | resveratrol | PD 98059 inhibits the reaction [resveratrol results in increased phosphorylation of and results in increased activity of MAPK1 protein] | decreases reaction|increases activity|increases phosphorylation | 15615701 |
| C059514 | resveratrol | resveratrol results in increased phosphorylation of and results in increased activity of MAPK1 protein | increases activity|increases phosphorylation | 15615701 |
| C059514 | resveratrol | tyrphostin AG 1478 inhibits the reaction [resveratrol results in increased phosphorylation of and results in increased activity of MAPK1 protein] | decreases reaction|increases activity|increases phosphorylation | 15615701 |
| C059514 | resveratrol | 4'-N-benzoylstaurosporine affects the reaction [resveratrol results in increased phosphorylation of and results in increased activity of and results in increased localization of MAPK1 protein] | affects reaction|increases activity|increases localization|increases phosphorylation | 15542774 |
| C059514 | resveratrol | AG 1879 inhibits the reaction [resveratrol results in increased phosphorylation of and results in increased activity of MAPK1 protein] | decreases reaction|increases activity|increases phosphorylation | 15615701 |
| C059514 | resveratrol | arginyl-glycyl-aspartic acid inhibits the reaction [resveratrol results in increased phosphorylation of MAPK1 protein] | decreases reaction|increases phosphorylation | 16790523 |
| C059514 | resveratrol | EGF protein inhibits the reaction [resveratrol results in increased phosphorylation of and results in increased activity of and results in increased localization of MAPK1 protein] | decreases reaction|increases activity|increases localization|increases phosphorylation | 15542774 |
| C059514 | resveratrol | fulvestrant inhibits the reaction [resveratrol results in increased phosphorylation of and results in increased activity of MAPK1 protein] | decreases reaction|increases activity|increases phosphorylation | 17689939 |
| C059514 | resveratrol | [ITGA5 protein binds to ITGB3 protein] promotes the reaction [resveratrol results in increased phosphorylation of MAPK1 protein] | affects binding|increases phosphorylation|increases reaction | 16790523 |
| C059514 | resveratrol | PD 98059 inhibits the reaction [resveratrol results in increased phosphorylation of and results in increased activity of MAPK1 protein] | decreases reaction|increases activity|increases phosphorylation | 17689939 |
| C059514 | resveratrol | PD 98059 inhibits the reaction [resveratrol results in increased phosphorylation of MAPK1 protein] | decreases reaction|increases phosphorylation | 17554206 16814113 |
| C059514 | resveratrol | PRKCA protein affects the reaction [EGF protein inhibits the reaction [resveratrol results in increased phosphorylation of and results in increased activity of and results in increased localization of MAPK1 protein]] | affects reaction|decreases reaction|increases activity|increases localization|increases phosphorylation | 15542774 |
| C059514 | resveratrol | resveratrol inhibits the reaction [lysophosphatidic acid results in increased phosphorylation of MAPK1 protein] | decreases reaction|increases phosphorylation | 17919812 |
| C059514 | resveratrol | resveratrol inhibits the reaction [N-Formylmethionine Leucyl-Phenylalanine results in increased phosphorylation of MAPK1 protein] | decreases reaction|increases phosphorylation | 16212921 |
| C059514 | resveratrol | resveratrol inhibits the reaction [NRG1 protein alternative form results in increased phosphorylation of MAPK1 protein] | decreases reaction|increases phosphorylation | 17651959 |
| C059514 | resveratrol | resveratrol inhibits the reaction [PDGFB protein results in increased phosphorylation of and results in increased activity of MAPK1 protein] | decreases reaction|increases activity|increases phosphorylation | 16343977 |
| C059514 | resveratrol | resveratrol inhibits the reaction [TNF protein results in increased phosphorylation of and results in increased activity of MAPK1 protein] | decreases reaction|increases activity|increases phosphorylation | 16317118 |
| C059514 | resveratrol | resveratrol results in decreased activity of MAPK1 protein | decreases activity | 15698585 |
| C059514 | resveratrol | resveratrol results in decreased phosphorylation of and results in decreased activity of MAPK1 protein | decreases activity|decreases phosphorylation | 16227395 |
| C059514 | resveratrol | resveratrol results in decreased phosphorylation of MAPK1 protein | decreases phosphorylation | 16761963 14749477 |
| C059514 | resveratrol | resveratrol results in increased phosphorylation of and results in increased activity of and affects the localization of MAPK1 protein | affects localization|increases activity|increases phosphorylation | 15542774 |
| C059514 | resveratrol | resveratrol results in increased phosphorylation of and results in increased activity of MAPK1 protein | increases activity|increases phosphorylation | 17689939 17554206 15615701 19321006 |
| C059514 | resveratrol | resveratrol results in increased phosphorylation of MAPK1 protein | increases phosphorylation | 17499741 16790523 16814113 |
| C059514 | resveratrol | SB 203580 inhibits the reaction [resveratrol results in increased phosphorylation of and results in increased activity of MAPK1 protein] | decreases reaction|increases activity|increases phosphorylation | 17689939 |
| C059514 | resveratrol | Staurosporine inhibits the reaction [EGF protein inhibits the reaction [resveratrol results in increased phosphorylation of and results in increased activity of and results in increased localization of MAPK1 protein]] | decreases reaction|increases activity|increases localization|increases phosphorylation | 15542774 |
| C059514 | resveratrol | Staurosporine promotes the reaction [resveratrol results in increased phosphorylation of and results in increased activity of and results in increased localization of MAPK1 protein] | increases activity|increases localization|increases phosphorylation|increases reaction | 15542774 |
| C059514 | resveratrol | Tetradecanoylphorbol Acetate inhibits the reaction [resveratrol results in increased phosphorylation of and results in increased activity of and affects the localization of MAPK1 protein] | affects localization|decreases reaction|increases activity|increases phosphorylation | 15542774 |
| C059514 | resveratrol | resveratrol inhibits the reaction [4-hydroxy-2-nonenal results in decreased phosphorylation of and results in decreased activity of MAPK1 protein] | decreases activity|decreases phosphorylation|decreases reaction | 16322078 |
| C059514 | resveratrol | resveratrol inhibits the reaction [Tetradecanoylphorbol Acetate results in increased phosphorylation of MAPK1 protein] | decreases reaction|increases phosphorylation | 16474181 |
| C059514 | resveratrol | resveratrol results in decreased phosphorylation of MAPK1 protein | decreases phosphorylation | 17675339 |
| C059514 | resveratrol | arginyl-glycyl-aspartic acid inhibits the reaction [resveratrol results in increased phosphorylation of MAPK1 protein] | decreases reaction|increases phosphorylation | 17984113 |
| C059514 | resveratrol | N-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide inhibits the reaction [resveratrol promotes the reaction [MAPK1 protein binds to PTGS2 protein]] | affects binding|decreases reaction|increases reaction | 17984113 |
| C059514 | resveratrol | PD 98059 inhibits the reaction [resveratrol results in increased phosphorylation of and affects the localization of MAPK1 protein] | affects localization|decreases reaction|increases phosphorylation | 17984113 |
| C059514 | resveratrol | PD 98059 inhibits the reaction [resveratrol results in increased phosphorylation of MAPK1 protein] | decreases reaction|increases phosphorylation | 16525036 |
| C059514 | resveratrol | resveratrol inhibits the reaction [EGF protein results in increased phosphorylation of MAPK1 protein] | decreases reaction|increases phosphorylation | 16626303 |
| C059514 | resveratrol | resveratrol inhibits the reaction [IGF1 protein results in increased phosphorylation of MAPK1 protein] | decreases reaction|increases phosphorylation | 16626303 |
| C059514 | resveratrol | resveratrol inhibits the reaction [INS1 protein results in increased phosphorylation of MAPK1 protein] | decreases reaction|increases phosphorylation | 16626303 |
| C059514 | resveratrol | resveratrol inhibits the reaction [N-Formylmethionine Leucyl-Phenylalanine results in increased phosphorylation of MAPK1 protein] | decreases reaction|increases phosphorylation | 16212921 |
| C059514 | resveratrol | resveratrol promotes the reaction [MAPK1 protein binds to PTGS2 protein] | affects binding|increases reaction | 17984113 |
| C059514 | resveratrol | resveratrol results in decreased phosphorylation of MAPK1 protein | decreases phosphorylation | 16626303 |
| C059514 | resveratrol | resveratrol results in increased phosphorylation of and affects the localization of MAPK1 protein | affects localization|increases phosphorylation | 17984113 |
| C059514 | resveratrol | resveratrol results in increased phosphorylation of and results in increased activity of MAPK1 protein | increases activity|increases phosphorylation | 15882976 16860989 |
| C059514 | resveratrol | resveratrol results in increased phosphorylation of MAPK1 protein | increases phosphorylation | 16525036 |
| C064758 | Ro 31-8220 | Ro 31-8220 inhibits the reaction [bufalin results in increased phosphorylation of MAPK1 protein] | decreases reaction|increases phosphorylation | 10712238 |
| C064758 | Ro 31-8220 | Ro 31-8220 inhibits the reaction [Carbachol results in increased phosphorylation of and results in increased activity of MAPK1 protein] | decreases reaction|increases activity|increases phosphorylation | 16877402 |
| C064758 | Ro 31-8220 | Ro 31-8220 inhibits the reaction [EGF protein results in increased phosphorylation of and results in increased activity of MAPK1 protein] | decreases reaction|increases activity|increases phosphorylation | 16877402 |
| C064758 | Ro 31-8220 | Ro 31-8220 inhibits the reaction [Phenylephrine results in increased phosphorylation of and results in increased activity of MAPK1 protein] | decreases reaction|increases activity|increases phosphorylation | 16877402 |
| C104586 | roscovitine | roscovitine results in increased phosphorylation of and results in increased activity of MAPK1 protein | increases activity|increases phosphorylation | 18722528 |
| D012402 | Rotenone | Rotenone inhibits the reaction [Aldosterone results in increased phosphorylation of and results in increased activity of MAPK1 protein] | decreases reaction|increases activity|increases phosphorylation | 17596522 |
| D012402 | Rotenone | [Rotenone co-treated with Thenoyltrifluoroacetone] results in decreased phosphorylation of MAPK1 protein | affects cotreatment|decreases phosphorylation | 16672322 |
| C085746 | rottlerin | rottlerin affects the phosphorylation of MAPK1 protein | affects phosphorylation | 17976640 |
| C085746 | rottlerin | rottlerin inhibits the reaction [Acetaldehyde results in increased phosphorylation of and results in increased activity of MAPK1 protein] | decreases reaction|increases activity|increases phosphorylation | 17030193 |
| C085746 | rottlerin | rottlerin inhibits the reaction [NTS protein results in increased phosphorylation of and results in increased activity of MAPK1 protein] | decreases reaction|increases activity|increases phosphorylation | 15177934 |
| C085746 | rottlerin | rottlerin inhibits the reaction [Tetradecanoylphorbol Acetate results in increased phosphorylation of MAPK1 protein] | decreases reaction|increases phosphorylation | 18628248 |
| C085746 | rottlerin | rottlerin results in decreased phosphorylation of MAPK1 protein | decreases phosphorylation | 19393235 |
| C085746 | rottlerin | rottlerin inhibits the reaction [P2RY1 protein affects the reaction [Nucleotides results in increased phosphorylation of and results in increased activity of MAPK1 protein]] | affects reaction|decreases reaction|increases activity|increases phosphorylation | 17620283 |
| C085746 | rottlerin | rottlerin inhibits the reaction [Phenylephrine results in increased activity of MAPK1 protein] | decreases reaction|increases activity | 12720544 |
| C085746 | rottlerin | rottlerin promotes the reaction [Phenylephrine results in increased phosphorylation of MAPK1 protein] | increases phosphorylation|increases reaction | 14975926 |
| D012430 | Ruthenium Red | Ruthenium Red inhibits the reaction [Phenylephrine results in increased phosphorylation of and results in increased activity of MAPK1 protein] | decreases reaction|increases activity|increases phosphorylation | 16513848 |
| D012431 | Rutin | Rutin inhibits the reaction [Glucose results in increased phosphorylation of MAPK1 protein] | decreases reaction|increases phosphorylation | 19557821 |
| C057823 | salmeterol | [salmeterol binds to and results in increased activity of ADRB2 protein] which results in increased phosphorylation of and results in increased activity of MAPK1 protein | affects binding|increases activity|increases phosphorylation | 16980553 |
| C093642 | SB 203580 | SB 203580 inhibits the reaction [Estradiol results in increased phosphorylation of and results in increased activity of MAPK1 protein] | decreases reaction|increases activity|increases phosphorylation | 17689939 |
| C093642 | SB 203580 | SB 203580 inhibits the reaction [resveratrol results in increased phosphorylation of and results in increased activity of MAPK1 protein] | decreases reaction|increases activity|increases phosphorylation | 17689939 |
| C093642 | SB 203580 | SB 203580 promotes the reaction [bufalin results in increased phosphorylation of MAPK1 protein] | increases phosphorylation|increases reaction | 10712238 |
| C093642 | SB 203580 | SB 203580 promotes the reaction [sodium arsenite results in increased phosphorylation of MAPK1 protein] | increases phosphorylation|increases reaction | 12547826 |
| C093642 | SB 203580 | SB 203580 promotes the reaction [Tetradecanoylphorbol Acetate results in increased phosphorylation of and results in increased activity of MAPK1 protein] | increases activity|increases phosphorylation|increases reaction | 10993886 |
| C093642 | SB 203580 | SB 203580 promotes the reaction [ferrous sulfate results in increased phosphorylation of MAPK1 protein] | increases phosphorylation|increases reaction | 17172471 |
| C093642 | SB 203580 | SB 203580 promotes the reaction [Iron results in increased phosphorylation of MAPK1 protein] | increases phosphorylation|increases reaction | 17172471 |
| D012631 | Secobarbital | Secobarbital results in decreased phosphorylation of MAPK1 protein | decreases phosphorylation | 15263067 |
| D012643 | Selenium | [Selenium co-treated with PD 98059] results in decreased expression of MAPK1 protein modified form | affects cotreatment|decreases expression | 18583539 |
| D012643 | Selenium | Selenium results in increased phosphorylation of and results in increased activity of MAPK1 protein | increases activity|increases phosphorylation | 18583539 |
| D012643 | Selenium | Selenium results in increased phosphorylation of and results in increased activity of MAPK1 protein | increases activity|increases phosphorylation | 17997286 |
| D012645 | Selenomethionine | Selenomethionine promotes the reaction [IL1B protein results in increased phosphorylation of MAPK1 protein] | increases phosphorylation|increases reaction | 16206353 |
| D017632 | Asbestos, Serpentine | Asbestos, Serpentine results in increased phosphorylation of MAPK1 protein | increases phosphorylation | 16571779 10751356 |
| D017632 | Asbestos, Serpentine | GM 6001 inhibits the reaction [Asbestos, Serpentine results in increased phosphorylation of MAPK1 protein] | decreases reaction|increases phosphorylation | 16571779 |
| D022621 | Shiga Toxin | ADRB2 protein promotes the reaction [Shiga Toxin results in increased activity of MAPK1 protein] | increases activity|increases reaction | 11675405 |
| D022621 | Shiga Toxin | Forskolin inhibits the reaction [Shiga Toxin results in increased activity of MAPK1 protein] | decreases reaction|increases activity | 11675405 |
| D022621 | Shiga Toxin | ICI 118551 inhibits the reaction [Terbutaline inhibits the reaction [Shiga Toxin results in increased expression of MAPK1 protein]] | decreases reaction|increases expression | 11675405 |
| D022621 | Shiga Toxin | KT 5720 inhibits the reaction [Terbutaline inhibits the reaction [Shiga Toxin results in increased expression of MAPK1 protein]] | decreases reaction|increases expression | 11675405 |
| D022621 | Shiga Toxin | N-(2-(4-bromocinnamylamino)ethyl)-5-isoquinolinesulfonamide inhibits the reaction [Terbutaline inhibits the reaction [Shiga Toxin results in increased expression of MAPK1 protein]] | decreases reaction|increases expression | 11675405 |
| D022621 | Shiga Toxin | Shiga Toxin results in increased activity of MAPK1 protein | increases activity | 11675405 |
| D022621 | Shiga Toxin | Terbutaline inhibits the reaction [Shiga Toxin results in increased activity of MAPK1 protein] | decreases reaction|increases activity | 11675405 |
| D022641 | Shiga Toxin 2 | Shiga Toxin 2 results in increased activity of MAPK1 protein | increases activity | 12826277 |
| D022641 | Shiga Toxin 2 | Terbutaline inhibits the reaction [Shiga Toxin 2 results in increased activity of MAPK1 protein] | decreases reaction|increases activity | 12826277 |
| D022641 | Shiga Toxin 2 | [Terbutaline results in increased activity of ADRB2 protein] inhibits the reaction [Shiga Toxin 2 results in increased activity of MAPK1 protein] | decreases reaction|increases activity | 12826277 |
| C040115 | shogaol | shogaol inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of MAPK1 protein] | decreases reaction|increases phosphorylation | 18683823 |
| D017640 | Silicates | Silicates results in increased phosphorylation of MAPK1 protein | increases phosphorylation | 11280724 |
| D012838 | Silymarin | Silymarin inhibits the reaction [Cadmium Chloride results in increased phosphorylation of and results in increased activity of MAPK1 protein] | decreases reaction|increases activity|increases phosphorylation | 16728380 |
| D012838 | Silymarin | Silymarin inhibits the reaction [Cadmium results in increased phosphorylation of and results in increased activity of MAPK1 protein] | decreases reaction|increases activity|increases phosphorylation | 16728380 |
| C424127 | SL 327 | SL 327 inhibits the reaction [Haloperidol results in increased phosphorylation of MAPK1 protein] | decreases reaction|increases phosphorylation | 12871586 |
| C424127 | SL 327 | SL 327 results in decreased phosphorylation of MAPK1 protein | decreases phosphorylation | 12871586 |
| C017947 | sodium arsenite | 4-(4-fluorophenyl)-2-(4-hydroxyphenyl)-5-(4-pyridyl)imidazole promotes the reaction [sodium arsenite results in increased phosphorylation of MAPK1 protein] | increases phosphorylation|increases reaction | 12547826 |
| C017947 | sodium arsenite | diacetyldichlorofluorescein inhibits the reaction [sodium arsenite results in increased phosphorylation of MAPK1 protein] | decreases reaction|increases phosphorylation | 16959797 |
| C017947 | sodium arsenite | p38alpha inhibitor CMPD1 promotes the reaction [sodium arsenite results in increased phosphorylation of MAPK1 protein] | increases phosphorylation|increases reaction | 12547826 |
| C017947 | sodium arsenite | PD 169316 promotes the reaction [sodium arsenite results in increased phosphorylation of MAPK1 protein] | increases phosphorylation|increases reaction | 12547826 |
| C017947 | sodium arsenite | PD 98059 inhibits the reaction [sodium arsenite results in increased phosphorylation of MAPK1 protein] | decreases reaction|increases phosphorylation | 12482858 12660819 |
| C017947 | sodium arsenite | SB 203580 promotes the reaction [sodium arsenite results in increased phosphorylation of MAPK1 protein] | increases phosphorylation|increases reaction | 12547826 |
| C017947 | sodium arsenite | sodium arsenite results in increased activity of MAPK1 protein | increases activity | 19414066 |
| C017947 | sodium arsenite | sodium arsenite results in increased expression of and results in increased phosphorylation of and results in increased activity of MAPK1 protein | increases activity|increases expression|increases phosphorylation | 19577553 |
| C017947 | sodium arsenite | sodium arsenite results in increased phosphorylation of and results in increased activity of MAPK1 protein | increases activity|increases phosphorylation | 12547826 11723127 15504454 11322385 |
| C017947 | sodium arsenite | sodium arsenite results in increased phosphorylation of MAPK1 protein | increases phosphorylation | 12660819 19168569 16959797 12475910 19010883 12482858 |
| C017947 | sodium arsenite | SU 6656 inhibits the reaction [sodium arsenite results in increased phosphorylation of and results in increased activity of MAPK1 protein] | decreases reaction|increases activity|increases phosphorylation | 15504454 |
| C017947 | sodium arsenite | tyrphostin AG 1478 inhibits the reaction [sodium arsenite results in increased phosphorylation of and results in increased activity of MAPK1 protein] | decreases reaction|increases activity|increases phosphorylation | 15504454 |
| C017947 | sodium arsenite | U 0126 inhibits the reaction [sodium arsenite results in increased expression of and results in increased phosphorylation of and results in increased activity of MAPK1 protein] | decreases reaction|increases activity|increases expression|increases phosphorylation | 19577553 |
| C017947 | sodium arsenite | U 0126 inhibits the reaction [sodium arsenite results in increased phosphorylation of MAPK1 protein] | decreases reaction|increases phosphorylation | 12547826 |
| C017947 | sodium arsenite | alpha-cyano-(3,4-dihydroxy)-N-benzylcinnamide promotes the reaction [sodium arsenite results in increased phosphorylation of MAPK1 protein] | increases phosphorylation|increases reaction | 20008137 |
| C017947 | sodium arsenite | IL6 protein affects the reaction [sodium arsenite results in increased phosphorylation of MAPK1 protein] | affects reaction|increases phosphorylation | 20008137 |
| C017947 | sodium arsenite | PD 98059 inhibits the reaction [sodium arsenite results in increased phosphorylation of MAPK1 protein] | decreases reaction|increases phosphorylation | 20008137 |
| C017947 | sodium arsenite | sodium arsenite results in increased phosphorylation of and results in increased activity of MAPK1 protein | increases activity|increases phosphorylation | 11723127 |
| C017947 | sodium arsenite | sodium arsenite results in increased phosphorylation of MAPK1 protein | increases phosphorylation | 20008137 18996350 |
| D012965 | Sodium Chloride | Acetylcysteine inhibits the reaction [Sodium Chloride results in increased phosphorylation of MAPK1 protein] | decreases reaction|increases phosphorylation | 16024921 |
| D012965 | Sodium Chloride | Reactive Oxygen Species affects the reaction [Sodium Chloride results in increased phosphorylation of MAPK1 protein] | affects reaction|increases phosphorylation | 16024921 |
| D012965 | Sodium Chloride | Sodium Chloride results in decreased phosphorylation of and results in decreased activity of MAPK1 protein | decreases activity|decreases phosphorylation | 15975986 |
| D012965 | Sodium Chloride | Sodium Chloride results in increased phosphorylation of MAPK1 protein | increases phosphorylation | 16024921 |
| D012965 | Sodium Chloride | [19-oxo-11-deoxycorticosterone acetate co-treated with Potassium Chloride co-treated with Sodium Chloride] results in increased phosphorylation of MAPK1 protein | affects cotreatment|increases phosphorylation | 18823320 |
| D012965 | Sodium Chloride | atrasentan inhibits the reaction [[19-oxo-11-deoxycorticosterone acetate co-treated with Potassium Chloride co-treated with Sodium Chloride] results in increased phosphorylation of MAPK1 protein] | affects cotreatment|decreases reaction|increases phosphorylation | 18823320 |
| D012980 | Sodium Salicylate | Sodium Salicylate results in decreased phosphorylation of and results in decreased activity of MAPK1 protein | decreases activity|decreases phosphorylation | 10993886 |
| D012980 | Sodium Salicylate | Sodium Salicylate inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of and results in increased activity of MAPK1 protein] | decreases reaction|increases activity|increases phosphorylation | 10357911 |
| D018038 | Sodium Selenite | Sodium Selenite results in increased phosphorylation of MAPK1 protein | increases phosphorylation | 15845651 |
| D018038 | Sodium Selenite | Sodium Selenite results in increased expression of MAPK1 protein | increases expression | 17342738 |
| C060506 | sphingosine 1-phosphate | sphingosine 1-phosphate results in increased phosphorylation of and results in increased activity of MAPK1 protein | increases activity|increases phosphorylation | 16365044 |
| C526005 | SR140333B | SR140333B inhibits the reaction [Capsaicin results in increased phosphorylation of MAPK1 protein] | decreases reaction|increases phosphorylation | 16788306 |
| D019311 | Staurosporine | Staurosporine inhibits the reaction [EGF protein inhibits the reaction [resveratrol results in increased phosphorylation of and results in increased activity of and results in increased localization of MAPK1 protein]] | decreases reaction|increases activity|increases localization|increases phosphorylation | 15542774 |
| D019311 | Staurosporine | Staurosporine inhibits the reaction [Homocysteine results in increased phosphorylation of MAPK1 protein] | decreases reaction|increases phosphorylation | 16251475 |
| D019311 | Staurosporine | Staurosporine inhibits the reaction [NTS protein results in increased phosphorylation of and results in increased activity of MAPK1 protein] | decreases reaction|increases activity|increases phosphorylation | 15177934 |
| D019311 | Staurosporine | Staurosporine promotes the reaction [resveratrol results in increased phosphorylation of and results in increased activity of and results in increased localization of MAPK1 protein] | increases activity|increases localization|increases phosphorylation|increases reaction | 15542774 |
| D013311 | Streptozocin | arjunolic acid inhibits the reaction [Streptozocin results in increased phosphorylation of MAPK1 protein] | decreases reaction|increases phosphorylation | 19682444 |
| D013311 | Streptozocin | Streptozocin results in increased phosphorylation of MAPK1 protein | increases phosphorylation | 19682444 |
| C105686 | SU 5402 | SU 5402 inhibits the reaction [FGF2 protein results in increased phosphorylation of MAPK1 protein] | decreases reaction|increases phosphorylation | 15631803 |
| C105686 | SU 5402 | SU 5402 results in decreased expression of MAPK1 protein | decreases expression | 14871245 |
| C105686 | SU 5402 | SU 5402 results in decreased phosphorylation of MAPK1 protein | decreases phosphorylation | 15029211 |
| C416927 | SU 6656 | SU 6656 inhibits the reaction [sodium arsenite results in increased phosphorylation of and results in increased activity of MAPK1 protein] | decreases reaction|increases activity|increases phosphorylation | 15504454 |
| D013395 | Sucrose | Sucrose results in decreased phosphorylation of and results in decreased activity of MAPK1 protein | decreases activity|decreases phosphorylation | 15975986 |
| D013395 | Sucrose | Sucrose results in increased phosphorylation of and results in increased activity of MAPK1 protein | increases activity|increases phosphorylation | 18267125 |
| C016766 | sulforafan | sulforafan results in increased phosphorylation of and results in increased activity of MAPK1 protein | increases activity|increases phosphorylation | 15896333 |
| C016766 | sulforafan | sulforafan results in increased phosphorylation of MAPK1 protein | increases phosphorylation | 16033772 |
| C452601 | sulindac derivative IND 12 | HRAS protein affects the reaction [sulindac derivative IND 12 results in decreased phosphorylation of and results in decreased activity of MAPK1 protein] | affects reaction|decreases activity|decreases phosphorylation | 11912145 |
| C452601 | sulindac derivative IND 12 | sulindac derivative IND 12 results in decreased phosphorylation of and results in decreased activity of MAPK1 protein | decreases activity|decreases phosphorylation | 11912145 |
| C025462 | sulindac sulfide | MAP2K1 protein inhibits the reaction [sulindac sulfide results in decreased phosphorylation of MAPK1 protein] | decreases phosphorylation|decreases reaction | 15548677 |
| C025462 | sulindac sulfide | MAPK1 protein promotes the reaction [sulindac sulfide results in increased expression of EGR1 mRNA] | increases expression|increases reaction | 17599376 |
| C025462 | sulindac sulfide | MAPK1 protein promotes the reaction [sulindac sulfide results in increased phosphorylation of and results in increased activity of ELK1 protein] | increases activity|increases phosphorylation|increases reaction | 17599376 |
| C025462 | sulindac sulfide | sulindac sulfide results in decreased phosphorylation of MAPK1 protein | decreases phosphorylation | 15548677 |
| C025462 | sulindac sulfide | sulindac sulfide results in increased phosphorylation of and affects the activity of MAPK1 protein | affects activity|increases phosphorylation | 17599376 |
| C025462 | sulindac sulfide | sulindac sulfide results in increased phosphorylation of MAPK1 protein | increases phosphorylation | 18261746 16079301 |
| C025462 | sulindac sulfide | [sulindac sulfide results in increased phosphorylation of MAPK1 protein] which results in increased expression of ATF3 protein | increases expression|increases phosphorylation | 16079301 |
| C025462 | sulindac sulfide | [sulindac sulfide results in increased phosphorylation of MAPK1 protein] which results in increased expression of THBS1 protein | increases expression|increases phosphorylation | 18261746 |
| C025463 | sulindac sulfone | MAP2K1 protein inhibits the reaction [sulindac sulfone results in decreased phosphorylation of MAPK1 protein] | decreases phosphorylation|decreases reaction | 15548677 |
| C025463 | sulindac sulfone | sulindac sulfone results in decreased phosphorylation of MAPK1 protein | decreases phosphorylation | 15548677 |
| D013481 | Superoxides | Superoxides affects the reaction [Glucose results in increased phosphorylation of MAPK1 protein] | affects reaction|increases phosphorylation | 16572112 |
| D013481 | Superoxides | Superoxides affects the reaction [Glycosylation End Products, Advanced results in increased phosphorylation of MAPK1 protein] | affects reaction|increases phosphorylation | 16572112 |
| D013498 | Suramin | Suramin inhibits the reaction [Hydrogen Peroxide results in increased activity of MAPK1 protein] | decreases reaction|increases activity | 15328380 |
| D013498 | Suramin | Suramin inhibits the reaction [Estradiol results in increased phosphorylation of MAPK1 protein] | decreases reaction|increases phosphorylation | 15930183 |
| D013498 | Suramin | Suramin inhibits the reaction [2,6-di-tert-butyl-4-hydroperoxy-4-methyl-2,5-cyclohexadienone results in increased phosphorylation of and results in increased activity of MAPK1 protein] | decreases reaction|increases activity|increases phosphorylation | 8758915 |
| D014284 | Triiodothyronine | tetraiodothyroacetic acid inhibits the reaction [Triiodothyronine results in increased phosphorylation of and results in increased activity of MAPK1 protein] | decreases reaction|increases activity|increases phosphorylation | 17174366 |
| D014284 | Triiodothyronine | Triiodothyronine results in increased phosphorylation of and results in increased activity of MAPK1 protein | increases activity|increases phosphorylation | 17174366 |
| D014284 | Triiodothyronine | Triiodothyronine inhibits the reaction [EGF protein results in increased phosphorylation of MAPK1 protein] | decreases reaction|increases phosphorylation | 16150908 |
| D014284 | Triiodothyronine | Triiodothyronine promotes the reaction [FGF18 protein results in increased phosphorylation of MAPK1 protein] | increases phosphorylation|increases reaction | 16150908 |
| D014284 | Triiodothyronine | Triiodothyronine promotes the reaction [FGF2 protein results in increased phosphorylation of MAPK1 protein] | increases phosphorylation|increases reaction | 16150908 |
| D014284 | Triiodothyronine | Triiodothyronine promotes the reaction [FGF9 protein results in increased phosphorylation of MAPK1 protein] | increases phosphorylation|increases reaction | 16150908 |
| D014284 | Triiodothyronine | Triiodothyronine promotes the reaction [FGF2 protein results in increased phosphorylation of and results in increased activity of MAPK1 protein] | increases activity|increases phosphorylation|increases reaction | 12805413 |
| D013974 | Thyroxine | PD 98059 inhibits the reaction [Thyroxine results in increased phosphorylation of and results in increased activity of MAPK1 protein] | decreases reaction|increases activity|increases phosphorylation | 17174366 |
| D013974 | Thyroxine | tetraiodothyroacetic acid inhibits the reaction [Thyroxine results in increased phosphorylation of and results in increased activity of MAPK1 protein] | decreases reaction|increases activity|increases phosphorylation | 17174366 |
| D013974 | Thyroxine | Thyroxine results in increased phosphorylation of and results in increased activity of MAPK1 protein | increases activity|increases phosphorylation | 17174366 |
| D013974 | Thyroxine | tetraiodothyroacetic acid inhibits the reaction [Thyroxine affects the localization of MAPK1 protein] | affects localization|decreases reaction | 17984113 |
| D013974 | Thyroxine | Thyroxine affects the localization of MAPK1 protein | affects localization | 17984113 |
| D013629 | Tamoxifen | AG 1879 inhibits the reaction [Tamoxifen results in increased phosphorylation of and results in increased activity of MAPK1 protein] | decreases reaction|increases activity|increases phosphorylation | 20211987 |
| D013629 | Tamoxifen | PD 98059 inhibits the reaction [Tamoxifen results in increased phosphorylation of and results in increased activity of MAPK1 protein] | decreases reaction|increases activity|increases phosphorylation | 20211987 |
| D013629 | Tamoxifen | Pertussis Toxin inhibits the reaction [Tamoxifen results in increased phosphorylation of and results in increased activity of MAPK1 protein] | decreases reaction|increases activity|increases phosphorylation | 20211987 |
| D013629 | Tamoxifen | SRC protein promotes the reaction [Tamoxifen results in increased phosphorylation of and results in increased activity of MAPK1 protein] | increases activity|increases phosphorylation|increases reaction | 20211987 |
| D013629 | Tamoxifen | Tamoxifen analog results in increased phosphorylation of MAPK1 protein | increases phosphorylation | 19549922 |
| D013629 | Tamoxifen | Tamoxifen results in decreased phosphorylation of MAPK1 protein | decreases phosphorylation | 20549698 |
| D013629 | Tamoxifen | Tamoxifen results in increased phosphorylation of and results in increased activity of MAPK1 protein | increases activity|increases phosphorylation | 20211987 |
| D013629 | Tamoxifen | TP53 protein inhibits the reaction [Tamoxifen results in decreased phosphorylation of MAPK1 protein] | decreases phosphorylation|decreases reaction | 20549698 |
| D013629 | Tamoxifen | Tamoxifen results in decreased phosphorylation of and results in decreased activity of MAPK1 protein | decreases activity|decreases phosphorylation | 19393235 |
| D013629 | Tamoxifen | Tamoxifen affects the reaction [bisphenol A results in increased phosphorylation of MAPK1 protein] | affects reaction|increases phosphorylation | 15242752 |
| D013629 | Tamoxifen | Tamoxifen affects the reaction [Diethylstilbestrol affects the phosphorylation of MAPK1 protein] | affects phosphorylation|affects reaction | 15242752 |
| D013629 | Tamoxifen | Tamoxifen affects the reaction [nonylphenol results in increased phosphorylation of MAPK1 protein] | affects reaction|increases phosphorylation | 15242752 |
| D013629 | Tamoxifen | Tamoxifen inhibits the reaction [Estradiol results in increased activity of MAPK1 protein] | decreases reaction|increases activity | 16713447 |
| D013726 | Terbutaline | ICI 118551 inhibits the reaction [Terbutaline inhibits the reaction [Shiga Toxin results in increased expression of MAPK1 protein]] | decreases reaction|increases expression | 11675405 |
| D013726 | Terbutaline | KT 5720 inhibits the reaction [Terbutaline inhibits the reaction [Shiga Toxin results in increased expression of MAPK1 protein]] | decreases reaction|increases expression | 11675405 |
| D013726 | Terbutaline | N-(2-(4-bromocinnamylamino)ethyl)-5-isoquinolinesulfonamide inhibits the reaction [Terbutaline inhibits the reaction [Shiga Toxin results in increased expression of MAPK1 protein]] | decreases reaction|increases expression | 11675405 |
| D013726 | Terbutaline | [Terbutaline binds to and results in increased activity of ADRB2 protein] which results in increased phosphorylation of and results in increased activity of MAPK1 protein | affects binding|increases activity|increases phosphorylation | 16980553 |
| D013726 | Terbutaline | Terbutaline inhibits the reaction [Shiga Toxin 2 results in increased activity of MAPK1 protein] | decreases reaction|increases activity | 12826277 |
| D013726 | Terbutaline | Terbutaline inhibits the reaction [Shiga Toxin results in increased activity of MAPK1 protein] | decreases reaction|increases activity | 11675405 |
| D013726 | Terbutaline | [Terbutaline results in increased activity of ADRB2 protein] inhibits the reaction [Shiga Toxin 2 results in increased activity of MAPK1 protein] | decreases reaction|increases activity | 12826277 |
| D013726 | Terbutaline | ADRB2 protein promotes the reaction [Terbutaline inhibits the reaction [Lipopolysaccharides results in increased activity of MAPK1 protein]] | decreases reaction|increases activity|increases reaction | 10469353 |
| D013726 | Terbutaline | ICI 118551 inhibits the reaction [Terbutaline inhibits the reaction [Lipopolysaccharides results in increased activity of MAPK1 protein]] | decreases reaction|increases activity | 12608646 |
| D013726 | Terbutaline | Terbutaline inhibits the reaction [Lipopolysaccharides results in increased activity of MAPK1 protein] | decreases reaction|increases activity | 10469353 10857765 12608646 |
| D013739 | Testosterone | [Testosterone results in increased activity of RAF1 protein] which results in increased activity of MAPK1 protein | increases activity | 20372086 |
| D013739 | Testosterone | AG 1879 inhibits the reaction [Testosterone results in increased phosphorylation of MAPK1 protein] | decreases reaction|increases phosphorylation | 17272394 |
| D013739 | Testosterone | EGF protein inhibits the reaction [AG 1879 inhibits the reaction [Testosterone results in increased phosphorylation of MAPK1 protein]] | decreases reaction|increases phosphorylation | 17272394 |
| D013739 | Testosterone | PD 98059 inhibits the reaction [Testosterone results in increased phosphorylation of MAPK1 protein] | decreases reaction|increases phosphorylation | 17272394 |
| D013739 | Testosterone | Testosterone results in increased phosphorylation of MAPK1 protein | increases phosphorylation | 17272394 |
| C020806 | tetrabromobisphenol A | tetrabromobisphenol A results in decreased phosphorylation of MAPK1 protein | decreases phosphorylation | 17254629 |
| C020806 | tetrabromobisphenol A | tetrabromobisphenol A results in increased phosphorylation of MAPK1 protein | increases phosphorylation | 15456914 17254629 |
| C020806 | tetrabromobisphenol A | U 0126 inhibits the reaction [tetrabromobisphenol A results in increased phosphorylation of MAPK1 protein] | decreases reaction|increases phosphorylation | 15456914 17254629 |
| C020806 | tetrabromobisphenol A | Verapamil inhibits the reaction [tetrabromobisphenol A results in increased phosphorylation of MAPK1 protein] | decreases reaction|increases phosphorylation | 15456914 |
| C020806 | tetrabromobisphenol A | tetrabromobisphenol A results in increased phosphorylation of MAPK1 protein | increases phosphorylation | 16198432 |
| C020806 | tetrabromobisphenol A | tetrabromobisphenol A results in increased phosphorylation of MAPK1 protein | increases phosphorylation | 17205976 |
| C020806 | tetrabromobisphenol A | U 0126 inhibits the reaction [tetrabromobisphenol A results in increased phosphorylation of MAPK1 protein] | decreases reaction|increases phosphorylation | 17205976 |
| D013749 | Tetrachlorodibenzodioxin | 3'-methoxy-4'-nitroflavone inhibits the reaction [Tetrachlorodibenzodioxin results in increased phosphorylation of and results in increased activity of MAPK1 protein] | decreases reaction|increases activity|increases phosphorylation | 12668121 |
| D013749 | Tetrachlorodibenzodioxin | alpha-naphthoflavone inhibits the reaction [[Tetrachlorodibenzodioxin co-treated with Oxygen deficiency] results in increased phosphorylation of MAPK1 protein] | affects cotreatment|decreases reaction|increases phosphorylation | 19578757 |
| D013749 | Tetrachlorodibenzodioxin | EGFR protein promotes the reaction [Tetrachlorodibenzodioxin results in increased phosphorylation of and results in increased activity of MAPK1 protein] | increases activity|increases phosphorylation|increases reaction | 11309286 |
| D013749 | Tetrachlorodibenzodioxin | [Tetrachlorodibenzodioxin co-treated with Oxygen deficiency] results in increased phosphorylation of MAPK1 protein | affects cotreatment|increases phosphorylation | 19578757 |
| D013749 | Tetrachlorodibenzodioxin | Tetrachlorodibenzodioxin results in increased activity of MAPK1 protein | increases activity | 16051281 |
| D013749 | Tetrachlorodibenzodioxin | Tetrachlorodibenzodioxin results in increased phosphorylation of and results in increased activity of MAPK1 protein | increases activity|increases phosphorylation | 12668121 11309286 17223712 19962423 |
| D013749 | Tetrachlorodibenzodioxin | Tetrachlorodibenzodioxin results in increased phosphorylation of and results in increased expression of MAPK1 protein | increases expression|increases phosphorylation | 16051281 |
| D013749 | Tetrachlorodibenzodioxin | Tetrachlorodibenzodioxin results in increased phosphorylation of MAPK1 protein | increases phosphorylation | 15313166 |
| D013749 | Tetrachlorodibenzodioxin | tyrphostin AG 1478 inhibits the reaction [Tetrachlorodibenzodioxin results in increased phosphorylation of and results in increased activity of MAPK1 protein] | decreases reaction|increases activity|increases phosphorylation | 11309286 |
| D013749 | Tetrachlorodibenzodioxin | MAPK1 protein promotes the reaction [Tetrachlorodibenzodioxin results in decreased expression of PPARG protein] | decreases expression|increases reaction | 12758056 |
| D013749 | Tetrachlorodibenzodioxin | MAPK1 protein promotes the reaction [Tetrachlorodibenzodioxin results in increased activity of AHR protein] | increases activity|increases reaction | 12213569 |
| D013749 | Tetrachlorodibenzodioxin | MAPK1 protein promotes the reaction [Tetrachlorodibenzodioxin results in increased expression of CYP1A1 protein] | increases expression|increases reaction | 12213569 |
| D013749 | Tetrachlorodibenzodioxin | [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of MAPK1 mRNA | affects cotreatment|increases expression | 17942748 |
| D013749 | Tetrachlorodibenzodioxin | Tetrachlorodibenzodioxin promotes the reaction [Dimethylnitrosamine results in increased phosphorylation of and results in increased activity of MAPK1 protein] | increases activity|increases phosphorylation|increases reaction | 19555203 |
| D013749 | Tetrachlorodibenzodioxin | Tetrachlorodibenzodioxin results in increased expression of MAPK1 mRNA | increases expression | 16906519 |
| D013749 | Tetrachlorodibenzodioxin | Tetrachlorodibenzodioxin results in increased phosphorylation of and results in increased activity of MAPK1 protein | increases activity|increases phosphorylation | 12213569 |
| D013749 | Tetrachlorodibenzodioxin | Tetrachlorodibenzodioxin results in increased phosphorylation of MAPK1 protein | increases phosphorylation | 20181658 |
| D013749 | Tetrachlorodibenzodioxin | TGFA gene mutant form inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of MAPK1 mRNA] | decreases reaction|increases expression | 16906519 |
| D013749 | Tetrachlorodibenzodioxin | U 0126 inhibits the reaction [Tetrachlorodibenzodioxin results in increased phosphorylation of and results in increased activity of MAPK1 protein] | decreases reaction|increases activity|increases phosphorylation | 12213569 |
| C117155 | tetracycline CMT-3 | tetracycline CMT-3 results in decreased phosphorylation of and results in decreased activity of MAPK1 protein | decreases activity|decreases phosphorylation | 15489642 |
| D013755 | Tetradecanoylphorbol Acetate | RAF1 protein affects the reaction [Tetradecanoylphorbol Acetate results in increased phosphorylation of MAPK1 protein] | affects reaction|increases phosphorylation | 17976640 |
| D013755 | Tetradecanoylphorbol Acetate | Tetradecanoylphorbol Acetate results in increased phosphorylation of MAPK1 protein | increases phosphorylation | 17976640 |
| D013755 | Tetradecanoylphorbol Acetate | 2-(2-chloro-4-iodophenylamino)-N-cyclopropylmethoxy-3,4-difluorobenzamide inhibits the reaction [Tetradecanoylphorbol Acetate results in increased activity of MAPK1 protein] | decreases reaction|increases activity | 11728381 |
| D013755 | Tetradecanoylphorbol Acetate | Acetylcysteine inhibits the reaction [Tetradecanoylphorbol Acetate results in increased phosphorylation of MAPK1 protein] | decreases reaction|increases phosphorylation | 15978937 |
| D013755 | Tetradecanoylphorbol Acetate | bisindolylmaleimide I inhibits the reaction [Tetradecanoylphorbol Acetate results in increased phosphorylation of MAPK1 protein] | decreases reaction|increases phosphorylation | 18628248 |
| D013755 | Tetradecanoylphorbol Acetate | bisindolylmaleimide inhibits the reaction [Tetradecanoylphorbol Acetate results in increased phosphorylation of and results in increased activity of MAPK1 protein] | decreases reaction|increases activity|increases phosphorylation | 12761878 |
| D013755 | Tetradecanoylphorbol Acetate | diphenyleneiodonium inhibits the reaction [Tetradecanoylphorbol Acetate results in increased phosphorylation of MAPK1 protein] | decreases reaction|increases phosphorylation | 19804834 15978937 |
| D013755 | Tetradecanoylphorbol Acetate | PD 98059 inhibits the reaction [Tetradecanoylphorbol Acetate results in increased phosphorylation of and results in increased activity of MAPK1 protein] | decreases reaction|increases activity|increases phosphorylation | 16091123 |
| D013755 | Tetradecanoylphorbol Acetate | PD 98059 inhibits the reaction [Tetradecanoylphorbol Acetate results in increased phosphorylation of MAPK1 protein] | decreases reaction|increases phosphorylation | 18628248 |
| D013755 | Tetradecanoylphorbol Acetate | PIN1 protein promotes the reaction [Tetradecanoylphorbol Acetate results in increased phosphorylation of MAPK1 protein] | increases phosphorylation|increases reaction | 20479004 |
| D013755 | Tetradecanoylphorbol Acetate | PLD2 protein promotes the reaction [[Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in increased phosphorylation of and results in increased activity of MAPK1 protein] | affects cotreatment|increases activity|increases phosphorylation|increases reaction | 18423386 |
| D013755 | Tetradecanoylphorbol Acetate | Quercetin inhibits the reaction [Tetradecanoylphorbol Acetate results in increased phosphorylation of MAPK1 protein] | decreases reaction|increases phosphorylation | 18628248 |
| D013755 | Tetradecanoylphorbol Acetate | Reactive Oxygen Species affects the reaction [Tetradecanoylphorbol Acetate results in increased phosphorylation of MAPK1 protein] | affects reaction|increases phosphorylation | 19804834 |
| D013755 | Tetradecanoylphorbol Acetate | rottlerin inhibits the reaction [Tetradecanoylphorbol Acetate results in increased phosphorylation of MAPK1 protein] | decreases reaction|increases phosphorylation | 18628248 |
| D013755 | Tetradecanoylphorbol Acetate | [Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in increased phosphorylation of and results in increased activity of MAPK1 protein | affects cotreatment|increases activity|increases phosphorylation | 18423386 |
| D013755 | Tetradecanoylphorbol Acetate | Tetradecanoylphorbol Acetate inhibits the reaction [resveratrol results in increased phosphorylation of and results in increased activity of and affects the localization of MAPK1 protein] | affects localization|decreases reaction|increases activity|increases phosphorylation | 15542774 |
| D013755 | Tetradecanoylphorbol Acetate | Tetradecanoylphorbol Acetate promotes the reaction [Homocysteine results in increased phosphorylation of MAPK1 protein] | increases phosphorylation|increases reaction | 16251475 |
| D013755 | Tetradecanoylphorbol Acetate | Tetradecanoylphorbol Acetate results in increased activity of MAPK1 protein | increases activity | 11728381 |
| D013755 | Tetradecanoylphorbol Acetate | Tetradecanoylphorbol Acetate results in increased expression of MAPK1 | increases expression | 15666830 |
| D013755 | Tetradecanoylphorbol Acetate | Tetradecanoylphorbol Acetate results in increased phosphorylation of and results in increased activity of MAPK1 protein | increases activity|increases phosphorylation | 12761878 16091123 |
| D013755 | Tetradecanoylphorbol Acetate | Tetradecanoylphorbol Acetate results in increased phosphorylation of MAPK1 protein | increases phosphorylation | 20479004 18628248 15978937 16838270 19804834 |
| D013755 | Tetradecanoylphorbol Acetate | Chlorogenic Acid inhibits the reaction [Tetradecanoylphorbol Acetate results in increased phosphorylation of MAPK1 protein] | decreases reaction|increases phosphorylation | 15944151 |
| D013755 | Tetradecanoylphorbol Acetate | geldanamycin inhibits the reaction [Tetradecanoylphorbol Acetate results in increased phosphorylation of and results in increased activity of MAPK1 protein] | decreases reaction|increases activity|increases phosphorylation | 8816498 |
| D013755 | Tetradecanoylphorbol Acetate | myricetin inhibits the reaction [Tetradecanoylphorbol Acetate results in increased phosphorylation of MAPK1 protein] | decreases reaction|increases phosphorylation | 17693661 |
| D013755 | Tetradecanoylphorbol Acetate | PLD2 protein promotes the reaction [[Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in increased phosphorylation of and results in increased activity of MAPK1 protein] | affects cotreatment|increases activity|increases phosphorylation|increases reaction | 18423386 |
| D013755 | Tetradecanoylphorbol Acetate | RAC2 protein affects the reaction [Tetradecanoylphorbol Acetate results in increased phosphorylation of MAPK1 protein] | affects reaction|increases phosphorylation | 11145705 |
| D013755 | Tetradecanoylphorbol Acetate | resveratrol inhibits the reaction [Tetradecanoylphorbol Acetate results in increased phosphorylation of MAPK1 protein] | decreases reaction|increases phosphorylation | 16474181 |
| D013755 | Tetradecanoylphorbol Acetate | SB 203580 promotes the reaction [Tetradecanoylphorbol Acetate results in increased phosphorylation of and results in increased activity of MAPK1 protein] | increases activity|increases phosphorylation|increases reaction | 10993886 |
| D013755 | Tetradecanoylphorbol Acetate | [Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in increased phosphorylation of and results in increased activity of MAPK1 protein | affects cotreatment|increases activity|increases phosphorylation | 18423386 |
| D013755 | Tetradecanoylphorbol Acetate | Tetradecanoylphorbol Acetate inhibits the reaction [NPY protein promotes the reaction [Phenylephrine results in increased phosphorylation of MAPK1 protein]] | decreases reaction|increases phosphorylation|increases reaction | 10660688 |
| D013755 | Tetradecanoylphorbol Acetate | Tetradecanoylphorbol Acetate inhibits the reaction [Phenylephrine results in increased phosphorylation of MAPK1 protein] | decreases reaction|increases phosphorylation | 10660688 |
| D013755 | Tetradecanoylphorbol Acetate | Tetradecanoylphorbol Acetate results in increased phosphorylation of and results in increased activity of MAPK1 protein | increases activity|increases phosphorylation | 15537826 10993886 8816498 |
| D013755 | Tetradecanoylphorbol Acetate | Tetradecanoylphorbol Acetate results in increased phosphorylation of MAPK1 protein | increases phosphorylation | 10874129 16474181 15122579 11145705 11195782 17693661 17306214 11583584 |
| D013755 | Tetradecanoylphorbol Acetate | zerumbone inhibits the reaction [Tetradecanoylphorbol Acetate results in increased phosphorylation of MAPK1 protein] | decreases reaction|increases phosphorylation | 15122579 |
| D013755 | Tetradecanoylphorbol Acetate | Go 6976 inhibits the reaction [Tetradecanoylphorbol Acetate results in increased activity of MAPK1 protein] | decreases reaction|increases activity | 12720544 |
| D013755 | Tetradecanoylphorbol Acetate | PD 98059 inhibits the reaction [Tetradecanoylphorbol Acetate results in increased phosphorylation of and results in increased activity of MAPK1 protein] | decreases reaction|increases activity|increases phosphorylation | 11532878 |
| D013755 | Tetradecanoylphorbol Acetate | Tetradecanoylphorbol Acetate inhibits the reaction [Dinoprost affects the localization of MAPK1 protein] | affects localization|decreases reaction | 15654655 |
| D013755 | Tetradecanoylphorbol Acetate | Tetradecanoylphorbol Acetate results in increased phosphorylation of and results in increased activity of MAPK1 protein | increases activity|increases phosphorylation | 16877402 11532878 |
| D013755 | Tetradecanoylphorbol Acetate | Tetradecanoylphorbol Acetate results in increased phosphorylation of MAPK1 protein | increases phosphorylation | 14975926 |
| C011126 | tetraiodothyroacetic acid | tetraiodothyroacetic acid inhibits the reaction [Thyroxine results in increased phosphorylation of and results in increased activity of MAPK1 protein] | decreases reaction|increases activity|increases phosphorylation | 17174366 |
| C011126 | tetraiodothyroacetic acid | tetraiodothyroacetic acid inhibits the reaction [Triiodothyronine results in increased phosphorylation of and results in increased activity of MAPK1 protein] | decreases reaction|increases activity|increases phosphorylation | 17174366 |
| C011126 | tetraiodothyroacetic acid | tetraiodothyroacetic acid inhibits the reaction [Thyroxine affects the localization of MAPK1 protein] | affects localization|decreases reaction | 17984113 |
| D013792 | Thalidomide | Thalidomide analog results in increased phosphorylation of MAPK1 protein | increases phosphorylation | 15858615 |
| D019284 | Thapsigargin | [1,2-bis(2-aminophenoxy)ethane N,N,N',N'-tetraacetic acid acetoxymethyl ester co-treated with Genistein] inhibits the reaction [Thapsigargin promotes the reaction [Homocysteine results in increased phosphorylation of MAPK1 protein]] | affects cotreatment|decreases reaction|increases phosphorylation|increases reaction | 16251475 |
| D019284 | Thapsigargin | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Thapsigargin results in increased phosphorylation of MAPK1 protein] | decreases reaction|increases phosphorylation | 15339911 |
| D019284 | Thapsigargin | Genistein inhibits the reaction [Thapsigargin promotes the reaction [Homocysteine results in increased phosphorylation of MAPK1 protein]] | decreases reaction|increases phosphorylation|increases reaction | 16251475 |
| D019284 | Thapsigargin | Thapsigargin promotes the reaction [Homocysteine results in increased phosphorylation of MAPK1 protein] | increases phosphorylation|increases reaction | 16251475 |
| D019284 | Thapsigargin | Thapsigargin results in increased phosphorylation of MAPK1 protein | increases phosphorylation | 15339911 |
| C056068 | theaflavin | theaflavin results in decreased phosphorylation of MAPK1 protein | decreases phosphorylation | 17499812 |
| D013804 | Thenoyltrifluoroacetone | [Rotenone co-treated with Thenoyltrifluoroacetone] results in decreased phosphorylation of MAPK1 protein | affects cotreatment|decreases phosphorylation | 16672322 |
| D013840 | Thiamylal | Thiamylal results in decreased phosphorylation of MAPK1 protein | decreases phosphorylation | 15263067 |
| D015244 | Thiorphan | Thiorphan affects the phosphorylation of MAPK1 protein | affects phosphorylation | 16405511 |
| C027385 | tibolone | tibolone metabolite results in decreased phosphorylation of MAPK1 protein | decreases phosphorylation | 14764805 |
| C027385 | tibolone | tibolone results in decreased phosphorylation of MAPK1 protein | decreases phosphorylation | 14764805 |
| D013999 | Timolol | RGS3 protein affects the reaction [[Timolol co-treated with Phenylephrine] results in increased phosphorylation of and results in increased activity of MAPK1 protein] | affects cotreatment|affects reaction|increases activity|increases phosphorylation | 18977218 |
| D013999 | Timolol | RGS4 protein affects the reaction [[Timolol co-treated with Phenylephrine] results in increased phosphorylation of and results in increased activity of MAPK1 protein] | affects cotreatment|affects reaction|increases activity|increases phosphorylation | 18977218 |
| D013999 | Timolol | [Timolol co-treated with Phenylephrine] results in increased phosphorylation of and results in increased activity of MAPK1 protein | affects cotreatment|increases activity|increases phosphorylation | 18977218 |
| C032628 | tin protoporphyrin IX | tin protoporphyrin IX inhibits the reaction [Curcumin inhibits the reaction [PDGFB protein results in increased phosphorylation of MAPK1 protein]] | decreases reaction|increases phosphorylation | 18784349 |
| C113106 | tocopheryloxybutyric acid | tocopheryloxybutyric acid inhibits the reaction [Urethane results in increased phosphorylation of and results in increased activity of MAPK1 protein] | decreases reaction|increases activity|increases phosphorylation | 11062179 |
| D014051 | Toluene 2,4-Diisocyanate | [Toluene 2,4-Diisocyanate binds to ALB protein] which results in increased phosphorylation of MAPK1 protein | affects binding|increases phosphorylation | 16908450 |
| D014051 | Toluene 2,4-Diisocyanate | tyrphostin AG 1478 inhibits the reaction [[Toluene 2,4-Diisocyanate binds to ALB protein] which results in increased phosphorylation of MAPK1 protein] | affects binding|decreases reaction|increases phosphorylation | 16908450 |
| D014212 | Tretinoin | ARL6IP5 protein affects the reaction [Tretinoin results in increased phosphorylation of MAPK1 protein] | affects reaction|increases phosphorylation | 16922813 |
| D014212 | Tretinoin | geldanamycin inhibits the reaction [Tretinoin results in increased phosphorylation of MAPK1 protein] | decreases reaction|increases phosphorylation | 17293044 |
| D014212 | Tretinoin | [LCP2 protein co-treated with CSF1R protein] promotes the reaction [Tretinoin results in increased phosphorylation of MAPK1 protein] | affects cotreatment|increases phosphorylation|increases reaction | 16439309 |
| D014212 | Tretinoin | PD 98059 inhibits the reaction [Tretinoin results in increased phosphorylation of MAPK1 protein] | decreases reaction|increases phosphorylation | 16149052 |
| D014212 | Tretinoin | [Tretinoin co-treated with Genistein] results in increased phosphorylation of MAPK1 protein | affects cotreatment|increases phosphorylation | 16149052 |
| D014212 | Tretinoin | Tretinoin results in increased phosphorylation of and affects the localization of and results in increased activity of MAPK1 protein | affects localization|increases activity|increases phosphorylation | 16149052 |
| D014212 | Tretinoin | Tretinoin results in increased phosphorylation of MAPK1 protein | increases phosphorylation | 16470170 17293044 16329108 |
| D014212 | Tretinoin | U 0126 inhibits the reaction [Tretinoin results in increased phosphorylation of MAPK1 protein] | decreases reaction|increases phosphorylation | 16149052 |
| D014212 | Tretinoin | Tretinoin results in increased phosphorylation of MAPK1 protein | increases phosphorylation | 17026715 |
| D014212 | Tretinoin | U 0126 inhibits the reaction [Tretinoin results in increased phosphorylation of MAPK1 protein] | decreases reaction|increases phosphorylation | 17026715 |
| D014212 | Tretinoin | Tretinoin results in decreased phosphorylation of and results in decreased activity of MAPK1 protein | decreases activity|decreases phosphorylation | 16043492 |
| C011559 | tributyltin | 1,2-bis(2-aminophenoxy)ethane N,N,N',N'-tetraacetic acid acetoxymethyl ester inhibits the reaction [tributyltin results in increased phosphorylation of MAPK1 protein] | decreases reaction|increases phosphorylation | 11042092 |
| C011559 | tributyltin | tributyltin results in increased phosphorylation of MAPK1 protein | increases phosphorylation | 11042092 |
| C447082 | tricarbonyldichlororuthenium (II) dimer | tricarbonyldichlororuthenium (II) dimer results in increased phosphorylation of MAPK1 protein | increases phosphorylation | 15876423 |
| C012589 | trichostatin A | [D 21266 co-treated with trichostatin A] results in decreased activity of MAPK1 protein | affects cotreatment|decreases activity | 15781658 |
| C012589 | trichostatin A | trichostatin A results in decreased activity of MAPK1 protein | decreases activity | 15179185 |
| C037718 | trimethyltin hydroxide | trimethyltin hydroxide results in increased phosphorylation of and results in increased activity of MAPK1 protein | increases activity|increases phosphorylation | 16181675 |
| C057693 | troglitazone | troglitazone results in increased phosphorylation of MAPK1 protein | increases phosphorylation | 16079301 |
| C057693 | troglitazone | [troglitazone results in increased phosphorylation of MAPK1 protein] which results in increased expression of ATF3 protein | increases expression|increases phosphorylation | 16079301 |
| D014439 | Tyramine | Butylated Hydroxytoluene inhibits the reaction [Tyramine results in increased activity of MAPK1 protein] | decreases reaction|increases activity | 17561096 |
| D014439 | Tyramine | N,N-dimethylsphingosine inhibits the reaction [Tyramine results in increased activity of MAPK1 protein] | decreases reaction|increases activity | 17561096 |
| D014439 | Tyramine | Tyramine results in increased activity of MAPK1 protein | increases activity | 17561096 |
| C118515 | tyrphostin 51 | tyrphostin 51 inhibits the reaction [Hydrogen Peroxide results in increased activity of MAPK1 protein] | decreases reaction|increases activity | 15328380 |
| C101044 | tyrphostin AG 1478 | tyrphostin AG 1478 inhibits the reaction [Estradiol results in increased phosphorylation of and results in increased activity of MAPK1 protein] | decreases reaction|increases activity|increases phosphorylation | 15615701 |
| C101044 | tyrphostin AG 1478 | tyrphostin AG 1478 inhibits the reaction [resveratrol results in increased phosphorylation of and results in increased activity of MAPK1 protein] | decreases reaction|increases activity|increases phosphorylation | 15615701 |
| C101044 | tyrphostin AG 1478 | tyrphostin AG 1478 inhibits the reaction [4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in increased phosphorylation of MAPK1 protein] | decreases reaction|increases phosphorylation | 16671086 |
| C101044 | tyrphostin AG 1478 | tyrphostin AG 1478 inhibits the reaction [Acrolein results in increased phosphorylation of MAPK1 protein] | decreases reaction|increases phosphorylation | 11329622 |
| C101044 | tyrphostin AG 1478 | tyrphostin AG 1478 inhibits the reaction [Calcitriol results in increased phosphorylation of and results in increased activity of MAPK1 protein] | decreases reaction|increases activity|increases phosphorylation | 12761878 |
| C101044 | tyrphostin AG 1478 | tyrphostin AG 1478 inhibits the reaction [EGF protein results in increased phosphorylation of and results in increased activity of MAPK1 protein] | decreases reaction|increases activity|increases phosphorylation | 11309286 |
| C101044 | tyrphostin AG 1478 | tyrphostin AG 1478 inhibits the reaction [Iloprost results in increased phosphorylation of and results in increased activity of MAPK1 protein] | decreases reaction|increases activity|increases phosphorylation | 16373414 |
| C101044 | tyrphostin AG 1478 | tyrphostin AG 1478 inhibits the reaction [NTS protein results in increased phosphorylation of and results in increased activity of MAPK1 protein] | decreases reaction|increases activity|increases phosphorylation | 15247267 15177934 |
| C101044 | tyrphostin AG 1478 | tyrphostin AG 1478 inhibits the reaction [sodium arsenite results in increased phosphorylation of and results in increased activity of MAPK1 protein] | decreases reaction|increases activity|increases phosphorylation | 15504454 |
| C101044 | tyrphostin AG 1478 | tyrphostin AG 1478 inhibits the reaction [TAC1 protein results in increased phosphorylation of and results in increased activity of MAPK1 protein] | decreases reaction|increases activity|increases phosphorylation | 15319441 |
| C101044 | tyrphostin AG 1478 | tyrphostin AG 1478 inhibits the reaction [Tetrachlorodibenzodioxin results in increased phosphorylation of and results in increased activity of MAPK1 protein] | decreases reaction|increases activity|increases phosphorylation | 11309286 |
| C101044 | tyrphostin AG 1478 | tyrphostin AG 1478 inhibits the reaction [TGFA protein results in increased phosphorylation of and results in increased activity of MAPK1 protein] | decreases reaction|increases activity|increases phosphorylation | 11309286 |
| C101044 | tyrphostin AG 1478 | tyrphostin AG 1478 inhibits the reaction [[Toluene 2,4-Diisocyanate binds to ALB protein] which results in increased phosphorylation of MAPK1 protein] | affects binding|decreases reaction|increases phosphorylation | 16908450 |
| C101044 | tyrphostin AG 1478 | tyrphostin AG 1478 results in decreased phosphorylation of and results in decreased activity of MAPK1 protein | decreases activity|decreases phosphorylation | 12761878 |
| C101044 | tyrphostin AG 1478 | tyrphostin AG 1478 inhibits the reaction [Phenylephrine results in increased phosphorylation of and results in increased activity of MAPK1 protein] | decreases reaction|increases activity|increases phosphorylation | 18360054 |
| C101044 | tyrphostin AG 1478 | tyrphostin AG 1478 inhibits the reaction [Doxorubicin results in increased phosphorylation of and results in increased activity of MAPK1 protein] | decreases reaction|increases activity|increases phosphorylation | 15843167 |
| C101044 | tyrphostin AG 1478 | tyrphostin AG 1478 inhibits the reaction [EGFR protein affects the reaction [EDN1 protein results in increased phosphorylation of MAPK1 protein]] | affects reaction|decreases reaction|increases phosphorylation | 16261333 |
| C101044 | tyrphostin AG 1478 | tyrphostin AG 1478 inhibits the reaction [Hydrogen Peroxide results in increased activity of MAPK1 protein] | decreases reaction|increases activity | 15574683 |
| C101044 | tyrphostin AG 1478 | tyrphostin AG 1478 inhibits the reaction [Metribolone results in increased phosphorylation of MAPK1 protein] | decreases reaction|increases phosphorylation | 17272394 |
| C101044 | tyrphostin AG 1478 | tyrphostin AG 1478 inhibits the reaction [Oleylethanolamide results in increased phosphorylation of MAPK1 protein] | decreases reaction|increases phosphorylation | 16269455 |
| C101044 | tyrphostin AG 1478 | tyrphostin AG 1478 inhibits the reaction [Phenylephrine results in increased phosphorylation of and results in increased activity of MAPK1 protein] | decreases reaction|increases activity|increases phosphorylation | 14676212 |
| C101044 | tyrphostin AG 1478 | tyrphostin AG 1478 inhibits the reaction [Uridine Triphosphate results in increased phosphorylation of and results in increased activity of MAPK1 protein] | decreases reaction|increases activity|increases phosphorylation | 14676212 |
| C098214 | tyrphostin AG825 | tyrphostin AG825 inhibits the reaction [Oleylethanolamide results in increased phosphorylation of MAPK1 protein] | decreases reaction|increases phosphorylation | 16269455 |
| C113580 | U 0126 | U 0126 inhibits the reaction [Dactinomycin results in increased phosphorylation of and results in increased activity of MAPK1 protein] | decreases reaction|increases activity|increases phosphorylation | 14640974 |
| C113580 | U 0126 | U 0126 inhibits the reaction [Cisplatin results in increased phosphorylation of and results in increased activity of MAPK1 protein] | decreases reaction|increases activity|increases phosphorylation | 16013042 |
| C113580 | U 0126 | FGF1 protein inhibits the reaction [U 0126 results in decreased phosphorylation of and results in decreased activity of MAPK1 protein] | decreases activity|decreases phosphorylation|decreases reaction | 15231676 |
| C113580 | U 0126 | NRG1 protein alternative form inhibits the reaction [U 0126 results in decreased phosphorylation of and results in decreased activity of MAPK1 protein] | decreases activity|decreases phosphorylation|decreases reaction | 15231676 |
| C113580 | U 0126 | [tert-Butylhydroperoxide co-treated with U 0126] results in decreased phosphorylation of MAPK1 protein | affects cotreatment|decreases phosphorylation | 17003459 |
| C113580 | U 0126 | U 0126 inhibits the reaction [4-hydroxyestradiol-17 beta results in increased phosphorylation of MAPK1 protein] | decreases reaction|increases phosphorylation | 15901486 |
| C113580 | U 0126 | U 0126 inhibits the reaction [4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in increased phosphorylation of MAPK1 protein] | decreases reaction|increases phosphorylation | 18508827 |
| C113580 | U 0126 | U 0126 inhibits the reaction [7-ketocholesterol results in increased phosphorylation of MAPK1 protein] | decreases reaction|increases phosphorylation | 15955068 |
| C113580 | U 0126 | U 0126 inhibits the reaction [arsenic trioxide results in increased phosphorylation of and results in increased activity of MAPK1 protein] | decreases reaction|increases activity|increases phosphorylation | 18299328 |
| C113580 | U 0126 | U 0126 inhibits the reaction [arsenic trioxide results in increased phosphorylation of MAPK1 protein] | decreases reaction|increases phosphorylation | 19088370 |
| C113580 | U 0126 | U 0126 inhibits the reaction [Dieldrin results in increased phosphorylation of MAPK1 protein] | decreases reaction|increases phosphorylation | 15888667 |
| C113580 | U 0126 | U 0126 inhibits the reaction [Doxorubicin results in increased phosphorylation of MAPK1 protein] | decreases reaction|increases phosphorylation | 15557793 18468633 |
| C113580 | U 0126 | U 0126 inhibits the reaction [Endosulfan results in increased phosphorylation of MAPK1 protein] | decreases reaction|increases phosphorylation | 15888667 |
| C113580 | U 0126 | U 0126 inhibits the reaction [FGF10 protein results in increased phosphorylation of MAPK1 protein] | decreases reaction|increases phosphorylation | 12574212 |
| C113580 | U 0126 | U 0126 inhibits the reaction [FGF7 protein results in increased phosphorylation of MAPK1 protein] | decreases reaction|increases phosphorylation | 12574212 |
| C113580 | U 0126 | U 0126 inhibits the reaction [Heptachlor results in increased phosphorylation of MAPK1 protein] | decreases reaction|increases phosphorylation | 15888667 |
| C113580 | U 0126 | U 0126 inhibits the reaction [Homocysteine results in increased phosphorylation of MAPK1 protein] | decreases reaction|increases phosphorylation | 16251475 |
| C113580 | U 0126 | U 0126 inhibits the reaction [IL17A protein results in increased phosphorylation of and results in increased activity of MAPK1 protein] | decreases reaction|increases activity|increases phosphorylation | 12016129 |
| C113580 | U 0126 | U 0126 inhibits the reaction [Lindane results in increased phosphorylation of MAPK1 protein] | decreases reaction|increases phosphorylation | 15888667 |
| C113580 | U 0126 | U 0126 inhibits the reaction [methoxyacetic acid results in increased phosphorylation of MAPK1 protein] | decreases reaction|increases phosphorylation | 18486176 |
| C113580 | U 0126 | U 0126 inhibits the reaction [NTS protein results in increased phosphorylation of and results in increased activity of MAPK1 protein] | decreases reaction|increases activity|increases phosphorylation | 15177934 |
| C113580 | U 0126 | U 0126 inhibits the reaction [Paclitaxel results in increased activity of MAPK1 protein] | decreases reaction|increases activity | 16211241 |
| C113580 | U 0126 | U 0126 inhibits the reaction [PDGFB protein results in increased phosphorylation of and results in increased activity of MAPK1 protein] | decreases reaction|increases activity|increases phosphorylation | 15919668 |
| C113580 | U 0126 | U 0126 inhibits the reaction [Progesterone promotes the reaction [EGF protein results in increased phosphorylation of MAPK1 protein]] | decreases reaction|increases phosphorylation|increases reaction | 16175315 |
| C113580 | U 0126 | U 0126 inhibits the reaction [sodium arsenite results in increased expression of and results in increased phosphorylation of and results in increased activity of MAPK1 protein] | decreases reaction|increases activity|increases expression|increases phosphorylation | 19577553 |
| C113580 | U 0126 | U 0126 inhibits the reaction [sodium arsenite results in increased phosphorylation of MAPK1 protein] | decreases reaction|increases phosphorylation | 12547826 |
| C113580 | U 0126 | U 0126 inhibits the reaction [tetrabromobisphenol A results in increased phosphorylation of MAPK1 protein] | decreases reaction|increases phosphorylation | 15456914 17254629 |
| C113580 | U 0126 | U 0126 inhibits the reaction [Tretinoin results in increased phosphorylation of MAPK1 protein] | decreases reaction|increases phosphorylation | 16149052 |
| C113580 | U 0126 | U 0126 results in decreased activity of MAPK1 protein | decreases activity | 15563584 15930308 |
| C113580 | U 0126 | U 0126 results in decreased phosphorylation of and results in decreased activity of MAPK1 protein | decreases activity|decreases phosphorylation | 15019843 14757120 15231676 |
| C113580 | U 0126 | U 0126 results in decreased phosphorylation of MAPK1 protein | decreases phosphorylation | 15930308 |
| C113580 | U 0126 | U 0126 inhibits the reaction [Estradiol results in increased phosphorylation of MAPK1 protein] | decreases reaction|increases phosphorylation | 17174166 |
| C113580 | U 0126 | U 0126 inhibits the reaction [icariin results in increased phosphorylation of MAPK1 protein] | decreases reaction|increases phosphorylation | 18423597 |
| C113580 | U 0126 | U 0126 inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of MAPK1 protein] | decreases reaction|increases phosphorylation | 11543732 |
| C113580 | U 0126 | U 0126 inhibits the reaction [LY 117018 results in increased phosphorylation of MAPK1 protein] | decreases reaction|increases phosphorylation | 17174166 |
| C113580 | U 0126 | U 0126 inhibits the reaction [octylphenol results in increased phosphorylation of MAPK1 protein] | decreases reaction|increases phosphorylation | 18417718 |
| C113580 | U 0126 | U 0126 inhibits the reaction [Phenylephrine results in increased phosphorylation of MAPK1 protein] | decreases reaction|increases phosphorylation | 12729908 |
| C113580 | U 0126 | U 0126 inhibits the reaction [Phosphatidic Acids results in increased phosphorylation of and results in increased activity of MAPK1 protein] | decreases reaction|increases activity|increases phosphorylation | 18358832 |
| C113580 | U 0126 | U 0126 inhibits the reaction [Raloxifene results in increased phosphorylation of MAPK1 protein] | decreases reaction|increases phosphorylation | 17174166 |
| C113580 | U 0126 | U 0126 inhibits the reaction [Tetrachlorodibenzodioxin results in increased phosphorylation of and results in increased activity of MAPK1 protein] | decreases reaction|increases activity|increases phosphorylation | 12213569 |
| C113580 | U 0126 | U 0126 inhibits the reaction [Tretinoin results in increased phosphorylation of MAPK1 protein] | decreases reaction|increases phosphorylation | 17026715 |
| C113580 | U 0126 | U 0126 results in decreased activity of MAPK1 protein | decreases activity | 11683414 |
| C113580 | U 0126 | U 0126 results in decreased phosphorylation of and results in decreased activity of MAPK1 protein | decreases activity|decreases phosphorylation | 12758056 18358832 |
| C113580 | U 0126 | U 0126 results in decreased phosphorylation of MAPK1 protein | decreases phosphorylation | 17369491 |
| C113580 | U 0126 | [U 0126 results in decreased phosphorylation of MAPK1 protein] inhibits the reaction [Pam(3)CSK(4) peptide results in increased metabolism of Eicosanoids] | decreases phosphorylation|decreases reaction|increases metabolic processing | 17369491 |
| C113580 | U 0126 | U 0126 inhibits the reaction [Calcimycin results in increased phosphorylation of and results in increased activity of MAPK1 protein] | decreases reaction|increases activity|increases phosphorylation | 16000378 |
| C113580 | U 0126 | U 0126 inhibits the reaction [Acetaminophen results in increased phosphorylation of and results in increased activity of MAPK1 protein] | decreases reaction|increases activity|increases phosphorylation | 17088403 |
| C113580 | U 0126 | U 0126 inhibits the reaction [Acetylcysteine results in increased phosphorylation of MAPK1 protein] | decreases reaction|increases phosphorylation | 16983658 |
| C113580 | U 0126 | U 0126 inhibits the reaction [Dextroamphetamine results in increased phosphorylation of MAPK1 protein] | decreases reaction|increases phosphorylation | 16459022 |
| C113580 | U 0126 | U 0126 inhibits the reaction [dibenzo(a,l)pyrene results in increased phosphorylation of MAPK1 protein] | decreases reaction|increases phosphorylation | 16005925 |
| C113580 | U 0126 | U 0126 inhibits the reaction [Ditiocarb results in increased phosphorylation of MAPK1 protein] | decreases reaction|increases phosphorylation | 16603213 |
| C113580 | U 0126 | U 0126 inhibits the reaction [Doxorubicin results in increased phosphorylation of and results in increased activity of MAPK1 protein] | decreases reaction|increases activity|increases phosphorylation | 15843167 |
| C113580 | U 0126 | U 0126 inhibits the reaction [Estradiol results in increased phosphorylation of MAPK1 protein] | decreases reaction|increases phosphorylation | 16123166 |
| C113580 | U 0126 | U 0126 inhibits the reaction [ferrous sulfate results in increased phosphorylation of MAPK1 protein] | decreases reaction|increases phosphorylation | 17172471 |
| C113580 | U 0126 | U 0126 inhibits the reaction [Hydrogen Peroxide results in increased activity of MAPK1 protein] | decreases reaction|increases activity | 12513686 |
| C113580 | U 0126 | U 0126 inhibits the reaction [IGF1 protein results in increased phosphorylation of MAPK1 protein] | decreases reaction|increases phosphorylation | 18388193 |
| C113580 | U 0126 | U 0126 inhibits the reaction [Iron results in increased phosphorylation of MAPK1 protein] | decreases reaction|increases phosphorylation | 17172471 |
| C113580 | U 0126 | U 0126 inhibits the reaction [manganese chloride results in increased phosphorylation of MAPK1 protein] | decreases reaction|increases phosphorylation | 16787641 |
| C113580 | U 0126 | U 0126 inhibits the reaction [Manganese results in increased phosphorylation of MAPK1 protein] | decreases reaction|increases phosphorylation | 16787641 |
| C113580 | U 0126 | U 0126 inhibits the reaction [NGF protein results in increased phosphorylation of and results in increased activity of MAPK1 protein] | decreases reaction|increases activity|increases phosphorylation | 14713289 |
| C113580 | U 0126 | U 0126 inhibits the reaction [Phenylephrine results in increased activity of MAPK1 protein] | decreases reaction|increases activity | 12513686 |
| C113580 | U 0126 | U 0126 inhibits the reaction [tetrabromobisphenol A results in increased phosphorylation of MAPK1 protein] | decreases reaction|increases phosphorylation | 17205976 |
| C113580 | U 0126 | U 0126 inhibits the reaction [zinc chloride results in increased phosphorylation of MAPK1 protein] | decreases reaction|increases phosphorylation | 16960431 |
| C113580 | U 0126 | U 0126 inhibits the reaction [Zinc results in increased phosphorylation of MAPK1 protein] | decreases reaction|increases phosphorylation | 16960431 |
| C113580 | U 0126 | U 0126 inhibits the reaction [N(6)-(3-iodobenzyl)-5'-N-methylcarboxamidoadenosine results in increased phosphorylation of MAPK1 protein] | decreases reaction|increases phosphorylation | 16025880 |
| C113580 | U 0126 | U 0126 results in decreased activity of MAPK1 protein | decreases activity | 15526378 15537881 |
| C045444 | U 69593 | norbinaltorphimine inhibits the reaction [U 69593 results in increased phosphorylation of MAPK1 protein] | decreases reaction|increases phosphorylation | 16954126 |
| C045444 | U 69593 | U 69593 results in increased phosphorylation of MAPK1 protein | increases phosphorylation | 16954126 |
| D014520 | Urethane | tocopheryloxybutyric acid inhibits the reaction [Urethane results in increased phosphorylation of and results in increased activity of MAPK1 protein] | decreases reaction|increases activity|increases phosphorylation | 11062179 |
| D014520 | Urethane | [Urethane co-treated with Freund's Adjuvant] results in increased expression of MAPK1 mRNA | affects cotreatment|increases expression | 12400877 |
| D014520 | Urethane | Urethane results in increased phosphorylation of and results in increased activity of MAPK1 protein | increases activity|increases phosphorylation | 11062179 |
| D014520 | Urethane | Vitamin E inhibits the reaction [Urethane results in increased phosphorylation of and results in increased activity of MAPK1 protein] | decreases reaction|increases activity|increases phosphorylation | 11062179 |
| D014520 | Urethane | Acetic Acid promotes the reaction [Urethane results in increased activity of MAPK1 protein] | increases activity|increases reaction | 12951195 |
| D014520 | Urethane | Urethane results in increased activity of MAPK1 protein | increases activity | 12951195 |
| D014530 | Uridine Diphosphate | Uridine Diphosphate results in increased phosphorylation of MAPK1 protein | increases phosphorylation | 15034929 |
| D014530 | Uridine Diphosphate | P2RY6 gene mutant form inhibits the reaction [Uridine Diphosphate results in increased phosphorylation of MAPK1 protein] | decreases reaction|increases phosphorylation | 18523137 |
| D014530 | Uridine Diphosphate | Uridine Diphosphate results in increased phosphorylation of MAPK1 protein | increases phosphorylation | 18523137 |
| D014544 | Uridine Triphosphate | Uridine Triphosphate results in increased phosphorylation of MAPK1 protein | increases phosphorylation | 15034929 |
| D014544 | Uridine Triphosphate | tyrphostin AG 1478 inhibits the reaction [Uridine Triphosphate results in increased phosphorylation of and results in increased activity of MAPK1 protein] | decreases reaction|increases activity|increases phosphorylation | 14676212 |
| C081489 | valsartan | valsartan inhibits the reaction [AGT protein results in increased phosphorylation of MAPK1 protein] | decreases reaction|increases phosphorylation | 19041135 |
| D014638 | Vanadates | Vanadates promotes the reaction [INS1 protein results in increased phosphorylation of MAPK1 protein] | increases phosphorylation|increases reaction | 16842748 |
| D014638 | Vanadates | [Vanadates co-treated with ferric chloride] results in increased phosphorylation of MAPK1 protein | affects cotreatment|increases phosphorylation | 16728372 |
| D014638 | Vanadates | Vanadates results in increased expression of MAPK1 protein | increases expression | 17874149 |
| D014639 | Vanadium | Vanadium results in increased phosphorylation of and results in increased activity of MAPK1 protein | increases activity|increases phosphorylation | 14622970 |
| D014639 | Vanadium | [Vanadium co-treated with Iron] results in increased phosphorylation of MAPK1 protein | affects cotreatment|increases phosphorylation | 16728372 |
| D014639 | Vanadium | Vanadium results in increased phosphorylation of and results in increased activity of MAPK1 protein | increases activity|increases phosphorylation | 14622970 |
| C066075 | vanadium pentoxide | vanadium pentoxide results in increased activity of MAPK1 protein | increases activity | 12676768 |
| C066075 | vanadium pentoxide | vanadium pentoxide results in increased phosphorylation of MAPK1 protein | increases phosphorylation | 12376484 |
| C459559 | vaticanol C | vaticanol C results in decreased expression of and results in decreased phosphorylation of MAPK1 protein | decreases expression|decreases phosphorylation | 15725661 |
| C047426 | venlafaxine | venlafaxine results in increased phosphorylation of MAPK1 protein | increases phosphorylation | 18511088 |
| D014700 | Verapamil | Verapamil inhibits the reaction [tetrabromobisphenol A results in increased phosphorylation of MAPK1 protein] | decreases reaction|increases phosphorylation | 15456914 |
| C025643 | vinclozolin | vinclozolin affects the expression of MAPK1 mRNA | affects expression | 19015723 |
| C025643 | vinclozolin | vinclozolin results in increased expression of MAPK1 mRNA | increases expression | 15686871 |
| D014801 | Vitamin A | 6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid inhibits the reaction [Vitamin A results in increased phosphorylation of MAPK1 protein] | decreases reaction|increases phosphorylation | 16510265 |
| D014801 | Vitamin A | AG 1879 inhibits the reaction [Vitamin A results in increased phosphorylation of MAPK1 protein] | decreases reaction|increases phosphorylation | 16510265 |
| D014801 | Vitamin A | PD 98059 inhibits the reaction [Vitamin A results in increased phosphorylation of MAPK1 protein] | decreases reaction|increases phosphorylation | 16510265 |
| D014801 | Vitamin A | Vitamin A results in decreased phosphorylation of and results in decreased activity of MAPK1 protein | decreases activity|decreases phosphorylation | 16043492 |
| D014801 | Vitamin A | Vitamin A results in increased phosphorylation of MAPK1 protein | increases phosphorylation | 16510265 |
| D014810 | Vitamin E | Vitamin E inhibits the reaction [Urethane results in increased phosphorylation of and results in increased activity of MAPK1 protein] | decreases reaction|increases activity|increases phosphorylation | 11062179 |
| D014814 | Vitamin U | Vitamin U results in increased activity of MAPK1 protein | increases activity | 20110751 |
| C111237 | vorinostat | [bortezomib co-treated with vorinostat] results in decreased expression of MAPK1 protein | affects cotreatment|decreases expression | 12893773 |
| C111237 | vorinostat | [D 21266 co-treated with vorinostat] results in decreased activity of MAPK1 protein | affects cotreatment|decreases activity | 15781658 |
| C111237 | vorinostat | vorinostat results in decreased expression of MAPK1 protein | decreases expression | 12893773 |
| C017967 | W 7 | W 7 inhibits the reaction [Hydrogen Peroxide results in increased activity of MAPK1 protein] | decreases reaction|increases activity | 15328380 |
| C090413 | WAY 100635 | WAY 100635 inhibits the reaction [Acetaminophen results in increased phosphorylation of and results in increased activity of MAPK1 protein] | decreases reaction|increases activity|increases phosphorylation | 17088403 |
| C113888 | WHI P154 | WHI P154 inhibits the reaction [2,2',4,6,6'-pentachlorobiphenyl results in increased phosphorylation of MAPK1 protein] | decreases reaction|increases phosphorylation | 16778083 |
| C070417 | Win 55212-2 | CNR2 protein affects the reaction [Win 55212-2 results in increased phosphorylation of and results in increased activity of MAPK1 protein] | affects reaction|increases activity|increases phosphorylation | 12734338 |
| C070417 | Win 55212-2 | Win 55212-2 results in increased phosphorylation of and results in increased activity of MAPK1 protein | increases activity|increases phosphorylation | 12734338 |
| C009687 | wortmannin | wortmannin inhibits the reaction [CXCL2 protein results in increased phosphorylation of and results in increased activity of MAPK1 protein] | decreases reaction|increases activity|increases phosphorylation | 15608143 |
| C009687 | wortmannin | wortmannin inhibits the reaction [NTS protein results in increased phosphorylation of and results in increased activity of MAPK1 protein] | decreases reaction|increases activity|increases phosphorylation | 15177934 |
| C009687 | wortmannin | wortmannin inhibits the reaction [[FGF2 protein binds to and results in increased activity of FGFR4 protein] which results in increased phosphorylation of MAPK1 protein] | affects binding|decreases reaction|increases activity|increases phosphorylation | 11336793 |
| C519885 | WP1066 | WP1066 results in decreased phosphorylation of MAPK1 protein | decreases phosphorylation | 18245540 |
| D017307 | Xamoterol | Xamoterol results in increased phosphorylation of MAPK1 protein | increases phosphorylation | 16671086 |
| C108830 | Y 27632 | Y 27632 inhibits the reaction [Phenylephrine results in increased phosphorylation of and results in increased activity of MAPK1 protein] | decreases reaction|increases activity|increases phosphorylation | 11739382 |
| C087958 | YM 529 | YM 529 results in decreased phosphorylation of MAPK1 protein | decreases phosphorylation | 17874104 |
| C403304 | zerumbone | zerumbone inhibits the reaction [Tetradecanoylphorbol Acetate results in increased phosphorylation of MAPK1 protein] | decreases reaction|increases phosphorylation | 15122579 |
| C063449 | zileuton | zileuton affects the expression of MAPK1 protein modified form | affects expression | 18059327 |
| D015032 | Zinc | [Clioquinol co-treated with Zinc] results in increased phosphorylation of MAPK1 protein | affects cotreatment|increases phosphorylation | 16648635 |
| D015032 | Zinc | Zinc results in increased phosphorylation of MAPK1 protein | increases phosphorylation | 16373669 16606632 |
| D015032 | Zinc | N,N'-diphenyl-4-phenylenediamine inhibits the reaction [Zinc results in increased phosphorylation of MAPK1 protein] | decreases reaction|increases phosphorylation | 16960431 |
| D015032 | Zinc | U 0126 inhibits the reaction [Zinc results in increased phosphorylation of MAPK1 protein] | decreases reaction|increases phosphorylation | 16960431 |
| D015032 | Zinc | Zinc results in increased phosphorylation of and results in increased activity of MAPK1 protein | increases activity|increases phosphorylation | 16960431 |
| C016837 | zinc chloride | N,N'-diphenyl-4-phenylenediamine inhibits the reaction [zinc chloride results in increased phosphorylation of MAPK1 protein] | decreases reaction|increases phosphorylation | 16960431 |
| C016837 | zinc chloride | U 0126 inhibits the reaction [zinc chloride results in increased phosphorylation of MAPK1 protein] | decreases reaction|increases phosphorylation | 16960431 |
| C016837 | zinc chloride | zinc chloride results in increased phosphorylation of and results in increased activity of MAPK1 protein | increases activity|increases phosphorylation | 16960431 |
| D019287 | Zinc Sulfate | Zinc Sulfate results in increased phosphorylation of MAPK1 protein | increases phosphorylation | 16606632 |
| C088658 | zoledronic acid | CYR61 protein affects the reaction [zoledronic acid results in decreased phosphorylation of and results in decreased activity of MAPK1 protein] | affects reaction|decreases activity|decreases phosphorylation | 19530242 |
| C088658 | zoledronic acid | gefitinib promotes the reaction [[zoledronic acid co-treated with 4-(5-(4-chlorophenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl)benzenesulfonamide] results in decreased phosphorylation of MAPK1 protein] | affects cotreatment|decreases phosphorylation|increases reaction | 16322342 |
| C088658 | zoledronic acid | [zoledronic acid co-treated with 4-(5-(4-chlorophenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl)benzenesulfonamide] results in decreased phosphorylation of MAPK1 protein | affects cotreatment|decreases phosphorylation | 16322342 |
| C088658 | zoledronic acid | zoledronic acid results in decreased phosphorylation of and results in decreased activity of MAPK1 protein | decreases activity|decreases phosphorylation | 19530242 |
| C088658 | zoledronic acid | zoledronic acid results in decreased phosphorylation of MAPK1 protein | decreases phosphorylation | 12799645 |
| C088658 | zoledronic acid | zoledronic acid results in increased phosphorylation of MAPK1 protein | increases phosphorylation | 16996129 17059425 |
| D015054 | Zymosan | Zymosan results in increased phosphorylation of MAPK1 protein | increases phosphorylation | 19041413 |
| D015054 | Zymosan | CLEC7A protein promotes the reaction [Zymosan results in increased activity of MAPK1 protein] | increases activity|increases reaction | 17458858 |
| D015054 | Zymosan | Dexamethasone inhibits the reaction [Zymosan results in increased phosphorylation of MAPK1 protein] | decreases reaction|increases phosphorylation | 10874129 |
| D015054 | Zymosan | glucan phosphate inhibits the reaction [Zymosan results in increased activity of MAPK1 protein] | decreases reaction|increases activity | 17458858 |
| D015054 | Zymosan | SYK protein promotes the reaction [Zymosan results in increased activity of MAPK1 protein] | increases activity|increases reaction | 17458858 |
| D015054 | Zymosan | Zymosan results in increased activity of MAPK1 protein | increases activity | 17458858 |
| D015054 | Zymosan | Zymosan results in increased phosphorylation of MAPK1 protein | increases phosphorylation | 10874129 |
| Disease ID | Disease Name | Direct Evidence | Inference Chemical Name | Inference Score | Publication |
|---|---|---|---|---|---|
| MESH:D000008 | Abdominal Neoplasms | Tamoxifen | 2.83 | 14745880 | |
| MESH:D000014 | Abnormalities, Drug-Induced | 2-ethoxyethanol | 32.30 | 7151721 6499820 6499812 6499823 6499796 | |
| MESH:D000014 | Abnormalities, Drug-Induced | Capsaicin | 32.30 | 18926900 | |
| MESH:D000014 | Abnormalities, Drug-Induced | Diethylhexyl Phthalate | 32.30 | 6734493 | |
| MESH:D000014 | Abnormalities, Drug-Induced | Ethanol | 32.30 | 18926900 17676605 | |
| MESH:D000014 | Abnormalities, Drug-Induced | Maneb | 32.30 | 982313 | |
| MESH:D000014 | Abnormalities, Drug-Induced | methoxyacetic acid | 32.30 | 12805644 1761407 1761404 15959878 3652986 | |
| MESH:D000014 | Abnormalities, Drug-Induced | methyl cellosolve | 32.30 | 3652986 6474471 6499812 | |
| MESH:D000014 | Abnormalities, Drug-Induced | Phenobarbital | 32.30 | 6195326 | |
| MESH:D000014 | Abnormalities, Drug-Induced | Phenytoin | 32.30 | 9118846 9677735 6195326 10563481 8986270 3425630 | |
| MESH:D000014 | Abnormalities, Drug-Induced | Terbutaline | 32.30 | 14610225 | |
| MESH:D000014 | Abnormalities, Drug-Induced | Tetrachlorodibenzodioxin | 32.30 | 15322242 14514962 11752688 | |
| MESH:D000014 | Abnormalities, Drug-Induced | Thalidomide | 32.30 | 8333272 | |
| MESH:D000015 | Abnormalities, Multiple | imatinib | 5.62 | 18322153 | |
| MESH:D000015 | Abnormalities, Multiple | Vitamin A | 5.62 | 10992263 | |
| MESH:D000022 | Abortion, Spontaneous | imatinib | 4.49 | 18322153 | |
| MESH:D000038 | Abscess | Drugs, Chinese Herbal | 4.58 | 15043669 | |
| MESH:D000138 | Acidosis | Ammonium Chloride | 8.21 | 18287403 | |
| MESH:D000138 | Acidosis | Ethanol | 8.21 | 11192467 | |
| MESH:D000138 | Acidosis | Zinc Sulfate | 8.21 | 7265320 | |
| MESH:D000152 | Acne Vulgaris | Ethinyl Estradiol | 6.44 | 17505938 | |
| MESH:D000152 | Acne Vulgaris | zileuton | 6.44 | 20436887 | |
| MESH:D000168 | Acrocephalosyndactylia | U 0126 | 3.81 | 17694057 | |
| MESH:D000169 | Acrodermatitis | Zinc | 3.70 | 17202136 17190629 16889938 | |
| MESH:D058186 | Acute Kidney Injury | Capsaicin | 20.09 | 18460982 | |
| MESH:D058186 | Acute Kidney Injury | Cisplatin | 20.09 | 12690470 15814532 17670903 | |
| MESH:D058186 | Acute Kidney Injury | Folic Acid | 20.09 | 16316344 16595132 17003819 | |
| MESH:D058186 | Acute Kidney Injury | Gentamicins | 20.09 | 11274264 | |
| MESH:D058186 | Acute Kidney Injury | pifithrin | 20.09 | 17670903 | |
| MESH:D058186 | Acute Kidney Injury | resveratrol | 20.09 | 16538975 | |
| MESH:D058186 | Acute Kidney Injury | Superoxides | 20.09 | 18460982 | |
| MESH:D058186 | Acute Kidney Injury | zoledronic acid | 20.09 | 19715164 | |
| MESH:D055371 | Acute Lung Injury | Acrolein | 22.53 | 20525806 21297076 | |
| MESH:D055371 | Acute Lung Injury | Chlorine | 22.53 | 20601635 | |
| MESH:D055371 | Acute Lung Injury | Lipopolysaccharides | 22.53 | 18653653 11850527 | |
| MESH:D055371 | Acute Lung Injury | Nickel | 22.53 | 16166738 | |
| MESH:D055371 | Acute Lung Injury | Oxygen | 22.53 | 16759491 | |
| MESH:D055371 | Acute Lung Injury | Particulate Matter | 22.53 | 12396868 | |
| MESH:D055371 | Acute Lung Injury | pirinixic acid | 22.53 | 18653653 | |
| MESH:D055371 | Acute Lung Injury | zileuton | 22.53 | 17118201 | |
| MESH:D000210 | Acute-Phase Reaction | zoledronic acid | 3.79 | 20200999 | |
| MESH:D000230 | Adenocarcinoma | 5-((4-methylphenyl)methylene)-2-(phenylamino)-4(5H)-thiazolone | 24.54 | 15831436 | |
| MESH:D000230 | Adenocarcinoma | arsenic trioxide | 24.54 | 19825857 11798837 | |
| MESH:D000230 | Adenocarcinoma | Benzo(a)pyrene | 24.54 | 20127859 20464547 | |
| MESH:D000230 | Adenocarcinoma | Cisplatin | 24.54 | 17638652 11798837 | |
| MESH:D000230 | Adenocarcinoma | daidzein | 24.54 | 11473722 | |
| MESH:D000230 | Adenocarcinoma | Dimethylnitrosamine | 24.54 | 16033868 | |
| MESH:D000230 | Adenocarcinoma | Doxorubicin | 24.54 | 17418594 | |
| MESH:D000230 | Adenocarcinoma | dracorhodin | 24.54 | 15215653 | |
| MESH:D000230 | Adenocarcinoma | Estradiol | 24.54 | 11473722 | |
| MESH:D000230 | Adenocarcinoma | Ethinyl Estradiol | 24.54 | 14692618 | |
| MESH:D000230 | Adenocarcinoma | Fenretinide | 24.54 | 10697514 | |
| MESH:D000230 | Adenocarcinoma | Genistein | 24.54 | 11473722 | |
| MESH:D000230 | Adenocarcinoma | Indomethacin | 24.54 | 16537180 | |
| MESH:D000230 | Adenocarcinoma | Methylnitrosourea | 24.54 | 15688392 15113128 | |
| MESH:D000230 | Adenocarcinoma | Urethane | 24.54 | 18316556 | |
| MESH:D002282 | Adenocarcinoma, Bronchiolo-Alveolar | Urethane | 3.99 | 15814487 | |
| MESH:D000236 | Adenoma | 4,4'-diaminodiphenylmethane | 20.54 | 3712494 | |
| MESH:D000236 | Adenoma | 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone | 20.54 | 16176798 | |
| MESH:D000236 | Adenoma | Benzo(a)pyrene | 20.54 | 6695378 | |
| MESH:D000236 | Adenoma | beta-Naphthoflavone | 20.54 | 19389873 | |
| MESH:D000236 | Adenoma | Diethylnitrosamine | 20.54 | 10737359 6695378 | |
| MESH:D000236 | Adenoma | Dimethylnitrosamine | 20.54 | 19555203 | |
| MESH:D000236 | Adenoma | Folic Acid | 20.54 | 16963246 | |
| MESH:D000236 | Adenoma | Indomethacin | 20.54 | 11497255 | |
| MESH:D000236 | Adenoma | resveratrol | 20.54 | 15688382 | |
| MESH:D000236 | Adenoma | Urethane | 20.54 | 10822126 11497255 16926031 17195641 6695378 10530776 17093202 | |
| MESH:D018248 | Adenoma, Liver Cell | DDT | 15.26 | 12597452 | |
| MESH:D018248 | Adenoma, Liver Cell | Diethylnitrosamine | 15.26 | 19061943 18056438 17620307 16434500 19052882 17162532 | |
| MESH:D018248 | Adenoma, Liver Cell | Phenobarbital | 15.26 | 17620307 | |
| MESH:D018248 | Adenoma, Liver Cell | pirinixic acid | 15.26 | 16434500 | |
| MESH:D018248 | Adenoma, Liver Cell | Tetrachlorodibenzodioxin | 15.26 | 16835633 | |
| MESH:D011125 | Adenomatous Polyposis Coli | Dinoprostone | 7.68 | 17942926 | |
| MESH:D011125 | Adenomatous Polyposis Coli | sulforafan | 7.68 | 17942926 | |
| MESH:D011125 | Adenomatous Polyposis Coli | sulindac sulfone | 7.68 | 16150858 | |
| MESH:D000310 | Adrenal Gland Neoplasms | sodium arsenite | 2.98 | 15276417 | |
| MESH:D000309 | Adrenal Insufficiency | Dehydroepiandrosterone | 4.09 | 17302879 | |
| MESH:D018246 | Adrenocortical Adenoma | Arsenic | 8.09 | 17306315 | |
| MESH:D018246 | Adrenocortical Adenoma | sodium arsenite | 8.09 | 16712894 17306315 | |
| MESH:D000380 | Agranulocytosis | Clozapine | 3.39 | 12649775 14617031 16160616 | |
| MESH:D000382 | Agricultural Workers' Diseases | 2,4-Dichlorophenoxyacetic Acid | 21.60 | 16132792 | |
| MESH:D000382 | Agricultural Workers' Diseases | Atrazine | 21.60 | 11874814 | |
| MESH:D000382 | Agricultural Workers' Diseases | Chlorpyrifos | 21.60 | 17119214 16611668 11874814 | |
| MESH:D000382 | Agricultural Workers' Diseases | DDT | 21.60 | 12584743 16487989 | |
| MESH:D000382 | Agricultural Workers' Diseases | Dichlorodiphenyl Dichloroethylene | 21.60 | 16487989 | |
| MESH:D000382 | Agricultural Workers' Diseases | Heptachlor | 21.60 | 12661182 | |
| MESH:D000382 | Agricultural Workers' Diseases | Lindane | 21.60 | 12661182 | |
| MESH:D000382 | Agricultural Workers' Diseases | Maneb | 21.60 | 8807224 | |
| MESH:D000382 | Agricultural Workers' Diseases | Paraquat | 21.60 | 11874814 | |
| MESH:D000419 | Albuminuria | Doxorubicin | 10.01 | 21441931 | |
| MESH:D000419 | Albuminuria | Losartan | 10.01 | 12586211 | |
| MESH:D000419 | Albuminuria | Raloxifene | 10.01 | 17451421 17308373 | |
| MESH:D020268 | Alcohol-Induced Disorders, Nervous System | Ethanol | 3.59 | 15451040 15451039 | |
| MESH:D019973 | Alcohol-Related Disorders | Curcumin | 3.36 | 17887948 | |
| MESH:D000505 | Alopecia | Capsaicin | 4.65 | 17569567 | |
| MESH:D000505 | Alopecia | Tretinoin | 4.65 | 15955085 | |
| MESH:D019896 | alpha 1-Antitrypsin Deficiency | Iron | 3.95 | 16640825 | |
| MESH:D016301 | Alveolar Bone Loss | Indomethacin | 3.65 | 17225004 | |
| MESH:D000544 | Alzheimer Disease | Acrolein | 32.39 | 17570602 15207723 14715435 | |
| MESH:D000544 | Alzheimer Disease | bis(4-hydroxycinnamoyl)methane | 32.39 | 19090986 | |
| MESH:D000544 | Alzheimer Disease | Clioquinol | 32.39 | 17308104 16648635 | |
| MESH:D000544 | Alzheimer Disease | Copper | 32.39 | 16410023 17119284 16866297 16325427 16886094 16962711 | |
| MESH:D000544 | Alzheimer Disease | Curcumin | 32.39 | 15590663 | |
| MESH:D000544 | Alzheimer Disease | Folic Acid | 32.39 | 17116317 | |
| MESH:D000544 | Alzheimer Disease | icariin | 32.39 | 19782061 19858766 | |
| MESH:D000544 | Alzheimer Disease | Indomethacin | 32.39 | 15579461 17627676 | |
| MESH:D000544 | Alzheimer Disease | Iron | 32.39 | 16640825 16563566 | |
| MESH:D000544 | Alzheimer Disease | Lithium | 32.39 | 19621015 | |
| MESH:D000544 | Alzheimer Disease | Nicotine | 32.39 | 16627626 | |
| MESH:D000544 | Alzheimer Disease | Nitric Oxide | 32.39 | 17556102 | |
| MESH:D000544 | Alzheimer Disease | Ozone | 32.39 | 15513908 | |
| MESH:D000544 | Alzheimer Disease | Particulate Matter | 32.39 | 15513908 | |
| MESH:D000544 | Alzheimer Disease | Plant Extracts | 32.39 | 16962711 | |
| MESH:D000544 | Alzheimer Disease | Raloxifene | 32.39 | 15800139 | |
| MESH:D000544 | Alzheimer Disease | resveratrol | 32.39 | 16162502 16183991 | |
| MESH:D000544 | Alzheimer Disease | sulindac sulfide | 32.39 | 18759972 | |
| MESH:D000544 | Alzheimer Disease | Zinc | 32.39 | 16325427 16580781 17119284 16410023 | |
| MESH:D019969 | Amphetamine-Related Disorders | Amphetamine | 4.35 | 15010207 16459022 16916582 18475255 | |
| MESH:D000686 | Amyloidosis | Diethylstilbestrol | 6.16 | 15469931 | |
| MESH:D000686 | Amyloidosis | Terbutaline | 6.16 | 7986221 | |
| MESH:D000690 | Amyotrophic Lateral Sclerosis | 4-hydroxy-2-nonenal | 5.77 | 10965797 | |
| MESH:D000690 | Amyotrophic Lateral Sclerosis | Copper | 5.77 | 10694572 | |
| MESH:D000690 | Amyotrophic Lateral Sclerosis | Thalidomide | 5.77 | 16510725 | |
| MESH:D000707 | Anaphylaxis | mangiferin | 3.81 | 16536907 14669257 | |
| MESH:D000740 | Anemia | Drugs, Chinese Herbal | 11.66 | 17963324 15504547 | |
| MESH:D000740 | Anemia | Iron | 11.66 | 16434484 16566752 | |
| MESH:D000740 | Anemia | Tetrachlorodibenzodioxin | 11.66 | 11748828 | |
| MESH:D000740 | Anemia | Vitamin A | 11.66 | 16960172 | |
| MESH:D000740 | Anemia | Zymosan | 11.66 | 18664788 | |
| MESH:D000743 | Anemia, Hemolytic | Quercetin | 2.68 | 17084956 | |
| MESH:D018798 | Anemia, Iron-Deficiency | Copper | 7.92 | 16614410 | |
| MESH:D018798 | Anemia, Iron-Deficiency | Iron | 7.92 | 17162259 17147795 16569441 17375513 17163184 | |
| MESH:D018798 | Anemia, Iron-Deficiency | Vitamin A | 7.92 | 16960172 | |
| MESH:D000748 | Anemia, Macrocytic | methyl cellosolve | 4.62 | 3699323 | |
| MESH:D000755 | Anemia, Sickle Cell | Zinc | 3.26 | 16916123 | |
| MESH:D000756 | Anemia, Sideroblastic | Iron | 12.44 | 16910769 | |
| MESH:D000756 | Anemia, Sideroblastic | Manganese | 12.44 | 16910769 | |
| MESH:D000756 | Anemia, Sideroblastic | manganese chloride | 12.44 | 16910769 | |
| MESH:D000756 | Anemia, Sideroblastic | Superoxides | 12.44 | 16910769 | |
| MESH:D000787 | Angina Pectoris | Diltiazem | 7.02 | 15929820 | |
| MESH:D000787 | Angina Pectoris | Drugs, Chinese Herbal | 7.02 | 11477813 | |
| MESH:D000799 | Angioedema | Acetaminophen | 10.76 | 10982225 | |
| MESH:D000799 | Angioedema | montelukast | 10.76 | 10982225 | |
| MESH:D000799 | Angioedema | salmeterol | 10.76 | 10982225 | |
| MESH:D000853 | Anophthalmos | Ethanol | 3.16 | 15513904 | |
| MESH:D000855 | Anorexia | Amphetamine | 7.97 | 12183048 12005258 16101753 16084549 | |
| MESH:D000855 | Anorexia | N-Methyl-3,4-methylenedioxyamphetamine | 7.97 | 15146954 | |
| MESH:D000855 | Anorexia | oleoylethanolamide | 7.97 | 15879057 | |
| MESH:D000860 | Anoxia | Oxygen | 5.95 | 20872349 | |
| MESH:D000860 | Anoxia | Zinc Sulfate | 5.95 | 7265320 | |
| MESH:D000987 | Antisocial Personality Disorder | Testosterone | 4.13 | 7506515 | |
| MESH:D001004 | Anus Diseases | Drugs, Chinese Herbal | 4.24 | 15043669 | |
| MESH:D001005 | Anus Neoplasms | Dacarbazine | 4.57 | 12170190 | |
| MESH:D001008 | Anxiety Disorders | Ethanol | 6.47 | 11141031 | |
| MESH:D001008 | Anxiety Disorders | Pentobarbital | 6.47 | 11141031 18313124 | |
| MESH:D001008 | Anxiety Disorders | vinclozolin | 6.47 | 19015723 | |
| MESH:D001014 | Aortic Aneurysm | Dinoprostone | 6.75 | 10231640 | |
| MESH:D001014 | Aortic Aneurysm | Indomethacin | 6.75 | 10231640 | |
| MESH:D017544 | Aortic Aneurysm, Abdominal | Benzo(a)pyrene | 10.55 | 19183758 | |
| MESH:D017544 | Aortic Aneurysm, Abdominal | Dinoprostone | 10.55 | 10388637 | |
| MESH:D017544 | Aortic Aneurysm, Abdominal | Indomethacin | 10.55 | 10388637 | |
| MESH:D001145 | Arrhythmias, Cardiac | Iron | 4.29 | 16604332 | |
| MESH:D001145 | Arrhythmias, Cardiac | Phenylephrine | 4.29 | 17460149 | |
| MESH:D020261 | Arsenic Poisoning | Arsenic | 2.19 | 18414634 12569548 16251483 16835338 | |
| MESH:D001161 | Arteriosclerosis | Acrolein | 14.79 | 15014928 | |
| MESH:D001161 | Arteriosclerosis | Cyclophosphamide | 14.79 | 15014928 | |
| MESH:D001161 | Arteriosclerosis | Dietary Fats | 14.79 | 15238619 | |
| MESH:D001161 | Arteriosclerosis | Ethinyl Estradiol | 14.79 | 11256880 | |
| MESH:D001161 | Arteriosclerosis | tibolone | 14.79 | 11256880 | |
| MESH:D018771 | Arthralgia | Indomethacin | 3.45 | 2160914 | |
| MESH:D001169 | Arthritis, Experimental | Dexamethasone | 14.57 | 17659584 | |
| MESH:D001169 | Arthritis, Experimental | Ethinyl Estradiol | 14.57 | 15885639 | |
| MESH:D001169 | Arthritis, Experimental | Plant Extracts | 14.57 | 14686799 | |
| MESH:D001169 | Arthritis, Experimental | resveratrol | 14.57 | 17115116 | |
| MESH:D001169 | Arthritis, Experimental | Thalidomide | 14.57 | 9598899 | |
| MESH:D001169 | Arthritis, Experimental | Tretinoin | 14.57 | 16412693 | |
| MESH:D001169 | Arthritis, Experimental | Zymosan | 14.57 | 15142272 15944321 16872482 15188379 17659584 | |
| MESH:D015210 | Arthritis, Gouty | Drugs, Chinese Herbal | 4.04 | 19655406 | |
| MESH:D001172 | Arthritis, Rheumatoid | Curcumin | 5.05 | 16807698 | |
| MESH:D001172 | Arthritis, Rheumatoid | Indomethacin | 5.05 | 11248219 | |
| MESH:D001172 | Arthritis, Rheumatoid | LY 117018 | 5.05 | 17907171 | |
| MESH:D001172 | Arthritis, Rheumatoid | Ozone | 5.05 | 15570426 | |
| MESH:D001172 | Arthritis, Rheumatoid | Tretinoin | 5.05 | 16292516 | |
| MESH:D001195 | Asbestosis | Asbestos, Serpentine | 4.02 | 10751356 | |
| MESH:D053627 | Asthenozoospermia | 2-ethoxyethanol | 7.00 | 10689203 6499823 6499807 | |
| MESH:D053627 | Asthenozoospermia | methyl cellosolve | 7.00 | 3987992 | |
| MESH:D001249 | Asthma | Acetaldehyde | 23.85 | 9600491 | |
| MESH:D001249 | Asthma | Albuterol | 23.85 | 11991558 9949315 | |
| MESH:D001249 | Asthma | epigallocatechin gallate | 23.85 | 16516891 | |
| MESH:D001249 | Asthma | formoterol | 23.85 | 12113382 10967152 | |
| MESH:D001249 | Asthma | Histamine | 23.85 | 16387687 | |
| MESH:D001249 | Asthma | montelukast | 23.85 | 16293801 17895592 19667530 20332717 10852428 19681236 | |
| MESH:D001249 | Asthma | Mustard Gas | 23.85 | 10378619 | |
| MESH:D001249 | Asthma | Ozone | 23.85 | 16373670 17854713 | |
| MESH:D001249 | Asthma | salmeterol | 23.85 | 11694805 10359889 | |
| MESH:D001249 | Asthma | Toluene 2,4-Diisocyanate | 23.85 | 7684630 6091946 18394133 12585506 10934080 6091945 8156442 15855793 15590891 12762349 170078 12684321 19187332 10797510 3040596 11742282 17015710 11467998 15590890 11077013 16210060 16792590 20032816 | |
| MESH:D001249 | Asthma | Tretinoin | 23.85 | 16456186 | |
| MESH:D001249 | Asthma | Vitamin A | 23.85 | 16732791 | |
| MESH:D001249 | Asthma | zileuton | 23.85 | 19214143 20332717 17944539 10181070 9620945 10764316 8598621 | |
| MESH:D001249 | Asthma | Zinc | 23.85 | 17085522 | |
| MESH:D055963 | Asthma, Aspirin-Induced | Aspirin | 5.56 | 20485159 12372130 | |
| MESH:D055963 | Asthma, Aspirin-Induced | montelukast | 5.56 | 19667532 | |
| MESH:D001250 | Asthma, Exercise-Induced | montelukast | 9.88 | 19667531 10984370 | |
| MESH:D001250 | Asthma, Exercise-Induced | salmeterol | 9.88 | 10984370 | |
| MESH:D001250 | Asthma, Exercise-Induced | zileuton | 9.88 | 10984370 | |
| MESH:D001259 | Ataxia | 1-Butanol | 6.52 | 7820390 | |
| MESH:D001259 | Ataxia | 2-ethoxyethanol | 6.52 | 7151721 | |
| MESH:D001260 | Ataxia Telangiectasia | Iron | 7.48 | 15336622 | |
| MESH:D001260 | Ataxia Telangiectasia | Quercetin | 7.48 | 15336622 | |
| MESH:D050197 | Atherosclerosis | 7-ketocholesterol | 25.17 | 16632123 | |
| MESH:D050197 | Atherosclerosis | Acrolein | 25.17 | 16037261 17363696 16126721 | |
| MESH:D050197 | Atherosclerosis | Arsenic | 25.17 | 19371607 12928151 | |
| MESH:D050197 | Atherosclerosis | Cadmium | 25.17 | 15687053 | |
| MESH:D050197 | Atherosclerosis | Curcumin | 25.17 | 18704882 | |
| MESH:D050197 | Atherosclerosis | Iron | 25.17 | 16632123 16640825 | |
| MESH:D050197 | Atherosclerosis | Losartan | 25.17 | 10821809 | |
| MESH:D050197 | Atherosclerosis | mangiferin | 25.17 | 18450471 | |
| MESH:D050197 | Atherosclerosis | Oxygen | 25.17 | 16391483 | |
| MESH:D050197 | Atherosclerosis | Phenytoin | 25.17 | 15136057 | |
| MESH:D050197 | Atherosclerosis | resveratrol | 25.17 | 16873680 17967414 | |
| MESH:D050197 | Atherosclerosis | Vitamin U | 25.17 | 7192109 | |
| MESH:D001284 | Atrophy | 2-ethoxyethanol | 8.85 | 6499799 15850284 | |
| MESH:D001284 | Atrophy | fulvestrant | 8.85 | 11514358 | |
| MESH:D001284 | Atrophy | methyl cellosolve | 8.85 | 6705890 3699323 2626667 | |
| MESH:D001321 | Autistic Disorder | Acetaminophen | 4.48 | 18445737 | |
| MESH:D001321 | Autistic Disorder | Adenosine | 4.48 | 20468076 | |
| MESH:D001321 | Autistic Disorder | Arachidonic Acid | 4.48 | 18582451 | |
| MESH:D001321 | Autistic Disorder | Docosahexaenoic Acids | 4.48 | 18582451 | |
| MESH:D001321 | Autistic Disorder | Folic Acid | 4.48 | 21388746 | |
| MESH:D001321 | Autistic Disorder | Haloperidol | 4.48 | 19368416 18080171 | |
| MESH:D001321 | Autistic Disorder | Homocysteine | 4.48 | 16297937 20468076 | |
| MESH:D001321 | Autistic Disorder | Iron | 4.48 | 17352947 | |
| MESH:D001321 | Autistic Disorder | Norepinephrine | 4.48 | 8570775 | |
| MESH:D001321 | Autistic Disorder | S-Adenosylmethionine | 4.48 | 16917939 19056591 | |
| MESH:D001321 | Autistic Disorder | Serotonin | 4.48 | 17157402 18405062 18361446 18062943 19221690 15132762 8570775 | |
| MESH:D001321 | Autistic Disorder | Terbutaline | 4.48 | 16417856 17400887 | |
| MESH:D001327 | Autoimmune Diseases | Curcumin | 12.41 | 19761891 | |
| MESH:D001327 | Autoimmune Diseases | epigallocatechin gallate | 12.41 | 19761891 | |
| MESH:D001327 | Autoimmune Diseases | Quercetin | 12.41 | 19761891 | |
| MESH:D001327 | Autoimmune Diseases | sulforafan | 12.41 | 19761891 | |
| MESH:D053713 | Azoospermia | 2-ethoxyethanol | 3.92 | 6499807 6492198 | |
| MESH:D001424 | Bacterial Infections | Iron | 3.51 | 16640825 | |
| MESH:D001471 | Barrett Esophagus | Tretinoin | 2.75 | 16935849 | |
| MESH:D001477 | Bartter Syndrome | Dinoprostone | 7.16 | 15976003 | |
| MESH:D001477 | Bartter Syndrome | Indomethacin | 7.16 | 10684365 | |
| MESH:D001660 | Biliary Tract Diseases | 4,4'-diaminodiphenylmethane | 3.29 | 11289319 1440618 | |
| MESH:D001714 | Bipolar Disorder | Lithium | 3.22 | 20338123 20046352 17594078 19153942 | |
| MESH:D001724 | Birth Weight | 2-ethoxyethanol | 4.78 | 6499823 2884743 | |
| MESH:D001768 | Blister | Mustard Gas | 3.45 | 19167455 | |
| MESH:D001778 | Blood Coagulation Disorders | arsenic trioxide | 12.44 | 16206674 | |
| MESH:D001778 | Blood Coagulation Disorders | ferrous sulfate | 12.44 | 6421970 | |
| MESH:D001778 | Blood Coagulation Disorders | pirinixic acid | 12.44 | 19483382 | |
| MESH:D001778 | Blood Coagulation Disorders | Tetrachlorodibenzodioxin | 12.44 | 12125929 | |
| MESH:D001778 | Blood Coagulation Disorders | Tretinoin | 12.44 | 16206674 16197459 | |
| MESH:D001836 | Body Weight Changes | 2-ethoxyethanol | 6.36 | 7151721 6499796 | |
| MESH:D001836 | Body Weight Changes | Tetrachlorodibenzodioxin | 6.36 | 15340226 | |
| MESH:D001847 | Bone Diseases | icariin | 4.70 | 18295595 | |
| MESH:D001848 | Bone Diseases, Developmental | Tetrachlorodibenzodioxin | 1.47 | 15746008 | |
| MESH:D001851 | Bone Diseases, Metabolic | Ginkgo biloba extract 761 | 4.64 | 19356626 | |
| MESH:D019046 | Bone Marrow Neoplasms | Cisplatin | 10.61 | 14601052 | |
| MESH:D019046 | Bone Marrow Neoplasms | Dactinomycin | 10.61 | 14601052 | |
| MESH:D019046 | Bone Marrow Neoplasms | Doxorubicin | 10.61 | 14601052 | |
| MESH:D001859 | Bone Neoplasms | imatinib | 8.48 | 15867366 | |
| MESH:D001859 | Bone Neoplasms | Paclitaxel | 8.48 | 15867366 | |
| MESH:D001859 | Bone Neoplasms | zoledronic acid | 8.48 | 11697798 15867366 19442620 16778634 16121404 17312309 | |
| MESH:D001862 | Bone Resorption | bisphenol A | 13.16 | 11985600 | |
| MESH:D001862 | Bone Resorption | Drugs, Chinese Herbal | 13.16 | 9881647 | |
| MESH:D001862 | Bone Resorption | Freund's Adjuvant | 13.16 | 16769263 | |
| MESH:D001862 | Bone Resorption | mangiferin | 13.16 | 9881647 | |
| MESH:D001862 | Bone Resorption | zoledronic acid | 13.16 | 18404659 15845617 16769263 11869084 18496637 8053405 | |
| MESH:D001919 | Bradycardia | Capsaicin | 15.37 | 18207255 | |
| MESH:D001919 | Bradycardia | Carbachol | 15.37 | 12411408 | |
| MESH:D001919 | Bradycardia | Isoproterenol | 15.37 | 6740701 | |
| MESH:D001919 | Bradycardia | Phenylephrine | 15.37 | 15306635 | |
| MESH:D001919 | Bradycardia | Serotonin | 15.37 | 8112388 | |
| MESH:D001929 | Brain Edema | Indomethacin | 7.20 | 11481608 | |
| MESH:D001929 | Brain Edema | zileuton | 7.20 | 19309543 | |
| MESH:D020201 | Brain Hemorrhage, Traumatic | Progesterone | 3.61 | 17868700 | |
| MESH:D001930 | Brain Injuries | Nitroprusside | 17.38 | 14637104 | |
| MESH:D001930 | Brain Injuries | Pregnanolone | 17.38 | 15380490 15665606 | |
| MESH:D001930 | Brain Injuries | Progesterone | 17.38 | 15665606 15845082 15380490 | |
| MESH:D001930 | Brain Injuries | Raloxifene | 17.38 | 16580743 | |
| MESH:D001930 | Brain Injuries | Zinc | 17.38 | 17109824 | |
| MESH:D002545 | Brain Ischemia | beta Carotene | 22.52 | 16157235 | |
| MESH:D002545 | Brain Ischemia | Capsaicin | 22.52 | 19211983 | |
| MESH:D002545 | Brain Ischemia | Curcumin | 22.52 | 16770732 | |
| MESH:D002545 | Brain Ischemia | icariin | 22.52 | 19303870 | |
| MESH:D002545 | Brain Ischemia | Indomethacin | 22.52 | 12524144 | |
| MESH:D002545 | Brain Ischemia | Plant Extracts | 22.52 | 16041641 | |
| MESH:D002545 | Brain Ischemia | resveratrol | 22.52 | 17600658 | |
| MESH:D001932 | Brain Neoplasms | Aspirin | 11.20 | 15481559 | |
| MESH:D001932 | Brain Neoplasms | Copper | 11.20 | 17079463 | |
| MESH:D001932 | Brain Neoplasms | Curcumin | 11.20 | 17596214 | |
| MESH:D001932 | Brain Neoplasms | Doxorubicin | 11.20 | 17150277 | |
| MESH:D001932 | Brain Neoplasms | Fenretinide | 11.20 | 16187019 | |
| MESH:D001943 | Breast Neoplasms | 4-hydroxyestradiol-17 beta | 63.86 | 16675129 | |
| MESH:D001943 | Breast Neoplasms | 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone | 63.86 | 20146248 | |
| MESH:D001943 | Breast Neoplasms | alitretinoin | 63.86 | 16344269 | |
| MESH:D001943 | Breast Neoplasms | Apigenin | 63.86 | 17132221 16541309 | |
| MESH:D001943 | Breast Neoplasms | Ascorbic Acid | 63.86 | 16443354 | |
| MESH:D001943 | Breast Neoplasms | Aspirin | 63.86 | 15161893 | |
| MESH:D001943 | Breast Neoplasms | Benzo(a)pyrene | 63.86 | 17474063 20146248 | |
| MESH:D001943 | Breast Neoplasms | beta-hexachlorocyclohexane | 63.86 | 12948864 17640349 | |
| MESH:D001943 | Breast Neoplasms | bisphenol A | 63.86 | 17123778 | |
| MESH:D001943 | Breast Neoplasms | Calcitriol | 63.86 | 11237771 | |
| MESH:D001943 | Breast Neoplasms | Chromium | 63.86 | 15986119 | |
| MESH:D001943 | Breast Neoplasms | Cisplatin | 63.86 | 18382427 19526202 | |
| MESH:D001943 | Breast Neoplasms | Copper | 63.86 | 17079463 15986119 | |
| MESH:D001943 | Breast Neoplasms | Curcumin | 63.86 | 19250217 16243823 18593918 18462866 | |
| MESH:D001943 | Breast Neoplasms | Cyclophosphamide | 63.86 | 18234424 18323546 12006526 15093573 17388661 17020986 11325840 16978400 15136595 | |
| MESH:D001943 | Breast Neoplasms | Dacarbazine | 63.86 | 17983394 | |
| MESH:D001943 | Breast Neoplasms | DDT | 63.86 | 16792888 12709520 | |
| MESH:D001943 | Breast Neoplasms | decitabine | 63.86 | 18320071 19208741 | |
| MESH:D001943 | Breast Neoplasms | Deferoxamine | 63.86 | 15993339 | |
| MESH:D001943 | Breast Neoplasms | Dichlorodiphenyl Dichloroethylene | 63.86 | 15061365 | |
| MESH:D001943 | Breast Neoplasms | Dieldrin | 63.86 | 15770527 11859874 | |
| MESH:D001943 | Breast Neoplasms | Dietary Fats | 63.86 | 20435547 | |
| MESH:D001943 | Breast Neoplasms | Diethylnitrosamine | 63.86 | 17474063 | |
| MESH:D001943 | Breast Neoplasms | Diethylstilbestrol | 63.86 | 17129689 15324884 | |
| MESH:D001943 | Breast Neoplasms | docetaxel | 63.86 | 16264153 16495393 18628466 15692762 19526202 17369602 15567936 | |
| MESH:D001943 | Breast Neoplasms | Doxorubicin | 63.86 | 11325840 15634643 15668708 17983394 18628466 16826403 16264153 15993339 18695136 18234424 19526202 17426702 16096432 15567936 15136595 15939500 16935488 17369602 16595493 15692762 15994142 16322301 16115903 18382427 | |
| MESH:D001943 | Breast Neoplasms | equol | 63.86 | 16898868 | |
| MESH:D001943 | Breast Neoplasms | Estradiol | 63.86 | 17289903 17018787 12948864 17261762 18497071 19861407 16675129 14630087 | |
| MESH:D001943 | Breast Neoplasms | Estrogens, Catechol | 63.86 | 17261777 | |
| MESH:D001943 | Breast Neoplasms | Fenretinide | 63.86 | 16601279 | |
| MESH:D001943 | Breast Neoplasms | Folic Acid | 63.86 | 16777985 | |
| MESH:D001943 | Breast Neoplasms | fulvestrant | 63.86 | 18984771 | |
| MESH:D001943 | Breast Neoplasms | Genistein | 63.86 | 16541309 16873071 17200150 | |
| MESH:D001943 | Breast Neoplasms | Heptachlor | 63.86 | 8738476 | |
| MESH:D001943 | Breast Neoplasms | imatinib | 63.86 | 17614352 | |
| MESH:D001943 | Breast Neoplasms | Indomethacin | 63.86 | 17401462 | |
| MESH:D001943 | Breast Neoplasms | kaempferol | 63.86 | 16756079 | |
| MESH:D001943 | Breast Neoplasms | lapatinib | 63.86 | 16091755 | |
| MESH:D001943 | Breast Neoplasms | letrozole | 63.86 | 16002280 17892469 | |
| MESH:D001943 | Breast Neoplasms | Lindane | 63.86 | 14688026 | |
| MESH:D001943 | Breast Neoplasms | Methylnitrosourea | 63.86 | 16253758 14633655 11306469 | |
| MESH:D001943 | Breast Neoplasms | Nickel | 63.86 | 15986119 | |
| MESH:D001943 | Breast Neoplasms | Nitric Oxide | 63.86 | 15631943 | |
| MESH:D001943 | Breast Neoplasms | Oxygen | 63.86 | 17263869 | |
| MESH:D001943 | Breast Neoplasms | Paclitaxel | 63.86 | 11325840 16273361 18223236 18323546 18234424 16244791 16115903 15136595 | |
| MESH:D001943 | Breast Neoplasms | Progesterone | 63.86 | 17614352 15562024 16175315 | |
| MESH:D001943 | Breast Neoplasms | Quercetin | 63.86 | 18628248 | |
| MESH:D001943 | Breast Neoplasms | Raloxifene | 63.86 | 17952589 15572757 17261762 15758505 16837676 17893378 17242785 16912660 17440819 17049068 17595753 15775269 | |
| MESH:D001943 | Breast Neoplasms | resveratrol | 63.86 | 17651959 17534123 16393696 | |
| MESH:D001943 | Breast Neoplasms | Tamoxifen | 63.86 | 18997820 19189210 16873071 18629630 19487384 19011961 17049068 19084267 19221464 19189212 16273361 20135344 21152245 20544844 16818667 15565566 19244106 11161223 17440819 19289846 19288272 18351453 18815881 19155303 20065188 20005174 20390343 15668708 19410462 19142967 19059307 18984771 21138602 18855134 17893378 19115204 17261762 16202921 19103187 17242785 18821012 19066611 19200415 18425577 20859285 | |
| MESH:D001943 | Breast Neoplasms | Testosterone | 63.86 | 17261762 | |
| MESH:D001943 | Breast Neoplasms | Tetrachlorodibenzodioxin | 63.86 | 20435547 | |
| MESH:D001943 | Breast Neoplasms | Toluene 2,4-Diisocyanate | 63.86 | 11921183 | |
| MESH:D001943 | Breast Neoplasms | Tretinoin | 63.86 | 16873071 16443354 16166294 | |
| MESH:D001943 | Breast Neoplasms | Vanadium | 63.86 | 15565634 | |
| MESH:D001943 | Breast Neoplasms | vorinostat | 63.86 | 16144943 | |
| MESH:D001943 | Breast Neoplasms | zoledronic acid | 63.86 | 18695136 16096432 | |
| MESH:D016535 | Bronchial Hyperreactivity | Ozone | 8.29 | 18417511 16777450 15516495 19059883 18315731 17626835 14754758 | |
| MESH:D016535 | Bronchial Hyperreactivity | Toluene 2,4-Diisocyanate | 8.29 | 15590891 8156442 12507178 | |
| MESH:D016535 | Bronchial Hyperreactivity | tyrphostin AG 1478 | 8.29 | 12794006 | |
| MESH:D016535 | Bronchial Hyperreactivity | zileuton | 8.29 | 12654629 12794006 12388339 | |
| MESH:D001986 | Bronchial Spasm | Histamine | 4.12 | 18298128 | |
| MESH:D001989 | Bronchiolitis Obliterans | Mustard Gas | 3.45 | 15286001 | |
| MESH:D001991 | Bronchitis | vanadium pentoxide | 4.51 | 17459161 | |
| MESH:D029481 | Bronchitis, Chronic | Mustard Gas | 7.88 | 17687719 10378619 | |
| MESH:D029481 | Bronchitis, Chronic | salmeterol | 7.88 | 17687719 | |
| MESH:D001997 | Bronchopulmonary Dysplasia | Tretinoin | 7.40 | 16813970 | |
| MESH:D001997 | Bronchopulmonary Dysplasia | Vitamin A | 7.40 | 17426644 17377406 | |
| MESH:D002051 | Burkitt Lymphoma | arsenic trioxide | 2.71 | 11589617 | |
| MESH:D002056 | Burns | Ethanol | 5.87 | 16374292 | |
| MESH:D002056 | Burns | Indomethacin | 5.87 | 10459503 | |
| MESH:D002057 | Burns, Chemical | Plant Extracts | 3.62 | 9625245 | |
| MESH:D002100 | Cachexia | Indomethacin | 6.78 | 16537180 15141370 11239499 15625704 | |
| MESH:D002100 | Cachexia | Ozone | 6.78 | 16183385 | |
| MESH:D002105 | Cadmium Poisoning | Quercetin | 3.81 | 16962696 | |
| MESH:D002177 | Candidiasis | moxifloxacin | 4.92 | 16352735 | |
| MESH:D002181 | Candidiasis, Vulvovaginal | Estradiol | 2.76 | 16111702 | |
| MESH:D019559 | Capillary Leak Syndrome | Acitretin | 7.39 | 17097361 | |
| MESH:D019559 | Capillary Leak Syndrome | Terbutaline | 7.39 | 11713377 9428835 | |
| MESH:D002252 | Carbon Tetrachloride Poisoning | Carbon Tetrachloride | 7.59 | 16124888 16097048 15721981 16227642 16011737 15673190 15700767 16192424 3786805 10355542 18705752 16050911 | |
| MESH:D002252 | Carbon Tetrachloride Poisoning | ferulic acid | 7.59 | 16011737 | |
| MESH:D002252 | Carbon Tetrachloride Poisoning | Vitamin E | 7.59 | 16050911 | |
| MESH:D002276 | Carcinoid Tumor | Dacarbazine | 11.60 | 16051944 | |
| MESH:D002276 | Carcinoid Tumor | Doxorubicin | 11.60 | 16051944 | |
| MESH:D002276 | Carcinoid Tumor | Streptozocin | 11.60 | 16051944 | |
| MESH:D002277 | Carcinoma | Curcumin | 8.05 | 18593918 | |
| MESH:D002277 | Carcinoma | Dimethylnitrosamine | 8.05 | 19555203 | |
| MESH:D002277 | Carcinoma | Hydrocarbons, Chlorinated | 8.05 | 12024805 | |
| MESH:D002277 | Carcinoma | Tetrachlorodibenzodioxin | 8.05 | 16835633 | |
| MESH:D002280 | Carcinoma, Basal Cell | Arsenic | 2.39 | 17687452 15504454 | |
| MESH:D018270 | Carcinoma, Ductal, Breast | Tamoxifen | 2.83 | 19066611 | |
| MESH:D018236 | Carcinoma, Embryonal | Tretinoin | 3.43 | 16168501 | |
| MESH:D006528 | Carcinoma, Hepatocellular | 2,4-dinitrotoluene | 56.63 | 16705839 | |
| MESH:D006528 | Carcinoma, Hepatocellular | 2,6-dinitrotoluene | 56.63 | 16705839 | |
| MESH:D006528 | Carcinoma, Hepatocellular | 3,7,11,15-tetramethyl-2,4,6,10,14-hexadecapentaenoic acid | 56.63 | 17270033 | |
| MESH:D006528 | Carcinoma, Hepatocellular | 4,4'-diaminodiphenylmethane | 56.63 | 7296757 3581430 | |
| MESH:D006528 | Carcinoma, Hepatocellular | Acetaminophen | 56.63 | 3084413 | |
| MESH:D006528 | Carcinoma, Hepatocellular | Arsenic | 56.63 | 16507464 17306315 | |
| MESH:D006528 | Carcinoma, Hepatocellular | arsenic trioxide | 56.63 | 16217749 15553829 15073043 14691202 11135700 | |
| MESH:D006528 | Carcinoma, Hepatocellular | AZD 6244 | 56.63 | 17876044 | |
| MESH:D006528 | Carcinoma, Hepatocellular | Carbon Tetrachloride | 56.63 | 18788625 | |
| MESH:D006528 | Carcinoma, Hepatocellular | Cisplatin | 56.63 | 17982673 | |
| MESH:D006528 | Carcinoma, Hepatocellular | Cyclophosphamide | 56.63 | 19701751 | |
| MESH:D006528 | Carcinoma, Hepatocellular | DDT | 56.63 | 12597452 | |
| MESH:D006528 | Carcinoma, Hepatocellular | Diethylnitrosamine | 56.63 | 16878318 18971187 16288022 21159647 17173139 20432363 19171122 20084675 3084413 19107877 17138121 16681979 20727157 19418558 10672840 17761372 20514400 16807293 16502159 16698587 16830150 19822196 17055752 18785209 16328049 18494052 19208518 20101231 18210153 18978308 17978847 20524982 19539802 19519916 16935385 19335982 20214788 11831363 19701751 19383236 18393292 20512989 16540662 20007298 19052882 10737359 18788625 17162532 19919837 19394651 16569478 18665156 18506893 18056438 16779866 18691550 20935162 17428255 3581430 | |
| MESH:D006528 | Carcinoma, Hepatocellular | Diethylstilbestrol | 56.63 | 15948411 16924424 | |
| MESH:D006528 | Carcinoma, Hepatocellular | Doxorubicin | 56.63 | 16234567 18059187 16023760 17876044 | |
| MESH:D006528 | Carcinoma, Hepatocellular | Estradiol | 56.63 | 16924424 | |
| MESH:D006528 | Carcinoma, Hepatocellular | Ethanol | 56.63 | 15763234 15289165 18788625 | |
| MESH:D006528 | Carcinoma, Hepatocellular | Fenretinide | 56.63 | 17159502 16270382 | |
| MESH:D006528 | Carcinoma, Hepatocellular | Genistein | 56.63 | 16924424 | |
| MESH:D006528 | Carcinoma, Hepatocellular | Indomethacin | 56.63 | 16391822 | |
| MESH:D006528 | Carcinoma, Hepatocellular | juzentaihoto | 56.63 | 18785209 | |
| MESH:D006528 | Carcinoma, Hepatocellular | malachite green | 56.63 | 12616621 | |
| MESH:D006528 | Carcinoma, Hepatocellular | morin | 56.63 | 19539802 | |
| MESH:D006528 | Carcinoma, Hepatocellular | Paclitaxel | 56.63 | 16313753 | |
| MESH:D006528 | Carcinoma, Hepatocellular | Phenobarbital | 56.63 | 17173139 20935162 1701930 20007298 6705139 | |
| MESH:D006528 | Carcinoma, Hepatocellular | Plant Extracts | 56.63 | 18834353 | |
| MESH:D006528 | Carcinoma, Hepatocellular | Quercetin | 56.63 | 12508355 19519916 | |
| MESH:D006528 | Carcinoma, Hepatocellular | resveratrol | 56.63 | 16227395 19321006 | |
| MESH:D006528 | Carcinoma, Hepatocellular | sodium arsenite | 56.63 | 16507464 17306315 15276417 | |
| MESH:D006528 | Carcinoma, Hepatocellular | Tamoxifen | 56.63 | 16924424 | |
| MESH:D006528 | Carcinoma, Hepatocellular | Thalidomide | 56.63 | 16313753 | |
| MESH:D006528 | Carcinoma, Hepatocellular | Tretinoin | 56.63 | 1917145 | |
| MESH:D006528 | Carcinoma, Hepatocellular | Vanadium | 56.63 | 16830150 16878318 | |
| MESH:D002278 | Carcinoma in Situ | bisphenol A | 3.28 | 17123778 | |
| MESH:D018827 | Carcinoma, Lewis Lung | Cyclophosphamide | 9.42 | 16152834 | |
| MESH:D018827 | Carcinoma, Lewis Lung | Indomethacin | 9.42 | 11053908 | |
| MESH:D018827 | Carcinoma, Lewis Lung | resveratrol | 9.42 | 16675471 | |
| MESH:D018276 | Carcinoma, Medullary | Indomethacin | 3.64 | 11352223 14736730 18791128 | |
| MESH:D002289 | Carcinoma, Non-Small-Cell Lung | 5-((4-methylphenyl)methylene)-2-(phenylamino)-4(5H)-thiazolone | 14.42 | 16179969 | |
| MESH:D002289 | Carcinoma, Non-Small-Cell Lung | bortezomib | 14.42 | 16052434 | |
| MESH:D002289 | Carcinoma, Non-Small-Cell Lung | Cisplatin | 14.42 | 16685392 12023789 | |
| MESH:D002289 | Carcinoma, Non-Small-Cell Lung | Curcumin | 14.42 | 18414057 | |
| MESH:D002289 | Carcinoma, Non-Small-Cell Lung | docetaxel | 14.42 | 11894018 | |
| MESH:D002289 | Carcinoma, Non-Small-Cell Lung | gefitinib | 14.42 | 18347146 19233551 20005069 17290066 15496427 16230376 | |
| MESH:D002289 | Carcinoma, Non-Small-Cell Lung | sulindac sulfide | 14.42 | 12391285 | |
| MESH:D002289 | Carcinoma, Non-Small-Cell Lung | sulindac sulfone | 14.42 | 18758305 | |
| MESH:D002289 | Carcinoma, Non-Small-Cell Lung | zoledronic acid | 14.42 | 19233551 | |
| MESH:D021441 | Carcinoma, Pancreatic Ductal | Quercetin | 3.28 | 17234771 | |
| MESH:D002291 | Carcinoma, Papillary | arsenic trioxide | 3.15 | 19014326 | |
| MESH:D002292 | Carcinoma, Renal Cell | 4,4'-diaminodiphenylmethane | 10.14 | 7296757 | |
| MESH:D002292 | Carcinoma, Renal Cell | Cyclophosphamide | 10.14 | 16201981 | |
| MESH:D002292 | Carcinoma, Renal Cell | Dacarbazine | 10.14 | 16201981 | |
| MESH:D002292 | Carcinoma, Renal Cell | Doxorubicin | 10.14 | 16201981 1485588 | |
| MESH:D002292 | Carcinoma, Renal Cell | Indomethacin | 10.14 | 17341418 | |
| MESH:D002292 | Carcinoma, Renal Cell | zoledronic acid | 10.14 | 18507039 | |
| MESH:D018288 | Carcinoma, Small Cell | arsenic trioxide | 2.55 | 12490120 | |
| MESH:D002294 | Carcinoma, Squamous Cell | Acetylcysteine | 30.52 | 17015178 | |
| MESH:D002294 | Carcinoma, Squamous Cell | Acitretin | 30.52 | 16196285 | |
| MESH:D002294 | Carcinoma, Squamous Cell | Arsenic | 30.52 | 17687452 18922899 15504454 | |
| MESH:D002294 | Carcinoma, Squamous Cell | Benzo(a)pyrene | 30.52 | 20419170 | |
| MESH:D002294 | Carcinoma, Squamous Cell | Calcitriol | 30.52 | 11237771 | |
| MESH:D002294 | Carcinoma, Squamous Cell | Cisplatin | 30.52 | 17066447 6189445 18337622 | |
| MESH:D002294 | Carcinoma, Squamous Cell | Curcumin | 30.52 | 18462866 | |
| MESH:D002294 | Carcinoma, Squamous Cell | decitabine | 30.52 | 19215824 | |
| MESH:D002294 | Carcinoma, Squamous Cell | Dimethylnitrosamine | 30.52 | 16033868 | |
| MESH:D002294 | Carcinoma, Squamous Cell | Doxorubicin | 30.52 | 6189445 | |
| MESH:D002294 | Carcinoma, Squamous Cell | Fenretinide | 30.52 | 16274795 | |
| MESH:D002294 | Carcinoma, Squamous Cell | Indomethacin | 30.52 | 15482327 12636206 | |
| MESH:D002294 | Carcinoma, Squamous Cell | resveratrol | 30.52 | 16227395 | |
| MESH:D002294 | Carcinoma, Squamous Cell | sodium arsenite | 30.52 | 18572023 | |
| MESH:D002294 | Carcinoma, Squamous Cell | Tetradecanoylphorbol Acetate | 30.52 | 18922899 | |
| MESH:D002294 | Carcinoma, Squamous Cell | Tretinoin | 30.52 | 16096774 16051514 | |
| MESH:D002294 | Carcinoma, Squamous Cell | Zinc | 30.52 | 16543248 | |
| MESH:D002295 | Carcinoma, Transitional Cell | Amiloride | 10.07 | 14644129 | |
| MESH:D002295 | Carcinoma, Transitional Cell | Arsenic | 10.07 | 18640142 | |
| MESH:D002295 | Carcinoma, Transitional Cell | Raloxifene | 10.07 | 17572228 | |
| MESH:D002295 | Carcinoma, Transitional Cell | Tamoxifen | 10.07 | 17572228 | |
| MESH:D006332 | Cardiomegaly | Atenolol | 39.07 | 15969258 | |
| MESH:D006332 | Cardiomegaly | atorvastatin | 39.07 | 18360054 | |
| MESH:D006332 | Cardiomegaly | Copper | 39.07 | 17327471 | |
| MESH:D006332 | Cardiomegaly | Doxazosin | 39.07 | 15969258 | |
| MESH:D006332 | Cardiomegaly | Ethanol | 39.07 | 19332462 | |
| MESH:D006332 | Cardiomegaly | Isoproterenol | 39.07 | 11179087 7544033 | |
| MESH:D006332 | Cardiomegaly | isorhapontigenin | 39.07 | 15607907 | |
| MESH:D006332 | Cardiomegaly | Losartan | 39.07 | 12586211 15969258 | |
| MESH:D006332 | Cardiomegaly | Norepinephrine | 39.07 | 11179087 | |
| MESH:D006332 | Cardiomegaly | Phenylephrine | 39.07 | 11179087 15728586 11754973 17124262 16170337 17287366 | |
| MESH:D006332 | Cardiomegaly | Plant Extracts | 39.07 | 17645561 | |
| MESH:D006332 | Cardiomegaly | Quercetin | 39.07 | 19794523 | |
| MESH:D006332 | Cardiomegaly | Tetrachlorodibenzodioxin | 39.07 | 16120746 18670907 18850075 | |
| MESH:D006332 | Cardiomegaly | Thyroxine | 39.07 | 18093424 | |
| MESH:D006332 | Cardiomegaly | valsartan | 39.07 | 19597038 | |
| MESH:D009202 | Cardiomyopathies | carvedilol | 15.78 | 15476868 | |
| MESH:D009202 | Cardiomyopathies | Doxorubicin | 15.78 | 17007740 17131338 16731534 17308081 16278810 17351982 17924179 18627295 16612575 16242529 15811867 16364871 17928571 16109756 15792986 17329180 17974986 17519947 16952015 16455267 17382496 16651473 15505089 15476868 16269455 | |
| MESH:D009202 | Cardiomyopathies | Iron | 15.78 | 16640825 | |
| MESH:D009202 | Cardiomyopathies | Oleylethanolamide | 15.78 | 16269455 | |
| MESH:D009202 | Cardiomyopathies | pimagedine | 15.78 | 16612575 | |
| MESH:D009202 | Cardiomyopathies | Razoxane | 15.78 | 17519947 | |
| MESH:D009202 | Cardiomyopathies | valsartan | 15.78 | 16247790 | |
| MESH:D002310 | Cardiomyopathy, Alcoholic | Acetaldehyde | 4.75 | 10525098 | |
| MESH:D002311 | Cardiomyopathy, Dilated | carvedilol | 4.07 | 19477965 | |
| MESH:D002311 | Cardiomyopathy, Dilated | Doxorubicin | 4.07 | 17334414 16243910 | |
| MESH:D002311 | Cardiomyopathy, Dilated | Iron | 4.07 | 16604332 | |
| MESH:D002318 | Cardiovascular Diseases | Aldosterone | 32.06 | 11230374 | |
| MESH:D002318 | Cardiovascular Diseases | Arsenic | 32.06 | 15738583 17938729 19152805 | |
| MESH:D002318 | Cardiovascular Diseases | atrasentan | 32.06 | 16219361 | |
| MESH:D002318 | Cardiovascular Diseases | daidzein | 32.06 | 16332659 | |
| MESH:D002318 | Cardiovascular Diseases | Folic Acid | 32.06 | 16755160 | |
| MESH:D002318 | Cardiovascular Diseases | Genistein | 32.06 | 16332659 | |
| MESH:D002318 | Cardiovascular Diseases | Hydrogen Peroxide | 32.06 | 16936243 | |
| MESH:D002318 | Cardiovascular Diseases | kaempferol | 32.06 | 16756079 | |
| MESH:D002318 | Cardiovascular Diseases | Particulate Matter | 32.06 | 12396868 | |
| MESH:D002318 | Cardiovascular Diseases | Raloxifene | 32.06 | 15775269 | |
| MESH:D002318 | Cardiovascular Diseases | resveratrol | 32.06 | 15458977 | |
| MESH:D002318 | Cardiovascular Diseases | valsartan | 32.06 | 11230374 | |
| MESH:D002318 | Cardiovascular Diseases | Zinc | 32.06 | 16936243 | |
| MESH:D002340 | Carotid Artery Diseases | Arsenic | 2.78 | 18022660 16973168 | |
| MESH:D020212 | Carotid Artery Injuries | tetracycline CMT-3 | 4.85 | 14507662 | |
| MESH:D002375 | Catalepsy | Haloperidol | 6.09 | 1977408 15215559 | |
| MESH:D002375 | Catalepsy | Norepinephrine | 6.09 | 8216760 | |
| MESH:D002386 | Cataract | Acetaminophen | 9.60 | 10977129 | |
| MESH:D002386 | Cataract | Adenosine Triphosphate | 9.60 | 15003327 | |
| MESH:D002386 | Cataract | Methylnitrosourea | 9.60 | 12484553 | |
| MESH:D002386 | Cataract | pimagedine | 9.60 | 17936468 15003327 | |
| MESH:D002386 | Cataract | Tretinoin | 9.60 | 17460283 | |
| MESH:D002471 | Cell Transformation, Neoplastic | 2,6-dinitrotoluene | 33.95 | 6135515 | |
| MESH:D002471 | Cell Transformation, Neoplastic | 4,4'-diaminodiphenylmethane | 33.95 | 7505956 | |
| MESH:D002471 | Cell Transformation, Neoplastic | 4-hydroxyestradiol-17 beta | 33.95 | 18226522 18566989 | |
| MESH:D002471 | Cell Transformation, Neoplastic | 7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide | 33.95 | 20889678 | |
| MESH:D002471 | Cell Transformation, Neoplastic | Acetylcysteine | 33.95 | 18226522 | |
| MESH:D002471 | Cell Transformation, Neoplastic | Cadmium | 33.95 | 17332340 | |
| MESH:D002471 | Cell Transformation, Neoplastic | cinnamic aldehyde | 33.95 | 8243401 | |
| MESH:D002471 | Cell Transformation, Neoplastic | Cyclosporine | 33.95 | 12371664 | |
| MESH:D002471 | Cell Transformation, Neoplastic | Diethylnitrosamine | 33.95 | 17174075 2727394 21159647 7505956 | |
| MESH:D002471 | Cell Transformation, Neoplastic | Dinoprost | 33.95 | 16192471 | |
| MESH:D002471 | Cell Transformation, Neoplastic | Dinoprostone | 33.95 | 16192471 | |
| MESH:D002471 | Cell Transformation, Neoplastic | Estradiol | 33.95 | 18566989 | |
| MESH:D002471 | Cell Transformation, Neoplastic | Methylnitrosourea | 33.95 | 7505956 2727394 | |
| MESH:D002471 | Cell Transformation, Neoplastic | sodium arsenite | 33.95 | 20056578 19524636 | |
| MESH:D002471 | Cell Transformation, Neoplastic | Vanadium | 33.95 | 17174075 | |
| MESH:D002493 | Central Nervous System Diseases | Phenobarbital | 6.15 | 4080065 | |
| MESH:D002493 | Central Nervous System Diseases | Phenytoin | 6.15 | 4080065 | |
| MESH:D018290 | Cervical Intraepithelial Neoplasia | Fenretinide | 7.35 | 16154183 | |
| MESH:D018290 | Cervical Intraepithelial Neoplasia | Tretinoin | 7.35 | 16129372 | |
| MESH:D002637 | Chest Pain | Acids | 4.70 | 15447763 | |
| MESH:D002659 | Child Development Disorders, Pervasive | Serotonin | 3.53 | 21254450 | |
| MESH:D002659 | Child Development Disorders, Pervasive | Testosterone | 3.53 | 20678186 | |
| MESH:D015362 | Child Nutrition Disorders | Vitamin A | 3.76 | 16153327 | |
| MESH:D018281 | Cholangiocarcinoma | Diethylnitrosamine | 7.35 | 19052882 | |
| MESH:D018281 | Cholangiocarcinoma | Tetrachlorodibenzodioxin | 7.35 | 16835633 | |
| MESH:D018281 | Cholangiocarcinoma | Thalidomide | 7.35 | 18291259 | |
| MESH:D002764 | Cholecystitis | 2-ethoxyethanol | 12.88 | 6499794 | |
| MESH:D002764 | Cholecystitis | Indomethacin | 12.88 | 11181007 | |
| MESH:D002764 | Cholecystitis | methyl cellosolve | 12.88 | 6499794 | |
| MESH:D002779 | Cholestasis | 4,4'-diaminodiphenylmethane | 13.20 | 9022650 19486331 | |
| MESH:D002779 | Cholestasis | Cyclosporine | 13.20 | 19486331 | |
| MESH:D002779 | Cholestasis | Ethinyl Estradiol | 13.20 | 17110522 11677210 16919318 17333356 17681005 16105132 15861022 | |
| MESH:D002779 | Cholestasis | Nitric Oxide | 13.20 | 16919318 | |
| MESH:D002779 | Cholestasis | pirinixic acid | 13.20 | 19176532 | |
| MESH:D002779 | Cholestasis | Vitamin A | 13.20 | 16175620 | |
| OMIM:601042 | CHOREOATHETOSIS/SPASTICITY, EPISODIC | Phenytoin | 4.16 | 11748493 | |
| MESH:D002822 | Choriocarcinoma | Tretinoin | 3.43 | 16461808 | |
| MESH:D019457 | Chromosome Breakage | Sodium Selenite | 3.07 | 15894690 | |
| MESH:D021081 | Chronobiology Disorders | Serotonin | 4.96 | 17157402 | |
| MESH:D016770 | Ciliophora Infections | malachite green | 4.15 | 15900690 16175963 | |
| MESH:D002971 | Cleft Lip | Ethanol | 5.47 | 15513904 | |
| MESH:D002971 | Cleft Lip | Folic Acid | 5.47 | 21254359 | |
| MESH:D002971 | Cleft Lip | Phenytoin | 5.47 | 2227380 | |
| MESH:D002972 | Cleft Palate | Ethanol | 11.19 | 15513904 | |
| MESH:D002972 | Cleft Palate | Folic Acid | 11.19 | 21254359 8946559 | |
| MESH:D002972 | Cleft Palate | Phenytoin | 11.19 | 2227380 6856622 6862529 10789828 3877104 1687470 | |
| MESH:D002972 | Cleft Palate | Tetrachlorodibenzodioxin | 11.19 | 15668235 15340226 16354765 8697196 12621046 | |
| MESH:D002972 | Cleft Palate | Tretinoin | 11.19 | 9407595 | |
| MESH:D002972 | Cleft Palate | Urethane | 11.19 | 12810352 | |
| MESH:D002972 | Cleft Palate | Vitamin A | 11.19 | 16054864 | |
| MESH:D003072 | Cognition Disorders | Clozapine | 6.16 | 17123785 | |
| MESH:D003072 | Cognition Disorders | Raloxifene | 6.16 | 15800139 | |
| MESH:D003092 | Colitis | Amiloride | 20.13 | 12065299 | |
| MESH:D003092 | Colitis | Curcumin | 20.13 | 16804969 16782535 18200517 | |
| MESH:D003092 | Colitis | resveratrol | 20.13 | 16474422 | |
| MESH:D003092 | Colitis | Rutin | 20.13 | 15652231 | |
| MESH:D003092 | Colitis | Selenium | 20.13 | 17936198 | |
| MESH:D003092 | Colitis | Thalidomide | 20.13 | 16680017 | |
| MESH:D003092 | Colitis | Tretinoin | 20.13 | 17035595 | |
| MESH:D003103 | Coloboma | Curcumin | 6.04 | 18809619 | |
| MESH:D003103 | Coloboma | Phenytoin | 6.04 | 9212184 | |
| MESH:D003110 | Colonic Neoplasms | 17-(allylamino)-17-demethoxygeldanamycin | 29.39 | 15993848 | |
| MESH:D003110 | Colonic Neoplasms | 3,7,11,15-tetramethyl-2,4,6,10,14-hexadecapentaenoic acid | 29.39 | 16596235 | |
| MESH:D003110 | Colonic Neoplasms | arsenite | 29.39 | 15037631 | |
| MESH:D003110 | Colonic Neoplasms | Aspirin | 29.39 | 12411196 | |
| MESH:D003110 | Colonic Neoplasms | Butyrates | 29.39 | 15936596 | |
| MESH:D003110 | Colonic Neoplasms | cinnamic aldehyde | 29.39 | 17510524 16343908 | |
| MESH:D003110 | Colonic Neoplasms | Curcumin | 29.39 | 19359593 16340194 | |
| MESH:D003110 | Colonic Neoplasms | decitabine | 29.39 | 17616700 | |
| MESH:D003110 | Colonic Neoplasms | Dexamethasone | 29.39 | 15824018 | |
| MESH:D003110 | Colonic Neoplasms | Genistein | 29.39 | 17182828 | |
| MESH:D003110 | Colonic Neoplasms | Indomethacin | 29.39 | 15637740 15625704 11260862 15786552 15936596 15963497 | |
| MESH:D003110 | Colonic Neoplasms | Iron | 29.39 | 16640825 | |
| MESH:D003110 | Colonic Neoplasms | oxaliplatin | 29.39 | 16510598 16004971 16024531 | |
| MESH:D003110 | Colonic Neoplasms | polyphenols | 29.39 | 16293270 | |
| MESH:D003110 | Colonic Neoplasms | Quercetin | 29.39 | 16640504 11134977 15741050 19440933 19056647 17148506 17191121 | |
| MESH:D003110 | Colonic Neoplasms | resveratrol | 29.39 | 16338953 | |
| MESH:D003110 | Colonic Neoplasms | Vanadium | 29.39 | 18155637 | |
| MESH:D003110 | Colonic Neoplasms | Vitamin A | 29.39 | 16267017 17219422 | |
| MESH:D003110 | Colonic Neoplasms | zileuton | 29.39 | 18927292 | |
| MESH:D015179 | Colorectal Neoplasms | Acrolein | 14.37 | 17597105 | |
| MESH:D015179 | Colorectal Neoplasms | arsenic trioxide | 14.37 | 20501625 | |
| MESH:D015179 | Colorectal Neoplasms | Aspirin | 14.37 | 17047198 | |
| MESH:D015179 | Colorectal Neoplasms | Cisplatin | 14.37 | 15273666 | |
| MESH:D015179 | Colorectal Neoplasms | Dacarbazine | 14.37 | 15273666 | |
| MESH:D015179 | Colorectal Neoplasms | decitabine | 14.37 | 18981723 | |
| MESH:D015179 | Colorectal Neoplasms | Doxorubicin | 14.37 | 18802399 18259882 | |
| MESH:D015179 | Colorectal Neoplasms | Fenretinide | 14.37 | 17273769 | |
| MESH:D015179 | Colorectal Neoplasms | Folic Acid | 14.37 | 17245555 16985020 17087956 17116713 16963246 | |
| MESH:D015179 | Colorectal Neoplasms | gefitinib | 14.37 | 17594712 | |
| MESH:D015179 | Colorectal Neoplasms | Indomethacin | 14.37 | 17054584 12606626 11197048 18059344 | |
| MESH:D015179 | Colorectal Neoplasms | oxaliplatin | 14.37 | 17401013 17594712 17695437 18448328 18509181 17255274 | |
| MESH:D015179 | Colorectal Neoplasms | Paclitaxel | 14.37 | 18802399 | |
| MESH:D015179 | Colorectal Neoplasms | Quercetin | 14.37 | 18852136 18095365 | |
| MESH:D015179 | Colorectal Neoplasms | resveratrol | 14.37 | 16550006 | |
| MESH:D015179 | Colorectal Neoplasms | sulindac sulfone | 14.37 | 18059344 10416599 11197048 10666051 | |
| MESH:D003128 | Coma | Ginkgo biloba extract 761 | 4.51 | 10836866 | |
| MESH:D003139 | Common Cold | Ascorbic Acid | 3.76 | 17323712 | |
| MESH:D000013 | Congenital Abnormalities | DDT | 9.84 | 15095906 | |
| MESH:D000013 | Congenital Abnormalities | methyl cellosolve | 9.84 | 6499821 12530607 | |
| MESH:D000013 | Congenital Abnormalities | Phenytoin | 9.84 | 10627286 | |
| MESH:D000013 | Congenital Abnormalities | Tetrachlorodibenzodioxin | 9.84 | 14669216 17141729 | |
| MESH:D016510 | Corneal Neovascularization | Curcumin | 7.06 | 18497527 | |
| MESH:D016510 | Corneal Neovascularization | Thalidomide | 7.06 | 9301478 | |
| MESH:D003324 | Coronary Artery Disease | atorvastatin | 4.31 | 16368305 | |
| MESH:D003324 | Coronary Artery Disease | Homocysteine | 4.31 | 16379339 | |
| MESH:D003324 | Coronary Artery Disease | valsartan | 4.31 | 17719468 | |
| MESH:D003327 | Coronary Disease | resveratrol | 2.46 | 16507316 | |
| MESH:D023903 | Coronary Restenosis | arsenic trioxide | 2.56 | 12609071 | |
| MESH:D018352 | Coronavirus Infections | Indomethacin | 3.99 | 17302372 | |
| MESH:D003371 | Cough | Capsaicin | 6.03 | 10350223 | |
| MESH:D003371 | Cough | Terbutaline | 6.03 | 19679606 | |
| MESH:D003384 | Coxsackievirus Infections | valsartan | 4.14 | 20392896 | |
| MESH:D003389 | Cranial Nerve Diseases | Thalidomide | 4.57 | 9200351 | |
| MESH:D019465 | Craniofacial Abnormalities | 6-methyl-2-(phenylethynyl)pyridine | 17.83 | 17065172 | |
| MESH:D019465 | Craniofacial Abnormalities | Acitretin | 17.83 | 8838291 | |
| MESH:D019465 | Craniofacial Abnormalities | arsenic trioxide | 17.83 | 10525206 | |
| MESH:D019465 | Craniofacial Abnormalities | decamethrin | 17.83 | 19861644 | |
| MESH:D019465 | Craniofacial Abnormalities | Dexamethasone | 17.83 | 17728286 | |
| MESH:D019465 | Craniofacial Abnormalities | Ethanol | 17.83 | 10194807 11873399 15451040 19302082 15513904 15451039 11198716 | |
| MESH:D019465 | Craniofacial Abnormalities | imatinib | 17.83 | 18322153 | |
| MESH:D019465 | Craniofacial Abnormalities | Lead | 17.83 | 19769572 | |
| MESH:D019465 | Craniofacial Abnormalities | lead acetate | 17.83 | 19769572 | |
| MESH:D019465 | Craniofacial Abnormalities | Phenytoin | 17.83 | 8986270 19952982 9212184 | |
| MESH:D019465 | Craniofacial Abnormalities | Reactive Oxygen Species | 17.83 | 15736158 | |
| MESH:D019465 | Craniofacial Abnormalities | Tetrachlorodibenzodioxin | 17.83 | 20055451 10048152 15322242 | |
| MESH:D019465 | Craniofacial Abnormalities | Thalidomide | 17.83 | 9200351 | |
| MESH:D019465 | Craniofacial Abnormalities | Tretinoin | 17.83 | 9664655 10589399 8800419 17551590 14991402 16925845 9142499 9224671 9211117 9125849 | |
| MESH:D019465 | Craniofacial Abnormalities | Vitamin A | 17.83 | 10992263 | |
| MESH:D019465 | Craniofacial Abnormalities | Vitamin E | 17.83 | 19769572 | |
| MESH:D019465 | Craniofacial Abnormalities | Zinc | 17.83 | 19302082 | |
| MESH:D003424 | Crohn Disease | Thalidomide | 3.07 | 16078585 | |
| MESH:D003456 | Cryptorchidism | Diethylstilbestrol | 5.92 | 16002989 12952375 | |
| MESH:D003456 | Cryptorchidism | vinclozolin | 5.92 | 14966744 | |
| MESH:D003457 | Cryptosporidiosis | mangiferin | 4.14 | 16547730 | |
| MESH:D003490 | Cyanosis | 2,4-dinitrotoluene | 9.34 | 18551238 | |
| MESH:D003490 | Cyanosis | 2,6-dinitrotoluene | 9.34 | 18551238 | |
| MESH:D003490 | Cyanosis | Endosulfan | 9.34 | 7900959 | |
| MESH:D003550 | Cystic Fibrosis | Acetylcysteine | 4.28 | 19747007 | |
| MESH:D003550 | Cystic Fibrosis | Docosahexaenoic Acids | 4.28 | 19747007 | |
| MESH:D003556 | Cystitis | Acrolein | 6.43 | 12161096 | |
| MESH:D003556 | Cystitis | Cyclophosphamide | 6.43 | 18433785 16989017 17979934 18093676 15643279 10498854 16413132 18295254 12913760 18483878 10700343 11948286 15276878 12161096 18372110 16651033 12388444 17010015 16614059 18710439 | |
| MESH:D007644 | Darier Disease | Lithium | 4.21 | 20338123 | |
| MESH:D003643 | Death | 2-ethoxyethanol | 4.25 | 6499796 | |
| MESH:D016757 | Death, Sudden, Cardiac | arsenic trioxide | 5.57 | 15213294 | |
| MESH:D016757 | Death, Sudden, Cardiac | Haloperidol | 5.57 | 20210726 | |
| MESH:D003665 | Decompression Sickness | zileuton | 4.50 | 18309904 | |
| MESH:D003704 | Dementia | Haloperidol | 7.77 | 11575062 | |
| MESH:D003704 | Dementia | Lead | 7.77 | 16140633 | |
| MESH:D003704 | Dementia | Methylmercury Compounds | 7.77 | 16140633 | |
| MESH:D015140 | Dementia, Vascular | Nitric Oxide | 4.25 | 17556102 | |
| MESH:D003711 | Demyelinating Diseases | Tamoxifen | 2.69 | 19031437 | |
| MESH:D003715 | Dengue | cholest-5-en-3 beta,7 alpha-diol | 4.71 | 19427377 | |
| MESH:D003866 | Depressive Disorder | venlafaxine | 3.55 | 20305041 | |
| MESH:D003865 | Depressive Disorder, Major | Raloxifene | 2.65 | 17474826 | |
| MESH:D017449 | Dermatitis, Allergic Contact | 4,4'-diaminodiphenylmethane | 11.06 | 8156756 11906362 12868966 14531868 18759878 11298694 8970840 2524372 | |
| MESH:D017449 | Dermatitis, Allergic Contact | cinnamic aldehyde | 11.06 | 11042091 | |
| MESH:D017449 | Dermatitis, Allergic Contact | cobaltous chloride | 11.06 | 15059100 16823706 11298694 | |
| MESH:D017449 | Dermatitis, Allergic Contact | Dexamethasone | 11.06 | 12438553 | |
| MESH:D017449 | Dermatitis, Allergic Contact | Maneb | 11.06 | 8807224 | |
| MESH:D017449 | Dermatitis, Allergic Contact | Nickel | 11.06 | 19470301 17100760 17244072 | |
| MESH:D017449 | Dermatitis, Allergic Contact | Propolis | 11.06 | 16191021 | |
| MESH:D017449 | Dermatitis, Allergic Contact | Toluene 2,4-Diisocyanate | 11.06 | 15491423 18759878 12956900 | |
| MESH:D003876 | Dermatitis, Atopic | Diethylhexyl Phthalate | 3.20 | 16882537 | |
| MESH:D003876 | Dermatitis, Atopic | pirinixic acid | 3.20 | 18249437 | |
| MESH:D003877 | Dermatitis, Contact | 4,4'-diaminodiphenylmethane | 6.66 | 2952479 3621924 | |
| MESH:D003877 | Dermatitis, Contact | Nickel | 6.66 | 2952479 | |
| MESH:D003877 | Dermatitis, Contact | Toluene 2,4-Diisocyanate | 6.66 | 17010967 | |
| MESH:D009783 | Dermatitis, Occupational | Maneb | 4.21 | 8807224 | |
| MESH:D002658 | Developmental Disabilities | 2,3,3',4,4',5-hexachlorobiphenyl | 4.13 | 19647017 | |
| MESH:D048909 | Diabetes Complications | erigeroflavanone | 7.88 | 19557877 | |
| MESH:D048909 | Diabetes Complications | Glycosylation End Products, Advanced | 7.88 | 19471234 | |
| MESH:D018500 | Diabetes Insipidus, Nephrogenic | 17-(allylamino)-17-demethoxygeldanamycin | 7.62 | 18854434 | |
| MESH:D018500 | Diabetes Insipidus, Nephrogenic | Lithium | 7.62 | 19244398 | |
| MESH:D003920 | Diabetes Mellitus | Iron | 12.80 | 16604332 16640825 | |
| MESH:D003920 | Diabetes Mellitus | Metformin | 12.80 | 17446233 | |
| MESH:D003920 | Diabetes Mellitus | Sodium Selenite | 12.80 | 16285004 | |
| MESH:D003920 | Diabetes Mellitus | Streptozocin | 12.80 | 16285004 | |
| MESH:D003920 | Diabetes Mellitus | Zinc | 12.80 | 16479319 | |
| MESH:D003921 | Diabetes Mellitus, Experimental | Cyclophosphamide | 13.26 | 10990075 15331540 11751995 | |
| MESH:D003921 | Diabetes Mellitus, Experimental | mangiferin | 13.26 | 12093613 19028559 | |
| MESH:D003921 | Diabetes Mellitus, Experimental | Quercetin | 13.26 | 19496084 | |
| MESH:D003921 | Diabetes Mellitus, Experimental | resveratrol | 13.26 | 16873680 | |
| MESH:D003921 | Diabetes Mellitus, Experimental | Streptozocin | 13.26 | 8740154 19586609 15862027 12644472 12446591 11260395 19496084 11055810 1374869 19298542 19960420 18715473 18603373 15298345 16684804 12083368 7637645 17874149 16286809 15831366 2177838 6379147 12093613 17442507 | |
| MESH:D003921 | Diabetes Mellitus, Experimental | valsartan | 13.26 | 11508273 | |
| MESH:D003922 | Diabetes Mellitus, Type 1 | Cyclophosphamide | 6.52 | 18772604 | |
| MESH:D003922 | Diabetes Mellitus, Type 1 | Dehydroepiandrosterone | 6.52 | 16616286 | |
| MESH:D003922 | Diabetes Mellitus, Type 1 | Iron | 6.52 | 16506275 | |
| MESH:D003922 | Diabetes Mellitus, Type 1 | Streptozocin | 6.52 | 18603373 | |
| MESH:D003922 | Diabetes Mellitus, Type 1 | Vitamin A | 6.52 | 16506275 | |
| MESH:D003924 | Diabetes Mellitus, Type 2 | alpha-Tocopherol | 27.74 | 16506275 | |
| MESH:D003924 | Diabetes Mellitus, Type 2 | Ascorbic Acid | 27.74 | 16506275 | |
| MESH:D003924 | Diabetes Mellitus, Type 2 | benidipine | 27.74 | 16387788 | |
| MESH:D003924 | Diabetes Mellitus, Type 2 | Clozapine | 27.74 | 16402076 | |
| MESH:D003924 | Diabetes Mellitus, Type 2 | Curcumin | 27.74 | 18403477 | |
| MESH:D003924 | Diabetes Mellitus, Type 2 | daidzein | 27.74 | 16647724 | |
| MESH:D003924 | Diabetes Mellitus, Type 2 | Diethylnitrosamine | 27.74 | 20387270 | |
| MESH:D003924 | Diabetes Mellitus, Type 2 | epigallocatechin gallate | 27.74 | 16988119 | |
| MESH:D003924 | Diabetes Mellitus, Type 2 | Folic Acid | 27.74 | 16886840 | |
| MESH:D003924 | Diabetes Mellitus, Type 2 | Genistein | 27.74 | 16647724 | |
| MESH:D003924 | Diabetes Mellitus, Type 2 | Iron | 27.74 | 16506275 | |
| MESH:D003924 | Diabetes Mellitus, Type 2 | mangiferin | 27.74 | 11315760 9881663 | |
| MESH:D003924 | Diabetes Mellitus, Type 2 | Metformin | 27.74 | 21186350 | |
| MESH:D003924 | Diabetes Mellitus, Type 2 | Streptozocin | 27.74 | 19586609 19647726 | |
| MESH:D003924 | Diabetes Mellitus, Type 2 | Tetrachlorodibenzodioxin | 27.74 | 17107852 | |
| MESH:D003924 | Diabetes Mellitus, Type 2 | troglitazone | 27.74 | 16023994 | |
| MESH:D003925 | Diabetic Angiopathies | Metformin | 7.18 | 16385087 | |
| MESH:D003925 | Diabetic Angiopathies | troglitazone | 7.18 | 12601628 | |
| MESH:D058065 | Diabetic Cardiomyopathies | Streptozocin | 4.03 | 16025228 | |
| MESH:D003928 | Diabetic Nephropathies | arjunolic acid | 31.28 | 19682444 | |
| MESH:D003928 | Diabetic Nephropathies | Curcumin | 31.28 | 18204486 | |
| MESH:D003928 | Diabetic Nephropathies | Estradiol | 31.28 | 19279558 | |
| MESH:D003928 | Diabetic Nephropathies | mangiferin | 31.28 | 19960420 19706694 | |
| MESH:D003928 | Diabetic Nephropathies | Plant Extracts | 31.28 | 19706694 | |
| MESH:D003928 | Diabetic Nephropathies | Raloxifene | 31.28 | 17451421 17308373 15920148 | |
| MESH:D003928 | Diabetic Nephropathies | resveratrol | 31.28 | 16286809 | |
| MESH:D003928 | Diabetic Nephropathies | Streptozocin | 31.28 | 19682444 19960420 | |
| MESH:D003928 | Diabetic Nephropathies | Tamoxifen | 31.28 | 19279558 | |
| MESH:D003928 | Diabetic Nephropathies | valsartan | 31.28 | 18630688 11427623 | |
| MESH:D003929 | Diabetic Neuropathies | Pregnanolone | 6.91 | 17187935 | |
| MESH:D003929 | Diabetic Neuropathies | Progesterone | 6.91 | 17187935 | |
| MESH:D003930 | Diabetic Retinopathy | Streptozocin | 3.78 | 17662242 | |
| MESH:D003967 | Diarrhea | 3-(2-hydroxy-4-(1,1-dimethylheptyl)phenyl)-4-(3-hydroxypropyl)cyclohexanol | 13.26 | 10611417 | |
| MESH:D003967 | Diarrhea | Dexamethasone | 13.26 | 7237001 | |
| MESH:D003967 | Diarrhea | Dinoprostone | 13.26 | 10446763 11488427 7237001 | |
| MESH:D003967 | Diarrhea | Indomethacin | 13.26 | 7237001 7907874 | |
| MESH:D003967 | Diarrhea | Serotonin | 13.26 | 11488427 8112388 10446763 | |
| MESH:D003967 | Diarrhea | Thiorphan | 13.26 | 3481337 | |
| MESH:D003967 | Diarrhea | vorinostat | 13.26 | 20479100 | |
| MESH:D006970 | Disorders of Excessive Somnolence | Clozapine | 3.83 | 15331141 | |
| OMIM:607208 | DRAVET SYNDROME | Phenytoin | 3.72 | 11748493 | |
| MESH:D003875 | Drug Eruptions | Phenytoin | 3.83 | 15024534 | |
| MESH:D004342 | Drug Hypersensitivity | Dacarbazine | 3.70 | 16508601 | |
| MESH:D056486 | Drug-Induced Liver Injury | 2,4-dinitrotoluene | 33.38 | 21346803 18551238 | |
| MESH:D056486 | Drug-Induced Liver Injury | 2,6-dinitrotoluene | 33.38 | 21346803 18551238 | |
| MESH:D056486 | Drug-Induced Liver Injury | 4,4'-diaminodiphenylmethane | 33.38 | 18692083 6679447 18289764 16192314 9022650 9653073 1440618 18648102 8291058 7440962 6482804 9328219 11289319 | |
| MESH:D056486 | Drug-Induced Liver Injury | Acetaminophen | 33.38 | 12153990 16177239 17562736 19739265 19420014 14986274 18713872 11834606 16393943 11461765 10663392 14725611 11739529 16227642 14550746 11421492 11743745 12705907 19370779 17522070 12594235 16081117 16485898 16109766 19164858 19085960 2444490 16781746 19923254 15968718 12540782 10774834 17906064 19416960 11529661 12392966 15619225 10915739 12958197 18071297 11287661 | |
| MESH:D056486 | Drug-Induced Liver Injury | Acetylcysteine | 33.38 | 11287661 | |
| MESH:D056486 | Drug-Induced Liver Injury | Carbon Tetrachloride | 33.38 | 10092053 21278145 3786805 9327722 7120509 15968718 15998439 10915739 19336974 16177239 11566570 19085960 6623471 7440962 4309450 16227642 6884620 2869522 3732212 17522070 7179309 15027814 | |
| MESH:D056486 | Drug-Induced Liver Injury | Diethylnitrosamine | 33.38 | 19107877 | |
| MESH:D056486 | Drug-Induced Liver Injury | Dimethylnitrosamine | 33.38 | 8172417 | |
| MESH:D056486 | Drug-Induced Liver Injury | Diquat | 33.38 | 18445702 18164269 | |
| MESH:D056486 | Drug-Induced Liver Injury | Doxorubicin | 33.38 | 17416283 | |
| MESH:D056486 | Drug-Induced Liver Injury | Drugs, Chinese Herbal | 33.38 | 15027814 | |
| MESH:D056486 | Drug-Induced Liver Injury | Ethanol | 33.38 | 11566570 | |
| MESH:D056486 | Drug-Induced Liver Injury | Gliotoxin | 33.38 | 19739265 | |
| MESH:D056486 | Drug-Induced Liver Injury | polyphenols | 33.38 | 19370779 | |
| MESH:D056486 | Drug-Induced Liver Injury | Prazosin | 33.38 | 18071297 | |
| MESH:D056486 | Drug-Induced Liver Injury | Selenium | 33.38 | 15131321 | |
| MESH:D056486 | Drug-Induced Liver Injury | Silymarin | 33.38 | 14998559 | |
| MESH:D056486 | Drug-Induced Liver Injury | Sodium Selenite | 33.38 | 15131321 | |
| MESH:D056486 | Drug-Induced Liver Injury | Tetrachlorodibenzodioxin | 33.38 | 20420201 | |
| MESH:D056486 | Drug-Induced Liver Injury | troglitazone | 33.38 | 14986274 | |
| MESH:D056486 | Drug-Induced Liver Injury | Vitamin U | 33.38 | 19923254 | |
| MESH:D056486 | Drug-Induced Liver Injury | zileuton | 33.38 | 17944539 | |
| MESH:D056487 | Drug-Induced Liver Injury, Chronic | Acetaminophen | 2.38 | 19426721 | |
| MESH:D004362 | Drug Toxicity | Cisplatin | 7.97 | 12231392 12649298 15033597 19839026 | |
| MESH:D004362 | Drug Toxicity | Doxorubicin | 7.97 | 18602426 | |
| MESH:D004362 | Drug Toxicity | Gentamicins | 7.97 | 15033597 11033412 | |
| MESH:D004362 | Drug Toxicity | Tetrachlorodibenzodioxin | 7.97 | 11462148 | |
| MESH:D015352 | Dry Eye Syndromes | Vitamin A | 4.10 | 16146918 | |
| MESH:D004374 | Ductus Arteriosus, Patent | Indomethacin | 3.45 | 18446180 12774134 18043480 16326151 17190690 16133044 | |
| MESH:D004381 | Duodenal Ulcer | Capsaicin | 6.26 | 11535926 10671773 | |
| MESH:D004381 | Duodenal Ulcer | Curcumin | 6.26 | 17351913 | |
| MESH:D004381 | Duodenal Ulcer | Indomethacin | 6.26 | 11595415 11595431 17045617 17351913 11535926 10671773 17151854 11991626 17329845 17202747 16699067 | |
| MESH:D050171 | Dyslipidemias | Clozapine | 4.16 | 16402076 | |
| MESH:D050171 | Dyslipidemias | Dietary Fats | 4.16 | 18367378 | |
| MESH:D004417 | Dyspnea | Albuterol | 18.30 | 20016425 | |
| MESH:D004417 | Dyspnea | Chlorine | 18.30 | 20016425 | |
| MESH:D004417 | Dyspnea | DDT | 18.30 | 16487989 | |
| MESH:D004417 | Dyspnea | Dichlorodiphenyl Dichloroethylene | 18.30 | 16487989 | |
| MESH:D004417 | Dyspnea | Endosulfan | 18.30 | 3388749 7900959 | |
| MESH:D004417 | Dyspnea | Oxygen | 18.30 | 20016425 | |
| MESH:D004421 | Dystonia | Phenobarbital | 2.41 | 1851702 | |
| MESH:D020821 | Dystonic Disorders | Nicotine | 4.22 | 17881519 | |
| MESH:C538011 | Eales disease | Ascorbic Acid | 12.72 | 9068938 | |
| MESH:C538011 | Eales disease | Vitamin A | 12.72 | 9068938 | |
| MESH:C538011 | Eales disease | Vitamin E | 12.72 | 9068938 | |
| MESH:D004480 | Ectromelia | Vitamin A | 4.10 | 16054864 | |
| MESH:D004485 | Eczema | Dexamethasone | 2.84 | 12438553 | |
| MESH:D004487 | Edema | Arachidonic Acid | 46.50 | 9831321 15177302 9599246 11698051 7990266 16716910 | |
| MESH:D004487 | Edema | Aspirin | 46.50 | 17259670 | |
| MESH:D004487 | Edema | bis(4-hydroxycinnamoyl)methane | 46.50 | 18449507 | |
| MESH:D004487 | Edema | bisindolylmaleimide I | 46.50 | 8273558 | |
| MESH:D004487 | Edema | demethoxycurcumin | 46.50 | 18449507 | |
| MESH:D004487 | Edema | Dexamethasone | 46.50 | 19703484 | |
| MESH:D004487 | Edema | imatinib | 46.50 | 19703484 | |
| MESH:D004487 | Edema | Indomethacin | 46.50 | 7907874 10653021 16100529 19703484 8273558 8985016 7990266 | |
| MESH:D004487 | Edema | Mustard Gas | 46.50 | 11402378 9260866 11428631 11428647 | |
| MESH:D004487 | Edema | pirinixic acid | 46.50 | 12083418 | |
| MESH:D004487 | Edema | Plant Extracts | 46.50 | 12787963 | |
| MESH:D004487 | Edema | Raloxifene | 46.50 | 15860553 | |
| MESH:D004487 | Edema | resveratrol | 46.50 | 8985016 | |
| MESH:D004487 | Edema | Serotonin | 46.50 | 18841975 | |
| MESH:D004487 | Edema | Sodium Salicylate | 46.50 | 10653021 | |
| MESH:D004487 | Edema | Staurosporine | 46.50 | 8273558 | |
| MESH:D004487 | Edema | Tetrachlorodibenzodioxin | 46.50 | 12711302 11000095 | |
| MESH:D004487 | Edema | Tetradecanoylphorbol Acetate | 46.50 | 11698051 9599246 16716910 8273558 8113982 7812673 15177302 | |
| MESH:D004487 | Edema | zileuton | 46.50 | 11698051 8273558 9831321 17118201 19703484 7990266 7812673 | |
| MESH:D004487 | Edema | Zymosan | 46.50 | 7907874 | |
| MESH:D004489 | Edema, Cardiac | Tetrachlorodibenzodioxin | 6.27 | 15322242 16714409 18230668 | |
| MESH:D004489 | Edema, Cardiac | Tretinoin | 6.27 | 18230668 | |
| MESH:D020964 | Embryo Loss | 2-ethoxyethanol | 4.78 | 6499796 | |
| MESH:D004646 | Emphysema | Endosulfan | 4.82 | 7900959 | |
| MESH:D004681 | Encephalomyelitis, Autoimmune, Experimental | 15-deoxy-delta(12,14)-prostaglandin J2 | 22.54 | 16844232 | |
| MESH:D004681 | Encephalomyelitis, Autoimmune, Experimental | Calcitriol | 22.54 | 15138306 | |
| MESH:D004681 | Encephalomyelitis, Autoimmune, Experimental | Ethinyl Estradiol | 22.54 | 12538720 | |
| MESH:D004681 | Encephalomyelitis, Autoimmune, Experimental | Phenytoin | 22.54 | 17654737 | |
| MESH:D004681 | Encephalomyelitis, Autoimmune, Experimental | Progesterone | 22.54 | 17692515 | |
| MESH:D004681 | Encephalomyelitis, Autoimmune, Experimental | Raloxifene | 22.54 | 15845917 | |
| MESH:D004681 | Encephalomyelitis, Autoimmune, Experimental | resveratrol | 22.54 | 17872969 | |
| MESH:D004681 | Encephalomyelitis, Autoimmune, Experimental | Tamoxifen | 22.54 | 19031437 | |
| MESH:D004701 | Endocrine Gland Neoplasms | decitabine | 8.33 | 19294695 | |
| MESH:D004701 | Endocrine Gland Neoplasms | trichostatin A | 8.33 | 19294695 | |
| MESH:D004714 | Endometrial Hyperplasia | Diethylstilbestrol | 6.29 | 16402032 | |
| MESH:D004714 | Endometrial Hyperplasia | Genistein | 6.29 | 16402032 | |
| MESH:D016889 | Endometrial Neoplasms | 4-hydroxytamoxifen | 24.09 | 19148513 | |
| MESH:D016889 | Endometrial Neoplasms | daidzein | 24.09 | 11473722 | |
| MESH:D016889 | Endometrial Neoplasms | Diethylstilbestrol | 24.09 | 15700306 16804899 | |
| MESH:D016889 | Endometrial Neoplasms | Doxorubicin | 24.09 | 17359293 | |
| MESH:D016889 | Endometrial Neoplasms | Estradiol | 24.09 | 18566989 11473722 19148513 | |
| MESH:D016889 | Endometrial Neoplasms | Estrogens, Catechol | 24.09 | 18566989 | |
| MESH:D016889 | Endometrial Neoplasms | Folic Acid | 24.09 | 17301261 | |
| MESH:D016889 | Endometrial Neoplasms | Genistein | 24.09 | 11473722 | |
| MESH:D016889 | Endometrial Neoplasms | Tamoxifen | 24.09 | 20544844 16202921 17893378 19155303 | |
| MESH:D016889 | Endometrial Neoplasms | Tretinoin | 24.09 | 16569247 | |
| MESH:D004715 | Endometriosis | Indomethacin | 9.27 | 15652904 | |
| MESH:D004715 | Endometriosis | Mifepristone | 9.27 | 16134523 | |
| MESH:D004715 | Endometriosis | Progesterone | 9.27 | 16134523 | |
| MESH:D004715 | Endometriosis | Tetrachlorodibenzodioxin | 9.27 | 10568697 9294722 | |
| MESH:D004719 | Endomyocardial Fibrosis | Doxorubicin | 8.36 | 18037988 | |
| MESH:D004719 | Endomyocardial Fibrosis | Plant Extracts | 8.36 | 15268973 | |
| MESH:D019446 | Endotoxemia | Indomethacin | 8.12 | 18509659 | |
| MESH:D019446 | Endotoxemia | Lipopolysaccharides | 8.12 | 15821434 15328337 17637181 | |
| MESH:D019446 | Endotoxemia | zileuton | 8.12 | 15328337 | |
| MESH:D004751 | Enteritis | Indomethacin | 3.05 | 17763956 10567023 16328016 | |
| MESH:D020345 | Enterocolitis, Necrotizing | Indomethacin | 6.83 | 17980183 | |
| MESH:D020345 | Enterocolitis, Necrotizing | resveratrol | 6.83 | 17923197 | |
| MESH:D004802 | Eosinophilia | Cyclophosphamide | 13.58 | 11006010 | |
| MESH:D004802 | Eosinophilia | Histamine | 13.58 | 12689652 | |
| MESH:D004802 | Eosinophilia | Indomethacin | 13.58 | 11298111 | |
| MESH:D004802 | Eosinophilia | montelukast | 13.58 | 10335014 | |
| MESH:D004802 | Eosinophilia | Toluene 2,4-Diisocyanate | 13.58 | 8156442 | |
| MESH:D004802 | Eosinophilia | zileuton | 13.58 | 10764316 8621850 | |
| MESH:D004816 | Epidermal Necrolysis, Toxic | Phenytoin | 3.57 | 20235791 | |
| MESH:D004820 | Epidermolysis Bullosa | Phenytoin | 4.50 | 1399206 6251365 | |
| MESH:D004831 | Epilepsies, Myoclonic | Phenobarbital | 2.46 | 3659116 | |
| MESH:D004828 | Epilepsies, Partial | Phenobarbital | 4.78 | 3922381 11558140 | |
| MESH:D004828 | Epilepsies, Partial | Phenytoin | 4.78 | 11558140 17116037 | |
| MESH:D004827 | Epilepsy | Adenosine | 10.20 | 11404469 | |
| MESH:D004827 | Epilepsy | Epinephrine | 10.20 | 821787 | |
| MESH:D004827 | Epilepsy | Norepinephrine | 10.20 | 821787 | |
| MESH:D004827 | Epilepsy | Phenobarbital | 10.20 | 20417680 | |
| MESH:D004827 | Epilepsy | Phenytoin | 10.20 | 821787 11434505 20417680 | |
| MESH:D004827 | Epilepsy | Plant Extracts | 10.20 | 19439326 19700373 | |
| MESH:D004832 | Epilepsy, Absence | Phenobarbital | 2.09 | 6401628 | |
| MESH:D017029 | Epilepsy, Complex Partial | Phenobarbital | 6.15 | 7750514 | |
| MESH:D017029 | Epilepsy, Complex Partial | Phenytoin | 6.15 | 7750514 | |
| MESH:D004830 | Epilepsy, Tonic-Clonic | Phenobarbital | 5.30 | 3659116 | |
| MESH:D004830 | Epilepsy, Tonic-Clonic | Phenytoin | 5.30 | 3659116 | |
| MESH:D007172 | Erectile Dysfunction | daidzein | 7.95 | 14972507 | |
| MESH:D007172 | Erectile Dysfunction | estradiol valerate | 7.95 | 14972507 | |
| MESH:D007172 | Erectile Dysfunction | icariin | 7.95 | 15329286 16281085 | |
| MESH:D004890 | Erythema | Mustard Gas | 3.45 | 9357497 | |
| MESH:D004931 | Esophageal Achalasia | Diethylnitrosamine | 3.39 | 16302075 | |
| MESH:D004935 | Esophageal Diseases | Capsaicin | 4.00 | 19566590 | |
| MESH:D004938 | Esophageal Neoplasms | 4,4'-diaminodiphenylmethane | 17.87 | 3581430 | |
| MESH:D004938 | Esophageal Neoplasms | 7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide | 17.87 | 20426865 | |
| MESH:D004938 | Esophageal Neoplasms | arsenic trioxide | 17.87 | 12903497 | |
| MESH:D004938 | Esophageal Neoplasms | Benzo(a)pyrene | 17.87 | 16530937 | |
| MESH:D004938 | Esophageal Neoplasms | Cisplatin | 17.87 | 17638652 15173087 16785472 15464296 16481741 | |
| MESH:D004938 | Esophageal Neoplasms | Dimethylnitrosamine | 17.87 | 17016578 | |
| MESH:D004938 | Esophageal Neoplasms | docetaxel | 17.87 | 16337965 | |
| MESH:D004938 | Esophageal Neoplasms | Ethanol | 17.87 | 16704527 | |
| MESH:D004938 | Esophageal Neoplasms | Indomethacin | 17.87 | 11005569 | |
| MESH:D004938 | Esophageal Neoplasms | nitrosobenzylmethylamine | 17.87 | 15547721 15264214 15150132 16510608 15623463 15547733 16805852 15878914 16704527 | |
| MESH:D004938 | Esophageal Neoplasms | Paclitaxel | 17.87 | 16481741 | |
| MESH:D004938 | Esophageal Neoplasms | Zinc | 17.87 | 16543248 | |
| MESH:D020329 | Essential Tremor | Lead | 4.24 | 18007985 14594619 | |
| MESH:D017889 | Exfoliation Syndrome | Folic Acid | 7.77 | 16504073 | |
| MESH:D017889 | Exfoliation Syndrome | Homocysteine | 7.77 | 16504073 | |
| MESH:D005124 | Eye Abnormalities | Tetrachlorodibenzodioxin | 4.03 | 11564622 | |
| MESH:D005124 | Eye Abnormalities | Tretinoin | 4.03 | 9664655 16938888 | |
| MESH:D005128 | Eye Diseases | Toluene 2,4-Diisocyanate | 4.05 | 18447907 | |
| MESH:D005221 | Fatigue | Amphetamine | 6.99 | 19890266 | |
| MESH:D005221 | Fatigue | vorinostat | 6.99 | 20479100 | |
| MESH:D005234 | Fatty Liver | 3,7,11,15-tetramethyl-2,4,6,10,14-hexadecapentaenoic acid | 48.22 | 21071580 | |
| MESH:D005234 | Fatty Liver | arsenic trioxide | 48.22 | 15073043 | |
| MESH:D005234 | Fatty Liver | arsenite | 48.22 | 18296743 | |
| MESH:D005234 | Fatty Liver | Carbon Tetrachloride | 48.22 | 12795759 17595544 12631006 16045604 15959796 16239168 61145 19224547 | |
| MESH:D005234 | Fatty Liver | Curcumin | 48.22 | 19297423 | |
| MESH:D005234 | Fatty Liver | Cyclosporine | 48.22 | 19224547 | |
| MESH:D005234 | Fatty Liver | Dietary Fats | 48.22 | 19004024 18296743 19551842 17967931 | |
| MESH:D005234 | Fatty Liver | Diethylnitrosamine | 48.22 | 21071580 20387270 | |
| MESH:D005234 | Fatty Liver | Ethanol | 48.22 | 16409862 18620774 19236843 | |
| MESH:D005234 | Fatty Liver | Ethinyl Estradiol | 48.22 | 15345470 | |
| MESH:D005234 | Fatty Liver | Fish Oils | 48.22 | 18620774 | |
| MESH:D005234 | Fatty Liver | Iron | 48.22 | 16640825 | |
| MESH:D005234 | Fatty Liver | mangiferin | 48.22 | 15975614 | |
| MESH:D005234 | Fatty Liver | pirinixic acid | 48.22 | 19236843 20131406 | |
| MESH:D005234 | Fatty Liver | Plant Extracts | 48.22 | 15975614 | |
| MESH:D005234 | Fatty Liver | Raloxifene | 48.22 | 17473493 | |
| MESH:D005234 | Fatty Liver | Tamoxifen | 48.22 | 14986274 19224547 | |
| MESH:D005235 | Fatty Liver, Alcoholic | Ethanol | 3.93 | 17920746 | |
| MESH:D052776 | Female Urogenital Diseases | Diethylstilbestrol | 3.83 | 16534752 16611131 15751030 16513791 16002989 | |
| MESH:D052776 | Female Urogenital Diseases | Tamoxifen | 3.83 | 16709447 | |
| MESH:D005264 | Femoral Fractures | zoledronic acid | 4.12 | 16234978 | |
| MESH:D005310 | Fetal Alcohol Syndrome | Ethanol | 3.59 | 10194807 16946407 15451040 15513904 | |
| MESH:D005313 | Fetal Death | 2-ethoxyethanol | 8.65 | 7151721 2884743 6499820 6499823 7198755 | |
| MESH:D005313 | Fetal Death | Phenytoin | 8.65 | 10627286 | |
| MESH:D005313 | Fetal Death | Tetrachlorodibenzodioxin | 8.65 | 11858732 | |
| MESH:D005317 | Fetal Growth Retardation | 2-ethoxyethanol | 9.32 | 6499796 | |
| MESH:D005317 | Fetal Growth Retardation | Lead | 9.32 | 19769572 | |
| MESH:D005317 | Fetal Growth Retardation | lead acetate | 9.32 | 19769572 | |
| MESH:D005327 | Fetal Resorption | 2-ethoxyethanol | 10.82 | 6499812 6499820 | |
| MESH:D005327 | Fetal Resorption | methyl cellosolve | 10.82 | 6474471 3987992 6499821 6499812 | |
| MESH:D005327 | Fetal Resorption | Vitamin A | 10.82 | 16054864 | |
| MESH:D020567 | Fetal Weight | 2-ethoxyethanol | 7.96 | 2884743 7151721 6499820 | |
| MESH:D020567 | Fetal Weight | methyl cellosolve | 7.96 | 6499821 6499812 6474471 | |
| MESH:D005334 | Fever | Arachidonic Acid | 12.22 | 11852909 | |
| MESH:D005334 | Fever | Dinoprost | 12.22 | 11852909 | |
| MESH:D005334 | Fever | Dinoprostone | 12.22 | 16997862 11852909 | |
| MESH:D005334 | Fever | Indomethacin | 12.22 | 11852909 17627676 10431976 | |
| MESH:D005334 | Fever | Lipopolysaccharides | 12.22 | 9205823 11852909 | |
| MESH:D005350 | Fibroma | 4,4'-diaminodiphenylmethane | 3.29 | 6705139 | |
| MESH:D018221 | Fibromatosis, Abdominal | Tamoxifen | 2.83 | 14745880 | |
| MESH:D018222 | Fibromatosis, Aggressive | Dacarbazine | 14.45 | 19069698 | |
| MESH:D018222 | Fibromatosis, Aggressive | Doxorubicin | 14.45 | 19069698 | |
| MESH:D018222 | Fibromatosis, Aggressive | imatinib | 14.45 | 17453242 | |
| MESH:D018222 | Fibromatosis, Aggressive | Tamoxifen | 14.45 | 19069698 | |
| MESH:D005354 | Fibrosarcoma | Indomethacin | 6.60 | 10962813 | |
| MESH:D005354 | Fibrosarcoma | Methylnitrosourea | 6.60 | 11555667 | |
| MESH:D005355 | Fibrosis | Albuterol | 44.65 | 15467267 | |
| MESH:D005355 | Fibrosis | arsenite | 44.65 | 18296743 | |
| MESH:D005355 | Fibrosis | baicalein | 44.65 | 19474275 | |
| MESH:D005355 | Fibrosis | Carbon Tetrachloride | 44.65 | 18705752 | |
| MESH:D005355 | Fibrosis | Curcumin | 44.65 | 18705752 | |
| MESH:D005355 | Fibrosis | Cyclosporine | 44.65 | 12168785 12639820 | |
| MESH:D005355 | Fibrosis | Dietary Fats | 44.65 | 18296743 | |
| MESH:D005355 | Fibrosis | Emodin | 44.65 | 19474275 | |
| MESH:D005355 | Fibrosis | Indomethacin | 44.65 | 17994277 | |
| MESH:D005355 | Fibrosis | Quercetin | 44.65 | 19474275 | |
| MESH:D005355 | Fibrosis | Terbutaline | 44.65 | 15467267 | |
| MESH:D005355 | Fibrosis | Tetrachlorodibenzodioxin | 44.65 | 20067830 | |
| MESH:D005355 | Fibrosis | Tretinoin | 44.65 | 17994277 | |
| MESH:D005355 | Fibrosis | valsartan | 44.65 | 16893502 | |
| MESH:D005391 | Firesetting Behavior | Testosterone | 4.13 | 7506515 | |
| MESH:D005393 | Fish Diseases | malachite green | 4.12 | 15900690 16175963 | |
| MESH:D005499 | Folliculitis | Indomethacin | 3.45 | 11298111 | |
| MESH:D005532 | Foot Deformities, Congenital | methoxyacetic acid | 7.02 | 3652986 | |
| MESH:D005532 | Foot Deformities, Congenital | methyl cellosolve | 7.02 | 3652986 | |
| MESH:D005534 | Foot Diseases | Arsenic | 3.83 | 6392382 | |
| MESH:D005596 | Fractures, Closed | montelukast | 7.62 | 19544365 | |
| MESH:D005596 | Fractures, Closed | zileuton | 7.62 | 19544365 | |
| MESH:D005621 | Friedreich Ataxia | Iron | 3.75 | 16604332 16640825 | |
| MESH:D005706 | Gallbladder Neoplasms | arsenic trioxide | 2.63 | 16904648 | |
| MESH:D005739 | Gas Poisoning | Albuterol | 10.19 | 20016425 | |
| MESH:D005739 | Gas Poisoning | Chlorine | 10.19 | 20016425 | |
| MESH:D005739 | Gas Poisoning | Oxygen | 10.19 | 20016425 | |
| MESH:D005756 | Gastritis | Acetaminophen | 23.67 | 16983495 | |
| MESH:D005756 | Gastritis | Diquat | 23.67 | 15046732 | |
| MESH:D005756 | Gastritis | Ethanol | 23.67 | 15046732 | |
| MESH:D005756 | Gastritis | Folic Acid | 23.67 | 17171786 | |
| MESH:D005756 | Gastritis | Indomethacin | 23.67 | 15046732 | |
| MESH:D005756 | Gastritis | Zinc | 23.67 | 17241300 | |
| MESH:D005770 | Gastrointestinal Neoplasms | Curcumin | 3.04 | 18462866 | |
| MESH:D030342 | Genetic Diseases, Inborn | vinclozolin | 3.23 | 16973722 | |
| MESH:D005832 | Genital Diseases, Male | vinclozolin | 3.57 | 16417039 | |
| MESH:D005833 | Genital Neoplasms, Female | Diethylstilbestrol | 7.19 | 16452187 | |
| MESH:D005833 | Genital Neoplasms, Female | sodium arsenite | 7.19 | 16452187 | |
| MESH:D005871 | Giant Lymph Node Hyperplasia | Thalidomide | 4.57 | 12701121 | |
| MESH:D005885 | Gingival Hyperplasia | Cyclosporine | 7.28 | 8708960 | |
| MESH:D005885 | Gingival Hyperplasia | Phenytoin | 7.28 | 9029455 | |
| MESH:D019214 | Gingival Overgrowth | Phenytoin | 4.50 | 14659971 16390469 | |
| MESH:D005901 | Glaucoma | Folic Acid | 6.48 | 16504073 | |
| MESH:D005901 | Glaucoma | Homocysteine | 6.48 | 16504073 | |
| MESH:D005909 | Glioblastoma | Aspirin | 42.52 | 12870263 | |
| MESH:D005909 | Glioblastoma | baicalein | 42.52 | 19804834 | |
| MESH:D005909 | Glioblastoma | Capsaicin | 42.52 | 18405923 | |
| MESH:D005909 | Glioblastoma | Curcumin | 42.52 | 17596214 | |
| MESH:D005909 | Glioblastoma | Dacarbazine | 42.52 | 12853885 12592361 | |
| MESH:D005909 | Glioblastoma | Doxorubicin | 42.52 | 17150277 | |
| MESH:D005909 | Glioblastoma | Fenretinide | 42.52 | 16187019 | |
| MESH:D005909 | Glioblastoma | Genistein | 42.52 | 16598420 | |
| MESH:D005909 | Glioblastoma | Indomethacin | 42.52 | 12870263 | |
| MESH:D005909 | Glioblastoma | Manganese | 42.52 | 17043766 | |
| MESH:D005909 | Glioblastoma | myricetin | 42.52 | 19804834 | |
| MESH:D005909 | Glioblastoma | Okadaic Acid | 42.52 | 17312396 | |
| MESH:D005909 | Glioblastoma | Quercetin | 42.52 | 19804834 | |
| MESH:D005909 | Glioblastoma | Testosterone | 42.52 | 17162496 | |
| MESH:D005909 | Glioblastoma | Tretinoin | 42.52 | 17312396 | |
| MESH:D005909 | Glioblastoma | trichostatin A | 42.52 | 18801729 | |
| MESH:D005910 | Glioma | Indomethacin | 5.36 | 16487511 18371953 | |
| MESH:D005910 | Glioma | Methylnitrosourea | 5.36 | 9825942 | |
| MESH:D005910 | Glioma | Quercetin | 5.36 | 17643826 | |
| MESH:D005910 | Glioma | Thalidomide | 5.36 | 16327979 | |
| MESH:D018316 | Gliosarcoma | Cyclophosphamide | 3.81 | 11389073 | |
| MESH:D005911 | Gliosis | Maneb | 8.73 | 11124998 | |
| MESH:D005911 | Gliosis | Paraquat | 8.73 | 11124998 | |
| MESH:D005922 | Glomerulonephritis, IGA | deoxynivalenol | 3.55 | 16524712 15173396 | |
| MESH:D015432 | Glomerulonephritis, Membranoproliferative | valsartan | 3.90 | 16928621 | |
| MESH:D005923 | Glomerulosclerosis, Focal Segmental | Indomethacin | 2.81 | 11849393 | |
| MESH:D006042 | Goiter | 4,4'-diaminodiphenylmethane | 2.42 | 7505956 | |
| MESH:D006058 | Gonadal Disorders | Tetrachlorodibenzodioxin | 2.86 | 10696789 | |
| MESH:D006073 | Gout | Indomethacin | 3.64 | 11248219 | |
| MESH:D006086 | Graft vs Host Disease | Cyclophosphamide | 3.37 | 15172196 16376943 11014644 | |
| MESH:D006130 | Growth Disorders | Amiloride | 4.54 | 19703807 | |
| MESH:D006130 | Growth Disorders | Zinc | 4.54 | 17217573 | |
| MESH:D006261 | Headache | Aspirin | 5.68 | 15240983 | |
| MESH:D006261 | Headache | Nitric Oxide | 5.68 | 11284996 11554966 | |
| MESH:D006258 | Head and Neck Neoplasms | marker/mechanism | 15342401 | ||
| MESH:D006258 | Head and Neck Neoplasms | Cisplatin | 12.53 | 15464296 15102660 | |
| MESH:D006258 | Head and Neck Neoplasms | Curcumin | 12.53 | 18829502 18462866 | |
| MESH:D006258 | Head and Neck Neoplasms | decitabine | 12.53 | 19215824 | |
| MESH:D006258 | Head and Neck Neoplasms | Doxorubicin | 12.53 | 15692506 | |
| MESH:D006258 | Head and Neck Neoplasms | Indomethacin | 12.53 | 15482327 | |
| MESH:D006258 | Head and Neck Neoplasms | Tretinoin | 12.53 | 16096774 | |
| MESH:D034381 | Hearing Loss | Cisplatin | 5.20 | 19898482 | |
| MESH:D034381 | Hearing Loss | Gentamicins | 5.20 | 19130971 15968427 17868369 18024279 | |
| MESH:D006317 | Hearing Loss, Noise-Induced | Tretinoin | 3.43 | 16084493 | |
| MESH:D006319 | Hearing Loss, Sensorineural | Cisplatin | 2.91 | 15464296 | |
| MESH:D006356 | Heartburn | Capsaicin | 4.00 | 19566590 | |
| MESH:D006330 | Heart Defects, Congenital | Acitretin | 21.66 | 8838291 | |
| MESH:D006330 | Heart Defects, Congenital | Ascorbic Acid | 21.66 | 16080930 | |
| MESH:D006330 | Heart Defects, Congenital | Benzo(a)pyrene | 21.66 | 20471113 | |
| MESH:D006330 | Heart Defects, Congenital | Folic Acid | 21.66 | 16524890 17286298 | |
| MESH:D006330 | Heart Defects, Congenital | Homocysteine | 21.66 | 19638421 | |
| MESH:D006330 | Heart Defects, Congenital | Lithium | 21.66 | 19638421 | |
| MESH:D006330 | Heart Defects, Congenital | Tetrachlorodibenzodioxin | 21.66 | 11294989 10048152 | |
| MESH:D006330 | Heart Defects, Congenital | Tretinoin | 21.66 | 14991402 9664655 | |
| MESH:D006330 | Heart Defects, Congenital | Vitamin A | 21.66 | 16080930 10992263 | |
| MESH:D006330 | Heart Defects, Congenital | Vitamin E | 21.66 | 16080930 | |
| MESH:D006331 | Heart Diseases | Doxorubicin | 14.63 | 16244372 16330681 17875725 16707910 16495754 17888722 16244371 12587719 16879835 18674790 16144979 18006777 14766674 | |
| MESH:D006331 | Heart Diseases | mangiferin | 14.63 | 12093613 | |
| MESH:D006331 | Heart Diseases | pifithrin | 14.63 | 14766674 | |
| MESH:D006331 | Heart Diseases | Raloxifene | 14.63 | 11110106 | |
| MESH:D006331 | Heart Diseases | Razoxane | 14.63 | 17875725 | |
| MESH:D006331 | Heart Diseases | Streptozocin | 14.63 | 12093613 | |
| MESH:D006331 | Heart Diseases | Urethane | 14.63 | 16046796 | |
| MESH:D006333 | Heart Failure | Atenolol | 25.51 | 20082655 | |
| MESH:D006333 | Heart Failure | atorvastatin | 25.51 | 16360360 | |
| MESH:D006333 | Heart Failure | Dobutamine | 25.51 | 17440445 | |
| MESH:D006333 | Heart Failure | Doxorubicin | 25.51 | 17481944 | |
| MESH:D006333 | Heart Failure | Isoproterenol | 25.51 | 18097624 | |
| MESH:D006333 | Heart Failure | Losartan | 25.51 | 10979640 | |
| MESH:D006333 | Heart Failure | pirinixic acid | 25.51 | 20558911 | |
| MESH:D006333 | Heart Failure | Plant Extracts | 25.51 | 18097624 | |
| MESH:D006333 | Heart Failure | Selenium | 25.51 | 17162251 | |
| MESH:D006333 | Heart Failure | valsartan | 25.51 | 19027736 | |
| MESH:D006333 | Heart Failure | Zinc | 25.51 | 17162251 | |
| MESH:D006335 | Heart Injuries | Zinc | 4.04 | 17074742 | |
| MESH:D006345 | Heart Septal Defects, Ventricular | methyl cellosolve | 4.08 | 6499821 | |
| MESH:D016481 | Helicobacter Infections | Zinc | 2.95 | 17241300 | |
| MESH:D006390 | Hemangioendothelioma | Razoxane | 4.69 | 15380572 | |
| MESH:D006394 | Hemangiosarcoma | Doxorubicin | 2.40 | 15692506 | |
| MESH:D006402 | Hematologic Diseases | 2-ethoxyethanol | 3.79 | 20172899 10514026 | |
| MESH:D006432 | Hemochromatosis | Iron | 3.08 | 17053826 16574947 17255318 16604332 17236123 16640825 | |
| MESH:D006457 | Hemoglobinuria, Paroxysmal | Cyclosporine | 2.72 | 15720958 | |
| MESH:D006461 | Hemolysis | 2-ethoxyethanol | 6.68 | 17874071 19051582 | |
| MESH:D006461 | Hemolysis | methyl cellosolve | 6.68 | 17874071 | |
| MESH:D006463 | Hemolytic-Uremic Syndrome | Lipopolysaccharides | 6.09 | 16366002 | |
| MESH:D006463 | Hemolytic-Uremic Syndrome | Shiga Toxin 2 | 6.09 | 16366002 | |
| MESH:D006467 | Hemophilia A | Cyclophosphamide | 3.61 | 11918545 | |
| MESH:D006470 | Hemorrhage | Endosulfan | 5.19 | 7900959 | |
| MESH:D006470 | Hemorrhage | Tetrachlorodibenzodioxin | 5.19 | 11000095 | |
| MESH:D006486 | Hemosiderosis | Iron | 3.51 | 16604332 | |
| MESH:D006501 | Hepatic Encephalopathy | Indomethacin | 2.99 | 15633222 | |
| MESH:D006504 | Hepatic Veno-Occlusive Disease | Cyclophosphamide | 3.81 | 14986274 | |
| MESH:D006505 | Hepatitis | 4,4'-diaminodiphenylmethane | 15.95 | 6705139 | |
| MESH:D006505 | Hepatitis | Carbon Tetrachloride | 15.95 | 19110552 19900420 | |
| MESH:D006505 | Hepatitis | DDT | 15.95 | 16487989 | |
| MESH:D006505 | Hepatitis | Dichlorodiphenyl Dichloroethylene | 15.95 | 16487989 | |
| MESH:D006505 | Hepatitis | Drugs, Chinese Herbal | 15.95 | 18339527 | |
| MESH:D006505 | Hepatitis | Zymosan | 15.95 | 19110552 | |
| MESH:D006526 | Hepatitis C | Enkephalin, Ala(2)-MePhe(4)-Gly(5)- | 4.67 | 17299060 | |
| MESH:D019698 | Hepatitis C, Chronic | Indomethacin | 3.05 | 15135802 | |
| MESH:D006521 | Hepatitis, Chronic | Copper | 3.58 | 17338147 | |
| MESH:D006525 | Hepatitis, Viral, Human | Iron | 3.75 | 16640825 | |
| MESH:D006527 | Hepatolenticular Degeneration | Copper | 12.97 | 19888908 17276780 16607473 17109627 17182432 | |
| MESH:D006527 | Hepatolenticular Degeneration | Iron | 12.97 | 17182432 | |
| MESH:D006527 | Hepatolenticular Degeneration | Zinc | 12.97 | 17276780 | |
| MESH:D006527 | Hepatolenticular Degeneration | Zinc Sulfate | 12.97 | 17063115 | |
| MESH:D006529 | Hepatomegaly | DDT | 13.08 | 2387028 | |
| MESH:D006529 | Hepatomegaly | Iron | 13.08 | 16890145 | |
| MESH:D006529 | Hepatomegaly | Phenobarbital | 13.08 | 16109766 | |
| MESH:D006529 | Hepatomegaly | pirinixic acid | 13.08 | 19176532 18467677 16221962 19772884 | |
| MESH:D006529 | Hepatomegaly | Tetrachlorodibenzodioxin | 13.08 | 15340226 12621046 16120746 | |
| MESH:D006529 | Hepatomegaly | zileuton | 13.08 | 8661344 | |
| MESH:D015417 | Hereditary Sensory and Motor Neuropathy | Curcumin | 3.36 | 17701891 | |
| MESH:D006548 | Hernia, Diaphragmatic | Ascorbic Acid | 5.30 | 16863852 16490937 | |
| MESH:D006548 | Hernia, Diaphragmatic | Dexamethasone | 5.30 | 7520565 | |
| MESH:D006548 | Hernia, Diaphragmatic | Vitamin A | 5.30 | 16863852 16490937 16877224 17436238 15707848 16292552 | |
| MESH:D006548 | Hernia, Diaphragmatic | Vitamin E | 5.30 | 16863852 16490937 | |
| MESH:D006558 | Herpes Genitalis | Estradiol | 3.30 | 15709030 | |
| MESH:D006561 | Herpes Simplex | mangiferin | 7.07 | 10715843 | |
| MESH:D006561 | Herpes Simplex | Plant Extracts | 7.07 | 10715843 | |
| MESH:D006561 | Herpes Simplex | resveratrol | 7.07 | 16876885 | |
| MESH:D006628 | Hirsutism | Testosterone | 3.93 | 17019078 | |
| MESH:D015658 | HIV Infections | beta Carotene | 7.36 | 16960176 | |
| MESH:D015658 | HIV Infections | Iron | 7.36 | 16597321 | |
| MESH:D015658 | HIV Infections | Nickel | 7.36 | 17263646 | |
| MESH:D015658 | HIV Infections | Plant Extracts | 7.36 | 12878215 | |
| MESH:D015658 | HIV Infections | Vitamin A | 7.36 | 16960176 | |
| MESH:D006679 | HIV Seropositivity | Folic Acid | 7.73 | 17209195 | |
| MESH:D006679 | HIV Seropositivity | Vitamin A | 7.73 | 17209195 | |
| MESH:D006689 | Hodgkin Disease | Cisplatin | 7.46 | 16200630 16170182 | |
| MESH:D006689 | Hodgkin Disease | Cyclophosphamide | 7.46 | 17606976 16135485 | |
| MESH:D006689 | Hodgkin Disease | Dacarbazine | 7.46 | 16170182 18501091 | |
| MESH:D006689 | Hodgkin Disease | Doxorubicin | 7.46 | 18501091 15147373 17606976 | |
| MESH:D006689 | Hodgkin Disease | sodium arsenite | 7.46 | 12676792 | |
| MESH:D019584 | Hot Flashes | Estradiol | 10.74 | 17088409 | |
| MESH:D019584 | Hot Flashes | Plant Extracts | 10.74 | 16566672 14716179 17454163 | |
| MESH:D019584 | Hot Flashes | venlafaxine | 10.74 | 14716179 | |
| MESH:D019584 | Hot Flashes | Vitamin E | 10.74 | 14716179 | |
| MESH:D006869 | Hydronephrosis | Tetrachlorodibenzodioxin | 2.33 | 16354765 15340226 16959395 8697196 18606429 | |
| MESH:D012001 | Hyperacusis | Aspirin | 4.04 | 15240983 | |
| MESH:D006930 | Hyperalgesia | Acetaminophen | 24.20 | 16870215 | |
| MESH:D006930 | Hyperalgesia | Capsaicin | 24.20 | 17434803 17043245 | |
| MESH:D006930 | Hyperalgesia | Dinoprostone | 24.20 | 16793879 | |
| MESH:D006930 | Hyperalgesia | Ethanol | 24.20 | 18783367 | |
| MESH:D006930 | Hyperalgesia | Freund's Adjuvant | 24.20 | 16769263 | |
| MESH:D006930 | Hyperalgesia | Indomethacin | 24.20 | 12727271 | |
| MESH:D006930 | Hyperalgesia | oxaliplatin | 24.20 | 17418472 | |
| MESH:D006930 | Hyperalgesia | Prazosin | 24.20 | 12727271 | |
| MESH:D006930 | Hyperalgesia | Tretinoin | 24.20 | 16870215 | |
| MESH:D006930 | Hyperalgesia | zoledronic acid | 24.20 | 16769263 | |
| MESH:D034321 | Hyperamylasemia | Indomethacin | 3.99 | 17883296 | |
| MESH:D017588 | Hyperandrogenism | Metformin | 6.77 | 15356085 17062894 | |
| MESH:D017588 | Hyperandrogenism | Testosterone | 6.77 | 17019078 | |
| MESH:D006932 | Hyperbilirubinemia | Carbon Tetrachloride | 2.83 | 16899240 | |
| MESH:D006934 | Hypercalcemia | bortezomib | 6.16 | 18089816 | |
| MESH:D006934 | Hypercalcemia | zoledronic acid | 6.16 | 18089816 19622757 | |
| MESH:D053565 | Hypercalciuria | Gentamicins | 4.01 | 17652376 | |
| MESH:D006937 | Hypercholesterolemia | atorvastatin | 12.22 | 11583720 | |
| MESH:D006937 | Hypercholesterolemia | Curcumin | 12.22 | 18704882 | |
| MESH:D006937 | Hypercholesterolemia | Dietary Fats | 12.22 | 21332399 | |
| MESH:D006937 | Hypercholesterolemia | resveratrol | 12.22 | 17188708 | |
| MESH:D006937 | Hypercholesterolemia | Vitamin U | 12.22 | 7195721 | |
| MESH:D006940 | Hyperemia | Indomethacin | 7.11 | 12524144 | |
| MESH:D006940 | Hyperemia | Nitric Oxide | 7.11 | 11156591 | |
| MESH:D017681 | Hypereosinophilic Syndrome | Tretinoin | 2.89 | 16778211 | |
| MESH:D006943 | Hyperglycemia | kaempferol | 6.87 | 18262572 | |
| MESH:D006943 | Hyperglycemia | pirinixic acid | 6.87 | 20558911 | |
| MESH:D006943 | Hyperglycemia | Quercetin | 6.87 | 11834736 18262572 | |
| MESH:D020138 | Hyperhomocysteinemia | Catechin | 16.31 | 17292331 | |
| MESH:D020138 | Hyperhomocysteinemia | Folic Acid | 16.31 | 16397167 16395265 16433478 16865747 16755160 | |
| MESH:D020138 | Hyperhomocysteinemia | Homocysteine | 16.31 | 17292331 18234410 17369066 | |
| MESH:D020138 | Hyperhomocysteinemia | Phenytoin | 16.31 | 10459572 | |
| MESH:D020138 | Hyperhomocysteinemia | Plant Extracts | 16.31 | 16484555 | |
| MESH:D020138 | Hyperhomocysteinemia | Superoxides | 16.31 | 12615666 | |
| MESH:D006946 | Hyperinsulinism | mangiferin | 3.50 | 11315760 9881663 | |
| MESH:D017488 | Hyperkeratosis, Epidermolytic | Arsenic | 2.89 | 17050553 | |
| MESH:D006948 | Hyperkinesis | Amphetamine | 9.64 | 1977408 14960337 | |
| MESH:D006948 | Hyperkinesis | Clozapine | 9.64 | 16046005 | |
| MESH:D006948 | Hyperkinesis | Methamphetamine | 9.64 | 17658665 | |
| MESH:D006949 | Hyperlipidemias | Dietary Fats | 23.03 | 21332399 | |
| MESH:D006949 | Hyperlipidemias | Fish Oils | 23.03 | 15752949 | |
| MESH:D006949 | Hyperlipidemias | Indomethacin | 23.03 | 17546600 | |
| MESH:D006949 | Hyperlipidemias | mangiferin | 23.03 | 15975614 | |
| MESH:D006949 | Hyperlipidemias | oleoylethanolamide | 23.03 | 15910890 | |
| MESH:D006949 | Hyperlipidemias | Plant Extracts | 23.03 | 15975614 15268973 | |
| MESH:D006949 | Hyperlipidemias | resveratrol | 23.03 | 16873680 | |
| MESH:D006949 | Hyperlipidemias | Vitamin U | 23.03 | 7192109 543882 | |
| MESH:D006938 | Hyperlipoproteinemia Type II | atorvastatin | 3.72 | 16238680 | |
| MESH:D006965 | Hyperplasia | 4,4'-diaminodiphenylmethane | 5.34 | 15034207 | |
| MESH:D006965 | Hyperplasia | Diethylstilbestrol | 5.34 | 14722030 12960047 | |
| MESH:D006967 | Hypersensitivity | Butylated Hydroxytoluene | 6.08 | 17604070 | |
| MESH:D006967 | Hypersensitivity | mangiferin | 6.08 | 16536907 | |
| MESH:D006967 | Hypersensitivity | Toluene 2,4-Diisocyanate | 6.08 | 11019492 10880147 | |
| MESH:D006968 | Hypersensitivity, Delayed | Fish Oils | 3.80 | 11484837 | |
| MESH:D006973 | Hypertension | Amiloride | 34.04 | 18524855 15174897 19344079 | |
| MESH:D006973 | Hypertension | Arsenic | 34.04 | 9931084 16076760 11953799 | |
| MESH:D006973 | Hypertension | Atenolol | 34.04 | 15237695 15969258 19249413 14597852 15188945 11910301 12717102 14700505 11593098 15614026 12022239 15453913 | |
| MESH:D006973 | Hypertension | atorvastatin | 34.04 | 17042910 | |
| MESH:D006973 | Hypertension | carvedilol | 34.04 | 16640825 | |
| MESH:D006973 | Hypertension | Cyclosporine | 34.04 | 10903974 | |
| MESH:D006973 | Hypertension | daidzein | 34.04 | 17169123 | |
| MESH:D006973 | Hypertension | Dexamethasone | 34.04 | 17042910 | |
| MESH:D006973 | Hypertension | Doxazosin | 34.04 | 15969258 | |
| MESH:D006973 | Hypertension | Losartan | 34.04 | 12586211 14597852 10090350 15969258 12512695 | |
| MESH:D006973 | Hypertension | Phenylephrine | 34.04 | 12717712 8949925 | |
| MESH:D006973 | Hypertension | Quercetin | 34.04 | 18356687 | |
| MESH:D006973 | Hypertension | Raloxifene | 34.04 | 17577099 15787275 | |
| MESH:D006973 | Hypertension | Sodium Chloride | 34.04 | 11507004 | |
| MESH:D006973 | Hypertension | Tetrachlorodibenzodioxin | 34.04 | 18670907 18850075 | |
| MESH:D006973 | Hypertension | valsartan | 34.04 | 10903974 20102058 18390891 18344623 11427623 12692753 16475468 12850387 | |
| MESH:D006973 | Hypertension | Verapamil | 34.04 | 17700361 | |
| MESH:D006974 | Hypertension, Malignant | valsartan | 4.68 | 11560862 | |
| MESH:D006975 | Hypertension, Portal | Carbon Tetrachloride | 6.25 | 15338365 | |
| MESH:D006975 | Hypertension, Portal | ginkgolide B | 6.25 | 16409839 | |
| MESH:D006976 | Hypertension, Pulmonary | gefitinib | 5.73 | 18424623 | |
| MESH:D006976 | Hypertension, Pulmonary | Nitric Oxide | 5.73 | 15838368 | |
| MESH:D006976 | Hypertension, Pulmonary | zileuton | 5.73 | 14726295 | |
| MESH:D006984 | Hypertrophy | Isoproterenol | 5.73 | 12791704 | |
| MESH:D006984 | Hypertrophy | Phenylephrine | 5.73 | 18502941 12791704 | |
| MESH:D017379 | Hypertrophy, Left Ventricular | Atenolol | 5.71 | 15237695 | |
| MESH:D017379 | Hypertrophy, Left Ventricular | resveratrol | 5.71 | 17488730 | |
| MESH:D017380 | Hypertrophy, Right Ventricular | gefitinib | 4.53 | 18424623 | |
| MESH:D006985 | Hyperventilation | Terbutaline | 4.39 | 10895896 | |
| MESH:D006986 | Hypervitaminosis A | Vitamin A | 4.44 | 16054864 | |
| MESH:D006987 | Hypesthesia | Arsenic | 3.83 | 16093927 | |
| MESH:D006996 | Hypocalcemia | zoledronic acid | 4.46 | 12669777 | |
| MESH:D007006 | Hypogonadism | Iron | 4.93 | 16640825 | |
| MESH:D007006 | Hypogonadism | Testosterone | 4.93 | 12002444 | |
| MESH:D007008 | Hypokalemia | Terbutaline | 4.39 | 17292646 | |
| MESH:D020514 | Hypokalemic Periodic Paralysis | Amiloride | 7.51 | 19822448 | |
| MESH:D020514 | Hypokalemic Periodic Paralysis | Potassium | 7.51 | 19822448 | |
| MESH:D007018 | Hypopituitarism | Testosterone | 4.47 | 17426086 | |
| MESH:D007021 | Hypospadias | Diethylstilbestrol | 5.72 | 16002989 | |
| MESH:D007021 | Hypospadias | Ethinyl Estradiol | 5.72 | 16945680 16569931 | |
| MESH:D007022 | Hypotension | Dopamine | 14.94 | 6740701 | |
| MESH:D007022 | Hypotension | Epinephrine | 14.94 | 6740701 | |
| MESH:D007022 | Hypotension | Isoproterenol | 14.94 | 6740701 | |
| MESH:D007022 | Hypotension | methanandamide | 14.94 | 14504685 | |
| MESH:D007022 | Hypotension | Norepinephrine | 14.94 | 6740701 | |
| MESH:D007022 | Hypotension | Zinc Sulfate | 14.94 | 7265320 | |
| MESH:D007037 | Hypothyroidism | Iron | 3.42 | 16640825 | |
| MESH:D007077 | Ileal Diseases | Indomethacin | 3.31 | 10574470 18306037 | |
| MESH:D007079 | Ileitis | Indomethacin | 3.64 | 16133968 10647630 10651667 | |
| MESH:D007154 | Immune System Diseases | Cyclophosphamide | 7.75 | 16076520 | |
| MESH:D007154 | Immune System Diseases | mangiferin | 7.75 | 16076520 | |
| MESH:D007174 | Impulse Control Disorders | Testosterone | 4.13 | 7506515 | |
| MESH:D007235 | Infant, Premature, Diseases | Indomethacin | 3.65 | 16133044 | |
| MESH:D020244 | Infarction, Middle Cerebral Artery | pifithrin | 14.44 | 19475672 | |
| MESH:D020244 | Infarction, Middle Cerebral Artery | Progesterone | 14.44 | 15869954 | |
| MESH:D020244 | Infarction, Middle Cerebral Artery | resveratrol | 14.44 | 17600658 | |
| MESH:D020244 | Infarction, Middle Cerebral Artery | zileuton | 14.44 | 19309543 | |
| MESH:D007246 | Infertility | Diethylstilbestrol | 2.74 | 15036965 | |
| MESH:D007247 | Infertility, Female | 2-ethoxyethanol | 8.05 | 6499823 | |
| MESH:D007247 | Infertility, Female | Dieldrin | 8.05 | 10630421 | |
| MESH:D007247 | Infertility, Female | Ethinyl Estradiol | 8.05 | 12013081 | |
| MESH:D007248 | Infertility, Male | 2,4-Dichlorophenoxyacetic Acid | 52.17 | 12948887 | |
| MESH:D007248 | Infertility, Male | 2-ethoxyethanol | 52.17 | 6499823 | |
| MESH:D007248 | Infertility, Male | Atrazine | 52.17 | 12948887 | |
| MESH:D007248 | Infertility, Male | Chlordan | 52.17 | 9432128 | |
| MESH:D007248 | Infertility, Male | Coumestrol | 52.17 | 16892005 | |
| MESH:D007248 | Infertility, Male | Cyclophosphamide | 52.17 | 7193160 16517039 | |
| MESH:D007248 | Infertility, Male | DDT | 52.17 | 17192596 17157474 | |
| MESH:D007248 | Infertility, Male | decitabine | 52.17 | 17581917 | |
| MESH:D007248 | Infertility, Male | Dichlorodiphenyl Dichloroethylene | 52.17 | 12948891 17192596 | |
| MESH:D007248 | Infertility, Male | Diquat | 52.17 | 4850670 | |
| MESH:D007248 | Infertility, Male | Endosulfan | 52.17 | 8588293 9432128 | |
| MESH:D007248 | Infertility, Male | Ethinyl Estradiol | 52.17 | 17937319 | |
| MESH:D007248 | Infertility, Male | fulvestrant | 52.17 | 11514358 | |
| MESH:D007248 | Infertility, Male | Lead | 52.17 | 16780224 | |
| MESH:D007248 | Infertility, Male | Methoxychlor | 52.17 | 16467254 11955947 | |
| MESH:D007248 | Infertility, Male | methyl cellosolve | 52.17 | 3987992 | |
| MESH:D007248 | Infertility, Male | Methylnitrosourea | 52.17 | 7193160 | |
| MESH:D007248 | Infertility, Male | Paraquat | 52.17 | 4850670 | |
| MESH:D007248 | Infertility, Male | sodium arsenite | 52.17 | 12646999 15346721 | |
| MESH:D007248 | Infertility, Male | vinclozolin | 52.17 | 16467254 | |
| MESH:D007249 | Inflammation | Amiloride | 63.74 | 17237260 | |
| MESH:D007249 | Inflammation | Arachidonic Acid | 63.74 | 17371808 15177302 9831321 | |
| MESH:D007249 | Inflammation | atorvastatin | 63.74 | 16908763 | |
| MESH:D007249 | Inflammation | bisindolylmaleimide I | 63.74 | 8273558 | |
| MESH:D007249 | Inflammation | Capsaicin | 63.74 | 16956363 | |
| MESH:D007249 | Inflammation | Curcumin | 63.74 | 18403477 17151092 16956363 | |
| MESH:D007249 | Inflammation | Dexamethasone | 63.74 | 11099482 8960868 | |
| MESH:D007249 | Inflammation | Dietary Fats | 63.74 | 20412841 | |
| MESH:D007249 | Inflammation | Diethylnitrosamine | 63.74 | 18785209 | |
| MESH:D007249 | Inflammation | Flavonoids | 63.74 | 17296493 | |
| MESH:D007249 | Inflammation | Freund's Adjuvant | 63.74 | 16793879 | |
| MESH:D007249 | Inflammation | Indomethacin | 63.74 | 3291741 7812673 12568917 | |
| MESH:D007249 | Inflammation | juzentaihoto | 63.74 | 18785209 | |
| MESH:D007249 | Inflammation | Lipopolysaccharides | 63.74 | 9205823 17237260 17963957 12878042 17255318 | |
| MESH:D007249 | Inflammation | Losartan | 63.74 | 12586211 | |
| MESH:D007249 | Inflammation | mangiferin | 63.74 | 15222974 | |
| MESH:D007249 | Inflammation | montelukast | 63.74 | 18059327 | |
| MESH:D007249 | Inflammation | Mustard Gas | 63.74 | 16001271 17524151 11428631 8975870 9357497 9260866 11402378 11428620 11428647 | |
| MESH:D007249 | Inflammation | Nickel | 63.74 | 16166738 | |
| MESH:D007249 | Inflammation | Plant Extracts | 63.74 | 12787963 16366677 19332304 15997105 | |
| MESH:D007249 | Inflammation | polyphenols | 63.74 | 16366677 | |
| MESH:D007249 | Inflammation | Progesterone | 63.74 | 15869954 | |
| MESH:D007249 | Inflammation | resveratrol | 63.74 | 16366677 | |
| MESH:D007249 | Inflammation | Silymarin | 63.74 | 17213517 | |
| MESH:D007249 | Inflammation | Tamoxifen | 63.74 | 19457130 | |
| MESH:D007249 | Inflammation | Tetrachlorodibenzodioxin | 63.74 | 12200463 12878042 | |
| MESH:D007249 | Inflammation | Tetradecanoylphorbol Acetate | 63.74 | 7562506 8273558 15177302 7812673 11698051 | |
| MESH:D007249 | Inflammation | Thalidomide | 63.74 | 16134734 | |
| MESH:D007249 | Inflammation | zileuton | 63.74 | 17118201 18295198 8960868 8621850 18309904 7812673 9831321 18059327 | |
| MESH:D007249 | Inflammation | Zymosan | 63.74 | 11289658 8014878 | |
| MESH:D015212 | Inflammatory Bowel Diseases | Curcumin | 4.52 | 18596194 18200517 | |
| MESH:D015212 | Inflammatory Bowel Diseases | Rutin | 4.52 | 15652231 | |
| MESH:D015212 | Inflammatory Bowel Diseases | zileuton | 4.52 | 15339030 | |
| MESH:D007251 | Influenza, Human | pyrrolidine dithiocarbamic acid | 17.36 | 18473937 | |
| MESH:D007251 | Influenza, Human | Quercetin | 17.36 | 16624496 | |
| MESH:D007251 | Influenza, Human | resveratrol | 17.36 | 16624496 | |
| MESH:D007251 | Influenza, Human | Selenium | 17.36 | 16624496 | |
| MESH:D007251 | Influenza, Human | Vitamin E | 17.36 | 16624496 | |
| MESH:D007299 | Insect Bites and Stings | decamethrin | 4.08 | 15189238 | |
| MESH:D007333 | Insulin Resistance | bisphenol A | 17.36 | 16393666 | |
| MESH:D007333 | Insulin Resistance | Dietary Fats | 17.36 | 18457598 11836018 | |
| MESH:D007333 | Insulin Resistance | Estradiol | 17.36 | 16393666 16627594 | |
| MESH:D007333 | Insulin Resistance | mangiferin | 17.36 | 11315760 | |
| MESH:D007333 | Insulin Resistance | Metformin | 17.36 | 17062894 | |
| MESH:D007333 | Insulin Resistance | pirinixic acid | 17.36 | 16306350 | |
| MESH:D007333 | Insulin Resistance | Propolis | 17.36 | 18057795 | |
| MESH:D007333 | Insulin Resistance | Sodium Selenite | 17.36 | 14714311 | |
| MESH:D007410 | Intestinal Diseases | Indomethacin | 13.54 | 18236018 15831440 15610444 17329856 10210152 11713966 11686837 11855677 17994277 | |
| MESH:D007410 | Intestinal Diseases | Nitric Oxide | 13.54 | 11574821 10210152 11713966 | |
| MESH:D007410 | Intestinal Diseases | pimagedine | 13.54 | 11713966 | |
| MESH:D007410 | Intestinal Diseases | Superoxides | 13.54 | 10210152 | |
| MESH:D007410 | Intestinal Diseases | Tretinoin | 13.54 | 17994277 | |
| MESH:D007414 | Intestinal Neoplasms | Curcumin | 4.96 | 10783313 | |
| MESH:D007414 | Intestinal Neoplasms | Plant Extracts | 4.96 | 12628509 12584176 12351151 | |
| MESH:D002532 | Intracranial Aneurysm | Reactive Oxygen Species | 3.48 | 19381132 | |
| MESH:D019586 | Intracranial Hypertension | Indomethacin | 8.49 | 15241188 | |
| MESH:D019586 | Intracranial Hypertension | Vitamin A | 8.49 | 15955940 | |
| MESH:D019189 | Iron Metabolism Disorders | Iron | 6.22 | 17163184 | |
| MESH:D019189 | Iron Metabolism Disorders | Lipopolysaccharides | 6.22 | 17255318 | |
| MESH:D043183 | Irritable Bowel Syndrome | Zymosan | 4.13 | 17553498 | |
| MESH:D007511 | Ischemia | mangiferin | 8.90 | 16806951 | |
| MESH:D007511 | Ischemia | morin | 8.90 | 16806951 | |
| MESH:D007511 | Ischemia | Zinc | 8.90 | 16584753 | |
| MESH:D007565 | Jaundice | 4,4'-diaminodiphenylmethane | 3.29 | 9022650 8074119 | |
| MESH:D007569 | Jaw Abnormalities | Ethanol | 8.05 | 15513904 | |
| MESH:D007569 | Jaw Abnormalities | Tetrachlorodibenzodioxin | 8.05 | 16580747 | |
| MESH:D007569 | Jaw Abnormalities | Tretinoin | 8.05 | 17551590 15992940 | |
| MESH:D007579 | Jejunal Diseases | Indomethacin | 3.31 | 10574470 18306037 16133968 | |
| MESH:D007627 | Keloid | Quercetin | 3.28 | 17086741 | |
| MESH:D007638 | Keratoconjunctivitis Sicca | Cyclosporine | 2.72 | 15604871 | |
| MESH:D007642 | Keratosis | Arsenic | 3.29 | 12749816 16930632 | |
| MESH:D017492 | Keratosis, Seborrheic | alitretinoin | 3.93 | 16144296 | |
| MESH:D007673 | Kidney Cortex Necrosis | Cisplatin | 7.63 | 15464296 | |
| MESH:D007673 | Kidney Cortex Necrosis | Gentamicins | 7.63 | 18842672 | |
| MESH:D007674 | Kidney Diseases | Acetaminophen | 39.73 | 15629191 12587719 | |
| MESH:D007674 | Kidney Diseases | Acrolein | 39.73 | 12488133 | |
| MESH:D007674 | Kidney Diseases | Cadmium | 39.73 | 16226777 16322080 16962696 | |
| MESH:D007674 | Kidney Diseases | Cadmium Chloride | 39.73 | 16962696 | |
| MESH:D007674 | Kidney Diseases | Chromium | 39.73 | 17934191 | |
| MESH:D007674 | Kidney Diseases | Cisplatin | 39.73 | 19839026 12649298 15190930 18289764 12231392 | |
| MESH:D007674 | Kidney Diseases | Cyclosporine | 39.73 | 8314463 10903974 18776723 | |
| MESH:D007674 | Kidney Diseases | Doxorubicin | 39.73 | 15369732 16775033 15699352 | |
| MESH:D007674 | Kidney Diseases | Estradiol | 39.73 | 15618244 | |
| MESH:D007674 | Kidney Diseases | Gentamicins | 39.73 | 18289764 19349640 17934191 | |
| MESH:D007674 | Kidney Diseases | Indomethacin | 39.73 | 17190690 | |
| MESH:D007674 | Kidney Diseases | mangiferin | 39.73 | 12093613 | |
| MESH:D007674 | Kidney Diseases | Quercetin | 39.73 | 16962696 | |
| MESH:D007674 | Kidney Diseases | sodium arsenite | 39.73 | 20008137 | |
| MESH:D007674 | Kidney Diseases | Streptozocin | 39.73 | 12093613 | |
| MESH:D007674 | Kidney Diseases | valsartan | 39.73 | 16893502 12164870 10903974 | |
| MESH:D007674 | Kidney Diseases | Vitamin E | 39.73 | 12488133 | |
| MESH:D007674 | Kidney Diseases | Zinc | 39.73 | 16960431 | |
| MESH:D007676 | Kidney Failure, Chronic | Copper | 14.75 | 16518626 | |
| MESH:D007676 | Kidney Failure, Chronic | Doxorubicin | 14.75 | 16707910 | |
| MESH:D007676 | Kidney Failure, Chronic | Hydrogen Peroxide | 14.75 | 16518626 | |
| MESH:D007676 | Kidney Failure, Chronic | Selenium | 14.75 | 16518626 | |
| MESH:D007676 | Kidney Failure, Chronic | Zinc | 14.75 | 16518626 | |
| MESH:D007680 | Kidney Neoplasms | 2,4-dinitrotoluene | 15.56 | 16705839 | |
| MESH:D007680 | Kidney Neoplasms | 2,6-dinitrotoluene | 15.56 | 16705839 | |
| MESH:D007680 | Kidney Neoplasms | 4,4'-diaminodiphenylmethane | 15.56 | 6582329 | |
| MESH:D007680 | Kidney Neoplasms | Cyclosporine | 15.56 | 12371664 | |
| MESH:D007680 | Kidney Neoplasms | Diethylstilbestrol | 15.56 | 15003126 14681315 16762066 | |
| MESH:D007680 | Kidney Neoplasms | Estradiol | 15.56 | 15610895 | |
| MESH:D007680 | Kidney Neoplasms | gefitinib | 15.56 | 18625569 | |
| MESH:D007680 | Kidney Neoplasms | Tamoxifen | 15.56 | 18625569 | |
| MESH:D007683 | Kidney Tubular Necrosis, Acute | Calcium | 10.03 | 16316344 | |
| MESH:D007683 | Kidney Tubular Necrosis, Acute | Cisplatin | 10.03 | 11231351 | |
| MESH:D007683 | Kidney Tubular Necrosis, Acute | Gentamicins | 10.03 | 11231351 | |
| MESH:D007855 | Lead Poisoning | Lead | 4.24 | 16700817 | |
| MESH:D007859 | Learning Disorders | Copper | 24.16 | 17134702 | |
| MESH:D007859 | Learning Disorders | DDT | 24.16 | 7589230 | |
| MESH:D007859 | Learning Disorders | Diethylstilbestrol | 24.16 | 17184923 | |
| MESH:D007859 | Learning Disorders | Endosulfan | 24.16 | 8157075 | |
| MESH:D007859 | Learning Disorders | Ethanol | 24.16 | 15451040 | |
| MESH:D007859 | Learning Disorders | icariin | 24.16 | 19782061 | |
| MESH:D007859 | Learning Disorders | Lead | 24.16 | 16384672 | |
| MESH:D007859 | Learning Disorders | mangiferin | 24.16 | 19182383 | |
| MESH:D007889 | Leiomyoma | Curcumin | 5.79 | 18555241 | |
| MESH:D007889 | Leiomyoma | Raloxifene | 5.79 | 16973256 | |
| MESH:D007896 | Leishmaniasis | Nitric Oxide | 3.21 | 17218153 | |
| MESH:D016773 | Leishmaniasis, Cutaneous | Gentamicins | 7.84 | 10219319 | |
| MESH:D016773 | Leishmaniasis, Cutaneous | Indomethacin | 7.84 | 11703811 12228301 10320625 | |
| MESH:D016773 | Leishmaniasis, Cutaneous | Sodium Chloride | 7.84 | 9499605 | |
| MESH:D016773 | Leishmaniasis, Cutaneous | Zinc Sulfate | 7.84 | 15237267 | |
| MESH:D007898 | Leishmaniasis, Visceral | Thalidomide | 3.04 | 16514283 | |
| MESH:D053609 | Lethargy | Terbutaline | 4.59 | 10895896 | |
| MESH:D007938 | Leukemia | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one | 19.39 | 12970779 | |
| MESH:D007938 | Leukemia | arsenic trioxide | 19.39 | 15070760 | |
| MESH:D007938 | Leukemia | Curcumin | 19.39 | 18462866 | |
| MESH:D007938 | Leukemia | Cyclophosphamide | 19.39 | 10602166 | |
| MESH:D007938 | Leukemia | decitabine | 19.39 | 18980019 19235587 | |
| MESH:D007938 | Leukemia | Genistein | 19.39 | 17468513 18980019 | |
| MESH:D007938 | Leukemia | kaempferol | 19.39 | 17468513 | |
| MESH:D007938 | Leukemia | Quercetin | 19.39 | 17468513 | |
| MESH:D007938 | Leukemia | roscovitine | 19.39 | 16275999 | |
| MESH:D007938 | Leukemia | Tretinoin | 19.39 | 17143497 | |
| MESH:D004915 | Leukemia, Erythroblastic, Acute | Doxorubicin | 8.53 | 16085563 | |
| MESH:D004915 | Leukemia, Erythroblastic, Acute | troglitazone | 8.53 | 16085563 | |
| MESH:D015451 | Leukemia, Lymphocytic, Chronic, B-Cell | Cyclophosphamide | 4.56 | 17008537 17802794 17296974 17658394 18587576 18172266 | |
| MESH:D015451 | Leukemia, Lymphocytic, Chronic, B-Cell | Drugs, Chinese Herbal | 4.56 | 15802533 | |
| MESH:D015451 | Leukemia, Lymphocytic, Chronic, B-Cell | fludarabine | 4.56 | 17802794 18172266 17296974 18587576 17658394 | |
| MESH:D015459 | Leukemia-Lymphoma, Adult T-Cell | arsenic trioxide | 17.69 | 17077332 12560223 | |
| MESH:D015459 | Leukemia-Lymphoma, Adult T-Cell | bortezomib | 17.69 | 18089816 | |
| MESH:D015459 | Leukemia-Lymphoma, Adult T-Cell | Curcumin | 17.69 | 16106398 | |
| MESH:D015459 | Leukemia-Lymphoma, Adult T-Cell | Docosahexaenoic Acids | 17.69 | 17077332 | |
| MESH:D015459 | Leukemia-Lymphoma, Adult T-Cell | Emodin | 17.69 | 17077332 | |
| MESH:D015459 | Leukemia-Lymphoma, Adult T-Cell | zoledronic acid | 17.69 | 18089816 | |
| MESH:D007948 | Leukemia, Monocytic, Acute | arsenic trioxide | 9.98 | 16972261 | |
| MESH:D007948 | Leukemia, Monocytic, Acute | PD 98059 | 9.98 | 16972261 | |
| MESH:D007948 | Leukemia, Monocytic, Acute | U 0126 | 9.98 | 16972261 | |
| MESH:D015464 | Leukemia, Myelogenous, Chronic, BCR-ABL Positive | arsenic trioxide | 14.25 | 14633726 | |
| MESH:D015464 | Leukemia, Myelogenous, Chronic, BCR-ABL Positive | Cyclophosphamide | 14.25 | 10373061 | |
| MESH:D015464 | Leukemia, Myelogenous, Chronic, BCR-ABL Positive | imatinib | 14.25 | 15107311 19208803 17301526 15748426 | |
| MESH:D015464 | Leukemia, Myelogenous, Chronic, BCR-ABL Positive | Indomethacin | 14.25 | 10785260 15631656 16572323 | |
| MESH:D015464 | Leukemia, Myelogenous, Chronic, BCR-ABL Positive | mangiferin | 14.25 | 15498116 | |
| MESH:D015464 | Leukemia, Myelogenous, Chronic, BCR-ABL Positive | zileuton | 14.25 | 19823023 19503090 | |
| MESH:D007951 | Leukemia, Myeloid | arsenic trioxide | 10.06 | 19077051 | |
| MESH:D007951 | Leukemia, Myeloid | decitabine | 10.06 | 19117987 18454857 17236224 | |
| MESH:D007951 | Leukemia, Myeloid | imatinib | 10.06 | 17236224 | |
| MESH:D007951 | Leukemia, Myeloid | Tretinoin | 10.06 | 16482212 16932348 19285840 | |
| MESH:D015470 | Leukemia, Myeloid, Acute | 2-(2-chloro-4-iodophenylamino)-N-cyclopropylmethoxy-3,4-difluorobenzamide | 11.73 | 17077328 16467208 | |
| MESH:D015470 | Leukemia, Myeloid, Acute | 6,7-dimethoxy-3-phenylquinoxaline | 11.73 | 17050201 | |
| MESH:D015470 | Leukemia, Myeloid, Acute | arsenic trioxide | 11.73 | 20471514 16467208 16968895 17050201 19850784 | |
| MESH:D015470 | Leukemia, Myeloid, Acute | bortezomib | 11.73 | 20471514 | |
| MESH:D015470 | Leukemia, Myeloid, Acute | decitabine | 11.73 | 19010910 19387464 17679729 18704418 18460780 18206229 | |
| MESH:D015470 | Leukemia, Myeloid, Acute | Deferoxamine | 11.73 | 20368581 | |
| MESH:D015470 | Leukemia, Myeloid, Acute | Indomethacin | 11.73 | 18360721 | |
| MESH:D015470 | Leukemia, Myeloid, Acute | Thalidomide | 11.73 | 18720364 | |
| MESH:D015470 | Leukemia, Myeloid, Acute | Tretinoin | 11.73 | 17596541 16294345 19850784 | |
| MESH:D015470 | Leukemia, Myeloid, Acute | trichostatin A | 11.73 | 18206229 | |
| MESH:D015477 | Leukemia, Myelomonocytic, Chronic | decitabine | 3.73 | 18055864 | |
| MESH:D015473 | Leukemia, Promyelocytic, Acute | 2-(2-chloro-4-iodophenylamino)-N-cyclopropylmethoxy-3,4-difluorobenzamide | 12.34 | 17077328 | |
| MESH:D015473 | Leukemia, Promyelocytic, Acute | Arsenic | 12.34 | 17339181 | |
| MESH:D015473 | Leukemia, Promyelocytic, Acute | arsenic trioxide | 12.34 | 12712474 17869043 17107899 15622746 15213294 19225113 16112521 16966277 19642359 12679006 11468182 15336539 19075265 12018890 19035177 16331271 17712046 11161223 16891316 15748426 17649720 16823087 9834237 17217047 16330433 | |
| MESH:D015473 | Leukemia, Promyelocytic, Acute | dracorhodin | 12.34 | 16864444 | |
| MESH:D015473 | Leukemia, Promyelocytic, Acute | resveratrol | 12.34 | 16087638 | |
| MESH:D015473 | Leukemia, Promyelocytic, Acute | Tretinoin | 12.34 | 19642359 16331271 19035177 17506722 17294898 12679006 17712046 16935935 17339181 16766008 17107899 17301526 17361223 19029980 16788101 19225113 9834237 17217047 19075265 17368321 17649720 15748426 16823087 16140955 16891316 | |
| MESH:D015458 | Leukemia, T-Cell | arsenic trioxide | 6.26 | 16882451 | |
| MESH:D015458 | Leukemia, T-Cell | Curcumin | 6.26 | 16106398 | |
| MESH:D007964 | Leukocytosis | Indomethacin | 3.65 | 16537180 | |
| MESH:D007969 | Leukomalacia, Periventricular | Indomethacin | 3.99 | 17980183 | |
| MESH:D007970 | Leukopenia | Cyclophosphamide | 6.18 | 10052129 11830472 | |
| MESH:D007970 | Leukopenia | Lipopolysaccharides | 6.18 | 15821434 | |
| MESH:D007972 | Leukoplakia, Oral | Fenretinide | 4.31 | 16707609 | |
| MESH:D020961 | Lewy Body Disease | Iron | 3.75 | 16563566 | |
| MESH:D007984 | Leydig Cell Tumor | vinclozolin | 3.03 | 16417039 | |
| MESH:D056929 | Liddle Syndrome | Amiloride | 4.29 | 19344079 | |
| MESH:D017880 | Limb Deformities, Congenital | Acitretin | 23.94 | 8838291 | |
| MESH:D017880 | Limb Deformities, Congenital | Dichlorodiphenyl Dichloroethylene | 23.94 | 12745335 | |
| MESH:D017880 | Limb Deformities, Congenital | Ethanol | 23.94 | 17676605 | |
| MESH:D017880 | Limb Deformities, Congenital | methoxyacetic acid | 23.94 | 12805644 15959878 | |
| MESH:D017880 | Limb Deformities, Congenital | methyl cellosolve | 23.94 | 6499821 | |
| MESH:D017880 | Limb Deformities, Congenital | Methylnitrosourea | 23.94 | 15526292 | |
| MESH:D017880 | Limb Deformities, Congenital | Thalidomide | 23.94 | 10473037 | |
| MESH:D017880 | Limb Deformities, Congenital | Tretinoin | 23.94 | 9224671 | |
| MESH:D017880 | Limb Deformities, Congenital | Vitamin A | 23.94 | 16054864 | |
| MESH:D008064 | Lipidoses | Clozapine | 3.50 | 17567588 | |
| MESH:D008064 | Lipidoses | Tamoxifen | 3.50 | 17567588 15342952 | |
| MESH:D008080 | Liposarcoma | Paclitaxel | 3.21 | 17353645 | |
| MESH:D008101 | Liver Abscess, Amebic | Indomethacin | 3.99 | 11479899 | |
| MESH:D008103 | Liver Cirrhosis | arsenite | 26.65 | 18296743 | |
| MESH:D008103 | Liver Cirrhosis | Carbon Tetrachloride | 26.65 | 16221502 16943688 11903743 17157831 16239168 11408273 21278145 17174718 17334410 | |
| MESH:D008103 | Liver Cirrhosis | Dietary Fats | 26.65 | 18296743 | |
| MESH:D008103 | Liver Cirrhosis | Diethylnitrosamine | 26.65 | 18522880 18407596 18665156 20032147 19638242 | |
| MESH:D008103 | Liver Cirrhosis | Drugs, Chinese Herbal | 26.65 | 17163593 | |
| MESH:D008103 | Liver Cirrhosis | Ethanol | 26.65 | 15289165 | |
| MESH:D008103 | Liver Cirrhosis | Iron | 26.65 | 16640825 | |
| MESH:D008103 | Liver Cirrhosis | Phenobarbital | 26.65 | 21047994 | |
| MESH:D008103 | Liver Cirrhosis | Plant Extracts | 26.65 | 17157831 | |
| MESH:D008103 | Liver Cirrhosis | Silymarin | 26.65 | 17213517 | |
| MESH:D008103 | Liver Cirrhosis | Thalidomide | 26.65 | 16943688 17174718 | |
| MESH:D008103 | Liver Cirrhosis | Vitamin A | 26.65 | 16256175 | |
| MESH:D008104 | Liver Cirrhosis, Alcoholic | Ethanol | 8.10 | 18295389 | |
| MESH:D008104 | Liver Cirrhosis, Alcoholic | Propolis | 8.10 | 18295389 | |
| MESH:D008105 | Liver Cirrhosis, Biliary | 4,4'-diaminodiphenylmethane | 1.91 | 15034207 9327722 | |
| MESH:D008106 | Liver Cirrhosis, Experimental | 4-(5-(4-chlorophenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl)benzenesulfonamide | 65.75 | 15876570 | |
| MESH:D008106 | Liver Cirrhosis, Experimental | Adenosine | 65.75 | 18263696 | |
| MESH:D008106 | Liver Cirrhosis, Experimental | arginyl-glycyl-aspartic acid | 65.75 | 15547672 | |
| MESH:D008106 | Liver Cirrhosis, Experimental | atorvastatin | 65.75 | 17347453 | |
| MESH:D008106 | Liver Cirrhosis, Experimental | Carbon Tetrachloride | 65.75 | 18279442 17823541 14724832 18395914 12389079 18472094 16192424 12741479 18054572 17761835 17900296 17714472 16116963 16015684 12445418 15730626 18705752 12546737 12632512 12649538 12609069 15673190 17766677 17557913 17721639 17869086 18339082 18472332 15959796 17481882 14620537 12898905 18006644 12632514 16097048 12586293 18156304 14748882 12958196 16136751 15650968 14716496 18395095 17708605 15057751 17805973 17631135 15338365 16011737 18412020 15876570 15818738 18420326 16248980 18418968 18210741 16027843 18251166 17976157 12666154 18205269 18277467 15362042 18376398 14512876 17922224 15123356 16638106 17525996 15931870 15052691 17944888 13678700 20821823 14716833 17640975 18166357 12667390 15893842 11481614 10355542 17698563 18263696 12445421 18317297 17565644 15996030 18429990 18481824 18187930 15370692 15925388 16033810 | |
| MESH:D008106 | Liver Cirrhosis, Experimental | Curcumin | 65.75 | 18006644 18705752 17355460 | |
| MESH:D008106 | Liver Cirrhosis, Experimental | Dexamethasone | 65.75 | 16718785 | |
| MESH:D008106 | Liver Cirrhosis, Experimental | Dimethylnitrosamine | 65.75 | 16270385 14726149 18210741 15161499 17881167 15723089 18364076 15744066 15081153 17201889 14568256 17534399 15339415 17203207 15864749 18629640 17640959 14643895 17348192 16603200 18672772 17198567 17724770 15369754 16042886 12925901 17465448 16627068 15086199 15504291 14659978 18567088 15763062 15383259 15492853 15298665 17666798 16169303 15942678 15591649 14709902 18637143 17036385 15798949 15099470 15793283 15138612 18239293 16009107 15571005 17719030 15577212 18237412 16570917 18095165 16544323 17432682 17196135 15067225 12918455 15479170 15733078 18371158 15366600 15842777 | |
| MESH:D008106 | Liver Cirrhosis, Experimental | Dinoprostone | 65.75 | 15816358 | |
| MESH:D008106 | Liver Cirrhosis, Experimental | Doxorubicin | 65.75 | 16595196 16439617 | |
| MESH:D008106 | Liver Cirrhosis, Experimental | Drugs, Chinese Herbal | 65.75 | 17348192 17881167 15818738 15744066 17629604 15754396 15763062 16610055 17036385 12632512 15864749 18567088 17666798 18606216 15641146 15339415 18237412 15849816 15383259 18371158 | |
| MESH:D008106 | Liver Cirrhosis, Experimental | Emodin | 65.75 | 15288473 | |
| MESH:D008106 | Liver Cirrhosis, Experimental | epigallocatechin gallate | 65.75 | 17481882 | |
| MESH:D008106 | Liver Cirrhosis, Experimental | Estradiol | 65.75 | 14716833 14659978 | |
| MESH:D008106 | Liver Cirrhosis, Experimental | Ethanol | 65.75 | 18166357 | |
| MESH:D008106 | Liver Cirrhosis, Experimental | farnesylthiosalicylic acid | 65.75 | 15288472 | |
| MESH:D008106 | Liver Cirrhosis, Experimental | ferulic acid | 65.75 | 16011737 | |
| MESH:D008106 | Liver Cirrhosis, Experimental | Genistein | 65.75 | 17823541 | |
| MESH:D008106 | Liver Cirrhosis, Experimental | Heparin | 65.75 | 16904936 | |
| MESH:D008106 | Liver Cirrhosis, Experimental | imatinib | 65.75 | 16596278 | |
| MESH:D008106 | Liver Cirrhosis, Experimental | inchinko-to | 65.75 | 15288473 | |
| MESH:D008106 | Liver Cirrhosis, Experimental | Indomethacin | 65.75 | 18194892 | |
| MESH:D008106 | Liver Cirrhosis, Experimental | Lipopolysaccharides | 65.75 | 12878042 | |
| MESH:D008106 | Liver Cirrhosis, Experimental | Losartan | 65.75 | 12445418 15573910 17900296 | |
| MESH:D008106 | Liver Cirrhosis, Experimental | morin | 65.75 | 18629640 | |
| MESH:D008106 | Liver Cirrhosis, Experimental | Nucleotides | 65.75 | 15465738 | |
| MESH:D008106 | Liver Cirrhosis, Experimental | pirinixic acid | 65.75 | 15474484 | |
| MESH:D008106 | Liver Cirrhosis, Experimental | Plant Extracts | 65.75 | 15479170 | |
| MESH:D008106 | Liver Cirrhosis, Experimental | Propolis | 65.75 | 18295389 | |
| MESH:D008106 | Liver Cirrhosis, Experimental | pyrrolidine dithiocarbamic acid | 65.75 | 15078482 | |
| MESH:D008106 | Liver Cirrhosis, Experimental | Quercetin | 65.75 | 12741479 | |
| MESH:D008106 | Liver Cirrhosis, Experimental | S-Adenosylmethionine | 65.75 | 15983038 | |
| MESH:D008106 | Liver Cirrhosis, Experimental | Silymarin | 65.75 | 15864749 17198567 18277467 15754394 | |
| MESH:D008106 | Liver Cirrhosis, Experimental | Tamoxifen | 65.75 | 18564211 | |
| MESH:D008106 | Liver Cirrhosis, Experimental | Tetrachlorodibenzodioxin | 65.75 | 12878042 | |
| MESH:D008106 | Liver Cirrhosis, Experimental | Thalidomide | 65.75 | 15465738 | |
| MESH:D008106 | Liver Cirrhosis, Experimental | Tretinoin | 65.75 | 16248980 18397230 | |
| MESH:D008106 | Liver Cirrhosis, Experimental | valsartan | 65.75 | 16872305 15504291 15619341 | |
| MESH:D008106 | Liver Cirrhosis, Experimental | Vitamin A | 65.75 | 16248980 | |
| MESH:D008106 | Liver Cirrhosis, Experimental | Vitamin E | 65.75 | 16169303 | |
| MESH:D008106 | Liver Cirrhosis, Experimental | Y 27632 | 65.75 | 13678700 | |
| MESH:D008107 | Liver Diseases | Acetaminophen | 33.04 | 19014921 16610002 19460945 16611625 12969438 19784758 11587558 12587719 | |
| MESH:D008107 | Liver Diseases | Arsenic | 33.04 | 11134558 | |
| MESH:D008107 | Liver Diseases | Capsaicin | 33.04 | 16956363 | |
| MESH:D008107 | Liver Diseases | Carbon Tetrachloride | 33.04 | 15830285 16964402 16246199 15720792 17285989 | |
| MESH:D008107 | Liver Diseases | Chlorpyrifos | 33.04 | 15991261 | |
| MESH:D008107 | Liver Diseases | Curcumin | 33.04 | 16956363 | |
| MESH:D008107 | Liver Diseases | DDT | 33.04 | 15729006 | |
| MESH:D008107 | Liver Diseases | Diethylnitrosamine | 33.04 | 17034775 | |
| MESH:D008107 | Liver Diseases | Dinoprostone | 33.04 | 15816358 | |
| MESH:D008107 | Liver Diseases | Docosahexaenoic Acids | 33.04 | 17056761 | |
| MESH:D008107 | Liver Diseases | Drugs, Chinese Herbal | 33.04 | 17207593 | |
| MESH:D008107 | Liver Diseases | Folic Acid | 33.04 | 16877991 | |
| MESH:D008107 | Liver Diseases | Hemin | 33.04 | 17173083 | |
| MESH:D008107 | Liver Diseases | Lindane | 33.04 | 1715830 | |
| MESH:D008107 | Liver Diseases | Phenobarbital | 33.04 | 19363144 | |
| MESH:D008107 | Liver Diseases | Phenytoin | 33.04 | 14986274 | |
| MESH:D008107 | Liver Diseases | Plant Extracts | 33.04 | 17034775 | |
| MESH:D008107 | Liver Diseases | polyphenols | 33.04 | 16698588 | |
| MESH:D008107 | Liver Diseases | Silymarin | 33.04 | 17213517 | |
| MESH:D008107 | Liver Diseases | Vitamin A | 33.04 | 16175620 | |
| MESH:D008108 | Liver Diseases, Alcoholic | Ethanol | 13.66 | 17207112 17347304 | |
| MESH:D008108 | Liver Diseases, Alcoholic | Iron | 13.66 | 17207112 16737972 | |
| MESH:D008108 | Liver Diseases, Alcoholic | Silymarin | 13.66 | 17213517 | |
| MESH:D008108 | Liver Diseases, Alcoholic | Vitamin A | 13.66 | 16762690 | |
| MESH:D017093 | Liver Failure | Carbon Tetrachloride | 2.51 | 15123358 | |
| MESH:D017114 | Liver Failure, Acute | Acetaminophen | 10.66 | 16871587 17185352 | |
| MESH:D017114 | Liver Failure, Acute | Carbon Tetrachloride | 10.66 | 14706259 16899240 | |
| MESH:D017114 | Liver Failure, Acute | Dimethylnitrosamine | 10.66 | 17457977 | |
| MESH:D017114 | Liver Failure, Acute | venlafaxine | 10.66 | 19857765 | |
| MESH:D008113 | Liver Neoplasms | 2,4,5,2',4',5'-hexachlorobiphenyl | 72.36 | 18644402 16835634 | |
| MESH:D008113 | Liver Neoplasms | 2,6-dinitrotoluene | 72.36 | 7678174 | |
| MESH:D008113 | Liver Neoplasms | 3,7,11,15-tetramethyl-2,4,6,10,14-hexadecapentaenoic acid | 72.36 | 21071580 | |
| MESH:D008113 | Liver Neoplasms | 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone | 72.36 | 15890375 | |
| MESH:D008113 | Liver Neoplasms | Arsenic | 72.36 | 16368122 | |
| MESH:D008113 | Liver Neoplasms | arsenic trioxide | 72.36 | 14682389 | |
| MESH:D008113 | Liver Neoplasms | Benzo(a)pyrene | 72.36 | 20195826 21137059 | |
| MESH:D008113 | Liver Neoplasms | beta-Naphthoflavone | 72.36 | 19389873 21295105 | |
| MESH:D008113 | Liver Neoplasms | Butylated Hydroxytoluene | 72.36 | 18177683 | |
| MESH:D008113 | Liver Neoplasms | Carbon Tetrachloride | 72.36 | 19294768 | |
| MESH:D008113 | Liver Neoplasms | Chlordan | 72.36 | 2422723 | |
| MESH:D008113 | Liver Neoplasms | Copper | 72.36 | 20302851 | |
| MESH:D008113 | Liver Neoplasms | DDT | 72.36 | 11948501 15975961 | |
| MESH:D008113 | Liver Neoplasms | Dehydroepiandrosterone | 72.36 | 18709148 | |
| MESH:D008113 | Liver Neoplasms | Dieldrin | 72.36 | 8742319 9539021 | |
| MESH:D008113 | Liver Neoplasms | Diethylhexyl Phthalate | 72.36 | 11940454 | |
| MESH:D008113 | Liver Neoplasms | Diethylnitrosamine | 72.36 | 19294768 19850985 19996281 20583210 18644402 19073162 15175105 2422723 18648771 21167192 19690152 19642983 19254457 21047994 12112319 20434301 19426721 19551842 20101389 16942905 18754104 9163691 12771043 19256749 20137499 19427195 19255062 20492335 18977376 19833225 21278145 21071580 19499222 18978307 19638242 2862719 20452335 20405173 10737359 19090486 20118626 20501860 19812893 15885732 | |
| MESH:D008113 | Liver Neoplasms | Diethylstilbestrol | 72.36 | 16712894 15890375 | |
| MESH:D008113 | Liver Neoplasms | Dimethylnitrosamine | 72.36 | 15890375 3113478 | |
| MESH:D008113 | Liver Neoplasms | Drugs, Chinese Herbal | 72.36 | 18339527 | |
| MESH:D008113 | Liver Neoplasms | Heptachlor | 72.36 | 2422723 9544696 | |
| MESH:D008113 | Liver Neoplasms | Iron | 72.36 | 16640825 20302851 | |
| MESH:D008113 | Liver Neoplasms | Phenobarbital | 72.36 | 19812893 15975961 19482888 8742319 19073162 21047994 | |
| MESH:D008113 | Liver Neoplasms | pirinixic acid | 72.36 | 15890375 16377806 20007298 | |
| MESH:D008113 | Liver Neoplasms | Plant Extracts | 72.36 | 19168119 | |
| MESH:D008113 | Liver Neoplasms | Quercetin | 72.36 | 18980244 | |
| MESH:D008113 | Liver Neoplasms | resveratrol | 72.36 | 19321006 19812893 20405173 19073162 | |
| MESH:D008113 | Liver Neoplasms | Silymarin | 72.36 | 19168119 | |
| MESH:D008113 | Liver Neoplasms | sodium arsenite | 72.36 | 16712894 15276417 | |
| MESH:D008113 | Liver Neoplasms | Tamoxifen | 72.36 | 16684651 | |
| MESH:D008113 | Liver Neoplasms | Tetrachlorodibenzodioxin | 72.36 | 16984957 | |
| MESH:D008113 | Liver Neoplasms | Urethane | 72.36 | 17093202 17559639 16391232 | |
| MESH:D008113 | Liver Neoplasms | zerumbone | 72.36 | 20452335 | |
| MESH:D008114 | Liver Neoplasms, Experimental | 2,6-dinitrotoluene | 33.52 | 6135515 2876784 2876786 | |
| MESH:D008114 | Liver Neoplasms, Experimental | 4,4'-diaminodiphenylmethane | 33.52 | 6587162 3712494 598648 1399818 | |
| MESH:D008114 | Liver Neoplasms, Experimental | arsenic trioxide | 33.52 | 20377131 | |
| MESH:D008114 | Liver Neoplasms, Experimental | Ascorbic Acid | 33.52 | 18544905 | |
| MESH:D008114 | Liver Neoplasms, Experimental | beta Carotene | 33.52 | 17113696 | |
| MESH:D008114 | Liver Neoplasms, Experimental | beta-Naphthoflavone | 33.52 | 18164116 | |
| MESH:D008114 | Liver Neoplasms, Experimental | Carbon Tetrachloride | 33.52 | 15583823 12014681 | |
| MESH:D008114 | Liver Neoplasms, Experimental | Dehydroepiandrosterone | 33.52 | 8603461 | |
| MESH:D008114 | Liver Neoplasms, Experimental | Diethylnitrosamine | 33.52 | 19539802 17942915 19009564 18308698 16267830 19004024 19519916 21159647 18775883 18079962 19126423 18282651 18164116 18253720 3124819 18093689 17174075 2563599 18544905 16842330 9362446 17854601 | |
| MESH:D008114 | Liver Neoplasms, Experimental | Dimethylnitrosamine | 33.52 | 1848544 15603536 6150874 | |
| MESH:D008114 | Liver Neoplasms, Experimental | Doxorubicin | 33.52 | 16842330 17085340 | |
| MESH:D008114 | Liver Neoplasms, Experimental | morin | 33.52 | 19539802 | |
| MESH:D008114 | Liver Neoplasms, Experimental | Phenobarbital | 33.52 | 17172636 18308698 2563599 6150874 1399818 | |
| MESH:D008114 | Liver Neoplasms, Experimental | Quercetin | 33.52 | 19519916 | |
| MESH:D008114 | Liver Neoplasms, Experimental | Tetrachlorodibenzodioxin | 33.52 | 12151625 | |
| MESH:D008114 | Liver Neoplasms, Experimental | Vanadium | 33.52 | 17174075 | |
| MESH:D008114 | Liver Neoplasms, Experimental | Vitamin A | 33.52 | 17113696 | |
| MESH:D008133 | Long QT Syndrome | arsenic trioxide | 3.90 | 15213294 | |
| MESH:D008133 | Long QT Syndrome | Dobutamine | 3.90 | 19353679 | |
| MESH:D038061 | Lower Extremity Deformities, Congenital | Methylnitrosourea | 3.79 | 16080182 | |
| MESH:D008171 | Lung Diseases | 2-chloroethyl ethyl sulfide | 29.99 | 12815614 16252256 18675330 | |
| MESH:D008171 | Lung Diseases | Acetylcysteine | 29.99 | 12815614 | |
| MESH:D008171 | Lung Diseases | Acrolein | 29.99 | 11504702 | |
| MESH:D008171 | Lung Diseases | Asbestos, Serpentine | 29.99 | 17200189 | |
| MESH:D008171 | Lung Diseases | Ascorbic Acid | 29.99 | 16863852 | |
| MESH:D008171 | Lung Diseases | chromium hexavalent ion | 29.99 | 16775837 | |
| MESH:D008171 | Lung Diseases | Dobutamine | 29.99 | 16638327 | |
| MESH:D008171 | Lung Diseases | Mustard Gas | 29.99 | 18702808 18161513 | |
| MESH:D008171 | Lung Diseases | Ozone | 29.99 | 19066396 8266340 | |
| MESH:D008171 | Lung Diseases | sodium arsenite | 29.99 | 19095001 | |
| MESH:D008171 | Lung Diseases | Vitamin A | 29.99 | 16863852 | |
| MESH:D008171 | Lung Diseases | Vitamin E | 29.99 | 16863852 | |
| MESH:D055370 | Lung Injury | Asbestos, Crocidolite | 14.34 | 17365036 | |
| MESH:D055370 | Lung Injury | Lipopolysaccharides | 14.34 | 21114838 | |
| MESH:D055370 | Lung Injury | Nitric Oxide | 14.34 | 11395602 | |
| MESH:D055370 | Lung Injury | Oxygen | 14.34 | 18339021 | |
| MESH:D055370 | Lung Injury | Ozone | 14.34 | 20417186 | |
| MESH:D055370 | Lung Injury | pyrrolidine dithiocarbamic acid | 14.34 | 16129981 | |
| MESH:D008175 | Lung Neoplasms | marker/mechanism | 12376484 11884234 | ||
| MESH:D008175 | Lung Neoplasms | 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone | 52.37 | 18813816 9255578 19931552 12438228 14755239 17139156 16061637 18508827 15893417 16401635 15172992 | |
| MESH:D008175 | Lung Neoplasms | Acetaldehyde | 52.37 | 17372256 | |
| MESH:D008175 | Lung Neoplasms | alitretinoin | 52.37 | 16413115 | |
| MESH:D008175 | Lung Neoplasms | alpha-Tocopherol | 52.37 | 16401635 | |
| MESH:D008175 | Lung Neoplasms | Arsenic | 52.37 | 17306315 17976673 19168569 | |
| MESH:D008175 | Lung Neoplasms | arsenic trioxide | 52.37 | 19825857 11798837 | |
| MESH:D008175 | Lung Neoplasms | arsenite | 52.37 | 16809336 | |
| MESH:D008175 | Lung Neoplasms | Asbestos, Serpentine | 52.37 | 11198217 | |
| MESH:D008175 | Lung Neoplasms | Ascorbic Acid | 52.37 | 16401635 | |
| MESH:D008175 | Lung Neoplasms | Benzo(a)pyrene | 52.37 | 20135361 20464547 6695378 18569708 20064080 18816296 18520028 17053015 20869020 | |
| MESH:D008175 | Lung Neoplasms | beta Carotene | 52.37 | 16401635 | |
| MESH:D008175 | Lung Neoplasms | Butylated Hydroxytoluene | 52.37 | 15390079 19925653 11246140 18597497 16337739 11696405 19359593 | |
| MESH:D008175 | Lung Neoplasms | chromium hexavalent ion | 52.37 | 16570259 16876463 | |
| MESH:D008175 | Lung Neoplasms | Cisplatin | 52.37 | 11798837 6189445 17225452 | |
| MESH:D008175 | Lung Neoplasms | Curcumin | 52.37 | 19359593 16243823 18462866 | |
| MESH:D008175 | Lung Neoplasms | Dexamethasone | 52.37 | 15824018 11195469 | |
| MESH:D008175 | Lung Neoplasms | Diethylnitrosamine | 52.37 | 6695378 20970405 20512841 21163286 | |
| MESH:D008175 | Lung Neoplasms | Dimethylnitrosamine | 52.37 | 16061637 11884234 19555203 | |
| MESH:D008175 | Lung Neoplasms | Doxorubicin | 52.37 | 17418594 6189445 | |
| MESH:D008175 | Lung Neoplasms | Drugs, Chinese Herbal | 52.37 | 18339527 | |
| MESH:D008175 | Lung Neoplasms | Humic Substances | 52.37 | 19686714 | |
| MESH:D008175 | Lung Neoplasms | Indomethacin | 52.37 | 16537180 11497255 11053908 | |
| MESH:D008175 | Lung Neoplasms | Iron | 52.37 | 16640825 | |
| MESH:D008175 | Lung Neoplasms | mangiferin | 52.37 | 18520028 18569708 18816296 | |
| MESH:D008175 | Lung Neoplasms | Methylnitrosourea | 52.37 | 18062963 | |
| MESH:D008175 | Lung Neoplasms | Mustard Gas | 52.37 | 8781369 3148597 | |
| MESH:D008175 | Lung Neoplasms | Ozone | 52.37 | 8597069 7614698 | |
| MESH:D008175 | Lung Neoplasms | Plant Extracts | 52.37 | 20869020 | |
| MESH:D008175 | Lung Neoplasms | Quercetin | 52.37 | 16280456 | |
| MESH:D008175 | Lung Neoplasms | sodium arsenite | 52.37 | 16712894 15276417 17306315 17077188 19931552 | |
| MESH:D008175 | Lung Neoplasms | Tamoxifen | 52.37 | 18625569 | |
| MESH:D008175 | Lung Neoplasms | Tetrachlorodibenzodioxin | 52.37 | 19555203 11884234 | |
| MESH:D008175 | Lung Neoplasms | Tetradecanoylphorbol Acetate | 52.37 | 11807781 | |
| MESH:D008175 | Lung Neoplasms | Urethane | 52.37 | 11992545 11074608 16926031 17093202 16391232 16337739 15166089 11497255 17255336 10530776 12957351 11552296 11544531 17195641 12466968 14587096 12765245 16788158 11246140 10779650 10822126 11062179 15902970 7750092 6695378 12117781 16289808 16007126 11893704 11307925 11323394 15136453 10997738 16204055 11807781 | |
| MESH:D008175 | Lung Neoplasms | vanadium pentoxide | 52.37 | 12376484 | |
| MESH:D008175 | Lung Neoplasms | Vitamin E | 52.37 | 11062179 | |
| MESH:D008180 | Lupus Erythematosus, Systemic | Folic Acid | 2.69 | 17718048 | |
| MESH:D008181 | Lupus Nephritis | Diethylstilbestrol | 3.44 | 15166399 | |
| MESH:D008223 | Lymphoma | bortezomib | 16.94 | 16098063 | |
| MESH:D008223 | Lymphoma | Curcumin | 16.94 | 18462866 | |
| MESH:D008223 | Lymphoma | Cyclophosphamide | 16.94 | 12854902 | |
| MESH:D008223 | Lymphoma | decitabine | 16.94 | 19470736 | |
| MESH:D008223 | Lymphoma | Diethylstilbestrol | 16.94 | 15700306 | |
| MESH:D008223 | Lymphoma | Doxorubicin | 16.94 | 16098063 | |
| MESH:D008223 | Lymphoma | Methylnitrosourea | 16.94 | 16257854 11418001 | |
| MESH:D008223 | Lymphoma | Nitric Oxide | 16.94 | 16166326 | |
| MESH:D016393 | Lymphoma, B-Cell | bortezomib | 15.29 | 16675587 | |
| MESH:D016393 | Lymphoma, B-Cell | Cyclophosphamide | 15.29 | 16675587 | |
| MESH:D016393 | Lymphoma, B-Cell | Methylnitrosourea | 15.29 | 14633661 | |
| MESH:D016393 | Lymphoma, B-Cell | resveratrol | 15.29 | 17088997 | |
| MESH:D016393 | Lymphoma, B-Cell | Sodium Selenite | 15.29 | 14737004 | |
| MESH:D017728 | Lymphoma, Large-Cell, Anaplastic | 17-(allylamino)-17-demethoxygeldanamycin | 4.91 | 17157164 | |
| MESH:D008228 | Lymphoma, Non-Hodgkin | 2,4-Dichlorophenoxyacetic Acid | 11.41 | 16132792 | |
| MESH:D008228 | Lymphoma, Non-Hodgkin | Cyclophosphamide | 11.41 | 11911406 | |
| MESH:D008228 | Lymphoma, Non-Hodgkin | Doxorubicin | 11.41 | 17654614 | |
| MESH:D008228 | Lymphoma, Non-Hodgkin | Paclitaxel | 11.41 | 14749477 | |
| MESH:D008228 | Lymphoma, Non-Hodgkin | resveratrol | 11.41 | 14749477 | |
| MESH:D016399 | Lymphoma, T-Cell | Curcumin | 6.04 | 16173963 | |
| MESH:D016399 | Lymphoma, T-Cell | Doxorubicin | 6.04 | 15621674 | |
| MESH:D016410 | Lymphoma, T-Cell, Cutaneous | vorinostat | 4.01 | 20479100 | |
| MESH:D008231 | Lymphopenia | methyl cellosolve | 4.08 | 3699323 | |
| MESH:D008268 | Macular Degeneration | Iron | 2.81 | 16640825 | |
| MESH:D052801 | Male Urogenital Diseases | Diethylstilbestrol | 3.78 | 16002989 | |
| MESH:D015674 | Mammary Neoplasms, Animal | resveratrol | 4.50 | 15688416 | |
| MESH:D015674 | Mammary Neoplasms, Animal | Tamoxifen | 4.50 | 19428831 | |
| MESH:D008325 | Mammary Neoplasms, Experimental | Butylated Hydroxytoluene | 36.52 | 1500032 | |
| MESH:D008325 | Mammary Neoplasms, Experimental | Corticosterone | 36.52 | 12807724 | |
| MESH:D008325 | Mammary Neoplasms, Experimental | Dehydroepiandrosterone | 36.52 | 16457693 | |
| MESH:D008325 | Mammary Neoplasms, Experimental | Doxorubicin | 36.52 | 15458769 | |
| MESH:D008325 | Mammary Neoplasms, Experimental | Drugs, Chinese Herbal | 36.52 | 14758024 | |
| MESH:D008325 | Mammary Neoplasms, Experimental | Estradiol | 36.52 | 17203775 11807958 16891317 11408345 | |
| MESH:D008325 | Mammary Neoplasms, Experimental | estradiol 3-benzoate | 36.52 | 15375486 | |
| MESH:D008325 | Mammary Neoplasms, Experimental | Fenretinide | 36.52 | 10697514 | |
| MESH:D008325 | Mammary Neoplasms, Experimental | gefitinib | 36.52 | 18375820 | |
| MESH:D008325 | Mammary Neoplasms, Experimental | Genistein | 36.52 | 12929590 14578162 | |
| MESH:D008325 | Mammary Neoplasms, Experimental | Methylnitrosourea | 36.52 | 10838139 11807958 16051031 16619500 19196723 11751437 16827153 15313902 17020996 15113128 14633655 10767621 16944150 12931682 17131329 14999141 15688392 | |
| MESH:D008325 | Mammary Neoplasms, Experimental | Progesterone | 36.52 | 17203775 11408345 | |
| MESH:D008325 | Mammary Neoplasms, Experimental | resveratrol | 36.52 | 8985016 11606380 | |
| MESH:D008325 | Mammary Neoplasms, Experimental | Selenium | 36.52 | 15318939 | |
| MESH:D008325 | Mammary Neoplasms, Experimental | Tamoxifen | 36.52 | 16827153 11731420 14580682 19196722 19196723 | |
| MESH:D008325 | Mammary Neoplasms, Experimental | Tetradecanoylphorbol Acetate | 36.52 | 8985016 | |
| MESH:D008325 | Mammary Neoplasms, Experimental | Zinc | 36.52 | 12773700 | |
| MESH:D008325 | Mammary Neoplasms, Experimental | zoledronic acid | 36.52 | 17312309 | |
| MESH:D020149 | Manganese Poisoning | Estradiol | 12.55 | 19453300 | |
| MESH:D020149 | Manganese Poisoning | Manganese | 12.55 | 16568477 19453300 16551646 | |
| MESH:D020149 | Manganese Poisoning | Tamoxifen | 12.55 | 19453300 | |
| MESH:D008382 | Marfan Syndrome | Atenolol | 7.74 | 19430350 | |
| MESH:D008382 | Marfan Syndrome | Losartan | 7.74 | 19430350 | |
| MESH:D019767 | Maxillofacial Abnormalities | Folic Acid | 3.99 | 16832597 | |
| MESH:D008527 | Medulloblastoma | bortezomib | 3.40 | 19213072 | |
| MESH:D008527 | Medulloblastoma | Tretinoin | 3.40 | 17453147 | |
| MESH:D008545 | Melanoma | 4-((3-bromophenyl)amino)-6,7-dimethoxyquinazoline | 41.64 | 16077934 | |
| MESH:D008545 | Melanoma | 6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid | 41.64 | 17992120 | |
| MESH:D008545 | Melanoma | Acitretin | 41.64 | 16109552 | |
| MESH:D008545 | Melanoma | betulinic acid | 41.64 | 16077934 | |
| MESH:D008545 | Melanoma | Cisplatin | 41.64 | 12393984 18505091 18176117 11135225 16432458 17023156 12374674 17761969 12883367 16248763 18332650 16809738 15577323 | |
| MESH:D008545 | Melanoma | Curcumin | 41.64 | 17885582 18462866 | |
| MESH:D008545 | Melanoma | Dacarbazine | 41.64 | 15522559 15577320 16034308 18176117 12556972 17709802 16809738 12883367 10623706 18332650 12640292 12202904 15020614 17239242 17623835 12439608 18505091 12417787 17023156 18445842 17562445 16508601 17119449 16966688 11254118 16273263 17761969 16098027 11712820 11746506 16939954 11135225 17973783 16928243 12025231 16225601 15917704 18281670 16760174 15176220 15577323 17576460 18089842 17508024 16248763 12535206 17334785 12393984 | |
| MESH:D008545 | Melanoma | decitabine | 41.64 | 16505122 17785578 | |
| MESH:D008545 | Melanoma | docetaxel | 41.64 | 12417787 | |
| MESH:D008545 | Melanoma | Doxorubicin | 41.64 | 16827129 | |
| MESH:D008545 | Melanoma | dracorhodin | 41.64 | 15684474 | |
| MESH:D008545 | Melanoma | epigallocatechin gallate | 41.64 | 11746506 17992120 | |
| MESH:D008545 | Melanoma | farnesylthiosalicylic acid | 41.64 | 12535206 | |
| MESH:D008545 | Melanoma | Fenretinide | 41.64 | 16270382 | |
| MESH:D008545 | Melanoma | Glucose | 41.64 | 14993021 | |
| MESH:D008545 | Melanoma | Histamine | 41.64 | 17709802 | |
| MESH:D008545 | Melanoma | Melphalan | 41.64 | 14993021 18388930 | |
| MESH:D008545 | Melanoma | N-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide | 41.64 | 16487513 | |
| MESH:D008545 | Melanoma | Paclitaxel | 41.64 | 12025231 16342250 12040289 | |
| MESH:D008545 | Melanoma | Reactive Oxygen Species | 41.64 | 17992120 | |
| MESH:D008545 | Melanoma | resveratrol | 41.64 | 17992120 | |
| MESH:D008545 | Melanoma | sodium arsenite | 41.64 | 19082730 16487513 | |
| MESH:D008545 | Melanoma | Tamoxifen | 41.64 | 12393984 19393235 | |
| MESH:D008545 | Melanoma | Thalidomide | 41.64 | 16098027 12829675 17089043 | |
| MESH:D008545 | Melanoma | Tretinoin | 41.64 | 16752155 | |
| MESH:D008545 | Melanoma | trichostatin A | 41.64 | 16505122 | |
| MESH:D018328 | Melanoma, Amelanotic | Cisplatin | 9.99 | 15990972 | |
| MESH:D018328 | Melanoma, Amelanotic | Dacarbazine | 9.99 | 15990972 | |
| MESH:D018328 | Melanoma, Amelanotic | Tamoxifen | 9.99 | 15990972 | |
| MESH:D008546 | Melanoma, Experimental | Acetaminophen | 8.94 | 19513568 | |
| MESH:D008546 | Melanoma, Experimental | Acrolein | 8.94 | 10803710 | |
| MESH:D008546 | Melanoma, Experimental | Cyclophosphamide | 8.94 | 16388313 | |
| MESH:D008569 | Memory Disorders | Curcumin | 16.35 | 17263510 | |
| MESH:D008569 | Memory Disorders | Ethanol | 16.35 | 18411066 15451040 | |
| MESH:D008569 | Memory Disorders | icariin | 16.35 | 19782061 | |
| MESH:D008569 | Memory Disorders | Lead | 16.35 | 16384672 17263510 | |
| MESH:D008569 | Memory Disorders | mangiferin | 16.35 | 19182383 | |
| MESH:D008569 | Memory Disorders | Methylmercury Compounds | 16.35 | 18436314 | |
| MESH:D008591 | Meningomyelocele | Homocysteine | 6.88 | 16602021 | |
| MESH:D008591 | Meningomyelocele | Tretinoin | 6.88 | 16940565 | |
| MESH:D007706 | Menkes Kinky Hair Syndrome | Copper | 4.17 | 17268249 17109627 | |
| MESH:D001523 | Mental Disorders | Clozapine | 5.80 | 16856516 | |
| MESH:D001523 | Mental Disorders | Haloperidol | 5.80 | 16856516 | |
| MESH:D001523 | Mental Disorders | Phosphates | 5.80 | 12686366 | |
| MESH:D001523 | Mental Disorders | venlafaxine | 5.80 | 16856516 | |
| MESH:D008607 | Mental Retardation | Phenytoin | 2.88 | 9212184 | |
| MESH:D008654 | Mesothelioma | Asbestos, Crocidolite | 9.81 | 16166281 16966607 18303189 | |
| MESH:D008654 | Mesothelioma | Atrazine | 9.81 | 1916698 | |
| MESH:D008654 | Mesothelioma | Cisplatin | 9.81 | 17638057 | |
| MESH:D008654 | Mesothelioma | Doxorubicin | 9.81 | 17638057 | |
| MESH:D008654 | Mesothelioma | Selenium | 9.81 | 15107826 | |
| MESH:D008654 | Mesothelioma | zoledronic acid | 9.81 | 16675582 | |
| MESH:D008659 | Metabolic Diseases | resveratrol | 2.80 | 17112576 | |
| MESH:D024821 | Metabolic Syndrome X | Clozapine | 2.94 | 19142101 | |
| MESH:D008664 | Metal Metabolism, Inborn Errors | Cyclosporine | 3.06 | 16801185 | |
| MESH:D008679 | Metaplasia | Ozone | 3.38 | 10496685 | |
| MESH:D008708 | Methemoglobinemia | malachite green | 3.96 | 18363129 | |
| MESH:D008881 | Migraine Disorders | Aspirin | 11.33 | 15240983 | |
| MESH:D008881 | Migraine Disorders | Indomethacin | 11.33 | 11903285 | |
| MESH:D008881 | Migraine Disorders | montelukast | 11.33 | 10759916 | |
| MESH:D008881 | Migraine Disorders | Nitric Oxide | 11.33 | 11701602 | |
| MESH:D008881 | Migraine Disorders | Tyramine | 11.33 | 10792367 | |
| MESH:D008881 | Migraine Disorders | venlafaxine | 11.33 | 18803445 | |
| MESH:D020326 | Migraine without Aura | Dinoprostone | 5.80 | 11304026 | |
| MESH:D020326 | Migraine without Aura | Nitric Oxide | 5.80 | 14659530 11304026 | |
| MESH:D028361 | Mitochondrial Diseases | Doxorubicin | 2.91 | 15792986 | |
| MESH:D018200 | Mixed Tumor, Mullerian | Raloxifene | 3.82 | 15863610 | |
| MESH:D009041 | Motion Sickness | Dextroamphetamine | 3.81 | 1613127 | |
| MESH:D009062 | Mouth Neoplasms | Benzo(a)pyrene | 6.10 | 16381670 | |
| MESH:D009062 | Mouth Neoplasms | Fenretinide | 6.10 | 16274795 | |
| MESH:D009062 | Mouth Neoplasms | Indomethacin | 6.10 | 12636206 | |
| MESH:D009069 | Movement Disorders | Manganese | 6.26 | 16551646 | |
| MESH:D009069 | Movement Disorders | Methylmercury Compounds | 6.26 | 18436314 | |
| MESH:D052016 | Mucositis | Doxorubicin | 3.10 | 17415656 | |
| MESH:D009101 | Multiple Myeloma | arsenic trioxide | 42.16 | 15949261 19417148 14977855 19549372 11468182 | |
| MESH:D009101 | Multiple Myeloma | bortezomib | 42.16 | 19112201 19372569 19112817 | |
| MESH:D009101 | Multiple Myeloma | Capsaicin | 42.16 | 17505005 | |
| MESH:D009101 | Multiple Myeloma | CPS 11 | 42.16 | 15858615 | |
| MESH:D009101 | Multiple Myeloma | CPS 49 | 42.16 | 15858615 | |
| MESH:D009101 | Multiple Myeloma | Curcumin | 42.16 | 19372569 | |
| MESH:D009101 | Multiple Myeloma | decitabine | 42.16 | 18172295 | |
| MESH:D009101 | Multiple Myeloma | Dexamethasone | 42.16 | 15867202 15744524 16118317 | |
| MESH:D009101 | Multiple Myeloma | Paclitaxel | 42.16 | 14749477 | |
| MESH:D009101 | Multiple Myeloma | picropodophyllin | 42.16 | 16166596 | |
| MESH:D009101 | Multiple Myeloma | Raloxifene | 42.16 | 16497877 | |
| MESH:D009101 | Multiple Myeloma | resveratrol | 42.16 | 17935668 16267019 17049120 16490592 14749477 17164350 | |
| MESH:D009101 | Multiple Myeloma | Thalidomide | 42.16 | 15744524 19112817 15939924 17168659 16445831 19112201 19372569 15867202 15920492 15741222 | |
| MESH:D009101 | Multiple Myeloma | trichostatin A | 42.16 | 18172295 | |
| MESH:D009101 | Multiple Myeloma | Vitamin A | 42.16 | 16374440 | |
| MESH:D009101 | Multiple Myeloma | zoledronic acid | 42.16 | 18089719 19621390 16996129 | |
| MESH:D009102 | Multiple Organ Failure | Zymosan | 3.61 | 10479408 15259001 15241586 15834315 10890648 17724436 12130978 12879239 15213630 18160304 | |
| MESH:D020528 | Multiple Sclerosis, Chronic Progressive | Iron | 3.95 | 17086897 | |
| MESH:D009128 | Muscle Spasticity | 3-(2-hydroxy-4-(1,1-dimethylheptyl)phenyl)-4-(3-hydroxypropyl)cyclohexanol | 7.97 | 17220914 | |
| MESH:D009128 | Muscle Spasticity | Win 55212-2 | 7.97 | 17220914 | |
| MESH:D009134 | Muscular Atrophy, Spinal | Curcumin | 11.43 | 17962980 | |
| MESH:D009134 | Muscular Atrophy, Spinal | epigallocatechin gallate | 11.43 | 17962980 | |
| MESH:D009134 | Muscular Atrophy, Spinal | resveratrol | 11.43 | 17962980 | |
| MESH:D009135 | Muscular Diseases | atorvastatin | 5.27 | 16239165 | |
| MESH:D009135 | Muscular Diseases | pirinixic acid | 5.27 | 16239165 | |
| MESH:D009137 | Muscular Dystrophy, Animal | Gentamicins | 4.54 | 18694830 | |
| MESH:D009145 | Mushroom Poisoning | Silymarin | 5.21 | 17213517 | |
| MESH:D009181 | Mycoses | Iron | 8.14 | 16640825 | |
| MESH:D009181 | Mycoses | Nystatin | 8.14 | 16374455 | |
| MESH:D009182 | Mycosis Fungoides | arsenic trioxide | 2.95 | 18349030 | |
| MESH:D009190 | Myelodysplastic Syndromes | arsenic trioxide | 9.56 | 16882451 16105982 | |
| MESH:D009190 | Myelodysplastic Syndromes | decitabine | 9.56 | 19157545 16882708 19010910 18608210 | |
| MESH:D009190 | Myelodysplastic Syndromes | Dexamethasone | 9.56 | 9809623 | |
| MESH:D009190 | Myelodysplastic Syndromes | Thalidomide | 9.56 | 18720364 | |
| MESH:D009190 | Myelodysplastic Syndromes | Tretinoin | 9.56 | 17596541 | |
| MESH:D009196 | Myeloproliferative Disorders | WP1066 | 5.40 | 18245540 | |
| MESH:D009203 | Myocardial Infarction | alpha-Tocopherol | 22.90 | 19595682 | |
| MESH:D009203 | Myocardial Infarction | Aspirin | 22.90 | 12692751 | |
| MESH:D009203 | Myocardial Infarction | Doxorubicin | 22.90 | 19429709 15857846 | |
| MESH:D009203 | Myocardial Infarction | Genistein | 22.90 | 17141266 | |
| MESH:D009203 | Myocardial Infarction | Homocysteine | 22.90 | 17412321 | |
| MESH:D009203 | Myocardial Infarction | Isoproterenol | 22.90 | 19595682 19172585 17052832 15740881 16697266 16584858 16538859 | |
| MESH:D009203 | Myocardial Infarction | Lithium | 22.90 | 16288908 | |
| MESH:D009203 | Myocardial Infarction | Losartan | 22.90 | 12692751 | |
| MESH:D009203 | Myocardial Infarction | mangiferin | 22.90 | 16697266 17052832 16584858 16538859 19172585 | |
| MESH:D009203 | Myocardial Infarction | pirinixic acid | 22.90 | 19151258 | |
| MESH:D009203 | Myocardial Infarction | Quercetin | 22.90 | 19595682 | |
| MESH:D009203 | Myocardial Infarction | resveratrol | 22.90 | 16456233 16525036 16317513 17188708 17125593 17015251 | |
| MESH:D017202 | Myocardial Ischemia | Arsenic | 13.07 | 15371236 | |
| MESH:D017202 | Myocardial Ischemia | Dobutamine | 13.07 | 12447174 | |
| MESH:D017202 | Myocardial Ischemia | Iron | 13.07 | 16604332 | |
| MESH:D017202 | Myocardial Ischemia | resveratrol | 13.07 | 17015251 17125593 | |
| MESH:D017202 | Myocardial Ischemia | Tetrachlorodibenzodioxin | 13.07 | 12213967 | |
| MESH:D015428 | Myocardial Reperfusion Injury | Estradiol | 14.53 | 16810080 | |
| MESH:D015428 | Myocardial Reperfusion Injury | Genistein | 14.53 | 17141266 | |
| MESH:D015428 | Myocardial Reperfusion Injury | Iron | 14.53 | 16604332 | |
| MESH:D015428 | Myocardial Reperfusion Injury | Norepinephrine | 14.53 | 15642760 | |
| MESH:D015428 | Myocardial Reperfusion Injury | pirinixic acid | 14.53 | 16411023 | |
| MESH:D015428 | Myocardial Reperfusion Injury | Quercetin | 14.53 | 19207477 | |
| MESH:D009205 | Myocarditis | Particulate Matter | 6.82 | 12563109 | |
| MESH:D009205 | Myocarditis | resveratrol | 6.82 | 17322642 | |
| MESH:D020191 | Myoclonic Epilepsies, Progressive | Phenobarbital | 6.88 | 17484760 | |
| MESH:D020191 | Myoclonic Epilepsies, Progressive | Phenytoin | 6.88 | 17484760 | |
| MESH:D009224 | Myotonia Congenita | Phenytoin | 3.72 | 1896199 | |
| MESH:D009232 | Myxoma | Raloxifene | 3.82 | 16343187 | |
| MESH:D009298 | Nasal Polyps | zileuton | 4.50 | 10665187 | |
| MESH:D009325 | Nausea | Aspirin | 6.56 | 15240983 | |
| MESH:D009325 | Nausea | vorinostat | 6.56 | 20479100 | |
| MESH:D009336 | Necrosis | 2,4-dinitrotoluene | 8.23 | 18551238 | |
| MESH:D009336 | Necrosis | 2,6-dinitrotoluene | 8.23 | 18551238 7678174 | |
| MESH:D009336 | Necrosis | 2-ethoxyethanol | 8.23 | 20172899 | |
| MESH:D009361 | Neoplasm Invasiveness | Amiloride | 19.55 | 14644129 | |
| MESH:D009361 | Neoplasm Invasiveness | arsenic trioxide | 19.55 | 16624393 | |
| MESH:D009361 | Neoplasm Invasiveness | bis(4-hydroxycinnamoyl)methane | 19.55 | 18495463 | |
| MESH:D009361 | Neoplasm Invasiveness | Curcumin | 19.55 | 18495463 | |
| MESH:D009361 | Neoplasm Invasiveness | demethoxycurcumin | 19.55 | 18495463 | |
| MESH:D009361 | Neoplasm Invasiveness | tetracycline CMT-3 | 19.55 | 11172680 11172682 | |
| MESH:D009362 | Neoplasm Metastasis | 4,4'-diaminodiphenylmethane | 20.66 | 3581430 | |
| MESH:D009362 | Neoplasm Metastasis | Acetylcysteine | 20.66 | 14720322 | |
| MESH:D009362 | Neoplasm Metastasis | Diethylnitrosamine | 20.66 | 9029167 3581430 | |
| MESH:D009362 | Neoplasm Metastasis | Doxorubicin | 20.66 | 18259882 | |
| MESH:D009362 | Neoplasm Metastasis | imatinib | 20.66 | 15867366 | |
| MESH:D009362 | Neoplasm Metastasis | Indomethacin | 20.66 | 11239499 11053908 16537180 | |
| MESH:D009362 | Neoplasm Metastasis | Paclitaxel | 20.66 | 15867366 | |
| MESH:D009362 | Neoplasm Metastasis | pentaacetyl geniposide | 20.66 | 19464279 | |
| MESH:D009362 | Neoplasm Metastasis | punarnavine | 20.66 | 19171408 | |
| MESH:D009362 | Neoplasm Metastasis | Tamoxifen | 20.66 | 19393235 | |
| MESH:D009362 | Neoplasm Metastasis | zoledronic acid | 20.66 | 19139120 17312309 15867366 | |
| MESH:D009364 | Neoplasm Recurrence, Local | Tamoxifen | 1.74 | 19410462 | |
| MESH:D009369 | Neoplasms | 2,4,5,2',4',5'-hexachlorobiphenyl | 40.42 | 8820588 | |
| MESH:D009369 | Neoplasms | Acrolein | 40.42 | 17329238 | |
| MESH:D009369 | Neoplasms | alitretinoin | 40.42 | 16946489 | |
| MESH:D009369 | Neoplasms | atrasentan | 40.42 | 16219361 | |
| MESH:D009369 | Neoplasms | Benzo(a)pyrene | 40.42 | 11141357 | |
| MESH:D009369 | Neoplasms | beta Carotene | 40.42 | 17051425 | |
| MESH:D009369 | Neoplasms | Cisplatin | 40.42 | 16773208 | |
| MESH:D009369 | Neoplasms | Cyclophosphamide | 40.42 | 18854779 | |
| MESH:D009369 | Neoplasms | DDT | 40.42 | 8820588 | |
| MESH:D009369 | Neoplasms | decitabine | 40.42 | 19470736 19116145 17925555 | |
| MESH:D009369 | Neoplasms | Dieldrin | 40.42 | 8820588 | |
| MESH:D009369 | Neoplasms | Diethylstilbestrol | 40.42 | 15313581 | |
| MESH:D009369 | Neoplasms | Fenretinide | 40.42 | 15958647 17353921 | |
| MESH:D009369 | Neoplasms | Lindane | 40.42 | 12807735 16818664 | |
| MESH:D009369 | Neoplasms | lycopene | 40.42 | 17051425 | |
| MESH:D009369 | Neoplasms | Methylnitrosourea | 40.42 | 15533788 | |
| MESH:D009369 | Neoplasms | Nicotine | 40.42 | 16365874 | |
| MESH:D009369 | Neoplasms | pirinixic acid | 40.42 | 17405874 | |
| MESH:D009369 | Neoplasms | Quercetin | 40.42 | 15185748 | |
| MESH:D009369 | Neoplasms | sodium arsenite | 40.42 | 11559025 | |
| MESH:D009369 | Neoplasms | Tretinoin | 40.42 | 16946489 16594593 | |
| MESH:D009369 | Neoplasms | Urethane | 40.42 | 15625555 | |
| MESH:D009374 | Neoplasms, Experimental | Asbestos, Serpentine | 18.03 | 11704859 | |
| MESH:D009374 | Neoplasms, Experimental | Indomethacin | 18.03 | 15625704 10663608 | |
| MESH:D009374 | Neoplasms, Experimental | Methylnitrosourea | 18.03 | 12696579 | |
| MESH:D009374 | Neoplasms, Experimental | resveratrol | 18.03 | 8985016 | |
| MESH:D009374 | Neoplasms, Experimental | sodium arsenite | 18.03 | 20056578 | |
| MESH:D009374 | Neoplasms, Experimental | Toluene 2,4-Diisocyanate | 18.03 | 1670384 | |
| MESH:D009374 | Neoplasms, Experimental | Urethane | 18.03 | 15582191 | |
| MESH:D009376 | Neoplasms, Hormone-Dependent | Curcumin | 8.65 | 12497104 | |
| MESH:D009376 | Neoplasms, Hormone-Dependent | imatinib | 8.65 | 17614352 | |
| MESH:D009376 | Neoplasms, Hormone-Dependent | Tamoxifen | 8.65 | 19196722 19189210 19200415 | |
| MESH:D009389 | Neovascularization, Pathologic | arsenite | 10.74 | 15738583 | |
| MESH:D009389 | Neovascularization, Pathologic | Copper | 10.74 | 17308104 | |
| MESH:D009389 | Neovascularization, Pathologic | Estradiol | 10.74 | 17289903 | |
| MESH:D009389 | Neovascularization, Pathologic | Nicotine | 10.74 | 16365874 | |
| MESH:D009393 | Nephritis | Acrolein | 4.56 | 12653641 | |
| MESH:D009395 | Nephritis, Interstitial | Cisplatin | 2.83 | 15464296 | |
| MESH:D009401 | Nephrosis | Doxorubicin | 3.10 | 16899518 16636307 | |
| MESH:D009402 | Nephrosis, Lipoid | Cyclosporine | 2.72 | 17954296 | |
| MESH:D009404 | Nephrotic Syndrome | atorvastatin | 13.49 | 19348381 | |
| MESH:D009404 | Nephrotic Syndrome | Cyclosporine | 13.49 | 18481113 19348381 | |
| MESH:D009404 | Nephrotic Syndrome | Doxorubicin | 13.49 | 15640375 16889571 | |
| MESH:D009404 | Nephrotic Syndrome | Iron | 13.49 | 17178036 | |
| MESH:D009404 | Nephrotic Syndrome | Vitamin U | 13.49 | 583214 | |
| MESH:D009410 | Nerve Degeneration | Maneb | 10.97 | 16893418 15350641 | |
| MESH:D009410 | Nerve Degeneration | Manganese | 10.97 | 16551646 | |
| MESH:D009410 | Nerve Degeneration | mangiferin | 10.97 | 17433543 | |
| MESH:D009410 | Nerve Degeneration | Paraquat | 10.97 | 16893418 | |
| MESH:D009410 | Nerve Degeneration | Rotenone | 10.97 | 18619942 15790535 17356569 | |
| MESH:D009421 | Nervous System Malformations | bisphenol A | 21.80 | 16427766 11399458 | |
| MESH:D009421 | Nervous System Malformations | Diethylstilbestrol | 21.80 | 11399458 | |
| MESH:D009421 | Nervous System Malformations | Estradiol | 21.80 | 11399458 16427766 | |
| MESH:D009421 | Nervous System Malformations | Genistein | 21.80 | 16427766 | |
| MESH:D009421 | Nervous System Malformations | Tetrachlorodibenzodioxin | 21.80 | 14600291 | |
| MESH:D009421 | Nervous System Malformations | Thalidomide | 21.80 | 16859833 | |
| MESH:D009421 | Nervous System Malformations | Tretinoin | 21.80 | 9125849 | |
| MESH:D009423 | Nervous System Neoplasms | Curcumin | 3.90 | 18462866 | |
| MESH:D009436 | Neural Tube Defects | 4,4'-diaminodiphenylmethane | 19.70 | 6679447 | |
| MESH:D009436 | Neural Tube Defects | Acetylcysteine | 19.70 | 19446573 | |
| MESH:D009436 | Neural Tube Defects | Arsenic | 19.70 | 16620997 | |
| MESH:D009436 | Neural Tube Defects | arsenic trioxide | 19.70 | 10525206 | |
| MESH:D009436 | Neural Tube Defects | Folic Acid | 19.70 | 17438019 | |
| MESH:D009436 | Neural Tube Defects | Phenytoin | 19.70 | 9118846 | |
| MESH:D009436 | Neural Tube Defects | sodium arsenite | 19.70 | 12854658 | |
| MESH:D009436 | Neural Tube Defects | Tretinoin | 19.70 | 9142499 | |
| MESH:D009436 | Neural Tube Defects | Vitamin A | 19.70 | 17400914 | |
| MESH:D009442 | Neurilemmoma | Methylnitrosourea | 3.79 | 11555667 | |
| MESH:D019954 | Neurobehavioral Manifestations | 2,3,3',4,4',5-hexachlorobiphenyl | 7.18 | 19647017 | |
| MESH:D019954 | Neurobehavioral Manifestations | Plant Extracts | 7.18 | 17168769 | |
| MESH:D009447 | Neuroblastoma | Cisplatin | 4.54 | 8761367 | |
| MESH:D009447 | Neuroblastoma | Cyclophosphamide | 4.54 | 16115947 15176712 8761367 | |
| MESH:D009447 | Neuroblastoma | Doxorubicin | 4.54 | 15555623 | |
| MESH:D019636 | Neurodegenerative Diseases | Acetaminophen | 16.96 | 18514411 | |
| MESH:D019636 | Neurodegenerative Diseases | Acrolein | 16.96 | 11342003 | |
| MESH:D019636 | Neurodegenerative Diseases | Amphetamine | 16.96 | 15183010 | |
| MESH:D019636 | Neurodegenerative Diseases | Diethylnitrosamine | 16.96 | 20387270 | |
| MESH:D019636 | Neurodegenerative Diseases | Indomethacin | 16.96 | 12349958 | |
| MESH:D019636 | Neurodegenerative Diseases | Iron | 16.96 | 17296847 16604332 | |
| MESH:D019636 | Neurodegenerative Diseases | resveratrol | 16.96 | 17652729 | |
| MESH:D017599 | Neuroectodermal Tumors | Cisplatin | 5.94 | 8761367 | |
| MESH:D017599 | Neuroectodermal Tumors | Cyclophosphamide | 5.94 | 12837982 8761367 | |
| MESH:D020078 | Neurogenic Inflammation | Arsenic | 12.34 | 17056641 | |
| MESH:D020078 | Neurogenic Inflammation | Capsaicin | 12.34 | 17961222 | |
| MESH:D020078 | Neurogenic Inflammation | Quercetin | 12.34 | 17929310 | |
| MESH:D020078 | Neurogenic Inflammation | resveratrol | 12.34 | 17929310 | |
| MESH:D009461 | Neurologic Manifestations | Diethylnitrosamine | 3.39 | 20387270 | |
| MESH:D009472 | Neuronal Ceroid-Lipofuscinoses | Fenretinide | 3.97 | 16303764 | |
| MESH:D020258 | Neurotoxicity Syndromes | Chlorpyrifos | 2.89 | 15081274 | |
| MESH:D009503 | Neutropenia | Cyclophosphamide | 6.51 | 8291058 | |
| MESH:D009503 | Neutropenia | Folic Acid | 6.51 | 16322990 | |
| MESH:D009503 | Neutropenia | Mustard Gas | 6.51 | 16761898 7688884 | |
| MESH:D009669 | Nose Neoplasms | chromium hexavalent ion | 4.97 | 16876463 | |
| MESH:D009669 | Nose Neoplasms | Hydrocarbons, Chlorinated | 4.97 | 12024805 | |
| MESH:D009765 | Obesity | 2-chloroethyl ethyl sulfide | 12.20 | 16289378 | |
| MESH:D009765 | Obesity | Ascorbic Acid | 12.20 | 17217161 | |
| MESH:D009765 | Obesity | Capsaicin | 12.20 | 19056576 | |
| MESH:D009765 | Obesity | Clozapine | 12.20 | 19142110 18515891 | |
| MESH:D009765 | Obesity | Curcumin | 12.20 | 19297423 | |
| MESH:D009765 | Obesity | Dietary Fats | 12.20 | 17217161 16723640 19632207 20518802 18457598 18674790 20132043 21332399 11836018 | |
| MESH:D009765 | Obesity | oleoylethanolamide | 12.20 | 15910890 | |
| MESH:D009765 | Obesity | pirinixic acid | 12.20 | 20558911 | |
| MESH:D009765 | Obesity | Plant Extracts | 12.20 | 19056576 20132043 | |
| MESH:D009771 | Obsessive-Compulsive Disorder | venlafaxine | 4.09 | 17503984 | |
| MESH:D007752 | Obstetric Labor, Premature | Indomethacin | 7.79 | 6374098 | |
| MESH:D007752 | Obstetric Labor, Premature | Terbutaline | 7.79 | 14998686 | |
| MESH:D009784 | Occupational Diseases | 2,4-dinitrotoluene | 9.04 | 16049721 12819281 | |
| MESH:D009784 | Occupational Diseases | 2,6-dinitrotoluene | 9.04 | 16049721 | |
| MESH:D009784 | Occupational Diseases | 4,4'-diaminodiphenylmethane | 9.04 | 6482804 4026338 | |
| MESH:D009784 | Occupational Diseases | Toluene 2,4-Diisocyanate | 9.04 | 18394133 11077013 3040596 6091946 12585506 6091945 8156442 | |
| MESH:D009845 | Oligospermia | 2-ethoxyethanol | 8.52 | 20172899 | |
| MESH:D009845 | Oligospermia | Cyclophosphamide | 8.52 | 16517039 | |
| MESH:D009845 | Oligospermia | methyl cellosolve | 8.52 | 3987992 | |
| MESH:D009902 | Optic Neuritis | 4,4'-diaminodiphenylmethane | 3.29 | 3988306 | |
| MESH:D010003 | Osteoarthritis | Aspirin | 5.22 | 7009135 | |
| MESH:D010003 | Osteoarthritis | Indomethacin | 5.22 | 7009135 | |
| MESH:D010003 | Osteoarthritis | Iron | 5.22 | 16640825 | |
| MESH:D010005 | Osteoarthropathy, Secondary Hypertrophic | Dinoprostone | 4.74 | 18500342 | |
| MESH:D010014 | Osteolysis | imatinib | 10.75 | 15867366 | |
| MESH:D010014 | Osteolysis | Paclitaxel | 10.75 | 15867366 | |
| MESH:D010014 | Osteolysis | zoledronic acid | 10.75 | 15867366 | |
| MESH:D010018 | Osteomalacia | Phenobarbital | 6.47 | 17016548 | |
| MESH:D010018 | Osteomalacia | Phenytoin | 6.47 | 17016548 | |
| MESH:D010024 | Osteoporosis | Calcium | 16.22 | 17882678 | |
| MESH:D010024 | Osteoporosis | Curcumin | 16.22 | 18719352 | |
| MESH:D010024 | Osteoporosis | Genistein | 16.22 | 19401787 | |
| MESH:D010024 | Osteoporosis | icariin | 16.22 | 18236786 19747809 | |
| MESH:D010024 | Osteoporosis | Iron | 16.22 | 16648989 16640825 | |
| MESH:D010024 | Osteoporosis | kaempferol | 16.22 | 16756079 | |
| MESH:D010024 | Osteoporosis | Raloxifene | 16.22 | 17882678 15775268 19059307 | |
| MESH:D010024 | Osteoporosis | zoledronic acid | 16.22 | 17882678 | |
| MESH:D015663 | Osteoporosis, Postmenopausal | Dehydroepiandrosterone | 23.24 | 16397352 | |
| MESH:D015663 | Osteoporosis, Postmenopausal | Drugs, Chinese Herbal | 23.24 | 16548355 | |
| MESH:D015663 | Osteoporosis, Postmenopausal | Genistein | 23.24 | 16169203 | |
| MESH:D015663 | Osteoporosis, Postmenopausal | LY 117018 | 23.24 | 17907171 17638036 | |
| MESH:D015663 | Osteoporosis, Postmenopausal | Quercetin | 23.24 | 19495926 | |
| MESH:D015663 | Osteoporosis, Postmenopausal | Raloxifene | 23.24 | 17823083 15758505 17893378 15579764 | |
| MESH:D015663 | Osteoporosis, Postmenopausal | resveratrol | 23.24 | 17513867 | |
| MESH:D012516 | Osteosarcoma | Doxorubicin | 2.64 | 15930896 | |
| MESH:D010049 | Ovarian Diseases | bisphenol A | 3.28 | 11985600 | |
| MESH:D010051 | Ovarian Neoplasms | marker/mechanism | 16211241 | ||
| MESH:D010051 | Ovarian Neoplasms | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one | 43.61 | 16211241 | |
| MESH:D010051 | Ovarian Neoplasms | 4-((3-bromophenyl)amino)-6,7-dimethoxyquinazoline | 43.61 | 16211241 | |
| MESH:D010051 | Ovarian Neoplasms | Arsenic | 43.61 | 17306315 | |
| MESH:D010051 | Ovarian Neoplasms | arsenic trioxide | 43.61 | 12452020 19769630 16624393 | |
| MESH:D010051 | Ovarian Neoplasms | Cisplatin | 43.61 | 6897625 19769630 15464296 17225452 | |
| MESH:D010051 | Ovarian Neoplasms | Curcumin | 43.61 | 19020741 18462866 | |
| MESH:D010051 | Ovarian Neoplasms | decitabine | 43.61 | 19331143 19259094 | |
| MESH:D010051 | Ovarian Neoplasms | Estradiol | 43.61 | 19401270 | |
| MESH:D010051 | Ovarian Neoplasms | Fenretinide | 43.61 | 16133793 | |
| MESH:D010051 | Ovarian Neoplasms | Genistein | 43.61 | 19005980 | |
| MESH:D010051 | Ovarian Neoplasms | Luteolin | 43.61 | 19005980 | |
| MESH:D010051 | Ovarian Neoplasms | Mifepristone | 43.61 | 16525653 | |
| MESH:D010051 | Ovarian Neoplasms | Paclitaxel | 43.61 | 11161223 | |
| MESH:D010051 | Ovarian Neoplasms | Progesterone | 43.61 | 16525653 17393432 | |
| MESH:D010051 | Ovarian Neoplasms | Quercetin | 43.61 | 19005980 | |
| MESH:D010051 | Ovarian Neoplasms | sodium arsenite | 43.61 | 15276417 17306315 | |
| MESH:D010051 | Ovarian Neoplasms | Thalidomide | 43.61 | 16288038 | |
| MESH:D010051 | Ovarian Neoplasms | Tretinoin | 43.61 | 16936753 | |
| MESH:D010051 | Ovarian Neoplasms | trichostatin A | 43.61 | 19331143 | |
| MESH:D010051 | Ovarian Neoplasms | U 0126 | 43.61 | 16211241 | |
| MESH:D010051 | Ovarian Neoplasms | Urethane | 43.61 | 16391232 | |
| MESH:D010146 | Pain | 1-(6-((3-methoxyestra-1,3,5(10)-trien-17-yl)amino)hexyl)-1H-pyrrole-2,5-dione | 19.75 | 18987195 | |
| MESH:D010146 | Pain | Acetaminophen | 19.75 | 16870215 | |
| MESH:D010146 | Pain | Aspirin | 19.75 | 6995502 6363464 | |
| MESH:D010146 | Pain | Capsaicin | 19.75 | 17043245 19081190 17084039 16996476 17434803 18987195 | |
| MESH:D010146 | Pain | Cyclophosphamide | 19.75 | 12161096 18093676 | |
| MESH:D010146 | Pain | Indomethacin | 19.75 | 17627676 3291741 17440234 13679232 | |
| MESH:D010146 | Pain | montelukast | 19.75 | 15935457 | |
| MESH:D010146 | Pain | Phenytoin | 19.75 | 15215642 | |
| MESH:D010146 | Pain | Tretinoin | 19.75 | 16870215 | |
| MESH:D010146 | Pain | zileuton | 19.75 | 15935457 | |
| MESH:D010146 | Pain | zoledronic acid | 19.75 | 16475674 | |
| MESH:D010149 | Pain, Postoperative | Indomethacin | 3.00 | 12538197 18702446 | |
| MESH:D010190 | Pancreatic Neoplasms | 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone | 37.73 | 12384795 | |
| MESH:D010190 | Pancreatic Neoplasms | arsenic trioxide | 37.73 | 15580305 | |
| MESH:D010190 | Pancreatic Neoplasms | Cisplatin | 37.73 | 19003803 | |
| MESH:D010190 | Pancreatic Neoplasms | Curcumin | 37.73 | 19196508 19401701 17440100 | |
| MESH:D010190 | Pancreatic Neoplasms | Cyclophosphamide | 37.73 | 11332152 | |
| MESH:D010190 | Pancreatic Neoplasms | Dacarbazine | 37.73 | 11583197 | |
| MESH:D010190 | Pancreatic Neoplasms | decitabine | 37.73 | 19294695 | |
| MESH:D010190 | Pancreatic Neoplasms | Diethylnitrosamine | 37.73 | 16540662 | |
| MESH:D010190 | Pancreatic Neoplasms | Ethanol | 37.73 | 12384795 | |
| MESH:D010190 | Pancreatic Neoplasms | Fenretinide | 37.73 | 15580305 | |
| MESH:D010190 | Pancreatic Neoplasms | Methylnitrosourea | 37.73 | 16965848 | |
| MESH:D010190 | Pancreatic Neoplasms | N-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide | 37.73 | 11504793 | |
| MESH:D010190 | Pancreatic Neoplasms | Phenobarbital | 37.73 | 16965848 | |
| MESH:D010190 | Pancreatic Neoplasms | Quercetin | 37.73 | 16965848 | |
| MESH:D010190 | Pancreatic Neoplasms | Reactive Oxygen Species | 37.73 | 15580305 | |
| MESH:D010190 | Pancreatic Neoplasms | Tetradecanoylphorbol Acetate | 37.73 | 15976015 | |
| MESH:D010190 | Pancreatic Neoplasms | Tretinoin | 37.73 | 15976015 | |
| MESH:D010190 | Pancreatic Neoplasms | trichostatin A | 37.73 | 19294695 | |
| MESH:D010195 | Pancreatitis | Indomethacin | 2.48 | 15028970 17883296 | |
| MESH:D016584 | Panic Disorder | Ethinyl Estradiol | 2.08 | 11578682 | |
| MESH:D010212 | Papilloma | 4,4'-diaminodiphenylmethane | 11.94 | 7296757 | |
| MESH:D010212 | Papilloma | Hydrogen Peroxide | 11.94 | 12065085 | |
| MESH:D010212 | Papilloma | Iron | 11.94 | 12065085 | |
| MESH:D010212 | Papilloma | Plant Extracts | 11.94 | 15173996 16517061 | |
| MESH:D010212 | Papilloma | Tetradecanoylphorbol Acetate | 11.94 | 18922899 12065085 8330346 18404319 | |
| MESH:D010214 | Papillon-Lefevre Disease | Acitretin | 5.19 | 16008657 | |
| MESH:D010235 | Paraganglioma | arsenic trioxide | 2.55 | 19927285 | |
| MESH:D010257 | Paraneoplastic Syndromes | Indomethacin | 3.99 | 16537180 | |
| MESH:D020447 | Parasomnias | Iron | 4.29 | 17352947 | |
| MESH:D010291 | Paresis | Thalidomide | 4.57 | 9200351 | |
| MESH:D010300 | Parkinson Disease | Acrolein | 17.70 | 17690948 | |
| MESH:D010300 | Parkinson Disease | Atrazine | 17.70 | 17218051 | |
| MESH:D010300 | Parkinson Disease | Dieldrin | 17.70 | 16112328 11181820 11445065 17291500 16809432 | |
| MESH:D010300 | Parkinson Disease | Ditiocarb | 17.70 | 11445065 | |
| MESH:D010300 | Parkinson Disease | Homocysteine | 17.70 | 16275827 | |
| MESH:D010300 | Parkinson Disease | Iron | 17.70 | 16640825 16563566 | |
| MESH:D010300 | Parkinson Disease | Maneb | 17.70 | 16140633 12911755 11124998 16510128 15824117 | |
| MESH:D010300 | Parkinson Disease | Manganese | 17.70 | 11181820 | |
| MESH:D010300 | Parkinson Disease | mangiferin | 17.70 | 17433543 | |
| MESH:D010300 | Parkinson Disease | Paraquat | 17.70 | 16140633 12911755 16510128 15451049 11124998 11445065 15824117 11181820 | |
| MESH:D010300 | Parkinson Disease | Rotenone | 17.70 | 19114014 19232380 18191903 16412576 15451049 11535288 18619942 11445065 16140633 | |
| MESH:D010302 | Parkinson Disease, Secondary | Paraquat | 2.79 | 16190885 | |
| MESH:D020734 | Parkinsonian Disorders | Indomethacin | 6.50 | 12349958 | |
| MESH:D020734 | Parkinsonian Disorders | Manganese | 6.50 | 16140633 | |
| MESH:D020734 | Parkinsonian Disorders | Rotenone | 6.50 | 15927086 15574749 15795934 18197244 | |
| MESH:D051302 | Paroxysmal Hemicrania | Indomethacin | 3.99 | 11903285 | |
| MESH:D010382 | Peliosis Hepatis | Tetrachlorodibenzodioxin | 2.52 | 12520081 | |
| MESH:D010437 | Peptic Ulcer | Indomethacin | 3.45 | 11148446 | |
| MESH:D010438 | Peptic Ulcer Hemorrhage | Aspirin | 3.84 | 11156591 | |
| MESH:D010518 | Periodontitis | Indomethacin | 6.73 | 17225004 | |
| MESH:D010518 | Periodontitis | mangiferin | 6.73 | 19026997 | |
| MESH:D010523 | Peripheral Nervous System Diseases | Arsenic | 4.70 | 16093927 | |
| MESH:D010523 | Peripheral Nervous System Diseases | Cisplatin | 4.70 | 15464296 | |
| MESH:D016491 | Peripheral Vascular Diseases | Arsenic | 7.46 | 15371236 6392382 16905509 | |
| MESH:D016491 | Peripheral Vascular Diseases | Cadmium | 7.46 | 15687053 | |
| MESH:D010538 | Peritonitis | Glucans | 10.86 | 19804847 | |
| MESH:D010538 | Peritonitis | Ozone | 10.86 | 16369182 | |
| MESH:D010538 | Peritonitis | zileuton | 10.86 | 17371808 | |
| MESH:D010538 | Peritonitis | Zymosan | 10.86 | 18977430 11985352 17826846 17371808 18557954 15979727 15259001 18760300 19088179 14761945 19641140 | |
| MESH:D020795 | Photophobia | Aspirin | 4.04 | 15240983 | |
| MESH:D010787 | Photosensitivity Disorders | 4,4'-diaminodiphenylmethane | 12.71 | 6228378 | |
| MESH:D010787 | Photosensitivity Disorders | 4-hydroxy-2-nonenal | 12.71 | 11550810 | |
| MESH:D010787 | Photosensitivity Disorders | Acrolein | 12.71 | 11550810 | |
| MESH:D003557 | Phyllodes Tumor | Dacarbazine | 8.66 | 17983394 | |
| MESH:D003557 | Phyllodes Tumor | Doxorubicin | 8.66 | 17983394 | |
| MESH:D010900 | Pituitary Diseases | Diethylstilbestrol | 8.36 | 14722030 | |
| MESH:D010900 | Pituitary Diseases | Iron | 8.36 | 16604332 | |
| MESH:D010911 | Pituitary Neoplasms | Diethylstilbestrol | 6.60 | 16977796 15687265 | |
| MESH:D010911 | Pituitary Neoplasms | Urethane | 6.60 | 16391232 | |
| MESH:D010954 | Plasmacytoma | Selenium | 3.16 | 15087411 | |
| MESH:D010995 | Pleural Diseases | Asbestos, Crocidolite | 7.11 | 10923243 | |
| MESH:D010995 | Pleural Diseases | Asbestos, Serpentine | 7.11 | 10923243 | |
| MESH:D010997 | Pleural Neoplasms | Cisplatin | 8.23 | 17638057 | |
| MESH:D010997 | Pleural Neoplasms | Doxorubicin | 8.23 | 17638057 | |
| MESH:D011014 | Pneumonia | Butylated Hydroxytoluene | 12.91 | 11893704 | |
| MESH:D011014 | Pneumonia | Lipopolysaccharides | 12.91 | 11605937 12224865 | |
| MESH:D011014 | Pneumonia | Ozone | 12.91 | 18929643 18381685 18007984 | |
| MESH:D011014 | Pneumonia | Paraquat | 12.91 | 12504350 | |
| MESH:D011015 | Pneumonia, Aspiration | Nitric Oxide | 3.66 | 18573544 | |
| MESH:D011041 | Poisoning | Iron | 3.86 | 16604332 | |
| MESH:D011041 | Poisoning | Mustard Gas | 3.86 | 15727166 | |
| MESH:D011085 | Polycystic Ovary Syndrome | Glycosylation End Products, Advanced | 6.07 | 17201808 | |
| MESH:D011085 | Polycystic Ovary Syndrome | Metformin | 6.07 | 17062894 15356085 | |
| MESH:D011087 | Polycythemia Vera | WP1066 | 5.07 | 18245540 | |
| MESH:D017689 | Polydactyly | Phenytoin | 3.51 | 9212184 | |
| MESH:D017499 | Porokeratosis | alitretinoin | 4.27 | 16144296 | |
| MESH:D017119 | Porphyria Cutanea Tarda | Iron | 5.59 | 16640825 | |
| MESH:D017119 | Porphyria Cutanea Tarda | Tetrachlorodibenzodioxin | 5.59 | 18163543 | |
| MESH:D011230 | Precancerous Conditions | Cyclosporine | 9.45 | 12371664 | |
| MESH:D011230 | Precancerous Conditions | Diethylnitrosamine | 9.45 | 2563599 | |
| MESH:D011230 | Precancerous Conditions | Phenobarbital | 9.45 | 2563599 | |
| MESH:D011230 | Precancerous Conditions | Quercetin | 9.45 | 19056647 | |
| MESH:D054198 | Precursor Cell Lymphoblastic Leukemia-Lymphoma | Cyclophosphamide | 7.34 | 21297632 | |
| MESH:D054198 | Precursor Cell Lymphoblastic Leukemia-Lymphoma | Dexamethasone | 7.34 | 21297632 | |
| MESH:D054198 | Precursor Cell Lymphoblastic Leukemia-Lymphoma | imatinib | 7.34 | 12476293 | |
| MESH:D054198 | Precursor Cell Lymphoblastic Leukemia-Lymphoma | Thalidomide | 7.34 | 17031469 | |
| MESH:D011225 | Pre-Eclampsia | Iloprost | 7.17 | 10329876 | |
| MESH:D011225 | Pre-Eclampsia | Iron | 7.17 | 16640825 | |
| MESH:D011225 | Pre-Eclampsia | Zinc | 7.17 | 17114810 | |
| MESH:D011248 | Pregnancy Complications | 2,4-Dichlorophenoxyacetic Acid | 4.09 | 2087686 | |
| MESH:D047928 | Premature Birth | Indomethacin | 3.45 | 17000239 | |
| MESH:D011297 | Prenatal Exposure Delayed Effects | 2-ethoxyethanol | 29.17 | 7198755 2884743 6499817 | |
| MESH:D011297 | Prenatal Exposure Delayed Effects | bisphenol A | 29.17 | 10548101 | |
| MESH:D011297 | Prenatal Exposure Delayed Effects | Diethylstilbestrol | 29.17 | 17184923 | |
| MESH:D011297 | Prenatal Exposure Delayed Effects | Lead | 29.17 | 16384672 | |
| MESH:D011297 | Prenatal Exposure Delayed Effects | methyl cellosolve | 29.17 | 6499817 7974496 12530607 | |
| MESH:D011297 | Prenatal Exposure Delayed Effects | Methylmercury Compounds | 29.17 | 18436314 | |
| MESH:D011297 | Prenatal Exposure Delayed Effects | resveratrol | 29.17 | 16679765 | |
| MESH:D011297 | Prenatal Exposure Delayed Effects | Tetrachlorodibenzodioxin | 29.17 | 11118676 11222880 11896295 11399792 | |
| MESH:D011297 | Prenatal Exposure Delayed Effects | vinclozolin | 29.17 | 18220299 18042343 19015723 | |
| MESH:D055728 | Primary Myelofibrosis | decitabine | 6.88 | 17616702 | |
| MESH:D055728 | Primary Myelofibrosis | trichostatin A | 6.88 | 17616702 | |
| MESH:D011350 | Proctocolitis | Acetic Acid | 5.70 | 11561086 | |
| MESH:D011469 | Prostatic Diseases | vinclozolin | 3.23 | 18220299 | |
| MESH:D011470 | Prostatic Hyperplasia | Calcitriol | 3.09 | 15572423 | |
| MESH:D019048 | Prostatic Intraepithelial Neoplasia | bisphenol A | 8.89 | 20887781 | |
| MESH:D019048 | Prostatic Intraepithelial Neoplasia | Estradiol | 8.89 | 20887781 | |
| MESH:D019048 | Prostatic Intraepithelial Neoplasia | Testosterone | 8.89 | 20887781 | |
| MESH:D011471 | Prostatic Neoplasms | Apigenin | 36.77 | 17132221 | |
| MESH:D011471 | Prostatic Neoplasms | Arsenic | 36.77 | 16140617 | |
| MESH:D011471 | Prostatic Neoplasms | arsenic trioxide | 36.77 | 19131511 | |
| MESH:D011471 | Prostatic Neoplasms | Benzo(a)pyrene | 36.77 | 17292933 | |
| MESH:D011471 | Prostatic Neoplasms | bicalutamide | 36.77 | 15638997 17914592 19011039 19240160 18487222 | |
| MESH:D011471 | Prostatic Neoplasms | bisphenol A | 36.77 | 16740699 | |
| MESH:D011471 | Prostatic Neoplasms | Cadmium | 36.77 | 17075824 | |
| MESH:D011471 | Prostatic Neoplasms | Calcitriol | 36.77 | 16289102 15754350 18247401 12479363 16644109 | |
| MESH:D011471 | Prostatic Neoplasms | Clioquinol | 36.77 | 17308104 | |
| MESH:D011471 | Prostatic Neoplasms | Copper | 36.77 | 17079463 17308104 | |
| MESH:D011471 | Prostatic Neoplasms | Coumestrol | 36.77 | 16921512 | |
| MESH:D011471 | Prostatic Neoplasms | Curcumin | 36.77 | 18226269 18156803 11398177 10851300 15129424 18769126 12497104 | |
| MESH:D011471 | Prostatic Neoplasms | Cyclophosphamide | 36.77 | 17136230 | |
| MESH:D011471 | Prostatic Neoplasms | DDT | 36.77 | 12584743 | |
| MESH:D011471 | Prostatic Neoplasms | Diethylstilbestrol | 36.77 | 17136230 15846301 15046698 | |
| MESH:D011471 | Prostatic Neoplasms | docetaxel | 36.77 | 18824434 16644109 19103299 16520278 | |
| MESH:D011471 | Prostatic Neoplasms | Doxorubicin | 36.77 | 15749863 18437689 16868541 15897917 16888761 16729912 | |
| MESH:D011471 | Prostatic Neoplasms | equol | 36.77 | 16925846 16898868 | |
| MESH:D011471 | Prostatic Neoplasms | Estradiol | 36.77 | 16740699 | |
| MESH:D011471 | Prostatic Neoplasms | Estrogens, Catechol | 36.77 | 17261777 | |
| MESH:D011471 | Prostatic Neoplasms | farnesylthiosalicylic acid | 36.77 | 16780807 | |
| MESH:D011471 | Prostatic Neoplasms | Fenretinide | 36.77 | 17024972 | |
| MESH:D011471 | Prostatic Neoplasms | gefitinib | 36.77 | 16685379 15651060 17914592 | |
| MESH:D011471 | Prostatic Neoplasms | Genistein | 36.77 | 15256057 16925846 15378649 | |
| MESH:D011471 | Prostatic Neoplasms | Heptachlor | 36.77 | 12661182 | |
| MESH:D011471 | Prostatic Neoplasms | Hyaluronic Acid | 36.77 | 16864594 | |
| MESH:D011471 | Prostatic Neoplasms | Lindane | 36.77 | 14688026 12661182 | |
| MESH:D011471 | Prostatic Neoplasms | lycopene | 36.77 | 15084515 17337101 | |
| MESH:D011471 | Prostatic Neoplasms | Melphalan | 36.77 | 15749863 | |
| MESH:D011471 | Prostatic Neoplasms | Methylnitrosourea | 36.77 | 15682402 12376480 | |
| MESH:D011471 | Prostatic Neoplasms | methylselenic acid | 36.77 | 16205645 | |
| MESH:D011471 | Prostatic Neoplasms | Paclitaxel | 36.77 | 17136230 17172428 16729912 16356831 | |
| MESH:D011471 | Prostatic Neoplasms | Plant Extracts | 36.77 | 17804756 14666653 | |
| MESH:D011471 | Prostatic Neoplasms | pyrrolidine dithiocarbamic acid | 36.77 | 16139439 | |
| MESH:D011471 | Prostatic Neoplasms | Quercetin | 36.77 | 17292933 14715546 | |
| MESH:D011471 | Prostatic Neoplasms | Raloxifene | 36.77 | 15731164 16536755 16220300 | |
| MESH:D011471 | Prostatic Neoplasms | resveratrol | 36.77 | 17636462 17675339 17718901 17804756 16731767 15767336 | |
| MESH:D011471 | Prostatic Neoplasms | roscovitine | 36.77 | 16140939 | |
| MESH:D011471 | Prostatic Neoplasms | sodium arsenite | 36.77 | 16039940 | |
| MESH:D011471 | Prostatic Neoplasms | Sodium Selenite | 36.77 | 18760546 | |
| MESH:D011471 | Prostatic Neoplasms | sulindac sulfone | 36.77 | 15570007 17908994 | |
| MESH:D011471 | Prostatic Neoplasms | Tamoxifen | 36.77 | 15067354 | |
| MESH:D011471 | Prostatic Neoplasms | tetracycline CMT-3 | 36.77 | 11857423 11172682 | |
| MESH:D011471 | Prostatic Neoplasms | Thalidomide | 36.77 | 16729912 | |
| MESH:D011471 | Prostatic Neoplasms | theaflavin | 36.77 | 17499812 | |
| MESH:D011471 | Prostatic Neoplasms | trichostatin A | 36.77 | 18798265 19789329 | |
| MESH:D011471 | Prostatic Neoplasms | Vitamin E | 36.77 | 15084515 | |
| MESH:D011471 | Prostatic Neoplasms | vorinostat | 36.77 | 17218635 | |
| MESH:D011471 | Prostatic Neoplasms | Zinc | 36.77 | 16606632 12429649 16700911 16517595 | |
| MESH:D011471 | Prostatic Neoplasms | zoledronic acid | 36.77 | 19103299 12438248 | |
| MESH:D011472 | Prostatitis | vinclozolin | 3.23 | 18629315 | |
| MESH:D011507 | Proteinuria | Arsenic | 12.20 | 21343184 | |
| MESH:D011507 | Proteinuria | Gentamicins | 12.20 | 15033597 | |
| MESH:D011507 | Proteinuria | Indomethacin | 12.20 | 11849393 | |
| MESH:D011507 | Proteinuria | Tretinoin | 12.20 | 16636307 | |
| MESH:D011507 | Proteinuria | valsartan | 12.20 | 12164870 18344623 17664856 | |
| MESH:D011528 | Protozoan Infections | Iron | 4.29 | 16640825 | |
| MESH:D011536 | Prurigo | Thalidomide | 4.57 | 12755975 | |
| MESH:D011537 | Pruritus | Ethinyl Estradiol | 6.74 | 16919318 15861022 | |
| MESH:D011537 | Pruritus | Mustard Gas | 6.74 | 18058305 | |
| MESH:D011537 | Pruritus | zileuton | 6.74 | 19657356 17827870 | |
| MESH:D019310 | Pseudolymphoma | Phenobarbital | 6.88 | 12752131 | |
| MESH:D019310 | Pseudolymphoma | Phenytoin | 6.88 | 12752131 1419762 8603615 | |
| MESH:D011565 | Psoriasis | Acitretin | 3.18 | 16385345 16924049 | |
| MESH:D011565 | Psoriasis | Cyclosporine | 3.18 | 16882103 | |
| MESH:D011595 | Psychomotor Agitation | Haloperidol | 3.30 | 11575062 | |
| MESH:D011618 | Psychotic Disorders | Clozapine | 4.45 | 15331141 | |
| MESH:D011618 | Psychotic Disorders | Haloperidol | 4.45 | 11575062 | |
| MESH:D011625 | Pterygium | Tretinoin | 3.09 | 16723453 | |
| MESH:D011629 | Puberty, Precocious | bisphenol A | 3.09 | 10548101 | |
| MESH:D011654 | Pulmonary Edema | Isoproterenol | 8.65 | 10903255 | |
| MESH:D011654 | Pulmonary Edema | Terbutaline | 8.65 | 10903255 | |
| MESH:D011654 | Pulmonary Edema | zileuton | 8.65 | 18309904 | |
| MESH:D011656 | Pulmonary Emphysema | Curcumin | 2.96 | 19168576 | |
| MESH:D011657 | Pulmonary Eosinophilia | alpha-Tocopherol | 11.66 | 14606601 | |
| MESH:D011657 | Pulmonary Eosinophilia | Ascorbic Acid | 11.66 | 14606601 | |
| MESH:D011657 | Pulmonary Eosinophilia | Toluene 2,4-Diisocyanate | 11.66 | 14606601 | |
| MESH:D011658 | Pulmonary Fibrosis | Asbestos, Amosite | 19.90 | 12475806 | |
| MESH:D011658 | Pulmonary Fibrosis | Asbestos, Crocidolite | 19.90 | 17365031 17975199 17322281 15814490 | |
| MESH:D011658 | Pulmonary Fibrosis | Asbestos, Serpentine | 19.90 | 18569384 15511213 | |
| MESH:D011658 | Pulmonary Fibrosis | Cyclophosphamide | 19.90 | 16636934 | |
| MESH:D011658 | Pulmonary Fibrosis | Drugs, Chinese Herbal | 19.90 | 16987627 | |
| MESH:D011658 | Pulmonary Fibrosis | gefitinib | 19.90 | 18424623 | |
| MESH:D011658 | Pulmonary Fibrosis | Mustard Gas | 19.90 | 17620002 17894541 17720292 17266442 10334151 | |
| MESH:D011658 | Pulmonary Fibrosis | Paraquat | 19.90 | 17997886 16324872 | |
| MESH:D011658 | Pulmonary Fibrosis | Particulate Matter | 19.90 | 12475806 | |
| MESH:D011658 | Pulmonary Fibrosis | troglitazone | 19.90 | 18162602 | |
| MESH:D011658 | Pulmonary Fibrosis | valsartan | 19.90 | 17241526 | |
| MESH:D011693 | Purpura | Raloxifene | 3.82 | 15770314 | |
| MESH:D011833 | Radiation Injuries, Experimental | mangiferin | 4.67 | 15830843 | |
| MESH:D011928 | Raynaud Disease | Iloprost | 4.91 | 16363279 | |
| MESH:D012003 | Rectal Fistula | Drugs, Chinese Herbal | 4.24 | 15043669 | |
| MESH:D012021 | Reflex, Abnormal | Pentobarbital | 4.32 | 10930210 | |
| MESH:D051437 | Renal Insufficiency | Acrolein | 18.87 | 12732208 | |
| MESH:D051437 | Renal Insufficiency | Cisplatin | 18.87 | 15464296 | |
| MESH:D051437 | Renal Insufficiency | Doxorubicin | 18.87 | 17922066 | |
| MESH:D051437 | Renal Insufficiency | Folic Acid | 18.87 | 15728788 | |
| MESH:D051437 | Renal Insufficiency | Gentamicins | 18.87 | 15728788 17132701 | |
| MESH:D051437 | Renal Insufficiency | Losartan | 18.87 | 15728788 | |
| MESH:D051436 | Renal Insufficiency, Chronic | resveratrol | 3.85 | 16325855 | |
| MESH:D015427 | Reperfusion Injury | Capsaicin | 8.01 | 18460982 19211983 | |
| MESH:D015427 | Reperfusion Injury | pirinixic acid | 8.01 | 19058328 | |
| MESH:D015427 | Reperfusion Injury | resveratrol | 8.01 | 17058453 16314181 16317513 17520802 15827377 | |
| MESH:D015427 | Reperfusion Injury | Superoxides | 8.01 | 18460982 | |
| MESH:D015427 | Reperfusion Injury | zileuton | 8.01 | 15266012 9865762 | |
| MESH:D012120 | Respiration Disorders | Chlorine | 3.50 | 18579056 | |
| MESH:D012128 | Respiratory Distress Syndrome, Adult | 2-chloroethyl ethyl sulfide | 22.07 | 18257742 16292752 12210543 | |
| MESH:D012128 | Respiratory Distress Syndrome, Adult | Acetylcysteine | 22.07 | 12210543 | |
| MESH:D012128 | Respiratory Distress Syndrome, Adult | Curcumin | 22.07 | 18379247 10666014 | |
| MESH:D012128 | Respiratory Distress Syndrome, Adult | Dexamethasone | 22.07 | 11700416 18379247 | |
| MESH:D012128 | Respiratory Distress Syndrome, Adult | Oxygen | 22.07 | 17627322 18339021 | |
| MESH:D012128 | Respiratory Distress Syndrome, Adult | Paraquat | 22.07 | 11700416 | |
| MESH:D012128 | Respiratory Distress Syndrome, Adult | pyrrolidine dithiocarbamic acid | 22.07 | 16129981 | |
| MESH:D012128 | Respiratory Distress Syndrome, Adult | Terbutaline | 22.07 | 2878809 | |
| MESH:D012127 | Respiratory Distress Syndrome, Newborn | Vitamin A | 4.10 | 16877224 | |
| MESH:D012130 | Respiratory Hypersensitivity | Lipopolysaccharides | 4.13 | 10835634 | |
| MESH:D012130 | Respiratory Hypersensitivity | Toluene 2,4-Diisocyanate | 4.13 | 20219652 16940033 7692837 | |
| MESH:D012135 | Respiratory Sounds | Atrazine | 6.83 | 11874814 | |
| MESH:D012135 | Respiratory Sounds | Chlorpyrifos | 6.83 | 17119214 11874814 16611668 | |
| MESH:D012135 | Respiratory Sounds | Paraquat | 6.83 | 11874814 | |
| MESH:D015619 | Respiratory System Abnormalities | Tetrachlorodibenzodioxin | 2.19 | 18990726 | |
| MESH:D012140 | Respiratory Tract Diseases | Chlorpyrifos | 5.51 | 16611668 17119214 | |
| MESH:D012140 | Respiratory Tract Diseases | Toluene 2,4-Diisocyanate | 5.51 | 18447907 | |
| MESH:D012148 | Restless Legs Syndrome | Iron | 3.11 | 16930377 | |
| MESH:D012162 | Retinal Degeneration | 4,4'-diaminodiphenylmethane | 12.73 | 3692021 | |
| MESH:D012162 | Retinal Degeneration | Fenretinide | 12.73 | 16303925 | |
| MESH:D012162 | Retinal Degeneration | Methylnitrosourea | 12.73 | 18155124 18172121 | |
| MESH:D012162 | Retinal Degeneration | Paraquat | 12.73 | 16458197 | |
| MESH:D012162 | Retinal Degeneration | Zinc | 12.73 | 16584753 | |
| MESH:D012173 | Retinitis | Gentamicins | 4.54 | 18644591 | |
| MESH:D012174 | Retinitis Pigmentosa | alpha-Tocopherol | 3.89 | 16849425 | |
| MESH:D012174 | Retinitis Pigmentosa | Ascorbic Acid | 3.89 | 16849425 | |
| MESH:D012174 | Retinitis Pigmentosa | manganese(III)-tetrakis(4-benzoic acid)porphyrin | 3.89 | 16849425 | |
| MESH:D012175 | Retinoblastoma | Methylnitrosourea | 3.79 | 11555667 | |
| MESH:D012208 | Rhabdomyosarcoma | decitabine | 5.59 | 19155313 | |
| MESH:D012208 | Rhabdomyosarcoma | Tretinoin | 5.59 | 16116481 16283617 | |
| MESH:D012220 | Rhinitis | Acetaldehyde | 13.79 | 17050345 | |
| MESH:D012220 | Rhinitis | Aspirin | 13.79 | 12372130 | |
| MESH:D012220 | Rhinitis | Histamine | 13.79 | 12689652 | |
| MESH:D012220 | Rhinitis | montelukast | 13.79 | 20332717 | |
| MESH:D012220 | Rhinitis | Toluene 2,4-Diisocyanate | 13.79 | 19050374 | |
| MESH:D012220 | Rhinitis | zileuton | 13.79 | 20332717 | |
| MESH:D012221 | Rhinitis, Allergic, Perennial | Drugs, Chinese Herbal | 6.11 | 15015336 | |
| MESH:D012221 | Rhinitis, Allergic, Perennial | Toluene 2,4-Diisocyanate | 6.11 | 15015336 12617775 | |
| MESH:D006255 | Rhinitis, Allergic, Seasonal | Toluene 2,4-Diisocyanate | 3.81 | 19075512 | |
| MESH:D012468 | Salivary Gland Neoplasms | Progesterone | 2.00 | 18045962 | |
| MESH:D012509 | Sarcoma | Curcumin | 9.92 | 18462866 | |
| MESH:D012509 | Sarcoma | Dacarbazine | 9.92 | 17898927 18313854 | |
| MESH:D012509 | Sarcoma | Doxorubicin | 9.92 | 15675481 17710206 16767912 17203757 15625365 18313854 | |
| MESH:D012509 | Sarcoma | Polysaccharides | 9.92 | 18753065 | |
| MESH:D012512 | Sarcoma, Ewing's | arsenic trioxide | 19.53 | 16646077 | |
| MESH:D012512 | Sarcoma, Ewing's | Cisplatin | 19.53 | 14601052 | |
| MESH:D012512 | Sarcoma, Ewing's | Dactinomycin | 19.53 | 14601052 | |
| MESH:D012512 | Sarcoma, Ewing's | Doxorubicin | 19.53 | 16326096 14601052 | |
| MESH:D012512 | Sarcoma, Ewing's | roscovitine | 19.53 | 16230394 | |
| MESH:D012512 | Sarcoma, Ewing's | zoledronic acid | 19.53 | 16121404 | |
| MESH:D012514 | Sarcoma, Kaposi | Doxorubicin | 3.10 | 17846226 | |
| MESH:D012554 | Schistosomiasis japonica | Quercetin | 3.81 | 16862918 | |
| MESH:D012555 | Schistosomiasis mansoni | Nitric Oxide | 3.81 | 9673227 | |
| MESH:D012559 | Schizophrenia | Clozapine | 3.64 | 11151749 20107430 19369910 20521326 20168265 18855531 16141801 17726453 20521320 11763009 17667964 18806925 17123785 20452607 20580759 | |
| MESH:D012559 | Schizophrenia | Copper | 3.64 | 16842975 | |
| MESH:D012559 | Schizophrenia | Folic Acid | 3.64 | 16641680 | |
| MESH:D012559 | Schizophrenia | Haloperidol | 3.64 | 20107430 19369910 1830565 18513383 | |
| MESH:D012559 | Schizophrenia | Homocysteine | 3.64 | 16641680 | |
| MESH:D019873 | Schnitzler Syndrome | Thalidomide | 4.23 | 16096327 | |
| MESH:D012595 | Scleroderma, Systemic | Cyclophosphamide | 3.21 | 16636934 | |
| MESH:D012640 | Seizures | 2,4-dinitrotoluene | 21.04 | 18551238 | |
| MESH:D012640 | Seizures | 2,6-dinitrotoluene | 21.04 | 18551238 | |
| MESH:D012640 | Seizures | Endosulfan | 21.04 | 10698677 7539098 | |
| MESH:D012640 | Seizures | Ethanol | 21.04 | 9754883 | |
| MESH:D012640 | Seizures | ferric chloride | 21.04 | 12941455 | |
| MESH:D012640 | Seizures | Lindane | 21.04 | 7539098 15475178 12842176 | |
| MESH:D012640 | Seizures | Lithium | 21.04 | 19660546 | |
| MESH:D012640 | Seizures | Nicotine | 21.04 | 17873105 | |
| MESH:D012640 | Seizures | Pentobarbital | 21.04 | 9754883 10087439 | |
| MESH:D012640 | Seizures | Phenobarbital | 21.04 | 3137016 16876388 11442880 4039156 | |
| MESH:D012640 | Seizures | Phenytoin | 21.04 | 9844417 15946322 16876388 11044598 3691417 10029267 19919933 3137016 | |
| MESH:D012640 | Seizures | Secobarbital | 21.04 | 9806000 | |
| MESH:D012640 | Seizures | Thiamylal | 21.04 | 9046859 | |
| MESH:D003294 | Seizures, Febrile | Phenobarbital | 3.12 | 6407741 | |
| MESH:D018805 | Sepsis | marker/mechanism | 15489642 | ||
| MESH:D018805 | Sepsis | Curcumin | 7.16 | 18389075 | |
| MESH:D018805 | Sepsis | tetracycline CMT-3 | 7.16 | 16003065 15489642 | |
| MESH:D018805 | Sepsis | Zymosan | 7.16 | 11441115 | |
| MESH:D012729 | Sex Chromosome Aberrations | Chlorpyrifos | 4.36 | 6418539 | |
| MESH:D012735 | Sexual Dysfunction, Physiological | Testosterone | 4.47 | 16631401 | |
| MESH:D012772 | Shock, Septic | lipoteichoic acid | 8.74 | 19573522 | |
| MESH:D012772 | Shock, Septic | mangiferin | 8.74 | 15177305 | |
| MESH:D012772 | Shock, Septic | Terbutaline | 8.74 | 3431524 | |
| MESH:D012852 | Sinusitis | Phenylephrine | 6.00 | 7327846 | |
| MESH:D012852 | Sinusitis | zileuton | 6.00 | 10665187 | |
| MESH:D012851 | Sinus Thrombosis, Intracranial | Aspirin | 7.05 | 12269725 | |
| MESH:D012851 | Sinus Thrombosis, Intracranial | Heparin | 7.05 | 12269725 | |
| MESH:D012871 | Skin Diseases | Arsenic | 7.26 | 17050553 6392382 15952646 19834688 18709164 16702368 17548696 16759981 16353154 17453740 17938729 | |
| MESH:D012871 | Skin Diseases | Ascorbic Acid | 7.26 | 18709164 | |
| MESH:D012871 | Skin Diseases | Folic Acid | 7.26 | 18709164 | |
| MESH:D012871 | Skin Diseases | Mustard Gas | 7.26 | 16961503 15451306 12880345 | |
| MESH:D012871 | Skin Diseases | Vitamin A | 7.26 | 18709164 | |
| MESH:D012871 | Skin Diseases | Vitamin E | 7.26 | 18709164 | |
| MESH:D012878 | Skin Neoplasms | Arsenic | 36.05 | 17976673 15504454 17029826 17050553 19538983 16251483 | |
| MESH:D012878 | Skin Neoplasms | Benzo(a)pyrene | 36.05 | 19755658 10029692 | |
| MESH:D012878 | Skin Neoplasms | Doxorubicin | 36.05 | 15692506 | |
| MESH:D012878 | Skin Neoplasms | Fenretinide | 36.05 | 16467112 | |
| MESH:D012878 | Skin Neoplasms | Glucose | 36.05 | 14993021 | |
| MESH:D012878 | Skin Neoplasms | Hydrogen Peroxide | 36.05 | 12065085 | |
| MESH:D012878 | Skin Neoplasms | Iron | 36.05 | 12065085 | |
| MESH:D012878 | Skin Neoplasms | Melphalan | 36.05 | 14993021 | |
| MESH:D012878 | Skin Neoplasms | Okadaic Acid | 36.05 | 12628509 | |
| MESH:D012878 | Skin Neoplasms | Plant Extracts | 36.05 | 16517061 15173996 | |
| MESH:D012878 | Skin Neoplasms | resveratrol | 36.05 | 15837718 8985016 | |
| MESH:D012878 | Skin Neoplasms | sodium arsenite | 36.05 | 18572023 19524636 | |
| MESH:D012878 | Skin Neoplasms | tert-Butylhydroperoxide | 36.05 | 8532709 | |
| MESH:D012878 | Skin Neoplasms | Tetrachlorodibenzodioxin | 36.05 | 16192470 | |
| MESH:D012878 | Skin Neoplasms | Tetradecanoylphorbol Acetate | 36.05 | 11807781 8330346 8985016 18404319 12065085 | |
| MESH:D012878 | Skin Neoplasms | Tretinoin | 36.05 | 16467112 | |
| MESH:D012878 | Skin Neoplasms | Urethane | 36.05 | 11807781 | |
| MESH:D020181 | Sleep Apnea, Obstructive | montelukast | 7.62 | 19118273 | |
| MESH:D020181 | Sleep Apnea, Obstructive | zileuton | 7.62 | 19118273 | |
| MESH:D055752 | Small Cell Lung Carcinoma | Cisplatin | 3.62 | 15464296 | |
| MESH:D012912 | Sneezing | Toluene 2,4-Diisocyanate | 3.81 | 19075512 19050374 | |
| MESH:D012983 | Soft Tissue Neoplasms | Doxorubicin | 2.91 | 17203757 16767912 15625365 | |
| MESH:D013088 | Spermatocele | Diethylstilbestrol | 10.32 | 16709447 16002989 | |
| MESH:D013088 | Spermatocele | Ethinyl Estradiol | 10.32 | 16709447 | |
| MESH:D013088 | Spermatocele | Tamoxifen | 10.32 | 16709447 | |
| OMIM:102530 | SPERMATOGENIC FAILURE 6 | Cyclophosphamide | 3.81 | 16517039 | |
| MESH:D013118 | Spinal Cord Diseases | Folic Acid | 3.79 | 16361298 | |
| MESH:D013119 | Spinal Cord Injuries | montelukast | 12.96 | 18059327 | |
| MESH:D013119 | Spinal Cord Injuries | Progesterone | 12.96 | 16503802 15862959 | |
| MESH:D013119 | Spinal Cord Injuries | Tamoxifen | 12.96 | 19457130 | |
| MESH:D013119 | Spinal Cord Injuries | zileuton | 12.96 | 18059327 | |
| MESH:D016135 | Spinal Dysraphism | sodium arsenite | 2.34 | 12854658 | |
| MESH:D013158 | Splenic Diseases | aniline | 7.94 | 15694462 | |
| MESH:D013158 | Splenic Diseases | Dimethylnitrosamine | 7.94 | 12587719 | |
| MESH:D013226 | Status Epilepticus | Lithium | 4.08 | 19570321 19430551 19951488 | |
| MESH:D019956 | Stereotypic Movement Disorder | Amphetamine | 4.69 | 1977408 | |
| MESH:D013262 | Stevens-Johnson Syndrome | Phenytoin | 3.51 | 20235791 | |
| MESH:D013272 | Stomach Diseases | beta Carotene | 10.82 | 17638125 | |
| MESH:D013272 | Stomach Diseases | Dexamethasone | 10.82 | 15472012 | |
| MESH:D013272 | Stomach Diseases | Indomethacin | 10.82 | 16280098 17207306 16184426 17160473 18209964 10486359 10192188 18545984 16113693 15038085 10215738 17638125 15472012 | |
| MESH:D013272 | Stomach Diseases | phosphoramidon | 10.82 | 16280098 | |
| MESH:D013274 | Stomach Neoplasms | arsenic trioxide | 20.42 | 17007042 | |
| MESH:D013274 | Stomach Neoplasms | Benzo(a)pyrene | 20.42 | 20155912 2093021 | |
| MESH:D013274 | Stomach Neoplasms | Butylated Hydroxyanisole | 20.42 | 3581430 1399818 | |
| MESH:D013274 | Stomach Neoplasms | Cisplatin | 20.42 | 18396642 15958060 17522103 | |
| MESH:D013274 | Stomach Neoplasms | decitabine | 20.42 | 19037991 | |
| MESH:D013274 | Stomach Neoplasms | Diethylnitrosamine | 20.42 | 18456281 | |
| MESH:D013274 | Stomach Neoplasms | Dimethylnitrosamine | 20.42 | 16033868 | |
| MESH:D013274 | Stomach Neoplasms | docetaxel | 20.42 | 16557585 | |
| MESH:D013274 | Stomach Neoplasms | Docosahexaenoic Acids | 20.42 | 19015929 | |
| MESH:D013274 | Stomach Neoplasms | Drugs, Chinese Herbal | 20.42 | 18339527 | |
| MESH:D013274 | Stomach Neoplasms | Ethanol | 20.42 | 18456281 | |
| MESH:D013274 | Stomach Neoplasms | Folic Acid | 20.42 | 17171786 | |
| MESH:D013274 | Stomach Neoplasms | imatinib | 20.42 | 15786421 | |
| MESH:D013274 | Stomach Neoplasms | Indomethacin | 20.42 | 15609394 | |
| MESH:D013274 | Stomach Neoplasms | Methylnitrosourea | 20.42 | 16257854 15930296 18593901 | |
| MESH:D013274 | Stomach Neoplasms | nitrosobenzylmethylamine | 20.42 | 17575124 12958204 | |
| MESH:D013274 | Stomach Neoplasms | Paclitaxel | 20.42 | 18396642 18506536 | |
| MESH:D013274 | Stomach Neoplasms | Sodium Chloride | 20.42 | 16646055 | |
| MESH:D013274 | Stomach Neoplasms | Tretinoin | 20.42 | 17261132 | |
| MESH:D013274 | Stomach Neoplasms | troglitazone | 20.42 | 15930296 | |
| MESH:D013276 | Stomach Ulcer | 2-ethoxyethanol | 39.90 | 6499799 | |
| MESH:D013276 | Stomach Ulcer | Acetic Acid | 39.90 | 19188055 | |
| MESH:D013276 | Stomach Ulcer | Acetylcysteine | 39.90 | 17918041 | |
| MESH:D013276 | Stomach Ulcer | Ascorbic Acid | 39.90 | 18726076 | |
| MESH:D013276 | Stomach Ulcer | beta Carotene | 39.90 | 12500499 | |
| MESH:D013276 | Stomach Ulcer | bis(4-hydroxycinnamoyl)methane | 39.90 | 19188055 | |
| MESH:D013276 | Stomach Ulcer | Curcumin | 39.90 | 16631530 19188055 | |
| MESH:D013276 | Stomach Ulcer | Dexamethasone | 39.90 | 15138204 | |
| MESH:D013276 | Stomach Ulcer | Ethanol | 39.90 | 9211565 16755016 11906479 17189318 17918041 9562338 | |
| MESH:D013276 | Stomach Ulcer | Indomethacin | 39.90 | 17654042 18299717 15138204 11595431 10423059 11523592 11906479 17627676 1323529 11145282 16150113 16169175 16397915 17657623 10750652 16252198 18726076 12467913 16631530 12498302 17895592 11595415 15104355 18431645 10878458 18237397 17977527 18087811 17918041 16934674 12077510 18181030 17135157 12500499 18543354 14567935 12787963 18209962 18193104 15255614 16755016 11729361 | |
| MESH:D013276 | Stomach Ulcer | mangiferin | 39.90 | 17918041 | |
| MESH:D013276 | Stomach Ulcer | montelukast | 39.90 | 17895592 | |
| MESH:D013276 | Stomach Ulcer | Nitric Oxide | 39.90 | 15138204 | |
| MESH:D013276 | Stomach Ulcer | phosphoramidon | 39.90 | 11145282 | |
| MESH:D013276 | Stomach Ulcer | pimagedine | 39.90 | 18209962 | |
| MESH:D013276 | Stomach Ulcer | Plant Extracts | 39.90 | 17135157 15255614 18193104 18237397 12787963 | |
| MESH:D013276 | Stomach Ulcer | Thalidomide | 39.90 | 15138204 | |
| MESH:D020521 | Stroke | Acrolein | 14.55 | 16269634 | |
| MESH:D020521 | Stroke | Ascorbic Acid | 14.55 | 16517955 16403987 | |
| MESH:D020521 | Stroke | Aspirin | 14.55 | 16403987 | |
| MESH:D020521 | Stroke | Folic Acid | 14.55 | 16517955 | |
| MESH:D020521 | Stroke | Raloxifene | 14.55 | 16837676 | |
| MESH:D020521 | Stroke | Vitamin E | 14.55 | 16517955 | |
| OMIM:601367 | STROKE, ISCHEMIC | resveratrol | 2.92 | 16321402 | |
| MESH:D013345 | Subarachnoid Hemorrhage | Drugs, Chinese Herbal | 7.99 | 17634840 | |
| MESH:D013345 | Subarachnoid Hemorrhage | pifithrin | 7.99 | 18364113 | |
| MESH:D019966 | Substance-Related Disorders | bisphenol A | 2.37 | 16684133 16045194 | |
| MESH:D013375 | Substance Withdrawal Syndrome | Ethanol | 5.11 | 9754883 | |
| MESH:D013375 | Substance Withdrawal Syndrome | Pentobarbital | 5.11 | 11529278 9754883 | |
| MESH:D013398 | Sudden Infant Death | Iron | 7.69 | 16640825 | |
| MESH:D013398 | Sudden Infant Death | Oxygen | 7.69 | 12563064 | |
| MESH:D015173 | Supratentorial Neoplasms | Cyclophosphamide | 3.37 | 12837982 | |
| MESH:D013576 | Syndactyly | methoxyacetic acid | 3.99 | 1761404 1761407 | |
| MESH:D013610 | Tachycardia | Nitroprusside | 9.01 | 15306635 | |
| MESH:D013610 | Tachycardia | Norepinephrine | 9.01 | 3261545 | |
| MESH:D013610 | Tachycardia | Terbutaline | 9.01 | 10895896 | |
| MESH:D017180 | Tachycardia, Ventricular | Haloperidol | 3.11 | 20210726 | |
| MESH:D024801 | Tauopathies | Paclitaxel | 3.14 | 16930453 | |
| MESH:D013705 | Temporomandibular Joint Disorders | Capsaicin | 12.81 | 17997062 | |
| MESH:D013705 | Temporomandibular Joint Disorders | Plant Extracts | 12.81 | 17997062 | |
| MESH:D013705 | Temporomandibular Joint Disorders | polyphenols | 12.81 | 17997062 | |
| MESH:D013733 | Testicular Diseases | 2-ethoxyethanol | 8.08 | 10048760 6499806 10514026 | |
| MESH:D013733 | Testicular Diseases | methoxyacetic acid | 8.08 | 6499806 18486176 | |
| MESH:D013733 | Testicular Diseases | methyl cellosolve | 8.08 | 6499806 | |
| MESH:D013736 | Testicular Neoplasms | Cisplatin | 3.02 | 17225452 15464296 | |
| MESH:D013742 | Tetanus | Propofol | 4.71 | 2903605 | |
| MESH:D013921 | Thrombocytopenia | Heparin | 7.54 | 16893407 16651880 | |
| MESH:D013921 | Thrombocytopenia | Lipopolysaccharides | 7.54 | 15821434 | |
| MESH:D013921 | Thrombocytopenia | vorinostat | 7.54 | 20479100 | |
| MESH:D019851 | Thrombophilia | Ethinyl Estradiol | 2.02 | 11994571 | |
| MESH:D013927 | Thrombosis | Aspirin | 6.68 | 17672075 | |
| MESH:D013927 | Thrombosis | Ethinyl Estradiol | 6.68 | 15669648 | |
| MESH:D013927 | Thrombosis | Heparin | 6.68 | 16893407 | |
| MESH:D013953 | Thymus Neoplasms | Methylnitrosourea | 3.55 | 11418001 | |
| MESH:D013959 | Thyroid Diseases | Tetrachlorodibenzodioxin | 6.70 | 12697716 | |
| MESH:D013959 | Thyroid Diseases | Thyroxine | 6.70 | 19910387 | |
| MESH:D018382 | Thyroid Hormone Resistance Syndrome | Atenolol | 4.71 | 9349583 | |
| MESH:D013964 | Thyroid Neoplasms | 2-(2-chloro-4-iodophenylamino)-N-cyclopropylmethoxy-3,4-difluorobenzamide | 36.61 | 16940797 | |
| MESH:D013964 | Thyroid Neoplasms | 4,4'-diaminodiphenylmethane | 36.61 | 6582329 1399818 7505956 6587162 3712494 | |
| MESH:D013964 | Thyroid Neoplasms | 4-amino-5-(4-methylphenyl)-7-(tert-butyl)pyrazolo(3,4-d)pyrimidine | 36.61 | 16940797 | |
| MESH:D013964 | Thyroid Neoplasms | arsenic trioxide | 36.61 | 19014326 | |
| MESH:D013964 | Thyroid Neoplasms | Butyrates | 36.61 | 17967635 | |
| MESH:D013964 | Thyroid Neoplasms | Dacarbazine | 36.61 | 15634649 11815960 | |
| MESH:D013964 | Thyroid Neoplasms | decitabine | 36.61 | 17967635 | |
| MESH:D013964 | Thyroid Neoplasms | Diethylnitrosamine | 36.61 | 7505956 | |
| MESH:D013964 | Thyroid Neoplasms | Doxorubicin | 36.61 | 16010429 17909728 | |
| MESH:D013964 | Thyroid Neoplasms | gefitinib | 36.61 | 16940797 | |
| MESH:D013964 | Thyroid Neoplasms | imatinib | 36.61 | 16940797 | |
| MESH:D013964 | Thyroid Neoplasms | Indomethacin | 36.61 | 14736730 11352223 18791128 | |
| MESH:D013964 | Thyroid Neoplasms | Methylnitrosourea | 36.61 | 7505956 3078959 | |
| MESH:D013964 | Thyroid Neoplasms | Phenobarbital | 36.61 | 1399818 | |
| MESH:D013964 | Thyroid Neoplasms | Tretinoin | 36.61 | 16026305 17045167 | |
| MESH:D013978 | Tibial Fractures | Estradiol | 8.01 | 19048282 | |
| MESH:D013978 | Tibial Fractures | Raloxifene | 8.01 | 19048282 | |
| OMIM:188890 | TOBACCO ADDICTION, SUSCEPTIBILITY TO | Nicotine | 3.32 | 16785264 16720336 11259349 | |
| MESH:D014029 | Tobacco Use Disorder | Nicotine | 3.78 | 15735609 18305452 18041664 17979512 | |
| MESH:D014062 | Tongue Neoplasms | Acitretin | 11.07 | 16196285 | |
| MESH:D014062 | Tongue Neoplasms | resveratrol | 11.07 | 16227395 | |
| MESH:D014062 | Tongue Neoplasms | Tretinoin | 11.07 | 16051514 | |
| MESH:D014062 | Tongue Neoplasms | Zinc | 11.07 | 16543248 | |
| MESH:D016171 | Torsades de Pointes | arsenic trioxide | 5.16 | 15213294 | |
| MESH:D016171 | Torsades de Pointes | Dobutamine | 5.16 | 19353679 | |
| MESH:D014202 | Tremor | Lead | 3.82 | 21145352 | |
| MESH:D014235 | Trichinellosis | mangiferin | 4.34 | 14669257 | |
| MESH:D014376 | Tuberculosis | Iron | 3.80 | 16597321 | |
| MESH:D014376 | Tuberculosis | Tretinoin | 3.80 | 16040207 | |
| MESH:D014456 | Ulcer | Indomethacin | 3.21 | 17380554 10574470 | |
| MESH:D001749 | Urinary Bladder Neoplasms | 2,4-dinitrotoluene | 34.16 | 16049721 | |
| MESH:D001749 | Urinary Bladder Neoplasms | 2,6-dinitrotoluene | 34.16 | 16049721 | |
| MESH:D001749 | Urinary Bladder Neoplasms | 4,4'-diaminodiphenylmethane | 34.16 | 8074119 | |
| MESH:D001749 | Urinary Bladder Neoplasms | Arsenic | 34.16 | 19322015 19429237 17306315 18640142 11144890 15987713 17976673 | |
| MESH:D001749 | Urinary Bladder Neoplasms | arsenic trioxide | 34.16 | 20435036 11780464 12973940 12845720 | |
| MESH:D001749 | Urinary Bladder Neoplasms | Benzo(a)pyrene | 34.16 | 17053015 | |
| MESH:D001749 | Urinary Bladder Neoplasms | Butylated Hydroxyanisole | 34.16 | 1399818 | |
| MESH:D001749 | Urinary Bladder Neoplasms | Cisplatin | 34.16 | 12973940 15464296 17225452 | |
| MESH:D001749 | Urinary Bladder Neoplasms | Curcumin | 34.16 | 18593936 | |
| MESH:D001749 | Urinary Bladder Neoplasms | Cyclophosphamide | 34.16 | 14692829 | |
| MESH:D001749 | Urinary Bladder Neoplasms | decitabine | 34.16 | 17616700 19087683 | |
| MESH:D001749 | Urinary Bladder Neoplasms | Diethylstilbestrol | 34.16 | 17306315 16452187 16712894 | |
| MESH:D001749 | Urinary Bladder Neoplasms | Doxorubicin | 34.16 | 17653716 | |
| MESH:D001749 | Urinary Bladder Neoplasms | Fenretinide | 34.16 | 16720286 | |
| MESH:D001749 | Urinary Bladder Neoplasms | Quercetin | 34.16 | 16720314 | |
| MESH:D001749 | Urinary Bladder Neoplasms | Raloxifene | 34.16 | 17572228 | |
| MESH:D001749 | Urinary Bladder Neoplasms | sodium arsenite | 34.16 | 17306315 11723127 16712894 16452187 | |
| MESH:D001749 | Urinary Bladder Neoplasms | Tamoxifen | 34.16 | 8653321 16712894 17572228 | |
| MESH:D014565 | Urogenital Neoplasms | Curcumin | 3.56 | 18462866 | |
| MESH:D014570 | Urologic Diseases | DDT | 7.05 | 16487989 | |
| MESH:D014570 | Urologic Diseases | Dichlorodiphenyl Dichloroethylene | 7.05 | 16487989 | |
| MESH:D014571 | Urologic Neoplasms | 2,4-dinitrotoluene | 6.38 | 10091137 | |
| MESH:D014571 | Urologic Neoplasms | 2,6-dinitrotoluene | 6.38 | 10091137 | |
| MESH:D014581 | Urticaria | Acetaminophen | 11.03 | 10982225 | |
| MESH:D014581 | Urticaria | Aspirin | 11.03 | 20485159 10982225 | |
| MESH:D014581 | Urticaria | Histamine | 11.03 | 18298128 | |
| MESH:D014581 | Urticaria | montelukast | 11.03 | 10982225 | |
| MESH:D014581 | Urticaria | salmeterol | 11.03 | 10982225 | |
| MESH:D002583 | Uterine Cervical Neoplasms | Cisplatin | 17.16 | 16803524 | |
| MESH:D002583 | Uterine Cervical Neoplasms | Diethylstilbestrol | 17.16 | 16175088 | |
| MESH:D002583 | Uterine Cervical Neoplasms | Fenretinide | 17.16 | 16154183 | |
| MESH:D002583 | Uterine Cervical Neoplasms | resveratrol | 17.16 | 17473185 | |
| MESH:D002583 | Uterine Cervical Neoplasms | sodium arsenite | 17.16 | 11813266 | |
| MESH:D002583 | Uterine Cervical Neoplasms | Tretinoin | 17.16 | 16129372 | |
| MESH:D014591 | Uterine Diseases | bisphenol A | 8.12 | 14652134 | |
| MESH:D014591 | Uterine Diseases | Diethylstilbestrol | 8.12 | 14652134 | |
| MESH:D014594 | Uterine Neoplasms | Diethylstilbestrol | 9.79 | 15809267 16690809 | |
| MESH:D014594 | Uterine Neoplasms | Ethinyl Estradiol | 9.79 | 14692618 | |
| MESH:D014594 | Uterine Neoplasms | resveratrol | 9.79 | 17044934 | |
| MESH:D014594 | Uterine Neoplasms | sulindac sulfide | 9.79 | 18645019 | |
| MESH:D014604 | Uveal Neoplasms | decitabine | 7.14 | 17785578 | |
| MESH:D014604 | Uveal Neoplasms | Tretinoin | 7.14 | 16752155 | |
| MESH:D014605 | Uveitis | Cyclosporine | 10.49 | 1336536 | |
| MESH:D014605 | Uveitis | Dexamethasone | 10.49 | 1336536 | |
| MESH:D014605 | Uveitis | Zymosan | 10.49 | 11006244 | |
| MESH:D014625 | Vaginal Neoplasms | Cisplatin | 9.11 | 15577323 | |
| MESH:D014625 | Vaginal Neoplasms | Dacarbazine | 9.11 | 15577323 | |
| MESH:D014625 | Vaginal Neoplasms | Diethylstilbestrol | 9.11 | 16513791 16002989 | |
| MESH:D014652 | Vascular Diseases | Arsenic | 10.55 | 17056641 | |
| MESH:D014652 | Vascular Diseases | sodium arsenite | 10.55 | 17056641 | |
| MESH:D014652 | Vascular Diseases | Thalidomide | 10.55 | 15741222 | |
| MESH:D054079 | Vascular Malformations | Tetrachlorodibenzodioxin | 2.86 | 12125929 | |
| MESH:D019043 | Vascular Neoplasms | Urethane | 4.19 | 10620525 | |
| MESH:D014657 | Vasculitis | Heparin | 4.39 | 20337814 | |
| MESH:D020301 | Vasospasm, Intracranial | Nicardipine | 9.93 | 19057314 | |
| MESH:D020301 | Vasospasm, Intracranial | Nitric Oxide Donors | 9.93 | 19057314 | |
| MESH:D020301 | Vasospasm, Intracranial | pifithrin | 9.93 | 18364113 | |
| MESH:D054556 | Venous Thromboembolism | Raloxifene | 3.48 | 16837676 | |
| MESH:D020246 | Venous Thrombosis | Ethinyl Estradiol | 1.97 | 14671159 15869587 | |
| MESH:D018487 | Ventricular Dysfunction, Left | Doxorubicin | 11.09 | 17678736 17638931 17334414 16364871 | |
| MESH:D018487 | Ventricular Dysfunction, Left | Isoproterenol | 11.09 | 18097624 | |
| MESH:D018487 | Ventricular Dysfunction, Left | Plant Extracts | 11.09 | 18097624 | |
| MESH:D018487 | Ventricular Dysfunction, Left | resveratrol | 11.09 | 17488730 | |
| MESH:D020257 | Ventricular Remodeling | Isoproterenol | 11.63 | 18097624 | |
| MESH:D020257 | Ventricular Remodeling | Plant Extracts | 11.63 | 18097624 | |
| MESH:D020257 | Ventricular Remodeling | valsartan | 11.63 | 19027736 | |
| MESH:D015837 | Vestibular Diseases | Gentamicins | 3.87 | 18776599 | |
| MESH:D014802 | Vitamin A Deficiency | Vitamin A | 3.66 | 16175781 16960172 16146918 | |
| MESH:D014820 | Vitiligo | Tretinoin | 2.43 | 16761959 | |
| MESH:D014839 | Vomiting | Cisplatin | 5.89 | 11897121 | |
| MESH:D014839 | Vomiting | Indomethacin | 5.89 | 11897121 | |
| MESH:D014846 | Vulvar Neoplasms | Raloxifene | 3.82 | 16343187 | |
| MESH:D019282 | Wasting Syndrome | Tetrachlorodibenzodioxin | 2.52 | 15886252 | |
| MESH:D015430 | Weight Gain | Clozapine | 4.74 | 20521320 17502770 16141801 20107430 16402076 20564506 | |
| MESH:D015430 | Weight Gain | Dietary Fats | 4.74 | 16723640 | |
| MESH:D015431 | Weight Loss | Clozapine | 3.39 | 17933447 | |
| MESH:D009396 | Wilms Tumor | Tretinoin | 2.43 | 16287080 | |
| MESH:D014947 | Wounds and Injuries | Drugs, Chinese Herbal | 8.22 | 16313111 | |
| MESH:D014947 | Wounds and Injuries | lysophosphatidic acid | 8.22 | 15541073 | |
| MESH:D014947 | Wounds and Injuries | Plant Extracts | 8.22 | 19894650 20213670 | |
| MESH:D014947 | Wounds and Injuries | sphingosine 1-phosphate | 8.22 | 15541073 | |
| MESH:D014985 | Xerophthalmia | Cyclosporine | 2.72 | 17120751 |
| Pathway ID | Pathway Name |
|---|---|
| KEGG:05221 | Acute myeloid leukemia |
| KEGG:04520 | Adherens junction |
| KEGG:04960 | Aldosterone-regulated sodium reabsorption |
| KEGG:05010 | Alzheimer's disease |
| REACT:18266 | Axon guidance |
| KEGG:04360 | Axon guidance |
| KEGG:04662 | B cell receptor signaling pathway |
| KEGG:05219 | Bladder cancer |
| KEGG:05142 | Chagas disease (American trypanosomiasis) |
| KEGG:04062 | Chemokine signaling pathway |
| KEGG:05220 | Chronic myeloid leukemia |
| KEGG:05210 | Colorectal cancer |
| KEGG:04320 | Dorso-ventral axis formation |
| KEGG:05213 | Endometrial cancer |
| KEGG:04012 | ErbB signaling pathway |
| KEGG:04664 | Fc epsilon RI signaling pathway |
| KEGG:04666 | Fc gamma R-mediated phagocytosis |
| KEGG:04510 | Focal adhesion |
| KEGG:04540 | Gap junction |
| KEGG:05214 | Glioma |
| KEGG:04724 | Glutamatergic synapse |
| KEGG:04912 | GnRH signaling pathway |
| REACT:604 | Hemostasis |
| KEGG:05160 | Hepatitis C |
| REACT:25035 | Innate immune response mediated by toll like receptors |
| KEGG:04910 | Insulin signaling pathway |
| KEGG:05140 | Leishmaniasis |
| KEGG:04730 | Long-term depression |
| KEGG:04720 | Long-term potentiation |
| KEGG:04010 | MAPK signaling pathway |
| KEGG:04916 | Melanogenesis |
| KEGG:05218 | Melanoma |
| KEGG:04150 | mTOR signaling pathway |
| KEGG:04650 | Natural killer cell mediated cytotoxicity |
| KEGG:04722 | Neurotrophin signaling pathway |
| KEGG:04621 | NOD-like receptor signaling pathway |
| KEGG:05223 | Non-small cell lung cancer |
| KEGG:04114 | Oocyte meiosis |
| REACT:15295 | Opioid Signalling |
| KEGG:04380 | Osteoclast differentiation |
| KEGG:05212 | Pancreatic cancer |
| KEGG:05200 | Pathways in cancer |
| KEGG:05020 | Prion diseases |
| KEGG:04914 | Progesterone-mediated oocyte maturation |
| KEGG:05215 | Prostate cancer |
| KEGG:04810 | Regulation of actin cytoskeleton |
| KEGG:05211 | Renal cell carcinoma |
| KEGG:05131 | Shigellosis |
| REACT:9417 | Signaling by EGFR |
| REACT:498 | Signaling by Insulin receptor |
| REACT:32280 | Signaling by PDGF |
| REACT:16888 | Signaling by PDGF |
| REACT:6900 | Signaling in Immune system |
| REACT:11061 | Signalling by NGF |
| REACT:13685 | Synaptic Transmission |
| KEGG:04660 | T cell receptor signaling pathway |
| KEGG:04350 | TGF-beta signaling pathway |
| KEGG:05216 | Thyroid cancer |
| KEGG:04620 | Toll-like receptor signaling pathway |
| KEGG:05145 | Toxoplasmosis |
| KEGG:05152 | Tuberculosis |
| KEGG:04930 | Type II diabetes mellitus |
| KEGG:04270 | Vascular smooth muscle contraction |
| KEGG:04370 | VEGF signaling pathway |
| Releated gene ID | Related gene Name |
|---|---|
| PA293 | PTGS2 |
| PA44 | AGTR2 |
| Releated disease ID | Related disease Name |
|---|---|
| PA444985 | Multiple Myeloma |
| PA443450 | Asthma |
| PA445062 | Neoplasms |
| Releated drug ID | Related drug Name |
|---|---|
| PA448497 | aspirin |
| PA449092 | colchicine |
| PA449396 | dopamine |
| PA451578 | tacrolimus |
| PA449780 | glutathione |
| PA164743471 | adenosine triphosphate |
| PA451123 | progesterone |
| PA450631 | nifedipine |
| PA451365 | sirolimus |
| PA448948 | chloroquine |
| PA164712535 | Beta Blocking Agents |
| PA450121 | isoproterenol |
| PA7000 | sorafenib |
| PA448976 | choline |
| PA448478 | l-arginine |
| PA450635 | nitric oxide |
| Drugbank ID | Action | Drug Name | Description |
|---|---|---|---|
| DB01064 | agonist | Isoproterenol | Sympathomimetics;Bronchodilator Agents;Adrenergic beta-Agonists;Cardiotonic Agents;Sympathomimetic |
| DB01169 | agonist | Arsenic trioxide | Antineoplastic Agents;Homeopathic Agents |
| DB02116 | - | Olomoucine | Enzyme Inhibitors |
| DB02482 | - | Phosphonothreonine | Indicators and Reagents |
| DB02733 | inhibitor | Purvalanol | |
| DB04338 | - | SB220025 | |
| DB06877 | - | N,N-DIMETHYL-4-(4-PHENYL-1H-PYRAZOL-3-YL)-1H-PYRROLE-2-CARBOXAMIDE | |
| DB07010 | - | N-BENZYL-4-[4-(3-CHLOROPHENYL)-1H-PYRAZOL-3-YL]-1H-PYRROLE-2-CARBOXAMIDE | |
| DB07264 | - | (S)-N-(1-(3-CHLORO-4-FLUOROPHENYL)-2-HYDROXYETHYL)-4-(4-(3-CHLOROPHENYL)-1H-PYRAZOL-3-YL)-1H-PYRROLE-2-CARBOXAMIDE | |
| DB07788 | - | (3R,5Z,8S,9S,11E)-8,9,16-TRIHYDROXY-14-METHOXY-3-METHYL-3,4,9,10-TETRAHYDRO-1H-2-BENZOXACYCLOTETRADECINE-1,7(8H)-DIONE | |
| DB07794 | - | 5-(2-PHENYLPYRAZOLO[1,5-A]PYRIDIN-3-YL)-1H-PYRAZOLO[3,4-C]PYRIDAZIN-3-AMINE | |
| DB07905 | - | (1aR,8S,13S,14S,15aR)-5,13,14-trihydroxy-3-methoxy-8-methyl-8,9,13,14,15,15a-hexahydro-6H-oxireno[k][2]benzoxacyclotetradecine-6,12(1aH)-dione | |
| DB08513 | - | [4-({5-(AMINOCARBONYL)-4-[(3-METHYLPHENYL)AMINO]PYRIMIDIN-2-YL}AMINO)PHENYL]ACETIC ACID | |
| DB08521 | - | 4-[5-(4-FLUORO-PHENYL)-2-(4-METHANESULFINYL-PHENYL)-3H-IMIDAZOL-4-YL]-PYRIDINE |
| No data |
| No data |
| No data |